CA2391491A1 - Very large scale immobilized peptide synthesis - Google Patents

Very large scale immobilized peptide synthesis Download PDF

Info

Publication number
CA2391491A1
CA2391491A1 CA 2391491 CA2391491A CA2391491A1 CA 2391491 A1 CA2391491 A1 CA 2391491A1 CA 2391491 CA2391491 CA 2391491 CA 2391491 A CA2391491 A CA 2391491A CA 2391491 A1 CA2391491 A1 CA 2391491A1
Authority
CA
Canada
Prior art keywords
substrate
light
different
nucleic acid
different nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2391491
Other languages
French (fr)
Inventor
J. Leighton Read
Stephen P. A. Fodor
Lubert Stryer
Michael C. Pirrung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affymetrix Inc
Original Assignee
Affymetrix, Inc.
J. Leighton Read
Stephen P. A. Fodor
Lubert Stryer
Michael C. Pirrung
Affymax N.V.
Affymax Technologies N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27001838&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2391491(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Affymetrix, Inc., J. Leighton Read, Stephen P. A. Fodor, Lubert Stryer, Michael C. Pirrung, Affymax N.V., Affymax Technologies N.V. filed Critical Affymetrix, Inc.
Publication of CA2391491A1 publication Critical patent/CA2391491A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L7/00Heating or cooling apparatus; Heat insulating devices
    • B01L7/52Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/14Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/042General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/045General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers using devices to improve synthesis, e.g. reactors, special vessels
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047Simultaneous synthesis of different peptide species; Peptide libraries
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/062General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha- or omega-carboxy functions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K17/00Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02Peptides being immobilised on, or in, an organic carrier
    • C07K17/06Peptides being immobilised on, or in, an organic carrier attached to the carrier via a bridging agent
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K17/00Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/14Peptides being immobilised on, or in, an inorganic carrier
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • C12Q1/6874Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B80/00Linkers or spacers specially adapted for combinatorial chemistry or libraries, e.g. traceless linkers or safety-catch linkers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/251Colorimeters; Construction thereof
    • G01N21/253Colorimeters; Construction thereof for batch operation, i.e. multisample apparatus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/645Specially adapted constructive features of fluorimeters
    • G01N21/6452Individual samples arranged in a regular 2D-array, e.g. multiwell plates
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/26Processing photosensitive materials; Apparatus therefor
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/26Processing photosensitive materials; Apparatus therefor
    • G03F7/265Selective reaction with inorganic or organometallic reagents after image-wise exposure, e.g. silylation
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/26Processing photosensitive materials; Apparatus therefor
    • G03F7/38Treatment before imagewise removal, e.g. prebaking
    • GPHYSICS
    • G11INFORMATION STORAGE
    • G11CSTATIC STORES
    • G11C13/00Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00
    • G11C13/0002Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00 using resistive RAM [RRAM] elements
    • G11C13/0009RRAM elements whose operation depends upon chemical change
    • G11C13/0014RRAM elements whose operation depends upon chemical change comprising cells based on organic memory material
    • GPHYSICS
    • G11INFORMATION STORAGE
    • G11CSTATIC STORES
    • G11C13/00Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00
    • G11C13/0002Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00 using resistive RAM [RRAM] elements
    • G11C13/0009RRAM elements whose operation depends upon chemical change
    • G11C13/0014RRAM elements whose operation depends upon chemical change comprising cells based on organic memory material
    • G11C13/0019RRAM elements whose operation depends upon chemical change comprising cells based on organic memory material comprising bio-molecules
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L25/00Assemblies consisting of a plurality of individual semiconductor or other solid state devices ; Multistep manufacturing processes thereof
    • H01L25/50Multistep manufacturing processes of assemblies consisting of devices, each device being of a type provided for in group H01L27/00 or H01L29/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00279Features relating to reactor vessels
    • B01J2219/00306Reactor vessels in a multiple arrangement
    • B01J2219/00313Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
    • B01J2219/00315Microtiter plates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00351Means for dispensing and evacuation of reagents
    • B01J2219/00427Means for dispensing and evacuation of reagents using masks
    • B01J2219/00432Photolithographic masks
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00351Means for dispensing and evacuation of reagents
    • B01J2219/00427Means for dispensing and evacuation of reagents using masks
    • B01J2219/00434Liquid crystal masks
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00351Means for dispensing and evacuation of reagents
    • B01J2219/00436Maskless processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00457Dispensing or evacuation of the solid phase support
    • B01J2219/00459Beads
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00457Dispensing or evacuation of the solid phase support
    • B01J2219/00459Beads
    • B01J2219/00468Beads by manipulation of individual beads
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00457Dispensing or evacuation of the solid phase support
    • B01J2219/00475Sheets
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00497Features relating to the solid phase supports
    • B01J2219/005Beads
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00497Features relating to the solid phase supports
    • B01J2219/00527Sheets
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00497Features relating to the solid phase supports
    • B01J2219/00527Sheets
    • B01J2219/00529DNA chips
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00497Features relating to the solid phase supports
    • B01J2219/00527Sheets
    • B01J2219/00531Sheets essentially square
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00585Parallel processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/0059Sequential processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00596Solid-phase processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00608DNA chips
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/0061The surface being organic
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00612Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports the surface being inorganic
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00614Delimitation of the attachment areas
    • B01J2219/00617Delimitation of the attachment areas by chemical means
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00614Delimitation of the attachment areas
    • B01J2219/00617Delimitation of the attachment areas by chemical means
    • B01J2219/00619Delimitation of the attachment areas by chemical means using hydrophilic or hydrophobic regions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00614Delimitation of the attachment areas
    • B01J2219/00621Delimitation of the attachment areas by physical means, e.g. trenches, raised areas
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00623Immobilisation or binding
    • B01J2219/00626Covalent
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00632Introduction of reactive groups to the surface
    • B01J2219/00637Introduction of reactive groups to the surface by coating it with another layer
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00639Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00646Making arrays on substantially continuous surfaces the compounds being bound to beads immobilised on the solid supports
    • B01J2219/00648Making arrays on substantially continuous surfaces the compounds being bound to beads immobilised on the solid supports by the use of solid beads
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00659Two-dimensional arrays
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/0068Means for controlling the apparatus of the process
    • B01J2219/00686Automatic
    • B01J2219/00689Automatic using computers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/0068Means for controlling the apparatus of the process
    • B01J2219/00695Synthesis control routines, e.g. using computer programs
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00709Type of synthesis
    • B01J2219/00711Light-directed synthesis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • B01J2219/00722Nucleotides
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • B01J2219/00725Peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11Compounds covalently bound to a solid support
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/10Libraries containing peptides or polypeptides, or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B60/00Apparatus specially adapted for use in combinatorial chemistry or with libraries
    • C40B60/14Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries
    • G01N15/1433
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L2924/00Indexing scheme for arrangements or methods for connecting or disconnecting semiconductor or solid-state bodies as covered by H01L24/00
    • H01L2924/0001Technical content checked by a classifier
    • H01L2924/0002Not covered by any one of groups H01L24/00, H01L24/00 and H01L2224/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/961Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/968High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/969Multiple layering of reactants
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/973Simultaneous determination of more than one analyte
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/809Multifield plates or multicontainer arrays
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31971Of carbohydrate
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2575Volumetric liquid transfer

Abstract

A method and device for preparing desired sequences on a substrate at known locations. Known locations (10) of a substrate (2) are irradiated by way of a mask (8) so as to activate a material (4) for binding. The substrate is then exposed to a first material (12) for binding thereto. Second locations (14) are then irradiated through a mask and exposed to a second material (16). A variety of sequences may be formed through selective irradiation of the substrate followed by application of selected materials. A reactor system and fluorescence detection system are also dis-closed.

Description

1' VERY LARGE SCALE IMMOBILIZED PEPTIDE SYNTHESIS
COPYRIGHT NOTICE
A portion of the disclosure of this patent document contains material which is subject to copyright protection.
The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure as it appears in'the Patent and Trademark Office patent file or records, but otherwise reserves all copyright rights whatsoever.
This application is a divisional application of Canadian Application No: 2,054;70 filed on June 7, 1990. A second divisional application, Canadian Application No. 2;278,883 was filed on August 17, 1999.
BACKGROUND OF THE INVENTION
The present invention relates to the synthesis and replacement materials at known locations. In particular, one embodiment of the invention provides a method and associated apparatus for preparing diverse chemical sequences at known locations on a single substrate surface. The inventions may be applied, for example, in the field of preparation of oligomer, peptide, nucleic acid, oligosaechari.de, phospholipid, polymer, or drug congener preparation; especially to create sources of chemical diversity for use in screening for biological activity.

'la The relationship betwEen structure and activity of molecules is a fundamental issue in the study of biological systems. Structure-activity relationships are important in understanding, for example; the function of enzymes, the ways in which cells communicate with each other, as well as cellular control and feedback systems.
Certain macromolecules are known to interact and bind to other molecules having a very specific three-dimensional spatial and electronic distribution. Any large molecule having such specificity can be considered a receptor, whether it is an enzyme catalyzing hydrolysis of a metabolic intermediate, a cell-surface protein mediating membrane transport of ions, a glycoprotein serving to identify a particular cell to its neighbors, an IgG-class antibody circslat:ng in the plasma, an alidcnucleotide saque.~.ce of DNA in the nucleus, o~ t:ne like. The various molecules whicz receptors.seect.ivelv bind are known as ligands.
Many assays are available for measuring the binding affinity of known receators and ligands, but the information which can be gained from such exper~.men~s is often limited by the number and type of ligancs which ale available. Novel ligands are sometimes discovered by c=Dance or by application of new technirues for t:~e elucidation o' molecular structure, incjuding x-ray crystallographic analysis and recombinant gene~.ic tec hricues f or pr o rains Small peptides are an exemplary syste:.~. ~cr explcr ing the relationship between s tructure and f~~.~.c ~:cn in bio.icgy: A peptide is a sza_uence of amino acids.
When the twenty naturally occurring amino acids are condensed into polymeric molecules they form a wide variety of three-dimensional configurations, each resulting from a particular amino acid sequence and solvent condition. The number of possible pentapeptides of the 20 naturally occurring amino acids, for example, is 20' or 3.2_million;different peptides. The likelihood than molecules of this size might be useful in recep'or-binding studies is supported by epitope analysis s.udies showing that some antibodies recognize sequences as shcr~
as a few amino acids with high speci~ici y. Furthe:.-.~,iore, the average molecular'weight of amino acids puts s:aall peptides in the size range of many currently useful pharmaceutical products.
Phar:uaceutical drug discavery is one type of research which relies on such a study of structure-acti~rity relationships. In most cases, contemporary pharmaceutical research can be desc:ibed as the process of discovering novel ligands with desirable patterns c~
specificity for biologica2ly important receptors.

Another example is research to niscover new compouncs for use in agriculture, such :as pesticides and herbicides.
Sometimes; the solution to a rational process of designing ligands is difficult or unyielding. .Prior methods of preparing large numbers of different polymers have been painstaking3y slow when used 'at a scale sufficient to permit effective rational or random screening. For example, the "Merrifi~ld" method (J. Ar,.
them. Soc. (2963) 85:2149-2154 has been used to synthesize peptides on a solid support. In the Merrifield method, an amino acid is covalently bonded to a support made of ~n insoluble polymer. Another amino acid with an alpha protected group is reacted wzth to covalently banded amino acid to for: a dipeptide. A°tew washing, the protective group '1s removed and a thin;
amino acid with an alpha protective group is added to t::e dipeptide. This process is continued until a peptide c~
a desired length and sequence is obtained. Using the Merrifield method, it is not economically practical ~o synthesize more than a handful of peptide seguences in a day.
To synthesize larger numbers of polymer sequences, it has also been prayosed to use a series o~
reaction vessels for polymer synthesis. For example, a tubular reactor syste~a'may be used to synthesize a linear polymer on a solid phase support by automated sec_uer.tia' addition of reagents. This method still does not enable the synthesis of a sufficiently large number of polymer sequences for effective economical screening.
Methods of preparing a plurality of polyner sequences are also known 2n which a foraminous container encloses a known quantity of reactive particles, the particles being larger in size than foramina of the 3c container. The contyiners may be selectively reacted with desired materials to synthesize desired sequences c~
product molecules. As with other'methods known in the art, this method cannot practically be used to synthesize a sufficient variety of polypeptides for effective screening.
Other techniques have also been described.
These methods include the synthesis of peptides on 96 plastic pins which fit the Format of standard microtiter plates. Unfortunately, while these tzchnicues have been somewhat useful, substantia3 problems remain. ror example, these methods continue to be limited in the I0 diversity of sequences which can be economically synthesized and screened:
From the above; it is seen that an improved method and apparatus for synthesizing a variety of chemical sequences at known locations is desired.
SUI~B~iA,RY OF THE INVENTION
An improved method and apparatus for the preparation of a variety of polymers is disclosed.
In one preferred embodiment, linker molecules are provided on a substrate. A fierminal end of the linker molecules is provided with a reactive functional group protected with a photoremovable protective grcup.
Using lithographic methbds, the photoremovable protective group is exposed to light and removed from the linker molecules in first selected regions. The substrate is then washed or otherwise contacted with a first monomer that reacts with exposed functional groups on the linker molecules. In a preferred embodiment, the monomer is an amiwo acid containing a photoremovable protective group at its amino or carboxy terminus and the linker molecule terminates in an amino or carboxy acid group bearing a photoremovable protective group.
A second set of selected regions is, thereafter, exposed to light and the photoremovable ;5 protective group on the linker molecule/protected aui~to acid is removed at the second set of regions. The substrate is then contacted with a second monomer containing a photpremovable protective group for raacticn with exposed functional groups: This process is rape3ted to selective)y app3y menomers until polymers of a desired length and desired chemical sequence are obtained..
Photolabile groups are then optionally removed and the sequence is, thereafter, optionally capped. Side chain protective graups, if present; are also removed.
By using the!lithographic technigues disclosed herein, it is possible to direct light to relatively small and precisely known locations on the substrate.
2t is, therefore, possible to synthesize polymers of a known chemical sequence at known.locations on the substrate.
The resu2ting substrate w'xll have a variety of uses incyuding; for example, screening large numi~ers of polymers for biological activity, To screen for biological activity, the substrate is exposed to one or more receptors such; as antibody whole cells, receptors on vesicles, lipids, or any one of a variety of other receptors. The receptors are preferably labeled with, for example, a fluorescent marker; radioactive marker, or a labeled antibody reactive with the receptor. The location of the marker on the substrate is.detected with, for example, photon detection or autoradiogranric techniques. Through knowledge of the sequence of the material at the location where binding is detected, it is possible to quickly determine which sequence binds with the receptor and, therefore; the technique can be used to screen large numbers of peptides. Other possible applications of the inventions herein include-diagnos;.ics in which various antibodies for particular receptors would be placed on a substrate and, for example, blood sera would be screened fo= immune deficiencies. Still further applications include, for example, selective "doping" of organic materia3s in semiconductor devices, and the like:

In connection with one aspect of the invention an improved reactor system,for synthesizing polymers is also dis-closed. The reactor system ine3udes a substrata mount which engages a sub trate around a periphery thereof. The substrate mount provides for a reactor space between the substrate and the mount through or into which reaction fluids are ptuaped or flowed. A mask is placed on or focused on~the substrate and illuminated so as to deprotect selected regions of the substrate in the reactor space. A monomer is pumped through the reactor space or otherwise contacted with the substrate and reacts with the deprotected regions., Hy se3.ectivel.y deprotecting regions on the substrate and flowing predeter~ained monomers through the reactor space, desired polymers at known locations may be synthesized.
Imprcved detection apparatus and methods are also disclosed. The detection method and apparatus utilize a substrate having a large variety of potymer sequences at known locations on a surface thereof. The substrate is exposed to a fluorescently labeled receptor which binds o one or more of the polymer sequences. The substrate is placed in a microscope detection apparatus for identification of locations where binding takes place. The mxcroscope;detection apparatus includes a monochromatic or polychromatic light source for directing light at the substrate, means for detecting fluoresced light from the substrate, and means for determining a location of the fluoresced light. The means for detecting light f3uoresced on the substrate may in some embodiments include a photon counter. The means for determining a .location of thefluoresced light may include an x/y translat~:on table for the substrate.
Translation of the slide and data coT3ection are recorded and managed by an appropriately programmed digital computer.

Therefore, in accordance with the invention of the present divisional application there is provided apparatus for detection of fluoreseently marked regions on a substrate comprising: a) a substrate bearing a plurality of different polymer sequences coupled to a surface of said substrate, each of said different polymer sequences being coupled in a different known location of said surface, each of said known location having an area of 102 em2 or less; b) a light source for directing light at said surface of said substrate; c) a means for deteetW g light fluoresced from a fluorescent label bound to the polymer sequences on said surface in response to said light source; d) means for translating said substrate from a first position to a second position relative to said'light source and/or said means for detecting light; and e) means for storing fluoresced light intensity as a function of location on said substrate, said means for storing connected to said means for translating and said means for detecting.
The invention also provides a system for determining binding of a fluorescently labeled receptor to a ligand comprising: a) a substrate bearing a plurality of different polymer sequences 'coupled to a surface of said substrate, each of said different polymer sequences being coupled in a different known location of said surface, each of said known locations having an area of l0-2 cm2 or less b) means for applying light to said surface of said substrate, said means for;appl.ying light providing simultaneous illumination at a plurality of said known locations; and c) an array of detectors for detecting light fluoresced at said plurality of known locations upon binding of a fluorescently labeled receptor to said polymer sequences.

7a The invention also provides an apparatus for detection of fluorescently marked locations on a substrate comprising: a) a substrate bearing a plurality of different polymer sequences coupled to a surface of said substrate, wherein said plurality of different polymer sequences comprises a plurality of :different nucleic acid sequences, each of said different polymer sequence being coupled in a different known location 'of said surface, each of said known locations having an area of 10~Z cm2 or less; b) a light source for directing, light at a surface of said substrate;
c) a detector for detecting light fluoresced from a fluorescent label bound to the polymer sequences on said surface in response to said light source; d) a translator for translating said substrate relative to said light source; and e) a data storage system for storing fluoresced light intensity as a function of location on said substrate, said data storage system connected to said translator and said detector.
The invention ai.so,provides an apparatus for detection of fluorescently marked locations on a surface of a substrate, comprising: °a point light source for generating an excitation light; a substrate bearing a plurality of different polymers coupled to a surface of said substrate, wherein said plurality of different polymers comprises a plurality of different nucleic acid sequences, each of said different polymer sequences being coupled in a different known location of said surface, each of said known locations having an area of 10-2 cm2 or less; an objective lens for focusing said point light source at said surface of said substrate, whereby locations, upon binding of a fluorescent label to the polymer sequences coupled therein, emit a fluoresced light in response to said excitation light; an x-y translation stage for moving said substrate 7b relative to said excitation light,~ a dichroic mirror for reflecting light having a wavelength of said excitation light and passing light having a wavelength of said fluoresced light; a photomultiplier and photon counter for detecting said fluoresced light; and an appropriately programmed computer for recordingsaid fluoresced light as a function of a position on said surface of said substrate from which said fluoresced light was emitted.
The invention also provides a method of detecting the presence of a fluorescent marker on a surface of a substrate, the method comprising: directing an excitation light at the surface of the substrate; and detecting light fluoresced from the surface of the substrate; wherein said surface of said substrate!bears a plurality of different nucleic acids covalently bound thereto, each of said different nucleic acids being bound at a different known location on the substrate; each of said known locations having an area of less than l0-2 cm2 and said fluorescent marker comprises a fluorescently labeled target nucleic acid that is capable of hybridizing with'one or mare of said plurality of different nucleic acids.
The invention also provides a method of determining whether a fluorescently labeled ligand binds to one or more of a plurality of different polymer sequences, wherein said fluorescently labeled ligand comprises a fluorescently labeled target nucleic acid, and said plurality of different polymer sequences on the surface of a substrate comprises a plurality of different nucleic acids, comprising: providing a plurality of different polymer sequences covalently bound to a surface of a substrate, each of said different polymer sequences being bound at a known location on the surface of the substrate, each of said known locations having an area of less than 10-2 cm2; contacting the surface of the substrate with the fluorescently labeled ligand; washing the surface to remove unbound fluorescently labeled ligand from the surface of the substrate; and detecting binding between the fluorescently labeled ligand and the one or more polymer sequences, said detecting step comprising directing an excitation light at the surface of the substrate, and detecting light fluoresced from the surface of the substrate:
The invention also provides a nucleic acid analysis apparatus comprising: a substrate bearing a plurality of different: nucleic acids; each of said different nucleic acids being attached to a different known location of the surface of said substrate, each of said known locations having an area of l0-2 cm2 or less, said substrate comprising more than l0 of such nucleic acids, at least some of said nucleic acids coupled to fiuorescently labeled target molecules; a light source for directing light at a surface of said substrates a detector for detecting light fluoresced from said surface in response to said light source; a translator for -translating said substrate relative to said light source; and a data storage system for storing fluoresced light intensity as a function of location on said substrate, said data storage system coupled to said translator and said detector.
The invention also provides an apparatus for detection of labeled locations on a substrate comprising:
a) a light source capable!of directing light at a surface of a substrate, said subs rate bearing a plurality of different polymer sequences attached to a surface of said substrate, each of said different polymer sequences occupying a different known location of said surface, each of said known locations having an area of 10-2 cm2 or less, and at least one of the polymers capable of being coupled to a labeled 7d receptor; b) a detector to detect light emitted from said surface in response to said light source to indicate which polymers) are coupled to the labeled receptor.
The invention also provides a method of detecting the presence of a fluorescent marker on a surface of a substrate, the method comprising: (1) directing an excitation light at a surface of a substrate, said substrate bearing a plurality of different polymer sequences attached to a surface of said substrate, each of said different polymer sequences- occupying a different known location of said surface, each of said known locations having an area of 10-2 cm2 or less, and at least one of the polymers capable of being coupled to a fluorescently labeled receptor; and (2) detecting light fluoresced from the surface of the substrate.
Our copending Canadian Application No. 2,278,883, also divided out of parent'Application No. 2,054,706 provides a reactor for facilitating reaction of chemical compounds, said reactor comprising: a body having a sealed cavity therein, said cavity being less than about 1,000 um deep; and an inlet port and an outlet port, said inlet pbrt and said outlet port being in fluid communication with said cavity for flowing fluid comprising nucleosides into and through said cavity.
The parent application, Canadian Application No.
2,054,706, provides a method of forming an array of diverse polymers on a substrate, a surface of said substrate comprising at least first and second known locations having polymer molecules thereon, said polymer molecules comprising a protective group at an active site, said method comprising the iC
steps of: removing said:protective group from polymer molecules in said first known location of said substrate to expose said active site, but not rerciosring said protect.i:ve group from polymer molecules in said second known location; exposing said first and second known locations of said surface to first selected monomer molecules, to couple said first selected monomer molecules in said firs known location but not said second known location, said first selected monomer molecules comprising a protective group at an active site; removing a protective group from at least a portion of said first selected monomer molecules in said first known location to expose an active site on said at least a portion of said first selected monomer molecules; and exposing said first and said second known location to second selected monomer molecules, forming polymer molecules in said first known location having a different monomer sequence than monomers in said second known location.
Furthermore, another embodiment of the invention of the parent application provides an apparatus for investigating by receptorlligand binding a nucleotide sequence, which apparatus .., comprises a substrate with a surface, said surface comprising at least 103 known locations, said known locations containing different polynucleotide sequences thereon, said known locations each occupying an area of less than 2.5 x 10'3 cm2.

Ir A further understanding of the nature and advantages of the inventions of the divisional applications and the parent application herein may be realized by reference to the remaining portions of t:~e specification and the attached S drawings.
BRIEF DESCRIPTION OF THE FTGURES
Fig. 1 illustrates masking and irradiation of a substrate at a first location. The substrate is shown in cross-sect~.an;
Fig. 2 illustrates t:3e substrate after application of a monomer "A" ;
Fig. 3 illustrates irradiation of the substrates at a second location;
Fig. 9 illustrates trie substrate after application of monomer "B" ;
Fig. 5 illustrates i:r'radiation of the "A" monomer;
Fig. 6 illustrates the substrate after a second application of "B" ;
Fig. ~ illustrates a completed substrate;
Figs. 8A end 8B illustrate alternative embodiments of a reactor system for forming;a glurality of polymers on a substrate;
Fig. 9 illustrates a detection apparatus for locating fluorescent markers on thz substrate;
Figs: l0A-lOM illustrates the method as it is applied to the production of the trimers of monomers "A" and "B":

Figs. 11A, 11S and I~C arp fluorescence traces fcr standard fluorescent beads;
Figs. 12A and 12B are fluorescence curves for NVOC slides not exposed and erposed to light respectively;
E"igs. 13A and 13B illustrate formation of a slide with a checkerboard pattern of Y~GFL and GGFL exposed to labeled Herz antibody; and $ .
Figs. 14A and 14B illustrate the mapping of szxteen sec_uences synthesized on two different glass slides.
DE'_T'AILED DESCRIPTION OF THE P:~.EFERRED EMBODIi~NTS
GONTEH'TS
I. Glossary II. General la III. Polymer Synthesis ZV. Details of One Embodiment of a Reactor System V: Details of One Embodiment of a Fluorescent Detection Device 13 VI. Determination of Relative Binding Strength of Receptors VII. Examples A. Slide Preparation 20 B. synthesis of Eight Trimers of ~~Au and ~gf~

C: Synthesis of a Dimer of an Aminopropyl Group and a Fluorescent Group D. emonstration of Signal Capabzlzty E. Determination of the Number of Molecules Per Unit Area F. Removal of NVOC and Attachment of a Fluorescent Marker 30 G: U.se of a Mask in Removal of NVOC

H: Attachment of YGGFL and Subsequent Exposure to Here Antibody and Goat Apt in~ous a I. Monomer-by-Monomer Formation of YGGFL and Sub equent Exposure to 'S Labeled Antibody CONTENTS
(Coat'd) J. Monomerby-Monomer Synthesis of YGGiL and PGGFL
K. Monomer-by Monomer Synthesis of YGGFI~ and YPGGFL
L. Synthesis of an Array of Sixteen Different Amino Acid Sequences and Estimation of Relative Binding Affiniay to Herz Antibody 1~ VII2.. Illustrative Alaernative Embodiment Ix. Conclusion I. Glossa~-v The following terns are intended to nave the following general meanings as they are used herein':
1. Complementary: Refers to the Lopvlogical compatibility or matching together of interacting surfaces of a ligand molecule and its receptor.
Thus, the receptor and its ligand can be described as complementary; and furthermore, the contact surface characteristics are complementary to each other.
'r 2. ypitone: The portion of an antigen molecule which is delineated by~the area of interaction with the subclass of receptors-known as antibodies.
3. ' and: A ligand is a molecule that is recocnized by a particular receptor: Examples of ligands that can be investigated by this invention include, but are not-restricted to, agon'2sts and antagonists fog cell meanbrane receptors, toxins and venoms, viral epitopes, hornones (e. g., opiates, steroids, etc.), hormone receptors, peptides, enzymes, enzyme Substrates, cofactors, drltgs, lectins, sugars, oligonucleotides, Nucleic acids, oligosaccharides, proteins, and monocianal antibodies.
4. ~ionomer~. A member of the set of small molecules which can be joined together to form a polymer. The set of monomers includes but is not restricted to, .
far example, the set of common L-amino acids, the set of D-amino acids,. the set of synthetic amino acids, the set of nucleotides and the set o:
10 pentoses and h~xoses. As used herein, monoae_s refers to any member of a basis set for synthesis of a polymer. For example; dimers of L-amino acids form a basis set of 40o monomers for synthesis of polypeptides: Different basis sets of monomers may be used at successive steps in the synthesis of a polymer.
a t' e: A polymer in which the monomers are aloha amino acids and which are joined together through a amide bonds and alternatively referred to as a polypeptide. In the context of this specification it should be appreciated that the amino acids may be the L-optical iso~aer or the D-optical isomer.
Peptides a.a more than t;~o amino acid monomers long, and often more than 20 amino acid monomers long.
Standard abbreviations for amino acids are used (e.c., P for proline:). These abbreviations are included in 8tr~ter;,Biochemstrv, Third Ed., 1988 6. Radiation: Energy which may be selectively applied including energy having a wavelength of between 10w4 and l0' meters including, for example, electron bear radiation, gammai radiation, x-ray radiation, ultra-vielet radiationy, visible light, infrared radiation, microwave radiation, and radio waves. "Irradiatie::"
refers to the appl~c3ticn of radiation to a surface.
7. Recsotor: A molecule,that has an affinity for a given ligand. Receptors may be naturally-occuring or manmade molecules. Also, they can be employed in their unaltered state or as aggregates with other species. Receptors may be attached, covalently or noncovalently; to a binding member, either directly or via a specific bending substance. Examples of receptors which can be employed by this invention include, but are not restricted to, antibodies, cell membrane re;c~ptor~, monoclonal antibodies and antisera reactive with specific antigenic determinants (such as on viruses, cell s or other materials), drug , polynucleotides, nucleic acids, peptides, cofactors, lectins, sugars, polysaccharides, cel3s, cellular membranes, and organelles. Receptors are sometimes referred to in the art as anti-ligands. As the terra receptors is used herein, no difference in meaning is intended.
A "Ligand Receptor Pair'! is formed when two macromolecules have combined through molecular recognition to form a complex.
Other examples of receptors which can be investigated by this invention include but are nct restricted to:
a) Microoraani~m r~ceators:, Determination of ligands which bind to receptors, such as specific transport proteins or enzymes essential t~ survival of mieroorganisms, is useful in a new class of antibiotics. Of particular value wouldbe antibiotics against opportunistic fungi, protozoa, and those bacteria resistant'to the antibiotics in current use.

b) Enzymes: For instances; the binding site of enzymes such as the enzymes responsible for cleaving neurotransatitters; determination of ligands whic:~ bind to certain receptors~to modulate the action of the enzymes which cleave the different neurotransmitters is useful in the development of drugs which can be used in the treatment of disorders of neurotransmission.

14 c) Artibcdies: Fcr instance, the inveht~on may be useful in investigating the liganc-binding site on the antibody molecule which combines with the epitope of an antigen of interest;

determining a s~cruence that mimics an antigenic 15 epitoce may lead to the development cf vaccines of which the immunogen is based on one or more of such sequences or Lead to the development of relatEd diagnostic agents or campounds useful in therapeutic treatments such as for auto-immune diseases (e. g., by blocking the binding of the "sel " antibodies).

d) Nucleic Acids: Sequences of nucleic acids may be synthesized to establish DNA or RNA binding sequences:

Z3 a) Cata~.ytic Polvuetti~ies: Polymers, preferably polypegtides, which are capable of promoting a chemical reaction involving the conversion of one or more reactants to one or more products.

Such polypeptides generally include a binding 30 site specific for at least one reactant or reaction intermediate and an active functionality proximate to the binding site, which functionality is capable of chemically modifying the bound reactant.

f) F~ormone receptors: For instance, the receptors far insulin and growy-~h hormone. Determination of the ligands which bind with high affinity to a receptor is useful in the development of, for example, an oral replacement of the daily inj~ctiors which diabetics must take to re?ieve the svmptons cf dabetss, and ir. the cthe;
case; a replacement for the scarce human growth hornone which can only be obtained from cadavers or by recombinant DNA technology.
Other examples are_the vasoconstrictive hormone receptors: deterainat'ion of those ligands yhich bind to a receptor may lead to t:~e development of drugs to c~ntrol,blood pressure.
g) Oviate receata=s: Determination of ligards which bind to the opiate receptors in the brain is useful in the development of less-addictive replacements for morphine and related drugs.
8. Substrate: A material having a rigid or semi-rigid surface. In many embodments, at least- one surface of the substrate will, be substantially flat, although in some embodiments it maybe desirable to physically separate,synthesis regions for different polymers with, for example, wells, raised regions, etched trenches, or the like. According to other embodiments, smal3 beads may be provided on the surface which may be released upon completion of the syntr.es is .
9. Protective G~c~ut: A material which 3s bound to a monomer unit and which may be spatially removed upon selective exposure to an activator such as electromagnetic radiation.. Examples of protective groups with utility herein include Nitroveratryloxy 14 .
carbonyl, Ni robenzyloxy carbonyl,. Dimethyl dimethoxybenzyloxy carbonyl, 5-3romo-7-nitroindolinyl, o-Fiydroxy-a-methyl cinnamoyl, and 2-Oxymethylene anthraquinone. Other examples of activators include icn beams, electric fields, magnetic fields; electron beams, x-ray, and the like.
10. Predefined Region: A predefined region is a IO localized area on a surface Which is, was, or is intended to be activated for formation of a pclvmer.
The predefined region may have any convenient shape, e.g:, circular, rectangular, elliptical, wedge-shaped, etc. For the sake of brevity herein, "predefined regions" are sometimes referred to simply as "regions."
11. Substantially Pure: A polymer is considered to be ~~substantialLy pure" within a predefined region of a substrate when it exhibits characteristics that distinguish it from other predefined regions.
Typically, purity will be measured in terms of biological activity or function as a result of uniform sequence. Such characteristics will typically be measured by way of binding with a selected ligand or receptaz.
II. Ge a a The present invention provides methods and apparatus for the preparation and use of a substrate having a plurality of polymer ser~uences in predefined regions. The invention is desczibed herein primarily with regard to the preparation of molecules containing sequences of amino acids, but, could readily be applied in the preparation of other polymers. Such polymers include, for example; both linear and cyclic polymers of nucleic acids, polysaccharides, phospholipids, and i~
peptides having either a-, p-, or w-amino acids, hetare-polymers in which a kncwn drug is covalently bound to a.~.y of the above, polyurethanes, polyesters, polycarbcnates, poiyureas, polyamides; polyethyleneiraines, polyarylene S sulfides, polysiloxanes, polyimides, polyacetates, cr other polymers which will be apparent upon review cf this disclosure. In a preferred embodiment, the inventicn herein is used in the synthesis of peptides.
The prepared substrate may, for example, be 1~ used in screening a variety of polymers as ligands for binding with a recepto=, although it will be apparent that the invention cou3d be used for the synthesis of a receptor for binding with a ligand. The substrate disclosed herein will have a wide variety of other uses.
1S Merely by way of example; the invention herein can be used in detenaining peptide, and nucleic acid seQUences which bind to proteins, finding seguence-specific binding drugs, identifying ep.itopes recogni2ed by antibodies, and evaluation of a variety of drugs for clinical and 20 diagnostic applications, as well as combinations of the above.
The invention preferably provides for the use of a substrate "S" with a surface. Linker molecules "L"
are optionally provided on a surface of the substrate.
23 The purpose of the linker: molecules, in some embodiments;
is to facilitate receptor recognition of the synthesized polymers.
Optionally, the linker molecules may be chemically protected for storage purposes. A chemical 30 storage protective group such as t-3oC (t-butaxycarbonyl) maybe used in some embodiments. Such chemcal protective group would be chemically removed upon exposure to, for example; acidic solution and °;aould serve to protect the surface during storage and be 3S removed prior to polymer preparation.
On the substrate or a distal end of the linker molecules, a functional group with a protective group P

is provided.: The protective greup Po may be remcved upcn expcsure to radiation, electric fields, electric currents, or ether activators to expose the functional group.
In a preferred embodiment, the radiation i:s ultraviolet (W), infrared (IR;, or visible light. As more fully described below, the protective g=oun may altzrnatively bean electrochemically-sensitive group which may be removed in the presence of an electric field. In still further a-lternative embodiments, ion beams, electron beams, or the like may be used fcr deprotection.
In some embod'lmentg,, the exposed regions and, therefore, the area upon which each distinct polymer sequence is synthesized are- smaller than about 1 cm2 cr less than 1 mmz. Ln preferred emoodiments the exposed area is less than about 10,000 ~cmz or, more preferably, less than 100 ~,m2 and may, in some embodiments, encompass the binding site for as few as a single molecule. Within these regions, each polymer is preferably synthesized in a substantially pure form:
Concurrently or after exposure of a known region of the substrate to light, the surface is contacted with a first monomer unit M, which reacts with the functional group which has been expo ed by the deprotection step. The first monomer includes a protective group P1. PI may or may not be the same as Po.
Accordingly, after a first cycle, known first regions of the surfacemay comprise the sequence:
S-L-Mi'pi while remaining regions of the,surface comprise the sequence:
S-L-Po .

i7 Thereafter, second regions of the surface (which may include the first region) are exposed to light and con-tacted with a second monomer M2 (which may or may not be the same as M1) having a protective group P2. P~,mav or may not be the same as Po and PI. After this second cycle, different regions of the substrate may ccznprzse one or more of the following sequences:
S'L_Mi'~'f z-Pz S-Ia-Mz-P~
S-L-Mi-pi and/or S-L-Po .
Tre above process is repeated until the substrate includes desired po3ymers of desired lengths. 3y controlling the locations of the substrate exposed to light and the reagents exposed to the substrate following exposure, the location of each sequence will be known.
. Thereafter, the,pzotective groups are removed from some or all of the substrate and the sequences are, optionally, capped with a capping unit C. The process results in a substrate having a surface with a plurality of polymers of the following general formula:
S-(L)-(Mi)-(M~)-(Mk) ... (Mx)-(C~
where square brackets indicate optional gr3ups, and Mi...M~ indicates any sequence of monomers. The number of monomers could cover a wide variety of values, but in a preferred. embodiment they will range from 2 to 100.
Zn some embodiments a plura3:ity of locations on the substrate polymers'are to contain a common monomer subsequence. For examcle, it may be desired to synthe-size a seguence S-MI-Mz'-M3 at first locations and a sequence S-M,~-Mz-M3 at second locations. The process would commence with irradiation of the first locations followed by c~ntac'ing with Ml-P, resulting in the sequence S-MI-P at the first location. The second locs-tions would then be iradiated and contacted with M4-P, resulting in the sequence S-?~4-P at the second locations.
Thereafter both the first and'second locations would be irradiated and contacted with the direr M2-?~3, resulti~g in the sequence S-Ml-Zri2-M3 at the first locaticns and S-M~-M2-M3 at the second locations. Of course, common subsequences of any length could be utilized including those in a range of 2 or-more monomers, 2 to 100 monomers, 2 to 20 monomers, and a mcst preferred range of 2 to 3 monomers.
According to other.smbodiments, a set of masks is used for the fiast monomer layer and, thereafter, is varied light wavelengths-are used for selective deprotection. For examp~:e, in the: process discussed above, first regions are first exposed through a mask and reacted with a first monomer having a first protective graup PI, whic:~ is, removable upon exposure to a first wavelength of light (e.g., IR). Second regions are masked and reacted with a second monomer having a second protecive group PZ, which is removable upon exposure to a second wavelength of light (e. g:, W). Thereafter; masks become unnecessary in the synthesis because the entire substrate may be exposed alternatively to the first and secand wavelengths of 'light in the deprotection cycle.
The polymers prepared on a substrate according to the above methods will have a variety of uses includ ing, for example, sc=eening for biological activity. In such screening activities, the substrate containing the seruences is expesed to an unlabeled or 3.abeled receptor such as an antibody, receptor on a cell, phospholipid vesicle, or any one of a variety of other receptors. In one preferred embodiment the polymers- are exposed to a first, unlabeled receptor of interest and, thereafter, exposed to a labeled receptor-specific recognition element, which is, for example, an antibody. This prvcass will provide signal amplification in the detection stage.
The reeeator molec~;xles gay bind with one o.
more polymers on the'substrate. The presence of~the labeled receptor and; therefore, the presence of a sequence which binds whh the receptor is detecte~, in a preferred embodiment through the use of autozadiography, detection of fluorescence with a charge-coupled device, fluorescence micrascopy, or the like. The sequence of the polymer at the locations where the receptor binding is detected may be used to determine all or part of a sequence which is complementary to the receptor.
Use of the inventy~n herein is illustra;.ed primarily with reference to screening for biological activity. The invention will; however, find many othe-r uses. For example, the invention may be used in infcz:nation storage ('e.g., on optical disks), production of molecular electronic devices, production of stationary phases in separation sciences, production of dyes and brightening agents, :photography, and in immobilization of cells, proteins, hectins; nucleic acids, polysaccharides and the like in patterns on a surface via molecular recognition of specific polymer sequences. By synthesizing the same compound in adjacent, progressively differing concentrations, a gradient will be established to control chemotaxis or to develop diagnostic dipsticks which, for example, titrate an antibody against an increasing amount of antigen. By synthesizing sev< ~al catalyst molecules in close proximity, more efficient multistep conversions may be achieved by ~~coordinate immobilization." Coordinate immobilization also may be used for e3ectron transfer systems, as well as to provide both structural integrity and other desirable properties to materials such as lubrication, wetting, etc.
According to alternative embodiments; molecular bindistribution or pha=macokinetic progerties may be examined. For example, to assess resistance to intestinal or serum,proteases, polymers may be capped with a fluorescent tag and exposed to biological fluids of interest.
~~I. P,id~,E?r SVZlthe515 Fig. l illustrates one embodiment of the invention disclosed herein in which a substrate 2 is shown in cross-section. Essentially, any conceivable substrate may be employed in the invention. The l~ substrate may be biological, nonbiological, organic, inorganic, or a combination of any of these, existing as particles, strands, precipitates, gels, sheets, tubing, spheres, containers, capillaries; pads, slices, filers, plates, slides, etc. The substrate may have any ,5 convenient shape, such as a dis;., square, sphere; circle, etc. The substrate is preferably flat but may take on a variety of alternative surface configurations. For , example, the substrata may contain raised or depressed regions on which the synthesis takes place. The 2p substrate and its surface preferably form a rigid support on which to carry out the reactions described herein.
The substrate and its surface is also chosen to prcvide appropriate light-absorbing characteristics. ror instance, the substrate may be a po3ymerized Langmui~
25 Blodgett film, functionalized glass, Si, Ge, GaAs, GaP, Si02, SiN4, modified silicon, or any one of a wide variety of gels or polymers such as (poly)tetraflucro-ethylene, (poly)viny3idenedifluoride; polystyrene, poiycarbonate, or combinations thereof. other substrate 3p materials will be readily apparent to those of skill in the art upon review of'this disclosure. In a preferre3 embodiment the substrata is flat glass or single-crystal silicon with surface relief features of less than 10 A.
According to some embodiments, the surface of 35 the substrate is etched using we31 known techniczues to provide for desired surface faatures. For example, by way of he formation of trenches, v-grooves mesa st.~,:ctures, or the like, the synthesis regions aay be more closely placed within the focus point of impingi.~.7 light, be provided with reflective "mirror" str~,:ctures far maximization of light collection from fluorescent v sources, or the hike.
Surfaces on the solid substrate will usually, though not always, be composed of tie same material as the substrate. Thus, the surface may be composed of any of a wide variety of materials, for example; polymers, plastics, resins, polysaccharides, silica or siliea-based materials, car:~on, metals; inorganic glasses, membranes, or any of the above-listed substrate materials. In some embodiments the surface may provide for the use of caged binding members which are attached fircly to the surace is of the substrate, Prieferabiy, the surface will contain reactive groups, which could be carboxyl, amino, hydroxyl, or the like: Most preferably, the surface will 2Q be optically transparent and will have surface Si-OH
functicnalities, such as, are found on silica surfaces.
The surface 4 of the substrate is preferably provided with a layer of linker molecules 6, although it will be understood that the linker molecules are not re 25 quired elements of the invention. The linker molecules are preferably of sufficient length to permit polymers in a completed substrate to into=act freely with molecules exposed to the substrate. The linker molecules should be 6-50 atoms long to provide sufficient exposure. The 30 life= molecules may be, for example, aryl acetylene, ethylene glycol oligomers captaining 2-l0 monomer uni s, diamines, diacids; amino acids, or combinations thereof.
Other linker molecules may be used in light of this disclsoure.
;S According to alternative embodiments, the linker molecules are selected based upon their hydrophilic/hydrophobic-properties to improve presentation of ynthesized polymers to certain receptors: For example, in the case of a hydrophilic receptor, hydrophilic linker molecules wi.Il be preferred so as to pex-mit the receptor to more closely approach the synthesi2ed polymer:
According to another alternative embcdiment, linker molecules are also provided with a photocleavabls group at an intermediate position. The photocleavable group is prefe=ably cleavable at a wavelength different from the protective group. This enables removal of the various polymers following completion of the synthesis by way of exposure to the different wavelengths of light.
The linker molecules can be attached to the substrate via carbon-carbon bonds using, for example, 35 (Poly)trifluorochloroethylene surfaces, or preferably, by siloxane bonds (using;:foz example, glass or silicon oxide ssrfaces). Siloxane bonds with the surface of the substrate may be formed in one embodiment via reactions of linker molecules bearing trichlorosilyl groups. The linker molecules may optionally be attached in an ordered array, i.e., as parts of the head groups in a polymerized Langmuir Blodgett film. In alternative embodiments, the linker molecules are adsorbed to the surface of the substrate.
The linker molecules and monomers used herein are provided with a functional group to which is bound a protective group. Preferably, the protective group is on the distal or terminal end of the linker molecule opposite the substrate. The protective group may be either a negative protective group (i.e.,,the p=otective group renders the linker molecules less reactive with a monomer upon exposure) or a positive protective group (i.e., the protective group renders the linker molecules more reactive with a monomer upon exposure). In the case of negative protective groups an additional step of reactivation will be reqtai=ed: In some embodiments, this will be done by heating.

The prctective group on the linker .~"oiecules may be selected from a.wide variety of positive night-reactive groups preferably -including vitro aromatic compounds such as o-nitrobenzyl derivatives or benzylsul-fonyl. In a preferred embodiment, s-nitrove=atryloxy-ca=bonyl (NVOC), 2-niarobenzyloxycarbonyl (NBOC) or r~,a-dimethyl-dimethoxybenzyioxycarbonyl (DDZ) is used:
In one embodiment, a vitro aromatic compound containing a benz~~' is hydr age:i ortho to t.:e vitro group is usad, i . a . , a c:~emical o f the f ora R~ RS O

H O ...
15 Rz ~ ~NO2 where RI is alkoxy, alkyl, halo, aryl, alkenyl, or hydrogen: RZ is alkoxy, alkyl, halo, azyl; vitro, or' 20 hydrogen: R3 is alkoxy, alkyl; halo; vitro, aryl, or hydrogen: Rs iS alkoxy,'alkyl, hydrogen, aryl, halo, or vitro; and RS is-alkyl, alkynyl, cyano, alkoxy, hydrogen, halo, ary3, or alkenyl. Other materials whicz may be used include o-hydroxy-a-methyl cinnamoyl der watives:
25 photoremovable protective gsoups are described in; fvr example, Patchornik, J: Fpm. Chem. Soc. (1910) 92:6333 and Amit et al., J. ora. Chem. (1974y ~.9:192a In an alternative embodiment the pcsitive 30 reactive group is activated for reaction with reagents in solution. For example, a, 5-bromo-7-nitre indoline group, when bound to a carbonyl, undergoes reaction upon exposure to light at 420 nm:
In a second aLternativ~ embodiment, the reactive group on the Tinker molecule is selected from a wide variety of'negatiVe light-reactive groups including a cinammate group.

Alternatively; the reactive group is activated or deactivated by electrcn beam lithography, x-ray lithography, or any other radiation. Suitable reac;.ive groups for el~ctran beam lithography include su?fonyl.
other methods may be used inc3uding, for example., expo-sure to a currant source. Other reactive groups and methods of activation may be used in light of this disclosure.
As shown in Fig. 1, the linking molecules ire pr-'e~abiy exposzd to; for example, light throuch a suitable mask 8 using photolithographic techniaues cf the type known in the semiconductor industry and described in, for example, Sze, VLSI Technoloav, McGraw-Hill (3983), and Mead et a-?., Introduce=cn tc zorc-Systems, Addison-Wesley (1880).
The 1 i-gh ~ may be directed at either the surface containing the g~otec~we groups or at the bac3c of the substrate, so long as the substrate is transparent to the wavelength of light needed for removal of the protective groups. In the embodiment shown in Fig: 1, light is directed at tie surface of the substrate captaining the protective groups. Fig. l illustrates the use of such masking techniczues as they are applied to a positive reactive group so as to activate linking molecules and expose functional groups in areas 10a and 10b:
The mask 8 !is in one embodiment a transparent support material selectively coated with a layer of opaque material. Portions of the opaque material are removed, leaving opaque>mat~rial in the precise pattern desired on the substrate surface. The mask is brought into cJ:ose proximity with, imaged on, or brought directly into contact with the substrate surface as shown in Fig. 1. "flpenings'! in the mask correspond to locations on the substrate where it is desired to remove photoremovable protective-groups from the substrate.
Alignment may be pe=formed using conventional alignment z5 techniques in which alignment r~ayks (not shown) ara used to accurately overlay successive masks with previous patterning steps, Or more sophisticated techniuaes ~av be used. For example; inteyferorsetis tec:~niques such as the one described.in Flanders et a~., "A New Interf erometric Alignment Technique," Apo. phvs. Lptt.
(1977) 31:426-428. may be used.
To e:lhanc~ contrast cf lig, t acolied to 1Q the substrata, it is desira5le to provide contrast enhancement mate=ials between the mask and the suysrrate according tc, some embodiments . This cont; as t enhznce:~er, t layer may comoris~ a molecule which. is deco:aposad by Light suc:~ as cuinone diazid or a material whic:, is 1 ~ tr ans ier. tlv bleac:~ed a t ~~e wave l eng th o f inter es ;: .
Transient bleaching cf materials will allow grea~c=
penetration where light is~applied,hereby enr;anci~c contrast. Alternatively, contrast enhancement mzv be provided by way of a cladded fiber optic bundle.
20 The light may be~f.~om a conventional incandescent source, a laser; a lase-r diode, or the like.
If non-colli~ate~ sources of light are used it may be desirable to provide a thick- or mufti-layered bask to prevent spreading of the fight onto the substrate. it may, further, be desirable in some embodimentsto ~:t;li~e groups which are sensitive to different wavelengths tc control synthesis. For example, by using grou~s.whic:-:
are sensitive to different ~;ravelength5, it is possible to select branch positions in'the synthesis of a polymer c~
30 eliminate certain masking steps. several reactive g~eu~s along crith their corresponding wavelengths for deprotec~ion are provided in Table 1.

Table 1 Approximate Group ' Denrotzction Wave~encth Nitrove=atryloxy carbonyl (NVOC) W (300-40o nm) Nitrobenzyloxy carbonyl (NBOC) W (300-350 n:i) Dimethyl dimethoxybenzyloxy carbonyl W (280-300 nm) 5-Bromo-7-nitroindolinyl W (420 nm) o-Hydroxy-a-methyl c'innamoyl UV (300-350 nm) 2-oxymethylene anthraqu.none UV (35e nm) While the invention is illustrated primarily herein by way of the use of a mask to iiiuminata selected regions the substrate, other techniques may also be used.
For example, the substrate may be translated under a modulated laser or diode light source. Such technicues are discussed in, for example, U.S. Patent No. 4,7I9,6?5 _ ,. (Feyrer et al.), In alternative embodiments a laser galvanometric scanner is utilize. In other embodiments, the synthesis may take place on yr in contact with a conventional liquid crystal (referred to herein as a "light valve") o= fiber optic light sources. By appropriately modulating liquid c:ystals, Light may be selectively controlled so: as to permit light to contact selected regions of the ubstrate: Alternatively, synthesis may take place on the end of a series of optical fibers to which light is selectively applied.
Other means of controlling the location of light exposure will be apparent to those- of skirl in the art:
The substrate;may be irradiated either in contact or not in contact with a solution (not shown) and is, preferably, irradiated in contact with a 35 Solution. The solution'conta'1ns reagents to prevent the by-products formed by irradiation from interfering with synthesis of the polymer according to some embodiments.
Such by-products might include, ~or example, carbon Z' dioxide, nitrosacarbonyl compounds, styrene der.vatives, indoie derivatives, and products of their photochemical reactions. Alternatively, the solution may contain reagents used to match the index of refraction of t:~e substrate. Reagents added to t'~e solution may further include, for example; acidic or basic buffers, thiols, substituted hydrazines and hydroxylamines, reducing agents~(e.g:, NADH) or reagents known to react with a given functional group (e, g., aryl nitroso + glyoxylic acid ~» aryl formhydroxamate + Co2).
Either concurrently with or after the irradiation step, the linker molecules are washed or otherwise contacted with a fltst monomer, illustrated by "A" in regions 12a and 12b in Fig. 2. Tha first Monomer reacts with the activated functional groups of the linkage molecules which have been exposed to light.
The first monomer, which is preferably an amino acid, is also provided with a photaprotective group. The photoprotective g=oup on the monomer may be the same as or different than the protective group used in.the linkage molecules; and may be selected from any of the above-described protective groups. In one embodiment, the protective groups for the A monomer is selected from the group NBOC and NVOC.
As shown in Fig: 3, the process of irradiating is thereafter repeated, with a mask repositioned so as to remove linkage protective groups and expose functional groups in regions 14a and 14b which are illustrated as being regions which were protectea in the previous masking step. As an alternative to repositioning of the first mask, in many embodiments a second mask will be utilized. In other alternative embodiments, same steps may provide fo-r illuminating a common region in successive steps: As shown in Fig. 3, it may be desirable to provide separation between irradiated regions. For example, separation of about 1-5 um may be appropriate to account for alignment tolerances.

As shown in Fig. 4, the subsgate is then exposed to a second protzctad monomer "B," producing B regions 15a and 16b. Thereafter, the substrate is again masked so as to remove the protectlY2 groums a:~d expose reactive groups on A region 12a and B region 16b.
The substrate is again exposed to monomer B, resulting in the foraation of the structure shown in Fig. 6. The dimers B-A and B-B have been produced cn the substrate.
A subsequent series of masking and contacting steps similar to those described above with A (not shown) provides the strscture shown in Fig. 7. The process provides all possible dimers of B and A, i.e:, B-A, A-B, A-A, and H-B:
The substrate, the area of synthesis, and the lc area for synthesis of each individual polymer could be of any size or shape. For example, squares, ellipsoids, rectangles, triangles, circles; or portions thereof, along with irregular geometric shapes, may be utilized.
Duplicate synthesis areas may a3so be applied to a single substrate for purposes of redundancy.
In one embodiment the regions 12 and 16 on the substrate will have a surface area of between about 1 c:n2 and 10-1° cm2. In some embodiments the regions l2 and 16 have areas of less than about 10-j cm2; 10-2 cmz; 10-3 cmZ, IO-4 cm2, 10-5 cmz, I0-6 cm2; i0-~ cm2; 10-8 cmZ, or lOwo cm2.
In a preferred embodiment, the regions 12 and 16 are between about 10x10 ~Cm and 500x500 ~cm.
In some embodiments a single substrate supports more than about 10 differ=ent monomer sequences and perferably more than about IOO different monomer seguences, although in some embodiments more than about 103, TOj, 105, 10b, 101, or 108 different sequences are provided on a substrate. Of course, within a region of the substrate in which a monomer sequence is synthesized; it is preferred that the monomer sequence be substantially pure: Ln some embodiments, regions of the substrate contain polymer sequences which are at least about l%, 5%, 10%, 15%; 20%, .~.5%, 30%, 35%, ~0%, 45%, 50%, 60%, 70$, 80%, 90%, 95%, 96%, 97%, 98g, or 99% pure.
According to same embodiments, several.
sequences are intentiona3ly provided within a single region so as to provide an initial screening for biological activity, after which materials within rec:cns exhibiting significant binding are further evaluatec.
q IV. Details of One Eriboc~iment of a Reactor System Fig. 8A schematically illustrates a preferred embodiment of a reactor system l00 for synthesizing polymers an the prepared sub,~trate in accordance wit:: one aspect of the invention: The reactor system induces a body 102 with a cavity 104 on a surface thereof. In preferred embodiments the cavity 104 is between about 50 and 1000 ~cm deep with a depth of about 500 ~cm preferred.
The bottom of the cavity is preferably provided with an array of ridges 106 Which extend laoth into the 20 plane of the:Figure and parallel to the plane of the Figure. The ridges are preferably about 50 to 200 ~m deep and spaced at about 2 to 3mm. The purpose of the ridges is to generate turbulent flow for better mixir.G.
The bottom surtace of the cavity is preferably light ~5 absorbing so as to prevent reflection of impinging light.
A substrate 11:2 is mounted above the cavity 104. The substrate is provided along its bottom surface 114 with a photoremovable protective group such as NVOC
with or without an intervening linker molecule . The p substrate is preferably transparent to a wide spectrum of light; but in same embodiments is transparent only at a wavelength at which the protective group may be removed (such as UV in the case of NVOC). The substrate in some embodiments is a conventional microscope glass slide or cover slip. The substrate is preferably as thin as possible; while still providing adequate physica3 support: Preferably, the substrate is less than about 1 mm thick, more preferably less than 0.5 mm thick, :yore preferably less than 0.1 mm trick, and most preferably less than o.05 mm thick: In alternative preferred embodiments, the substrate is quartz or silicon.
The substrate and the body serve to seal the cavity except for an inlet fort 108 and an outlet port 110. The body and the substrate may be mated for sealing in some embodiments with one or more gaskets. According to a preferred embodiment, the body is provided wit:. two i0 concentric gas~sts and the intarvening space i,s held at vacuum to ensure mating of the substrate to the gaskets.
Fluid is pumz~ed through the inlet port into the cavity by way of a pump 116 ~thich may be, for example, a model no. H-120-S made by Elder Laboratories. Selected fluids are circulated into the cavity by the pump, through the cavity, and out the outlet for reei~culation or disposal. The reactor may be subjected to ultrasonic radiation and/or heated to aid in agitation in some embodiments.
Above the Substrate i12, a lent 120 is provided which may be, for example, a 2" lOOmm focal length fined silica lens. For the sake of a compact system, a reflective mirror l22 may be provided for directing light from a light source 124 onto the substrate. ~,igr~t source 124 may be, for example, a Xe(Hg) light source manufactured by Oriel and having~model no. 66024. A
second lens 12fi may be provided for the purpose of projectirc a mask image onto the substrate in combination with lens 120. This for~.a of lithography is referred to herein as projection'printing. As will be apparent from this disclosure, proximity printing and the like may also be used according to ame embodiments.
Light from the bight source is permitted to reach only selected locations on-the substrate as a result of mask 128. Mask IZ8 maybe, for example, a glass slide having etched chrome thereon. The mask 128 in one embodiment is provided with a grid of transparent locations andopaque'locations. Such masks may be manufactured by, for exaixple, Photo Sciences, Inca Ligh passes freely through the transparent regions of the mask, but is. reflected from or absorbed by other regions.
Therefore, only selected regions of the substrate are expo ed to light.
As discussed above, light valves (LCD's}
may be used as an alternative to conventional masks to selectively expose regions of the substrate.
Alt~raatively, fiber opt.ic'faceplates such as those available from Schott Glass, Inc, may be used for the, purpose of contrast enhancement of the mask or as the sale means of restricting th~.region to which light is applied. Such f3caplates would be placed directly above IS or on the sub trate in the reactor shown in Fig. 8A: Ia still further embodiments; flys-dye lenses, tapered =fiber optic faceplates, or the like; may be used for contrast enhancement.
In order to provide for illumination of regicns smaller than a wavelength of light, more elaborate techniques may be utilized. For example, according to one preferred embodiment, light is directed at the substrata by way of molecular microcrysta~.s on the t~p of, for example, micropipettes. Such devices are 25 disclosed in 'Lieherman ,e~ a~., "A Light Source Smaller Than the Optical Wavelength;" Science (1990) 247;59-61>
In operation, the substrate i5 placed on the fl cavity and sealed thereto. A11 operations in the process cf preparing the substrate are carried out in a room lit primarily or entirely by light of a Wavelength outside of the light range at which the protective group is removed.
For example, in the case of NVOC, the room should be lit 35 With a.conventional darkroom light which provides little or no UV light. A11 operations are preferably conducted at about room temperature.

A first, deprotection fluid (Without a monomer;
is circulated through the cavity. The solution preferably is of 5 mM sulfuric acid in dioxane solution which serves to keea exposed amino groups protonated and decreases their reactivity with photolysis by-products.
Absorptive materia3:s such as N;N-diethylamino 2,4-dinitrobenzene, for example, may be included in the deprotection f3uid which serves to absorb light and prevent reflection and unwanted photolysis.
1Q The slide is, thereafter, positioned in a light raypath fram the mask such that first locations or, the substrate are illuminated and, therefore, deprotected.
In preferred embodi-~ents the substrate is illuminated for between about l and 15 minutes with a preferred 15 illumination time of about l0 minutes at 10-20 mW/c~n= wit'.~.
365 nm light. The slides are neutralized (i..e., brought to a pH of about 7) after photolysis with, for example, a.
solution of di-isopropylethylamine (DIEA) in methylene chloride for about 5 minutes.
The first monomer is then placed at the first locations on the substrate. After irradiation, the slide is removed, treated in bulk, and then reinstalled in the flow cell. Rlternatively, a fluid containing the first monomer ,preferably also protected by a protective group, is circulated through the cavity by way of pump 116. Lf, for example, it is: de fired to attach the amino acid Y to the substrate at the first locations; the amino acid Y
(bearing a p:otective group on its a-nitrogen), along with reagents used to render the monomer reactive, and/or p a carier, is circulated from a s orage container 11s, through the pump, through the cavity, and back to the inlet of the pump.
The monomer carrier aoiution is, in a preferred embodiment; formed b~ mixing of a first solution 3S (referred to herein as solution "A") and a second solution (raferrsd to herein as solution "H"): Table 2 provides an illustration of a mixture which :nay : a used for sarution A.
Tab3,e 2 reap t . ~ Ve t- arri er p: ti n ttA n LOO mg NVOC amino protected amino acid 37 mg Ii08T (1-Hydroxybenzotriazole) 250 ~1 DMF (D:i.methylformamzde) 86 u1 DIEA (Diisopropylethylamine) The compo ition of solution B is illus~razs~: in Table 3. Solutions A and H are mixed and allowec to react at soo:a temperature for about 8 minutes, t!~en diluted with 2 m1 of DMF, and 500 ~c1 are applied to the surface of the slide or the solution is circulated through the reactor system and allowed to react far about 0 2 hours at room temperature: The slide is then washed with DMF, methylene chloride and ethanol.
Reore ent~tive MQ;p;omer Carrier Sol~ut~ an 250 ~l DMF
111 mg BQP (Benzotriazolyl-n-oxy-tris(dimethylaminc) phosphoniumhexafluorophosphate) As the solution containing the monomer to be attached is circulated through the cavity the amino acid or other monomer will react at its carboxy teranus with amino groups on the regions of the substrate which have been deprotectad. Of course, while the invention is illustrated by way of circulation of the monomer through the cavity, the invention cou3d be practiced by way o' removing tae slide frcm the reactor and submersing i~.. in an appropriate monomer solution.
After addition of the first monomer, the solution containing the first amino acid is then purged from the system. Aftzr circulation of a sufficient amount of the DMF/methylene chloride Such. that removal of the amino acid can be assured (e.g., about 50x times the volume of the cavity and carrier lines), the mask or substrate is repositioned, or a new mask is utilized such la that second regions on the substrate will be exposed to light and the light l24 is engaged for a second expcsure.
This will deprotect second regions on the substrate and the process is repeated until the desired polymer sequences have been ynthesized. .
15 The entire derivatized substrate is then exposed to a receptor of interest, preferably labeled with, for example, a fluorescent marker, by circ~~laticn of a solution or suspension of the receptor thrbugh the.
cavity yr by contacting the surface of the slide in bulk.
The receptor will prefez8ntially bind. to certain regions of the substrate which contain complementary seguences.
Antibodies are typically suspended in what is commonly referred to as: "supercacktail,": whic:~ may be, for example, a solution of about I~ BSA (bovine seru:.~, albumin), o:5% T'ween'~in PHS (phosphate buffered sa?iney buffer. The antibodies are diluted into the supercacktail buffer to a final concentration of, for example, about 0.3. to 4 ~sg/ml.
Fig. 88 illustrates an alterna rive prat erred 3Q embodiment of the reactor shown in Fig. 8A. According to this embodi.went, the mask 128 is placed directly in contact with the substrate. Preferably, the etched portion of the mask is placed face down so as to reduce the effects of light dispersion: According to this 35 embodiment; the imaging lenses'120 and iZ6 are not necessari because the mask is brought into close proximity with the substrate.
* trade-mark j5 Fog pur~oses of increasing the signal -to-noise ratio of the tech.~.ique; some embodyments of the invention provide for exposure of the substrata to a first labeled or u~~.labeiec recsp~~r fllowed by exposure of a labeled, second receptor (e. g:, an antibody) which bfinds~at multirle sites or. she first receptor. If, for example, the first receptor is an antibody derived from a first species of an animal, t.'~e second receptor is an antibody derived from a second species directed to epitopes associated with the fist species. In the case of a mouse antibody, for example, fluorescently labeled goat antibody or antiserum which is antimouse may be used to hind at multiple sites an the mouse antibody, providing several times the fluor~scencs compared to the attachme.~.~
of a single mouse antfibody at each binding site. This process may be reaeate3 again with additional antibodies (e.g., goat-mouse-goat, etc.) for further signal amplification.
In preferred embodiments an ordered sequence of 2~y masks is utilized. Tn soiae embodiments it is possible to use as few as a single mask to synthesize all of the possible polymers of a given monomer set.
If, for example, it is desired to synthesiza all 16 dinuc3eotides from-four bases, a l cm scuare synthesis region is divided conceptually into 16 boxes, each 0.25 c~ wide: Denote the four monomer units by A, B, C, and D. The first reactions are carried out in four vent=cal columns, each 0.25 cm wide. The first mask exposes the legt~bost column of boxes, where A is 30 oouPled. The second mask exposes the next column;
where 8 is coupled; followed-by a third mask, for the C column: and a f::nal mask that exposes the right-most column, for D. The first, second, third, and fourth masks may be a single mask translated to different 35 locations.

The process is repeated in the horizontal directicn for the second unit of the dimer. This time, the masks allow exposure of horizontal rows, acain 0.25 cm wide. A, B; C, and D are sequentially coupled using masks that expose horizontal fourths of the reaction area. The resulting substrate contains all 16 dinucleotides of four bases:
The eight masks used to synthesize the dinucieotide are related to one another by trans?at.on c.
rotation. In fact, one mask can be used in all eight steps if it is: suitably rotated and translated. :or example, in the example above, a mask with a single transparent region could be sequentially used to expose each of the vertical columns, translated 90', and then ,s sequentially used to allow exposure of the horizontal rows.
Tables 4 and 5 provide a simple computer program in Quick Basic for planning a masking program and a sample output; respectively, for the synthesis of a p°lYmer chain of three monomers ("residues") having three-diffe=ent monomers in the first Ieyel, four different monomers in the second level, and five different monomers in the third le~ei in a striped pattern. The -output of t:~e program is the nurber of cells, the number of "stripes" (light regions) on each mask, and the amount of translation required far each exposure of the mask.

a 1e 4 Ma k ~t-ra~,egv Pro.~rar~.
DE:INT A-Z
DIM b(20), w(20), 1(500) F $ - "I:PT1: "
OPEN f$ FAR OUTPUT AS #1 jmax - 3 'Number of residues b(i) - 3: b(2) - 4: b(3) - 5 'Number of building blacks zor res 1,2,3 g - I: lmax(I) - l FOR j - 1 TO j max : g- g * b ( ~ ) : ' NEXT j w(0) - 0: w(1) - g / b(1) PRINT ~1, "M.ASK2 . BAS " DAT~$ , TI?YiE$ : PRINT #1, PRINT T1, USING ":lumber of residues:" ; fax FOR j ~ 1 TO jmax ?P,INT w l , USING " Residue ~ =~ building blocks" ; j ; b ( j ) NEXT j PRINT ,=1, "
PRINT T, L!SING "Number of cells-~x"; g: PRINT #l, FOR j - 2 TO jmax lmax(j) - lmax(j - 1) * b(j - 1) w(j ) - w(j - 1) / b(3 ) NEXT j FOR j - 1 TO j max PRT_NT #1; USING "Mask for residue ~"; j: PRINT #1, PRINT #L, USING " Numcer of stripes-"; lmax(j) PRINT =I, USING " Wfdth of each stripe-~a"; w(j) FOR 1 - 1 TO lmax(j) a - 1 + (1 - 1) * w(j - 1) ae - a + w(j) ~ I
PRINT ~1, USING " St:i;pe ~e begins at location and ends at ~"~ 1; a; ae PRINT =1, PRINT ~1, USING " For each of os# building blocks, translate mask by ~~
cells)"; b(j); w(j), .
PRINT #1, . PRINT #1, . PRINT #I, NEXT j m Copyright 1990, Affymax N.V.

Tab a Masking StrateQV Output 'lumber of residues- 3 Residue 1 3 building blocks Residue 2 4 building blocks Residue 3 5 building blocks Number of cells- 60 Mask for residue 1 Number o= stripes- 1 Width of each stripe- 20 Str~pe l begins at location 1 and ends at 20 For each of 3 building Mocks, translate mask by 20 cells) ::ask for residue 2 Number of stripes- 3 Width of each stripe- S
Stripe l begins at location 1 and ends at 5 Stripe 2 begins at location 21 and ends at 25 Stripe 3 begins at location 4l and ends at 45 For each of 4 building blocks; cransiate mask by 5 cells) Mask for residue 3 Number of stripes- 12 Width of each stripe- I
Stripe 1 begins at location I and ends at 1 S;.ipe 2 begins at location 6 and ends at 6 Stripe 3 begins at location I1 and ends at 11 Stripe 4 begins at location I6 and ends at 16 Stripe 5 begins at location 21 and ends at 2I
Stripe 6 begins at location 26 and ends at 26 Stripe 7 begins at location 31 and ends at 3I
Stripe 8 begins at location 36 and ends at 36 Stripe 9 begins at location 41 and ends at 4I
Stripe 1O begins at location 46 and ends at 46 Stripe 1l begins at location 51 and ends at 51 Stripe 12 begins at location 56 and ends at 56 For each of 5 building blocks, translate mask by l cells) ~ Copyrigh 1990, Affymax N.V:

V. Details of ~~e ~ ~odime.~.~ of A Fluor=_scfl.~.t -Detection Device Fig. 9 illustrates a fl~:orescent 'detectic;.
device far detecting fluorescantl:: ?abeied receptors on a substrate: A substrate 112 is placed on an x/_~
translation table 202. In a preferred e~odi:~2nz t'.-.=_ x/y transiaticn table i5 a model. no . ~ M5 0 0-yl man4f actor ;d by Newport Corporation. The x/y ~_anslaticn table connected to and controlled by an aapratriatev i0 Programmed digital camputer 204 which may be, =ar example, an apprapriately program.~ed LB:~ PC/Aor A
compatible coma~ter. Of cau=se, other ;:omputa= sys~_:~s, special purpose hardware, of the l;ke c:.;:ld reacilv ~' substituted for tie ~T. com~u,;.er used herein for 15 illus tra ripe . Computer sof triare f :,r the tr ars=a tic-and data coilac~ion functions described :~erei:: can ~~
provided based on commerciaz :.y ava~.l ~bi~ sof t.:are including, for example, "Lab Windc~rs~~ licensee by National Inst~ents':
The substrate and x/y translation table a.-=
planed under a microscape 206 which includes one or pore objectives 208. Light '(abo4t 488 em) fram a Laser 2=0, which in some embodiments is a model no. 2020-05 arccn ion laser manufactured by.Spectrapysics, is direcz=c at the substrate by a dichroic mirrc~ 207 which gasses greater than about 520 em i~ght bLt ref'ects ~38 em light. Dic:~roic mirror 207 may be; for example, a w~del no. FT510 manuzacturad by Carl Zeiss. Light reflec==:
from the mir;or then enters the m=croscope 206 whic:: :aay be, for example, a model no. Axioscov 20 manufactured by Carl Zeiss. Fluorescein-harked materials on the substrate will =luoresce >488 em light, and t::e fluflresced light will be co?lected by t:':e micrcsc,~,pe 3c and passed through the mirror. T:~e fluoresce~c lic::=
from the substrate is then directe3 thr;.ugh a ;~avele.-.gt:~
filter 209 and, thereafter throng:. an aperture plate 2I1.
* trade-mark wavelength filter 209 may be, for example, a model no. 0G~30 manufactured by Melles Griot and aperture plats 211 may be, for example, a model no. 477352/:~a7380 manufactured by Cari Zeiss.
The fluoresced lfight then enters a photomultipli~r tube 212 which in some embcdi:aents is a model no. 8943-02 manufactured by Hamamatsu, the sicnal is amplified in preamplifier 214 and~photons are counted by photon counter 216: The number of photons is recorded as a function of the location in t:~e computer 204.
Pre-Amp 2Z4 may be, for example, a model no. SR440 manufactured by Stanford Research Systems and photon counter 2I5 may be a model no. SR4D0 manufactured by Stanford Research Systems. The substrate is then moved to a subseauent location and the process is repeated.
In preferred embodiments the data are acquired every 1 to 100 ~cm with a data collection diameter of about 0:8 to 10 ~cm preferred. In embodiments with sufficiently high fluorescence, a CCD detector with broadfield illumination is utilized:
By counting the number of photons generated in a given area in response to the laser, it is possible to determine where fluorescent marked molecules are located on the substrate. Consequently, for a slide wh.ic:~ has a matrix of poiypeptidesfor example, synthesized on the surface hereof, it is possible to determine which of the polypeptides is complementary to a fluorescently marked receptor.
According to preferred embodiments, the intensity and duration of the light applied to the substrate is controlled by varying the laser power and scan stage rate foz improved signal-to-noise ratio by maximizing fluorescence emission-and minimizing background noise.
35 While the detection apparatus has been illustrated primarily herein with regard to t!~e detection of marked receptors, the invention will find application ~1 in other areas. For example, the detactian apparatus discicsed herein could be used in the fields of catalysis, DNA or protein gel scanning, and t:~e like.
VI . DeteT-mination of Rel ati.VA
~indincr Strength of ~,ecettors The signal=to-noise ratio of the present invention is sufficient?y high that not only can the presence or absence of a redeptor on a ligand be detected, but also the relative binding affini~~y of receptors to a variety of sequences can be deter";inec.
In practice it is found that a receator will bind to several peptide sequences in an array, but will bind muc:z more strongly; to some secxuences than others.
Strong binding affinity will be evidenced herein. by a strong fluorescent or radiographic signal since many receptor molecules will bind in a region of a strongly bound ligand. Conversely, a weak binding affinity will be evidenced by a weak fluorescent or radiographic signal due to the relatively small number of receptor molecules which bind in a particular region of a substrate having a ligand with a weak binding affinity, for the receptor.
Consat~uently; it becomes possible to determine =elative binding avidity (or affinity in the case of univalent l~ interactions) of a ligand herein by way of the intensify of a fluorescent or radiographic signal in a region containing that ligand.
Semiquantitative data on affinities might also be obtained by varying washing conditions and concentrations of the receptor. Thz would be done by comparison to known ligand receptor pairs, for example.
VII. Exam~Ies The following examples are provided t~
illustrate the efficacy of the inventions here n. All operations were conducted at about ambient temneratu=es and pressures unless indicated to the contrarv.

A. Slide Prpnaration Before attachment of reactive groups it is preferred to clean the substrate wrich is, in a preferred emi~cdiment a glass substrate such. as a microscope slide or cover slip. according to one embodiment the slide is soaked in an alkaline bath consisting of, for example, 1 liter of 95% ethanol with 120 ml of water ard:120 grams of sodium hydroxide for L2 hours. The slides are then washed under running water and allowed to air dry, anc i0 rinsed once with a solu~icn of 95% ethanol.
The slides are then aminated with, for exa:~ple, aminopropyitriethoxysilane for the purpose of attaching amino groups to the glass surface on linker molecules, although any omega funct~onalized silane could also be 1~ used for this purpose. in one embodiment 0.10 aminopropyltriethoxysilane is utilized, although solutions with concentrations from l0-'% to l0% may be used, with about IO-3% to 2% preferred. A 0:1% mixture is prepared by adding to 100 ml of a 95% ethanol/5% water 20 mixture, 10O microliters (~l) of aminopropyltriethoxy-silane. The mixture is agitated at about ambient temperature on a rotary shaker for about 5 minutes.
500 u1 of thismixture is then applied to the surface of one side of each cleaned slide. After 4 minutes, the 25 slides are decanted of this solution and rinsed three times by dipping in, for example, 100% ethanol.
After the plates dry, they are placed in a 110-120'C vacuum oven for about 20 minutes, and then allowed to cure at room temperature for about l2 hours 30 in an argon environment. The slides are then dipped into DMF (dimethylformamide) solution, followed by a thorough washing with methylene chloride:
The aminated surface of the Tide is then exposed to about 500 u1 of, for example; a 30 milli:~olar 25 (mM) solution of NVDC-GAGA (gamma amino butyric acid) NhS
(N-hydroxysuc~ini~ide) in DMF for attachment of a NVOC-GABA to each of the amino groups.

The surface is washed :pith, fir example, ~MF, methylene chloride, and etzanal.
Any u~rsacted a~inoprcpyl siiane on the surface--that is, these amino grcu~s which have nc:.':ad the NVOC-GAGA attached--are now capped with acct 1 ~r Y' ~ ours (to preventfurther'reaction) by exposure to a 1:3 mixture of acetic anhydride in pyridine for 1 hour.
other materials whicmay perform this residual capping function include tri;luorcacetic anhydride; formicacetic a~Ydride, or other reactive acyiating agents. Fi.~.ally, the slides are washed again with DMF, methylene c::'_~ride, and ethanol.
r T..;~.~,r.s Cr ttpn and tmt~
g. Svn~hesis of E_a;
F:ig. 10 illustrates a possible synthesis of the eight trimers of the t:ao-:~onc~z~r set: gly, phe (represented by ttAtt and t3, ~n respectively) . A gla=_5 slide bearing silane groups terminating in 6-nitre-veratryloxycarboxamide (NVOC-NH) residues is prepared as a substrate. Active esters (pentafluorophenyl, OBt, etc:) of gly and phe pratectad at the amino group ;pith NVOC are prepared as reagents:: While not pertiner~ to this example, if side chain protecting gsoups are rpcuired for the monomer set, these must not be 23 photoreactive at the wave?ength of light used to protect the primary chain.
For a monomer set of size n, n x E cycles are required to synthesize all possible sequences of length t. A cycle consists of:
30 1. Irradiation through ,an appropriate »:ask to expose t:'~e- amino groups at the si;.es where the next residue is to be added, with appropriate washes to remove t'.~.e by-products o~ the deprotection.
35 2. Addition of a single activated and protected (with t::e same phot~chem:cally-removablegroup) monomer, which wil'_ react only at the sites addressed in step 1; ::~th appropriate washes to remove the excess reagent f i ~m the surf ace .
The above cycle is repeated for.eacn member of the monomer set unti-1 each location on the surface has been extended by one residue i:~ one embodiment. In ct:~er embodiments, save-ral residues are sequentially added a~
one location before moving on to t2~.e next location:
Cycle times wil? generally be limitzd by the coupling reaction rate, now as short as 20 min in autematea peptide synthesizers. This step is optionally followed by addition of a protecting group to stabilize the ar=ay for later testing. For some types of polymers (e. g., peptides), a final deprotection of the entire ,5 surface (removal of photoprotective side chain groups) may be reauired.
More particularly, as shown in Fig. 20A, she glas 20 is provided with regions 22, 24, 26, 23, 30, 32, 34, and 36. Regions 30, 32, 34, and 36 are masked, as shown in Fig: 108 and the glass is irradiated and ex-posed to a reagent containg "A" (e.g., gly), with t~.e resulting structure shown in Fig. lQC. Thereafter, regions 22, 24; 26, and 28 are masked, the glass is irradiated (as shown in Fig. lOD~ and exposed to a 5 reagent containing "H" (e. g., phe), with the result_.a structure shown in Fig. IOE: The process pr4ceeds, consecutively masking and exposing the sections as s;~own until the structure shown in Fig. lOM is obtained. The glass is irradiated and the terminal groups are, optionally, capped by acetylation. As shown, all possible trimers of gly/phe are obtained.
In this example, no side chain protective group removal is necessary. If it is des iced, side chain deprotection may be accomplished by treatment with ethanedithiol and trifluoroacetic acid.
In general, the number of steps needed to obtain a particular polymer chain is defined by:

n x E (1) where:
n = the numrae~ of monomers i~ the basis set of monomers, and L = the number ~of monomer units in a pclymer chain.
Conversely; tie synthesi2ed number of szauences of length E will be:
nc. (2) Of course, greater diversity is obtained b_J
.- using masking strategies which will also include the synthesis of polymers having a length of less than E.
If, in the extreme case, all polymers having a lengt:: , less than or equal to E are synthesized, the number of polymers synthesized will be:
nt + nt:. + . . . + n1 : ( 3 ) The maximum number of lithographic steps needed will generally be n for'each "layer" of monomers, i.e., the total number of masks (and, therefore, t:~e number of lithographic steps) needed will be n x E. The size of the transparent mask regions will vary in accardanea with the area of the substrate availab3e for synthesis and the number of sequences to be formed. In general; the size 0 of the synthesis areas will be:
size of synthesis areas _ (A)/(S) where:
35 ,A is the total area available for synthesis;
and S is the number of sequences desired in to area.
I t will be aDarec'iated by those of skit 1 i~
the art that the above method could readily be used to simultaneously produca thousands or millions oz oligcmers on a substrate using the photolithographic tec:~nicues disclosed herein. Consea_uently, the methcd rssult in the ability to practically test large numi~ers of, for example, dl, ti, tetra; penta, hexa, hepta, octapeptides, dodecapeatides, er larger polypeptides (or coriespondinrly, polynucleotides).
The above examale has illustrated the me~::cd by ~aav of a manual example. It will of course be appreciated that autoaate:- ~r semi-automated methcds cou?d be used. The substrate would be mounted in a flow cell for automated addition and removal of reage.~.as, to minimize the volume of reagents needed, and to more carefully control reaction condit.ons. Successive masks Q . could be applied manually or automatically.
~, C. Synthesis of a Dimer of an Aminoaroavl Groua and a Fluorescent Groub In synthesizing the dim~r of an amiroar pyl group and a fluorescent-group, a functionalizec durapore*
membrane was used as a substrate: The duraaare me~~rane was a polyviny2idine difluoride with aminopropyl Groups.
The aminoprapyl groups were protected with the DDZ group by reaction of the carbonyl chloride with the amino groups, a reaction readily known to t,.'~ose of skill in the art. The surface bearing these groups was placee in a solution of THF and contacted with a mask bearing a checkerboard pattern of 1 mm opacrue and transparent regions. The mask was exposesi to ultraviolet light having a wavelength down to at least about 280 nm yor about 5 minutes at ambient temperature, although a wide range of exposure times and temperatures may be * trade-mark apcr cpr late in var ions embodiments of the inver. tio.~. , For example, iZ one ebbodiment, an exposure time of between about 1 and 5000 seco.~ds may be used at process temz~eratures of betwee:~ -70 and -~50 ~ C.
In one pref ery ed emnodianent , exposure times c f between about l and 500 seecnds at about ambient pressure are used. In some preferred embodiments, presssre above ambient is used to prevent evaporation.
Tre surface of the membrane was then washed fcr about l hour with a fluorescent label which irciuded an active ester bound to a chelate of a lanthanide. wash times will vary over a wide range of values frc:,i about a few minutes to a few hours. .These materials fluoresce in the red and the green visible region. Afte.'he reaction with the active ester in the fluoronhcre was complete, the locations in which the fluorophore was bound could be visualized by exposing them to ultraviolet light and observing-the-red and the green fluoresce.~.ce.
It was observed that the derivatized regions of the substrate closely corresponded to the original pattern of the mask.
D. Demonstration of Signal Canabilitv Signal detection capability was c3emcnstraZed I5 using a low-level standard fluorescent bead kit manufactured by Flow Cytomet~y Standards and having :~edel no. 824. This kit includes 5:8 ~cm diameter beads, each impregnated with a known number of fluorescein molecules.
One of the beads was placed in the illumination field on the scan stage as shown in Fig. 9 in a field of a laser spot which was initially shuttered. Alter being po itioned in the illumination field, the photon detection equipment was turned on;. The laser beam was unblocked and it interacted with the particle bead, which then fluoresced. Fluorescence curves of beads impregnated with 7,000 and 29,000 fluorescein r.:olecules, are shown in Figs: 11A and 1L3, respectively. On each curve, traces for beads without fluorescein molecules aye also shown. These experiments were performed wish 4$3 r.:a excitation, with 100 I~W of laser power. The light was focused throuch a 40 power 0.75 NA objective.
The fluorescence intensity in all cases'started off at a high valise and then decreased exponentially.
The fall-off in intensity is due to photableaching o the fluorescein molecules: The traces of beads without fluorescein molecules are used for background subtraction. The difference in the initial exponential decay between labeled and noniabe~;ed beads is integrated to give the total number of photcn counts, and this :number is related to the number of noiecules per bead.
Therefore; it is possible to deduce the number cf photcrs per fluorescein molecule that can be detected. :or t:e curves illust~at~ed in Fig. 1l, this calculation indicates the radiation of about 40 to SO photons per fluorescein molecule are detected.
p ~. Determination of the Number of Molecules Per Unit-Area Aminoprop~lated glass microscope slides pre~ared according to the methods discussed above were utilized in order to establish the density of labeling c_' the slides. The free amino termini of the slides were reacted with FITC (fluorescein isothiocyanatP) which forms a covalent linkage with the amino group. The slide is then Scanned to count the number of fluorescent photons generated in a region which, using the estimated 30 40-SO photons per fluorescent molecule, enables the calculation of the number of molecules which are on the surface per unit area.
A slide with aminaprapyl silane on its surface was immersed in a l mM solution of FITC in DMF for 35 1 hour at about ambient temperature. After reaction, the slide was washed twice with DMF and then washed with ethanol, water, and then ethanol again. It was then drie3 anci stored in the dark until it was react' to ~=
examined.
Through the use of curves similar to thcs2 shown in Fig. L1, and by integrating the fluoreseer~
G counts under the exponentially decaying signs:, the number of free amino groups on the surface after deri:vitization was determined. Z t was determined t'.-.at slides wit.' labeling densities of 1 fluoroscein per 103x103 to ~2x2 nm could be reproducibly made as the canc~ntration of aminopropyltriethoxysilane varied _=om IO-5% to 10-1% .
F, removal of NVOG and Attachment of A Fluorescent Marker NVOC-BABA groups were attached as descri'cec above. The entire surface of one slide was e,coos2c to light so as to expose a'free amino group at the enc of the gamma amino butyric acid. This slide, and a duplicate which was not exposed, were then exposed 20 to fluo~escein isothiocyanate:(FZTC).
Fig. 12A illustrates the slide whic:: was ::ot exposed to light, but which was exposed to FITC. T~:e units of the x axis are time and the units of the y axis 'are counts. The trace contains a certain amount of background fluoresc8nce. The duplicate slide was extosec to 35O nm broaaband illumination for about l ninut= .
(12 mW/cm2, -350 nm illumination), washed and react=d with FZTC. The fluorescence curves for this slide a~-e shown in Fig. 1ZH. A large increase in the level c=
p fluorescence is observed, which indicates photolysi_=
has expo ed a number of amino graups on the surface of the slides for attachment of a fluorescent marker.

G. Use of a Masl~ in Removal of NVOC' The next experiment was performed wit:: a C.1%
ami.~.corcpylated slide. Light from a Hg-Xe are lamp was imaged onto the subs rate through a laser-ablated chrome-on-glass mask in direct contact wi~,:h the substrate.
This slide was illuminated for approximately 5 minutes, with 12 mW of 350 nm broadband light and then eacted with the l mM FITC solution. It was put on the IO laser detection scanning.stage and a graph was plotted as a two-dimensional representation of position color-coded for fluorescence intensi y. The experiment was repeated a number of times through various masks. The fluorescence patterns for a 100x100 ~m mask; a 50 um 15 mask, a 20 ~cm mask, and a 10 um mask indicate that the mask pattern is distinct down to at least about l0 um squares using this lithographic technique.
H. Attachment of'YGGFL and Subsecruent ~xDOSUrp to 20 Herz'Antibodv and Goat A~ntimouse Zn order-to establish that receptors to a particular polypeptide sequence would bind to a surface-bound peptide and be defected; Leu enkephalin was coupled to the surface and recognized by an antibody. A slide was derivatized with0:1% amino-propyl-tr~ethoxysilane and protected with NVOC. A 500 ~m checkerboard mask was used to expose the slide in a flow cell using backside contact printing. The Leu enkephalin sequence (HZN-tyrosine,glycine,glycine,phenylalanine,leucine-CO=H, 30 o~erwise refer=ed to herein as YGGFL) was attached via its carboxy end to the exposed amino groups on the surfaceof theslide. The peptide was added in DMF
solution with the 80P/HDHT/D3EA coupling reagents and recirculat~d through the flow cell for 2 hours at room 35 temperature.
A'first antibody, known as the Herz antibody, was applied tb the surface of the slide for 45 minutes at 2 ug/ml in a sup~rcocktail (cAntaining I% BSA and 1% ova~.bumin a?so in this case). A second antibcdy, goat anti-mouse fluorescein canjugate,.was then adde3 at 2 ~cg/ml in the supercacktail buffer, and allowed to incubate for 2 hours.
The results of this experiment were plctted as fluorescence intensity as a function of position. This image was taken at IO um steps and showed that not only can deprot2ction be carried out in a well deffined pattern, but also that (1) the method provided for successful coupl:.ng of peptides to the surface of the substrate, (2) the surface of a bound,peptide was available for binding with a~, antibody, arid (3) that the detection apparatus capabilities were suf;icient 15- to detect binding of a receptor.
3. Manamer-by-Monomer Fornation of YGGFT and Sub,~eauent Exvosure to Labeled Ant~,~odv Monomer-by-monomer synthesis of YGGFL and GGFL
in alternate squares was performed on a slide in a checkerboard pattern and the resulting slide was exposed to the Herz antibody. This experimentis illustrated in Figs. I3A and i3H.
In Fig: 13A, a slide is shown which is derivatized with the aminopropyi group, protec.ed in this case with t-BOC (t-butoxycarbonyl), The elide was treated with TFA:to remove the t-HOC protecting group.
E-aminocaproic acid-, which was t-BOC protected at its ami:~o group, was then coupled onto the aminopropyl 0 groups. The aminocaproic acid serves as a spacer between the aminopropyl group and the peptide to be synthesized.
The amino end of the spacer was deprotected and coupled to NVOC-leucine: The entire slide was then illuminated with I2 mW of 325 nm broadband illumination. The slida 35 was then coupled with NttOC-phenylalanine and washed. The entire slide was again illuminated, then coup3ed to NVOC-glycine and washed. The slide was again illuminated and coupled to NVOC-g'.:y cine to fore the seauence shown i~
the last portion of Fig. 13A.
As shown in Fig. 138, altdrnating regions of the slide were then illuminated using a projecticn print using a 500x500 ~um checkerboard mask: thus, the amirc group of glycine was exposed only in the lighted areas.
When the next coupling chemistr-~r step was carried cut, NVOC-tyrosine was added; and it coupled only at those spots which had received illumination: The entire slide was then illuminated to remove all the NVOC groups, leaving a checkerboard of YGGFL in the lighted areas and in the other areas, GGFL. The Herz antibody (which recognizes the YGGr~L~ but not GGFL) was then added, followed by goat anti-mouse fluorescein conjugate.
,~ The resulting fluorescence scan showed dark areas containing the tetrapeptide GGF~L, which is not reccgrized by the Herz antibody (and thus there is nc binding of the goat anti-mouse antibody with fluorescein conjugate), and red areas in which YGGFL was present.
The YGGFL pentapeptide is recognized by the Herz antibcdy and, therefore; there is antibody in the lighted regions for the fluorescein-conjugated goat anti-rouse to recognize.
Similar patterns for a 50 ~,m mask used in G3 direct contact ("proximity print") with the substra;.e provided a pattern which was more distinct and the corners of the checkerboard pattern were touching as a result of the mask being placed in direct contact with the substrate (which reflects the increase in rasolLt~cn using this technique)., J. Monomer-bv-Monomer Synthesis of YGGFL and PGGFL
A synthesis using a 50 ~m checkerboard mask similar to that shorn in Fig. 13 was conducted. However, P was added to the GGFL sites on the substrate through an additional coupling step. P.was added by exposing protected GGFL to light through a mask, and subseguence exposure to P in the manner set forth above. Therefore, half of the regions on t.'~e substrato contained YGGFL and the remaining half contained PGGFL.
The fluorescence plot for this experimen;.
showed the regions are again readily discernable~bet-,aeen those in which binding did and d:d not occur. This experiment demonstrated that antibcdies are able to recognize a specific sec_uenc~ and that the re.ccgnition is not length-dependent.
'0 K. Monomer-bv-Monomer ~vnthesis of vGGFL and vpGG~'~
In order to further demonstrate t:~e cperability of the invention, a 50 ~;m checkerboard pattern of ,~ alternating YGGCL and YPGGFL was synthesized cn a substrate using technicues like-those set forth above.
The resulting fluorescence plot showed that the ant_bccv was clearly able to recognize the YGGFL sequence and did not bind significantly at the YPGGFL regions:
L. Synthesi of an Arrav of Sixteen Differ~nt Amino Acid Secruences and ~'stimation of Rep ativ~
Bindincr Affinity to HeTz Antibody Using techniques similar to those set forth above, an array of 16 different amino acid sacuences (replicated four times) was synthesized on eacof two glass substrates. The sequences were synthesized by attaching the sequence NVOC-GFL across the entire surface of the slides: Using;a series of masks, two layers of amino acids were then selectively applied to the substrate. Each region had dimensions of 0.25 cm x 0.0625 cm. The first slide ccn ained amino acid sequences containing only L amino acids while the second slide contained selected D amino acids. Figs. 14A
and 14B illustrate a map of the various regions on the first and second s ides, respectively. The patterns shown in Figs. i4A and 14B were duplicated four times on each slide. The slides were then, exposed to the rier~
antibody and fluorescein-labeled goat anti-:house.
A fluarescencs plat of the first slide, whic contained only L amino acids snowed red areas (indicating strong binding, i.e., 14,9,000 courts or more) and black areas (indicating little or no binding of the Herz antibody, i.e., 20;000 counts or less). The secruen,ce YGGFL was clearly most strongly recognized. The sequences YAGFL and YSGFL also exhibited strong recognition of he antibody. By contrast, most of t::e remaining sequences howed little or no binding. The four duplicate portions of the slide were extremely consistent in the amount of binding shown therein.
A fluorescence plat of the D amino acic slide indicated that strongest binding was exhibited by the YGGFL sequence. Significant binding was also detec;.ec to YaGFL, YsGFL, and YpGFL: The-remaining sequences snowed less binding with the antibody. Low binding efficiency of the sequence yGGFL was observed:
Table 6 fists the various sequences tested in order of relative fluorescence, which provides information regarding relative binding affinity.
~5 Table 6 Apaa~ent 8indina to I~erz Ab a.a. ce D_a:a'' get L -YGGFh ' YGGFL ' YAGF L YaGFL

YSGFL YsGFL

LGGFh YpGFL

FGGF L fGGFL

YFGF L yGGF L

I~IGi L f 3GFL

FAGFL wGGFL

wGGFL yaGFL

fpGF:

waGF L

VIII. Ill ustrative Alternative Embodiment According tc an alternative embodiment of t::e invention; the methods provide for attaching to the surface a caged binding member which in its caged fog has a relatively low aff;pity for other potentially binding species, such ~s receptors and speci~:c bir.;~g substances.

Accor3ing to this alternative embodi~ert, t:~e invention provides methods for forming predef ;ned regicns on a surface of a solid support, wherein the oredef_ned regions are capable of'immobiliting receptors. The methods make use of caged binding members attached ~~ the surface to enable selective activation of the prede==ned ~5 regions. The caged binding members are liberated t:, act as binding members ultimately capable of binding receptors upon se? ective act~.vation of the predefine reaiors: The activated binding members are then used to immobilize specific molecules such as receptors on the predefined region of the surface. The above procedure is repeated at'the same Qr different sites on the surface so as to provide a surface prepared with a piurali.ty of regions on the surface contain'lng; for example, the sa:~e or different receptors, when receators immobilized in this way have a differential affinity for one or more ligands, screenings and assays for the ligands can be conducted in the regions of the surface containing the receators.
The alternative embodiment may maKe use of novel caged binding members attached to the substrate.
CaCed (unactivated),meiabers have a relatively low 1~ affinit;r for receptors of substances that specifically bind to uncaged binding members when compared with the corresponding affinities of activated binding members.
Thus, the binding; members are protected from reaction until a suitable source of energy is applied to the regions of the surface desired to be activated. Upon applicationof a suitable'energy source, the caging groups labilize, thereby presenting the activated binding member. A typical energy source will be light.
Once the binding members on the surface are activated they maybe attached to a receptor: The receptor chosen may be a monoclonal antibody, a nucleic acid sequence, a drug receptor, etc. The receptor will usually, though not always, be prepared so as to permit attaching it; directly or indirectly, to abinding member. For example, a specific binding substance having a strong binding affinity for the binding member and a strong affinity for the receptor or a conjugate of the receptor may be used to act as a bridge between bindi~g members and receptors if desired. The method uses a ;5 receptor prepared such that the receptor retains its activity towar3 a particular ligand:

Preferably, the caged binding member attached to the solid substrate will be a photoactiJatable biotin complex, i.e., a biotin molecule that has been chemically, modified with photoactivatable protectirig.groups so that it has a significantly reduced binding affinity for avidin or avidin analogs than does natural biotin: In a preferred embodiment, the protecting groups localized in a predefined region of the surface will be removed upon application of a suitable source of radiation to give bindingmembers, that are biotin or a functionally analogous compound having substantially the same binding affinity for avidin or a'vidin analogs as does biotin.
In another preferred. embodiment, avidin or an avidin analog is incubated with activated binding members on the surface until the avidin binds strongly to the binding members.
The avid:in so immobilized on predefined regions of the surface can then be incubated with a desired receptor or conjugate of a desired receptor . The receptor will preferably be bi.otinylated, e.g., a biotinylated antibody, when avidin is immobilized on the predefined regions of the surface.
Alternatively, a preferred embodiment will present an av:idin/bi.otinylated receptor complex, which has been previously prepared, to activated binding members on the surface.

Il. Conclusion The inventions of the present application and related Canadian Application Nos: 2,27f,883 and 2,054,706 provide greatly improved methods and apparatus for synthesis of S polymers on substrates. Lt is to be understood that the above description is intended to be, illustrative and not restrictive.
Many embodiments will be apparent to those of skill in the art upon reviewing the above description. By way of example, the invention has been described primarily with reference to the use of photoremovable protective groups, but it will be readily recognized by those of skill in the art that sources of radiation other than light could also be used. For example, in some embodiments it may be de irable to use protective groups which are sensitive to electron beam irradiation, x-ray irradiation, in combination with electron beam lithograph, or x-ray lithography techniques: Alternatively, the group could be removed by exposure to an electric current. The scope of the inventions of the present application and related Canadian Application Nos: 2,278,883 and 2,054,706, should, therefore, be determined not with reference to the above description, but should instead be determined with reference to the appended claims; along with the full scope of equivalents to which such claims are entitlsd.

Claims (52)

1. Apparatus for detection of fluorescently marked regions on a substrate comprising:

a) a substrate bearing a plurality of different polymer sequences coupled to a surface of said substrate, each of said different polymer sequences being coupled in a different known location of said surface, each of said known location having an area of 10-2 cm2 or less;

b) a light source for directing light at said surface of said substrate;

c) a means for detecting light fluoresced from a fluorescent label bound to the polymer sequences on said surface in response to said light sources;

d) means for translating said substrate from a first position to a second position relative to said light source and/or said means for detecting light; and e) means for storing fluoresced light intensity as a function of location on said substrate, said means for storing connected to said means for translating and said means for detecting.
2. A system for determining binding of a fluorescently labeled receptor to a ligand comprising:

a) a substrate bearing a plurality of different polymer sequences coupled to a surface of said substrate, each of said different polymer sequences being coupled in a different known location of said surface, each of said known locations having an area of 10-2 cm2 or less;

b) means for applying light to said surface of said substrate, said means for applying light providing simultaneous illumination at a plurality of said known locations; and c) an array of detectors for detecting light fluoresced at said plurality of known locations upon binding of a fluorescently labeled receptor to said polymer sequences.
3. A system as recited in claim 2, wherein said means for applying light comprises a point light source and a cylindrical lens for focusing said point light source along a substantially linear path.
4. A system as recited in claim 2, wherein said array of detectors comprises a linear array.
5. A system as recited in claim 2, wherein said array of detectors comprises a linear CCD array.
6. An apparatus for detection of fluorescently marked locations on a substrate comprising:

a) a substrate bearing a plurality of different polymer sequences coupled to a surface of said substrate, wherein said plurality of different polymer sequences comprises a plurality of different nucleic acid sequences, each of said different polymer sequences being coupled in a different known location of said surface, each of said known locations having an area of 10-2 cm2 or less;

b) a light source for directing light at a surface of said substrate;

c) a detector for detecting light fluoresced from a fluorescent label bound to the polymer sequences on said surface in response to said light source;

d) a translator for translating said substrate relative to said light source; and e) a data storage system for storing fluoresced light intensity as a function of location on said substrate, said data storage system connected to said translator and said detector.
7. The apparatus as recited in claim 6, wherein said plurality of different nucleic acid sequences comprises greater than 10 different nucleic acid sequences on a surface of said substrate.
8. The apparatus as recited in claim 6, wherein said plurality of different nucleic acid sequences comprises at least 100 different nucleic acid sequences on a surface of said substrate.
9. The apparatus as recited in claim 6, wherein said plurality of different nucleic acid sequences comprises at least 1,000 different nucleic acid sequences on a surface of said substrate.
10. The apparatus as recited in claim 6, wherein said plurality of different nucleic acid sequences comprises greater than 10,000 different nucleic acid sequences on a surface of said substrate.
11. The apparatus a recited in claim 6, wherein said plurality or different nucleic acid sequences comprises greater than 100,000 different nucleic acid sequences on a surface of said substrate.
12. The apparatus as recited in claim 6, wherein each of said different nucleic acid sequences is in a known location on a surface of said substrate, said known location having an area of less than 10,000 µm2.
13. An apparatus for detecting fluorescently marked locations on a surface of a substrate, comprising:

a point light source for generating an excitation light;
a substrate bearing: a plurality of different polymers coupled to a surface of said substrate, wherein said plurality of different polymers comprises a plurality of different nucleic acid sequences, each of said different polymer sequences being coupled in a different known location of said surface, each of said known locations having an area of 10-2 cm2 or less;

an objective lens for focusing said point light source at said surface of said substrate, whereby locations, upon binding of a fluorescent label to the polymer sequences coupled therein, emit a fluoresced light in response to said excitation light;

an x-y translation stage for moving said substrate relative to said excitation light;

a dichroic mirror for reflecting light having a wavelength of said excitation light and passing light having a wavelength of said fluoresced light;

a photomultiplier and photon counter for detecting said fluoresced light; and an appropriately programmed computer for recording said fluoresced light as a function of a position on said surface of said substrate from which said fluoresced light was emitted.
14. The apparatus as recited in claim 13, wherein said plurality of different nucleic acid sequences comprises greater than 10 different nucleic acid sequences on a surface of said substrate.
15. The apparatus as recited in claim 13, wherein said plurality of different nucleic acid sequences comprises at least 100 different nucleic acid sequences on a surface of said substrate.
16. The apparatus as recited in claim 13, wherein said plurality of different nucleic acid sequences Comprises a least 1,000 different nucleic acid sequences on a surface of said substrate.
17. The apparatus as recited in claim 13, wherein said plurality of different: nucleic acid sequences comprises greater than 10,000 different nucleic acid sequences on a surface of said substrate.
18. The apparatus as recited in claim 13, wherein said plurality of different nucleic acid sequences comprises greater than 100,000 different nucleic acid sequences on a surface of said substrate.
19. The apparatus as recited in claim 13, wherein each of said different nucleic acid sequences is in a known location on a surface of said substrate, said known location having an area of less than 10,000 µm2.
20. A method of detecting the presence of a fluorescent marker on a surface of a substrate, the method comprising:

directing an excitation light at the surface of the substrate: and detecting light fluoresced from the surface of the substrate;

wherein said surface of said substrate bears a plurality of different nucleic acids covalently bound thereto, each of said different nucleic acids being bound at a different known location on the substrate, each of said known locations having an area of less than 10 -2 cm2 and said fluorescent marker comprises a fluorescently labeled target nucleic acid that is capable of hybridizing with one or more of said plurality of different nucleic acids.
21. A method of determining whether a fluorescently labeled ligand binds to one or more of a plurality of different polymer sequences, wherein said fluorescently labeled ligand comprises, a fluorescently labeled target nucleic acid, and said plurality of different polymer sequences on the surface of a substrate comprises a plurality of different nucleic acids, comprising:

providing a plurality of different polymer sequences covalently bound to a surface of a substrate, each of said different polymer sequences being bound at a known location on the surface of the substrate, each of said known locations having an area of less than 10 -2 cm2;

contacting the surface of the substrate with the fluorescently labeled ligand;

washing the surface to remove unbound fluorescently labeled ligand from the surface of the substrate; and detecting binding between the fluorescently labeled ligand and the one or more polymer sequences, said detecting step comprising directing an excitation light at the surface of the substrate, and detecting light fluoresced from the surface of the substrate.
22. The method as recited in claim 21, wherein the plurality of different nucleic acids comprises greater than different nucleic acids on a surface of said substrate.
23. The method as recited in claim 21, wherein the plurality of different nucleic acids comprises at least 100 different nucleic acids on a surface of said substrate.
24. The method as recited in claim 21, wherein the plurality of different nucleic acids comprises at least 1,000 different nucleic acids on a surface of said substrate.
25. The method as recited in claim 21, wherein the plurality of different nucleic acids comprises greater than 10,000 different nucleic acids on a surface of said substrate.
26. The method as recited in claim 21, wherein the plurality of different nucleic acids comprises greater than 100,000 different nucleic acids on a surface of said substrate.
27. The method as recited in claim 21, wherein each of the different nucleic acid sequences is in a known location on a surface of said substrate, said known location having an area of less than 10,000 µm2.
28. A nucleic acid analysis apparatus comprising:
a substrate bearing a plurality of different nucleic acids; each of said different nucleic acids being attached to a different known location of the surface of said substrate, each of said known locations having an area of 10-2 cm2 or less, said substrate comprising more than 10 of such nucleic acids, at least some of said nucleic acids coupled to fluorescently labeled target molecules;

a light source for directing light at a surface of said substrate;

a detector for detecting light fluoresced from said surface in response to said light source;

a translator for translating said substrate relative to said light source; and a data storage system for storing fluoresced light intensity as a function of location on said substrate, said data storage system coupled to said translator and said detector.
29. An apparatus for detection of labeled locations on a substrate comprising:
a) a light source capable of directing light at a surface of a substrate, said substrate bearing a plurality of different polymer sequences attached to a surface of said substrate, each of said different polymer sequences occupying a different known location of said surface, each of sand known locations having an area of 10 -2 cm2 or less, and at least one of the polymers capable of being coupled to a labeled receptor;

b) a detector to detect light emitted from said surface in response to said light source to indicate which polymer(s) are coupled to the labeled receptor.
30. The apparatus of claim 29, further comprising a translator to translate said substrate relative to said light source.
31. The apparatus of claim 29, wherein the receptor is fluorescently labeled and the emitted light is fluoresced light.
32. The apparatus of claim 31 further comprising a data storage system to store fluoresced light intensity as a function of location on said substrate.
33. The apparatus of any one of preceding claims 29 to 32, wherein said plurality of different polymer sequences comprises greater than 10 different nucleic acid sequences on a surface of said substrate.
34. The apparatus of any one of preceding claims 29 to 32, wherein said plurality of different polymer sequences comprises at least 100 different nucleic acid sequences on a surface of said substrate.
35. The apparatus of any one of preceding claims 29 to 32, wherein said plurality of different polymer sequences comprises at least 1,000 different nucleic acid sequences on a surface of said substrate.
36. The apparatus as recited in any one of preceding claims 29 to 32, wherein said plurality of different polymer sequences comprises greater than 10,000 different nucleic acid sequences on a surface of said substrate.
37. The apparatus as recited in anyone of preceding claims 29 to 32, wherein said plurality of different polymer sequences comprises greater than 100,000 different nucleic acid sequences on a surface of said substrate.
38. The apparatus as recited in any one of claims 29 to 37, wherein each of said different nucleic acid sequences is in a known location on a surface of said substrate; said known location having an area of less than 10 -4 cm2.
39. The apparatus of any one of preceding claims 29 to 38, wherein the light source is a point light source that directs an excitation light;

the translator is an x-y translation stage;

the detector comprises a photomultiplier and photon counter to detect said fluoresced light;

the data storage system comprises an appropriately programmed computer to record said fluoresced light as a function of a position on said surface of said substrate from which said fluoresced light was emitted;

and the apparatus further comprises:

an objective lens and a dichroic mirror to reflect light from the light source having a wavelength of said excitation light and to pass light having a wavelength of said fluoresced light to the detector.
40. The apparatus of claim 39, wherein the appropriately programmed computer further comprises a video display to display the recorded fluoresced light as a function of position.
41. The apparatus of claim 39 or 40, wherein the light source is a laser.
42. The apparatus of claim 39 ar 40, wherein the polymers are nucleic acids and the receptor is a labeled polynucleotide.
43. A method of detecting the presence of a fluorescent marker on a surface of a substrate, the method comprising:
(1) directing excitation light at a surface of a substrate, said substrate bearing a plurality of different polymer sequences attached to a surface of said substrate, each of said different polymer sequences occupying a different known location of said surface, each of said known locations having an area of 10 -2 cm2 or less, and at least one of the polymers capable of being coupled to a fluorescently labeled receptor; and (2) detecting light fluoresced from the surface of the substrate.
44. The method of claim 43 further comprising:

(1) translating the substrate relative to the light source; and (2) repeating, step (1).
45. A method of determining whether one or more of a plurality of different polymer sequences binds to a fluorescently labeled receptor, comprising:

(1) providing an apparatus comprising:

a) a substrate bearing a plurality of different polymer sequences attached to a surface of said substrate, each of said different polymer sequences occupying a different known location of said surface, each of said known locations having an area of 10 -2 cm2 or less;

b) a light source to direct light at a surface of said substrate;

c) a detector to detect light fluoresced from said surface in response to said light source; and d) a translator to translate said substrate relative to said light source;

(2) contacting the surface of the substrate with the fluorescently labeled receptor; and (3) detecting binding between the fluorescently labeled receptor and one or more different polymer sequences by directing an excitation light at the surface of the substrate, and detecting light fluoresced from the surface of the substrate.
46. The method of claim 45, further comprising washing the surface to remove unbound fluorescently labeled receptor from the surface of the substrate.
47. The method of claim 46, wherein the polymers are nucleic acids and he receptor is a fluorescently labeled nucleic acid.
48. The method as recited in claim 46, wherein the apparatus is as described in any one of claims 31 to 42.
49. The method as recited in any one of claims 20 to 27 and 43 to 48, further comprising recording the fluoresced light and storing the data therefrom in an appropriately programmed computer.
50. The method as recited in claim 49, wherein the method further comprises displaying the data derived from the method.
51. The apparatus of claim 1, wherein said polymer sequences on said substrate have a density of at least 1,000/cm2.
52. The apparatus of claim 6, wherein said polymer sequences on said substrate have a density of at least 1,000/cm2.
CA 2391491 1989-06-07 1990-06-07 Very large scale immobilized peptide synthesis Abandoned CA2391491A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36290189A 1989-06-07 1989-06-07
US362,901 1989-06-07
US492,462 1990-03-07
US07/492,462 US5143854A (en) 1989-06-07 1990-03-07 Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
CA 2278878 CA2278878C (en) 1989-06-07 1990-06-07 Very large scale immobilized peptide synthesis

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA 2278878 Division CA2278878C (en) 1989-06-07 1990-06-07 Very large scale immobilized peptide synthesis

Publications (1)

Publication Number Publication Date
CA2391491A1 true CA2391491A1 (en) 1990-12-13

Family

ID=27001838

Family Applications (4)

Application Number Title Priority Date Filing Date
CA 2278883 Expired - Lifetime CA2278883C (en) 1989-06-07 1990-06-07 Very large scale immobilized peptide synthesis
CA 2278878 Expired - Lifetime CA2278878C (en) 1989-06-07 1990-06-07 Very large scale immobilized peptide synthesis
CA 2054706 Expired - Lifetime CA2054706C (en) 1989-06-07 1990-06-07 Very large scale immobilized polymer synthesis
CA 2391491 Abandoned CA2391491A1 (en) 1989-06-07 1990-06-07 Very large scale immobilized peptide synthesis

Family Applications Before (3)

Application Number Title Priority Date Filing Date
CA 2278883 Expired - Lifetime CA2278883C (en) 1989-06-07 1990-06-07 Very large scale immobilized peptide synthesis
CA 2278878 Expired - Lifetime CA2278878C (en) 1989-06-07 1990-06-07 Very large scale immobilized peptide synthesis
CA 2054706 Expired - Lifetime CA2054706C (en) 1989-06-07 1990-06-07 Very large scale immobilized polymer synthesis

Country Status (22)

Country Link
US (19) US5143854A (en)
EP (4) EP0619321B1 (en)
JP (5) JP3759161B2 (en)
KR (2) KR970001577B1 (en)
AT (2) ATE110738T1 (en)
AU (2) AU651795B2 (en)
BR (1) BR9007425A (en)
CA (4) CA2278883C (en)
DE (3) DE953835T1 (en)
DK (2) DK0476014T3 (en)
ES (2) ES2129101T3 (en)
FI (1) FI109130B (en)
GB (1) GB2248840B (en)
HK (2) HK61395A (en)
HU (1) HU223462B1 (en)
IL (1) IL94551A (en)
NL (1) NL191992C (en)
NO (1) NO301233B1 (en)
NZ (1) NZ233886A (en)
SG (1) SG13595G (en)
TW (1) TW434254B (en)
WO (1) WO1990015070A1 (en)

Families Citing this family (3506)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
US6270961B1 (en) * 1987-04-01 2001-08-07 Hyseq, Inc. Methods and apparatus for DNA sequencing and DNA identification
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US6054270A (en) * 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
US7811751B2 (en) 1988-05-03 2010-10-12 Oxford Gene Technology Limited Analysing polynucleotide sequences
US5871928A (en) * 1989-06-07 1999-02-16 Fodor; Stephen P. A. Methods for nucleic acid analysis
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US6309822B1 (en) 1989-06-07 2001-10-30 Affymetrix, Inc. Method for comparing copy number of nucleic acid sequences
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US6955915B2 (en) * 1989-06-07 2005-10-18 Affymetrix, Inc. Apparatus comprising polymers
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6379895B1 (en) 1989-06-07 2002-04-30 Affymetrix, Inc. Photolithographic and other means for manufacturing arrays
US6346413B1 (en) 1989-06-07 2002-02-12 Affymetrix, Inc. Polymer arrays
US5527681A (en) * 1989-06-07 1996-06-18 Affymax Technologies N.V. Immobilized molecular synthesis of systematically substituted compounds
US5547839A (en) * 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US6551784B2 (en) 1989-06-07 2003-04-22 Affymetrix Inc Method of comparing nucleic acid sequences
US5925525A (en) * 1989-06-07 1999-07-20 Affymetrix, Inc. Method of identifying nucleotide differences
US6919211B1 (en) * 1989-06-07 2005-07-19 Affymetrix, Inc. Polypeptide arrays
US6406844B1 (en) 1989-06-07 2002-06-18 Affymetrix, Inc. Very large scale immobilized polymer synthesis
US5242974A (en) * 1991-11-22 1993-09-07 Affymax Technologies N.V. Polymer reversal on solid surfaces
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
US5545522A (en) 1989-09-22 1996-08-13 Van Gelder; Russell N. Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
US5252743A (en) * 1989-11-13 1993-10-12 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
US6506558B1 (en) 1990-03-07 2003-01-14 Affymetrix Inc. Very large scale immobilized polymer synthesis
US5252296A (en) * 1990-05-15 1993-10-12 Chiron Corporation Method and apparatus for biopolymer synthesis
DE4027675C2 (en) * 1990-08-31 1997-05-07 Biotechnolog Forschung Gmbh Process for the parallel production of carrier-bound or free peptides, carrier-bound peptides and their use
ATE244065T1 (en) * 1990-12-06 2003-07-15 Affymetrix Inc METHODS AND REAGENTS FOR VERY LARGE SCALE IMMOBILIZED POLYMER SYNTHESIS
DE69132843T2 (en) 1990-12-06 2002-09-12 Affymetrix Inc N D Ges D Staat Identification of nucleic acids in samples
US5658728A (en) * 1991-06-19 1997-08-19 Gosney, Jr.; William Milton Templates for nucleic acid molecules
GB2258236B (en) * 1991-07-30 1995-03-22 Hitachi Europ Ltd Molecular synthesis
US5449754A (en) * 1991-08-07 1995-09-12 H & N Instruments, Inc. Generation of combinatorial libraries
AU2422492A (en) * 1991-08-07 1993-03-02 H & N Instruments, Inc. Synthesis of chain chemical compounds
JPH05206017A (en) * 1991-08-09 1993-08-13 Internatl Business Mach Corp <Ibm> Lithographic exposure system and its method
US6589726B1 (en) 1991-09-04 2003-07-08 Metrigen, Inc. Method and apparatus for in situ synthesis on a solid support
US6921636B1 (en) * 1991-09-04 2005-07-26 Metrigen, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5474796A (en) 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5846717A (en) 1996-01-24 1998-12-08 Third Wave Technologies, Inc. Detection of nucleic acid sequences by invader-directed cleavage
US5639603A (en) * 1991-09-18 1997-06-17 Affymax Technologies N.V. Synthesizing and screening molecular diversity
US5770358A (en) * 1991-09-18 1998-06-23 Affymax Technologies N.V. Tagged synthetic oligomer libraries
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
US5733731A (en) * 1991-10-16 1998-03-31 Affymax Technologies N.V. Peptide library and screening method
US5849486A (en) * 1993-11-01 1998-12-15 Nanogen, Inc. Methods for hybridization analysis utilizing electrically controlled hybridization
US6048690A (en) * 1991-11-07 2000-04-11 Nanogen, Inc. Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis
US6017696A (en) 1993-11-01 2000-01-25 Nanogen, Inc. Methods for electronic stringency control for molecular biological analysis and diagnostics
US5632957A (en) 1993-11-01 1997-05-27 Nanogen Molecular biological diagnostic systems including electrodes
US6652808B1 (en) 1991-11-07 2003-11-25 Nanotronics, Inc. Methods for the electronic assembly and fabrication of devices
US6051380A (en) * 1993-11-01 2000-04-18 Nanogen, Inc. Methods and procedures for molecular biological analysis and diagnostics
US5605662A (en) * 1993-11-01 1997-02-25 Nanogen, Inc. Active programmable electronic devices for molecular biological analysis and diagnostics
US6569382B1 (en) * 1991-11-07 2003-05-27 Nanogen, Inc. Methods apparatus for the electronic, homogeneous assembly and fabrication of devices
US5556961A (en) * 1991-11-15 1996-09-17 Foote; Robert S. Nucleosides with 5'-O-photolabile protecting groups
IL103674A0 (en) * 1991-11-19 1993-04-04 Houston Advanced Res Center Method and apparatus for molecule detection
US5846708A (en) * 1991-11-19 1998-12-08 Massachusetts Institiute Of Technology Optical and electrical methods and apparatus for molecule detection
US6943034B1 (en) 1991-11-22 2005-09-13 Affymetrix, Inc. Combinatorial strategies for polymer synthesis
US5412087A (en) * 1992-04-24 1995-05-02 Affymax Technologies N.V. Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
US5384261A (en) * 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
US5324633A (en) * 1991-11-22 1994-06-28 Affymax Technologies N.V. Method and apparatus for measuring binding affinity
DE69233331T3 (en) * 1991-11-22 2007-08-30 Affymetrix, Inc., Santa Clara Combinatorial Polymersynthesis Strategies
US5550215A (en) * 1991-11-22 1996-08-27 Holmes; Christopher P. Polymer reversal on solid surfaces
US6468740B1 (en) 1992-11-05 2002-10-22 Affymetrix, Inc. Cyclic and substituted immobilized molecular synthesis
DE69333650T2 (en) * 1992-02-19 2006-01-12 The Public Health Research Institute Of The City Of New York, Inc. NEW ARRANGEMENT OF OLIGONUCLEOTIDES AND THEIR BENEFITS FOR SORTING, ISOLATING, SEQUENCING AND MANIPULATING NUCLEIC ACIDS
US5359115A (en) * 1992-03-26 1994-10-25 Affymax Technologies, N.V. Methods for the synthesis of phosphonate esters
US5541061A (en) * 1992-04-29 1996-07-30 Affymax Technologies N.V. Methods for screening factorial chemical libraries
US5728802A (en) * 1992-05-06 1998-03-17 Affymax Technologies N.V. Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1)
US5648458A (en) * 1992-05-06 1997-07-15 Affymax Technologies N.V. Peptides and compounds that bind to ELAM-1
US5643873A (en) * 1992-05-06 1997-07-01 Affymax Technologies N.V. Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1
US5849545A (en) * 1992-05-11 1998-12-15 Evotec Biosystems Gmbh Substrate material for simultaneously binding genotypic and phenotypic substances
JPH0622798A (en) * 1992-07-07 1994-02-01 Hitachi Ltd Method for determining base sequence
US5585275A (en) * 1992-09-02 1996-12-17 Arris Pharmaceutical Corporation Pilot apparatus for peptide synthesis and screening
US5591646A (en) * 1992-09-02 1997-01-07 Arris Pharmaceutical Method and apparatus for peptide synthesis and screening
US5420328A (en) * 1992-09-11 1995-05-30 Affymax Technologies, N.V. Methods for the synthesis of phosphonate esters
US5288514A (en) * 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US5877278A (en) * 1992-09-24 1999-03-02 Chiron Corporation Synthesis of N-substituted oligomers
US5567391A (en) * 1992-10-08 1996-10-22 Warner-Lambert Company Apparatus for multiple simultaneous synthesis
US5324483B1 (en) * 1992-10-08 1996-09-24 Warner Lambert Co Apparatus for multiple simultaneous synthesis
US5702672A (en) * 1992-10-08 1997-12-30 Warner-Lambert Company Apparatus and method for multiple simultaneous synthesis
US5714127A (en) * 1992-10-08 1998-02-03 Warner-Lambert Company System for multiple simultaneous synthesis
US5554501A (en) * 1992-10-29 1996-09-10 Beckman Instruments, Inc. Biopolymer synthesis using surface activated biaxially oriented polypropylene
WO1994010128A1 (en) * 1992-11-02 1994-05-11 Affymax Technologies N.V. Novel photoreactive protecting groups
HUT73150A (en) * 1992-11-06 1996-06-28 Chiron Mimotopes Pty Ltd Modular polymer and support for the synthesis thereof
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
RU2134693C1 (en) * 1993-02-23 1999-08-20 Зе Трастис оф Принстон Юниверсити Methods of forming glycoside bonds, chemical composition, glycoside and glycoside library
US6864048B2 (en) * 1993-04-28 2005-03-08 Affymetrix, Inc. Factorial chemical libraries
US6632613B1 (en) * 1993-06-02 2003-10-14 University Of Utah Research Foundation Compositions and kits for fluorescence polarization assay of large molecules
US6008058A (en) * 1993-06-18 1999-12-28 University Of Louisville Cyclic peptide mixtures via side chain or backbone attachment and solid phase synthesis
US6153379A (en) * 1993-06-22 2000-11-28 Baylor College Of Medicine Parallel primer extension approach to nucleic acid sequence analysis
US7001722B1 (en) 1993-06-22 2006-02-21 Baylor College Of Medicine Parallel primer extension approach to nucleic acid sequence analysis
US5837832A (en) * 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5858659A (en) * 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US7115364B1 (en) 1993-10-26 2006-10-03 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
WO1995000530A1 (en) 1993-06-25 1995-01-05 Affymax Technologies N.V. Hybridization and sequencing of nucleic acids
US20030134291A1 (en) * 1993-06-25 2003-07-17 Affymetrix, Inc. Polymorphism detection
US5861242A (en) * 1993-06-25 1999-01-19 Affymetrix, Inc. Array of nucleic acid probes on biological chips for diagnosis of HIV and methods of using the same
US6027880A (en) * 1995-08-02 2000-02-22 Affymetrix, Inc. Arrays of nucleic acid probes and methods of using the same for detecting cystic fibrosis
CN1143977A (en) * 1993-07-23 1997-02-26 希斯克有限公司 Method for screening unknown organisms
US6401267B1 (en) 1993-09-27 2002-06-11 Radoje Drmanac Methods and compositions for efficient nucleic acid sequencing
JPH0798276A (en) * 1993-09-28 1995-04-11 Hitachi Electron Eng Co Ltd Determining device for appangement of dna base
US5512131A (en) * 1993-10-04 1996-04-30 President And Fellows Of Harvard College Formation of microstamped patterns on surfaces and derivative articles
US6776094B1 (en) * 1993-10-04 2004-08-17 President & Fellows Of Harvard College Kit For Microcontact Printing
US5900160A (en) * 1993-10-04 1999-05-04 President And Fellows Of Harvard College Methods of etching articles via microcontact printing
US5776748A (en) 1993-10-04 1998-07-07 President And Fellows Of Harvard College Method of formation of microstamped patterns on plates for adhesion of cells and other biological materials, devices and uses therefor
US6180239B1 (en) 1993-10-04 2001-01-30 President And Fellows Of Harvard College Microcontact printing on surfaces and derivative articles
CA2173990A1 (en) * 1993-10-12 1995-04-20 Narasinga Rao A library of glyco-peptides useful for identification of cell adhesion inhibitors
US20030232361A1 (en) * 1993-10-26 2003-12-18 Affymetrix, Inc. Nucleic acid array preparation using purified phosphoramidites
US5879656A (en) * 1993-10-26 1999-03-09 Thomas Jefferson University Methods of treating metastatic colorectal cancer with ST receptor binding compounds
US6156501A (en) * 1993-10-26 2000-12-05 Affymetrix, Inc. Arrays of modified nucleic acid probes and methods of use
US6309823B1 (en) 1993-10-26 2001-10-30 Affymetrix, Inc. Arrays of nucleic acid probes for analyzing biotransformation genes and methods of using the same
US6045996A (en) * 1993-10-26 2000-04-04 Affymetrix, Inc. Hybridization assays on oligonucleotide arrays
US20060229824A1 (en) * 1993-10-26 2006-10-12 Affymetrix, Inc. Arrays of nucleic acid probes for analyzing biotransformation genes
US20120329677A9 (en) * 1993-10-26 2012-12-27 Cronin Maureen T Arrays of nucleic acid probes for detecting cystic fibrosis
US7375198B2 (en) * 1993-10-26 2008-05-20 Affymetrix, Inc. Modified nucleic acid probes
US7097839B1 (en) * 1993-10-26 2006-08-29 Thomas Jefferson University ST receptor binding compounds and methods of using the same
US6893816B1 (en) 1993-10-28 2005-05-17 Houston Advanced Research Center Microfabricated, flowthrough porous apparatus for discrete detection of binding reactions
ES2176308T3 (en) * 1993-10-28 2002-12-01 Houston Advanced Res Ct POROUS MICROSTRUCTURE DEVICE THAT ALLOWS A FLOW.
US5429807A (en) * 1993-10-28 1995-07-04 Beckman Instruments, Inc. Method and apparatus for creating biopolymer arrays on a solid support surface
US5922545A (en) * 1993-10-29 1999-07-13 Affymax Technologies N.V. In vitro peptide and antibody display libraries
US6306348B1 (en) * 1993-11-01 2001-10-23 Nanogen, Inc. Inorganic permeation layer for micro-electric device
US6309602B1 (en) 1993-11-01 2001-10-30 Nanogen, Inc. Stacked, reconfigurable system for electrophoretic transport of charged materials
US6254827B1 (en) 1993-11-01 2001-07-03 Nanogen, Inc. Methods for fabricating multi-component devices for molecular biological analysis and diagnostics
US6287517B1 (en) 1993-11-01 2001-09-11 Nanogen, Inc. Laminated assembly for active bioelectronic devices
US7172864B1 (en) * 1993-11-01 2007-02-06 Nanogen Methods for electronically-controlled enzymatic reactions
US6225059B1 (en) 1993-11-01 2001-05-01 Nanogen, Inc. Advanced active electronic devices including collection electrodes for molecular biological analysis and diagnostics
US20040077074A1 (en) * 1993-11-01 2004-04-22 Nanogen, Inc. Multi-chambered analysis device
US7314708B1 (en) * 1998-08-04 2008-01-01 Nanogen, Inc. Method and apparatus for electronic synthesis of molecular structures
US6638482B1 (en) 1993-11-01 2003-10-28 Nanogen, Inc. Reconfigurable detection and analysis apparatus and method
US7101661B1 (en) 1993-11-01 2006-09-05 Nanogen, Inc. Apparatus for active programmable matrix devices
US6315953B1 (en) 1993-11-01 2001-11-13 Nanogen, Inc. Devices for molecular biological analysis and diagnostics including waveguides
US6375899B1 (en) 1993-11-01 2002-04-23 Nanogen, Inc. Electrophoretic buss for transport of charged materials in a multi-chamber system
US5965452A (en) 1996-07-09 1999-10-12 Nanogen, Inc. Multiplexed active biologic array
US6319472B1 (en) 1993-11-01 2001-11-20 Nanogen, Inc. System including functionally separated regions in electrophoretic system
US6068818A (en) 1993-11-01 2000-05-30 Nanogen, Inc. Multicomponent devices for molecular biological analysis and diagnostics
US6726880B1 (en) 1993-11-01 2004-04-27 Nanogen, Inc. Electronic device for performing active biological operations and method of using same
US7582421B2 (en) * 1993-11-01 2009-09-01 Nanogen, Inc. Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip
US6331274B1 (en) 1993-11-01 2001-12-18 Nanogen, Inc. Advanced active circuits and devices for molecular biological analysis and diagnostics
US6129828A (en) 1996-09-06 2000-10-10 Nanogen, Inc. Apparatus and methods for active biological sample preparation
US5503805A (en) * 1993-11-02 1996-04-02 Affymax Technologies N.V. Apparatus and method for parallel coupling reactions
US6165778A (en) * 1993-11-02 2000-12-26 Affymax Technologies N.V. Reaction vessel agitation apparatus
US7034110B2 (en) * 1994-01-05 2006-04-25 Arqule, Inc. Method of identifying chemical compounds having selected properties for a particular application
GB9401833D0 (en) * 1994-02-01 1994-03-30 Isis Innovation Method for discovering ligands
US6741344B1 (en) 1994-02-10 2004-05-25 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
US5578832A (en) * 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US20030017081A1 (en) * 1994-02-10 2003-01-23 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US5631734A (en) * 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
US6090555A (en) * 1997-12-11 2000-07-18 Affymetrix, Inc. Scanned image alignment systems and methods
GB9404709D0 (en) * 1994-03-11 1994-04-27 Multilyte Ltd Binding assay
US6015880A (en) * 1994-03-16 2000-01-18 California Institute Of Technology Method and substrate for performing multiple sequential reactions on a matrix
US5502246A (en) * 1994-03-22 1996-03-26 Eli Lilly And Company Solid-phase synthesis utilizing photochemical carbon-sulfur bond cleavage of thioethers
EP0751950B1 (en) * 1994-03-23 2000-10-25 The Penn State Research Foundation Method for identifying members of combinatorial libraries
US5871918A (en) * 1996-06-20 1999-02-16 The University Of North Carolina At Chapel Hill Electrochemical detection of nucleic acid hybridization
US5571639A (en) * 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
EP0695941B1 (en) * 1994-06-08 2002-07-31 Affymetrix, Inc. Method and apparatus for packaging a chip
US6287850B1 (en) * 1995-06-07 2001-09-11 Affymetrix, Inc. Bioarray chip reaction apparatus and its manufacture
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
US7323298B1 (en) 1994-06-17 2008-01-29 The Board Of Trustees Of The Leland Stanford Junior University Microarray for determining the relative abundances of polynuceotide sequences
US7615368B1 (en) 1994-06-17 2009-11-10 The Board Of Trustees Of The Leland Stanford Junior University Microarrays of polypeptides
US7378236B1 (en) 1994-06-17 2008-05-27 The Board Of Trustees Of The Leland Stanford Junior University Method for analyzing gene expression patterns
US5807522A (en) * 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5525735A (en) * 1994-06-22 1996-06-11 Affymax Technologies Nv Methods for synthesizing diverse collections of pyrrolidine compounds
US5525734A (en) * 1994-06-22 1996-06-11 Affymax Technologies N.V. Methods for synthesizing diverse collections of pyrrolidine compounds
DE69531545T2 (en) * 1994-06-23 2004-06-24 Affymax Technologies N.V., Willemstad PHOTOLABILE CONNECTIONS AND METHOD FOR THE USE THEREOF
US5679773A (en) * 1995-01-17 1997-10-21 Affymax Technologies N.V Reagants and methods for immobilized polymer synthesis and display
US6071394A (en) * 1996-09-06 2000-06-06 Nanogen, Inc. Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis
US6379897B1 (en) * 2000-11-09 2002-04-30 Nanogen, Inc. Methods for gene expression monitoring on electronic microarrays
US7857957B2 (en) 1994-07-07 2010-12-28 Gamida For Life B.V. Integrated portable biological detection system
US6403367B1 (en) 1994-07-07 2002-06-11 Nanogen, Inc. Integrated portable biological detection system
US5710000A (en) 1994-09-16 1998-01-20 Affymetrix, Inc. Capturing sequences adjacent to Type-IIs restriction sites for genomic library mapping
US6327031B1 (en) * 1998-09-18 2001-12-04 Burstein Technologies, Inc. Apparatus and semi-reflective optical system for carrying out analysis of samples
US6558633B1 (en) 1994-09-21 2003-05-06 Isis Pharmaceuticals, Inc. Chemical reaction apparatus and methods
US5695934A (en) * 1994-10-13 1997-12-09 Lynx Therapeutics, Inc. Massively parallel sequencing of sorted polynucleotides
USRE43097E1 (en) 1994-10-13 2012-01-10 Illumina, Inc. Massively parallel signature sequencing by ligation of encoded adaptors
US5604097A (en) 1994-10-13 1997-02-18 Spectragen, Inc. Methods for sorting polynucleotides using oligonucleotide tags
US7767627B1 (en) 1994-10-18 2010-08-03 Symyx Solutions, Inc. Combinatorial synthesis of inorganic or composite materials
US5985356A (en) 1994-10-18 1999-11-16 The Regents Of The University Of California Combinatorial synthesis of novel materials
US6121048A (en) * 1994-10-18 2000-09-19 Zaffaroni; Alejandro C. Method of conducting a plurality of reactions
US6004617A (en) * 1994-10-18 1999-12-21 The Regents Of The University Of California Combinatorial synthesis of novel materials
US5556752A (en) * 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US6600996B2 (en) 1994-10-21 2003-07-29 Affymetrix, Inc. Computer-aided techniques for analyzing biological sequences
US6974666B1 (en) 1994-10-21 2005-12-13 Appymetric, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US8236493B2 (en) 1994-10-21 2012-08-07 Affymetrix, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US5795716A (en) 1994-10-21 1998-08-18 Chee; Mark S. Computer-aided visualization and analysis system for sequence evaluation
US5585069A (en) * 1994-11-10 1996-12-17 David Sarnoff Research Center, Inc. Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis
US5603351A (en) 1995-06-07 1997-02-18 David Sarnoff Research Center, Inc. Method and system for inhibiting cross-contamination in fluids of combinatorial chemistry device
US5486633A (en) * 1994-11-10 1996-01-23 Duke University Photochemically-removable silyl protecting groups
KR100314996B1 (en) * 1994-11-10 2002-01-15 윌리암 제이. 버크 Liquid distribution system
SE9404166D0 (en) * 1994-11-30 1994-11-30 Pharmacia Biotech Ab Multifunctional surfaces
US5830645A (en) * 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5622826A (en) * 1994-12-22 1997-04-22 Houston Advanced Research Center Method for immobilization of molecules on platinum solid support surfaces
US5712171A (en) 1995-01-20 1998-01-27 Arqule, Inc. Method of generating a plurality of chemical compounds in a spatially arranged array
US5959098A (en) 1996-04-17 1999-09-28 Affymetrix, Inc. Substrate preparation process
US6239273B1 (en) 1995-02-27 2001-05-29 Affymetrix, Inc. Printing molecular library arrays
US5599695A (en) * 1995-02-27 1997-02-04 Affymetrix, Inc. Printing molecular library arrays using deprotection agents solely in the vapor phase
US5908926A (en) * 1995-03-16 1999-06-01 Duke University 5'to 3' nucleic acid synthesis using 3'-photoremovable protecting group
US6428955B1 (en) 1995-03-17 2002-08-06 Sequenom, Inc. DNA diagnostics based on mass spectrometry
US7803529B1 (en) 1995-04-11 2010-09-28 Sequenom, Inc. Solid phase sequencing of biopolymers
US5925562A (en) * 1995-04-25 1999-07-20 Irori Remotely programmable matrices with memories
US5961923A (en) * 1995-04-25 1999-10-05 Irori Matrices with memories and uses thereof
US5751629A (en) 1995-04-25 1998-05-12 Irori Remotely programmable matrices with memories
US6025129A (en) * 1995-04-25 2000-02-15 Irori Remotely programmable matrices with memories and uses thereof
US5874214A (en) 1995-04-25 1999-02-23 Irori Remotely programmable matrices with memories
US6284459B1 (en) 1995-04-25 2001-09-04 Discovery Partners International Solid support matrices with memories and combinatorial libraries therefrom
US6329139B1 (en) 1995-04-25 2001-12-11 Discovery Partners International Automated sorting system for matrices with memory
US6416714B1 (en) * 1995-04-25 2002-07-09 Discovery Partners International, Inc. Remotely programmable matrices with memories
US6017496A (en) 1995-06-07 2000-01-25 Irori Matrices with memories and uses thereof
US6100026A (en) * 1995-04-25 2000-08-08 Irori Matrices with memories and uses thereof
US6331273B1 (en) 1995-04-25 2001-12-18 Discovery Partners International Remotely programmable matrices with memories
US5741462A (en) * 1995-04-25 1998-04-21 Irori Remotely programmable matrices with memories
US5624711A (en) * 1995-04-27 1997-04-29 Affymax Technologies, N.V. Derivatization of solid supports and methods for oligomer synthesis
US5830655A (en) 1995-05-22 1998-11-03 Sri International Oligonucleotide sizing using cleavable primers
US5958792A (en) * 1995-06-07 1999-09-28 Chiron Corporation Combinatorial libraries of substrate-bound cyclic organic compounds
US6251864B1 (en) 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
US5869451A (en) * 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6720149B1 (en) * 1995-06-07 2004-04-13 Affymetrix, Inc. Methods for concurrently processing multiple biological chip assays
US5683983A (en) * 1995-06-07 1997-11-04 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US5545531A (en) * 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US5677280A (en) * 1995-06-07 1997-10-14 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US5668110A (en) * 1995-06-07 1997-09-16 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5654276A (en) * 1995-06-07 1997-08-05 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
DE69637473T2 (en) 1995-06-07 2009-05-07 Glaxo Group Ltd., Greenford PEPTIDES AND COMPOUNDS BINDING ON A THROMBOPOIETIN RECEPTOR
US6387625B1 (en) 1995-06-27 2002-05-14 The University Of North Carolina At Chapel Hill Monolayer and electrode for detecting a label-bearing target and method of use thereof
US6127127A (en) * 1995-06-27 2000-10-03 The University Of North Carolina At Chapel Hill Monolayer and electrode for detecting a label-bearing target and method of use thereof
US6346387B1 (en) 1995-06-27 2002-02-12 Xanthon, Inc. Detection of binding reactions using labels detected by mediated catalytic electrochemistry
US5968745A (en) * 1995-06-27 1999-10-19 The University Of North Carolina At Chapel Hill Polymer-electrodes for detecting nucleic acid hybridization and method of use thereof
US6180346B1 (en) 1995-06-27 2001-01-30 The Universtiy Of North Carolina At Chapel Hill Electropolymerizable film, and method of making and use thereof
US6361951B1 (en) 1995-06-27 2002-03-26 The University Of North Carolina At Chapel Hill Electrochemical detection of nucleic acid hybridization
US6132971A (en) * 1995-06-27 2000-10-17 The University Of North Carolina At Chapel Hill Microelectronic device
US20050100946A1 (en) * 1995-06-29 2005-05-12 Affymetrix, Inc. Integrated nucleic acid diagnostic device and method for in-situ confocal microscopy
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US6168948B1 (en) 1995-06-29 2001-01-02 Affymetrix, Inc. Miniaturized genetic analysis systems and methods
US20020022261A1 (en) * 1995-06-29 2002-02-21 Anderson Rolfe C. Miniaturized genetic analysis systems and methods
US5968740A (en) * 1995-07-24 1999-10-19 Affymetrix, Inc. Method of Identifying a Base in a Nucleic Acid
US6326140B1 (en) 1995-08-09 2001-12-04 Regents Of The University Of California Systems for generating and analyzing stimulus-response output signal matrices
US5633724A (en) * 1995-08-29 1997-05-27 Hewlett-Packard Company Evanescent scanning of biochemical array
US5759779A (en) * 1995-08-29 1998-06-02 Dehlinger; Peter J. Polynucleotide-array assay and methods
US7026114B1 (en) 1995-09-13 2006-04-11 Affymetrix, Inc. Methods and compositions for monitoring polymer array synthesis
US5733729A (en) * 1995-09-14 1998-03-31 Affymetrix, Inc. Computer-aided probability base calling for arrays of nucleic acid probes on chips
US5843655A (en) * 1995-09-18 1998-12-01 Affymetrix, Inc. Methods for testing oligonucleotide arrays
US20040086917A1 (en) * 1995-09-27 2004-05-06 Nanogen, Inc. Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis
US20020068357A1 (en) * 1995-09-28 2002-06-06 Mathies Richard A. Miniaturized integrated nucleic acid processing and analysis device and method
US6132580A (en) * 1995-09-28 2000-10-17 The Regents Of The University Of California Miniature reaction chamber and devices incorporating same
US20040175718A1 (en) * 1995-10-16 2004-09-09 Affymetrix, Inc. Computer-aided visualization and analysis system for sequence evaluation
US5658734A (en) * 1995-10-17 1997-08-19 International Business Machines Corporation Process for synthesizing chemical compounds
US7455964B1 (en) 1996-07-15 2008-11-25 The Hospital For Sick Children Genes from the 20q13 amplicon and their uses
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
US5763263A (en) * 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
US6953663B1 (en) * 1995-11-29 2005-10-11 Affymetrix, Inc. Polymorphism detection
US6300063B1 (en) 1995-11-29 2001-10-09 Affymetrix, Inc. Polymorphism detection
US20110028350A1 (en) * 1995-12-15 2011-02-03 Affymetrix, Inc. Photocleavable protecting groups
US6147205A (en) 1995-12-15 2000-11-14 Affymetrix, Inc. Photocleavable protecting groups and methods for their use
US6022963A (en) * 1995-12-15 2000-02-08 Affymetrix, Inc. Synthesis of oligonucleotide arrays using photocleavable protecting groups
US6660233B1 (en) * 1996-01-16 2003-12-09 Beckman Coulter, Inc. Analytical biochemistry system with robotically carried bioarray
US7291463B2 (en) * 1996-01-23 2007-11-06 Affymetrix, Inc. Nucleic acid labeling compounds
US6965020B2 (en) 1996-01-23 2005-11-15 Affymetrix, Inc. Nucleic acid labeling compounds
US6864059B2 (en) * 1996-01-23 2005-03-08 Affymetrix, Inc. Biotin containing C-glycoside nucleic acid labeling compounds
EP0880598A4 (en) 1996-01-23 2005-02-23 Affymetrix Inc Nucleic acid analysis techniques
US7423143B2 (en) * 1996-01-23 2008-09-09 Affymetrix. Inc. Nucleic acid labeling compounds
US20040210045A1 (en) * 1996-01-23 2004-10-21 Mcgall Glenn Nucleic acid labeling compounds
US7282327B2 (en) * 1996-01-23 2007-10-16 Affymetrix, Inc. Nucleic acid labeling compounds
US20010018514A1 (en) * 1998-07-31 2001-08-30 Mcgall Glenn H. Nucleic acid labeling compounds
US7527928B2 (en) * 1996-11-29 2009-05-05 Third Wave Technologies, Inc. Reactions on a solid surface
US6924094B1 (en) 1996-02-08 2005-08-02 Affymetrix, Inc. Chip-based species identification and phenotypic characterization of microorganisms
EP1728875A3 (en) 1996-02-08 2007-05-09 Affymetrix, Inc. Chip-based speciation and phenotypic characterization of microorganisms
AU2189397A (en) 1996-02-08 1997-08-28 Affymetrix, Inc. Chip-based speciation and phenotypic characterization of microorganisms
EP0920440B1 (en) * 1996-02-09 2012-08-22 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US6852487B1 (en) * 1996-02-09 2005-02-08 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US20020150921A1 (en) * 1996-02-09 2002-10-17 Francis Barany Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US6838256B2 (en) 1996-02-12 2005-01-04 Gene Logic Inc. Coding sequences of the human BRCA1 gene
US6130322A (en) * 1996-02-12 2000-10-10 Gene Logic, Inc. Coding sequences of the human BRCA1 gene
US20030022184A1 (en) * 1996-02-12 2003-01-30 Oncormed. Inc. Coding sequences of the human BRCA1 gene
DE19609272C2 (en) * 1996-02-27 2000-05-25 Schering Ag Process for the parallel synthesis of large numbers of 2,6-disubstituted quinoline derivatives
US6063633A (en) 1996-02-28 2000-05-16 The University Of Houston Catalyst testing process and apparatus
WO1997033000A1 (en) 1996-03-04 1997-09-12 Genetrace Systems, Inc. Methods of screening nucleic acids using mass spectrometry
EP1025437A4 (en) * 1996-03-08 2002-10-23 Smithkline Beecham Corp A method for determining the affinity of proteins for chemical agents during screening of combinatorial libraries
US6013440A (en) 1996-03-11 2000-01-11 Affymetrix, Inc. Nucleic acid affinity columns
US20030165931A1 (en) * 1998-03-11 2003-09-04 Bruno Tocque Qualitative differential screening
US6881571B1 (en) 1998-03-11 2005-04-19 Exonhit Therapeutics S.A. Qualitative differential screening
FR2775984B1 (en) 1998-03-11 2006-09-15 Bioscreen Therapeutics Sa QUALITATIVE DIFFERENTIAL SCREENING
US6361937B1 (en) * 1996-03-19 2002-03-26 Affymetrix, Incorporated Computer-aided nucleic acid sequencing
AU2320597A (en) 1996-03-19 1997-10-10 Molecular Tool, Inc. Method for determining the nucleotide sequence of a polynucleotide
US6528324B1 (en) * 1996-03-22 2003-03-04 Ontogen Corporation Apparatus for pre-determined mass sorting of positional-encoded solid phase synthesis supports
US6114122A (en) * 1996-03-26 2000-09-05 Affymetrix, Inc. Fluidics station with a mounting system and method of using
US6777217B1 (en) 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
DE19612356B4 (en) * 1996-03-28 2007-04-26 Clondiag Chip Technologies Gmbh Optical detection of hybridization signals
US6458530B1 (en) 1996-04-04 2002-10-01 Affymetrix Inc. Selecting tag nucleic acids
US5733509A (en) * 1996-04-17 1998-03-31 Motorola, Inc. Method and system for synthesizing oligonucleotides using nucleotide-specific dispensing bars
US6706875B1 (en) 1996-04-17 2004-03-16 Affyemtrix, Inc. Substrate preparation process
DE69732101T2 (en) 1996-04-17 2005-12-22 Köster, Hubert, Dr., Cambridge COMBINATIONAL PROTECTION GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES
EP2290364A1 (en) 1996-04-25 2011-03-02 BioArray Solutions Ltd. Light-controlled electrokinetic assembly of particles near surfaces
US6958245B2 (en) 1996-04-25 2005-10-25 Bioarray Solutions Ltd. Array cytometry
US6165335A (en) 1996-04-25 2000-12-26 Pence And Mcgill University Biosensor device and method
US7144119B2 (en) * 1996-04-25 2006-12-05 Bioarray Solutions Ltd. System and method for programmable illumination pattern generation
JP2000512744A (en) * 1996-05-16 2000-09-26 アフィメトリックス,インコーポレイテッド System and method for detecting label material
US5958342A (en) * 1996-05-17 1999-09-28 Incyte Pharmaceuticals, Inc. Jet droplet device
WO1997045559A1 (en) 1996-05-29 1997-12-04 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
US5989835A (en) * 1997-02-27 1999-11-23 Cellomics, Inc. System for cell-based screening
US20060141539A1 (en) * 1996-05-30 2006-06-29 Taylor D L Miniaturized cell array methods and apparatus for cell-based screening
US6103479A (en) * 1996-05-30 2000-08-15 Cellomics, Inc. Miniaturized cell array methods and apparatus for cell-based screening
US7091311B2 (en) * 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
WO1997046313A1 (en) * 1996-06-07 1997-12-11 Eos Biotechnology, Inc. Immobilised linear oligonucleotide arrays
US5770370A (en) * 1996-06-14 1998-06-23 David Sarnoff Research Center, Inc. Nuclease protection assays
US5914229A (en) * 1996-06-14 1999-06-22 Sarnoff Corporation Method for amplifying a polynucleotide
EP0912752A1 (en) * 1996-06-14 1999-05-06 Sarnoff Corporation Method for polynucleotide sequencing
US5912124A (en) * 1996-06-14 1999-06-15 Sarnoff Corporation Padlock probe detection
SE9602545L (en) * 1996-06-25 1997-12-26 Michael Mecklenburg Method of discriminating complex biological samples
US6331275B1 (en) 1996-07-08 2001-12-18 Burstein Technologies, Inc. Spatially addressable, cleavable reflective signal elements, assay device and method
EP0918845A4 (en) 1996-07-08 2000-08-30 Burstein Lab Inc Cleavable signal element device and method
US6342349B1 (en) 1996-07-08 2002-01-29 Burstein Technologies, Inc. Optical disk-based assay devices and methods
US20050069923A1 (en) * 1996-07-08 2005-03-31 Mullis Kary Banks Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
US20050214827A1 (en) * 1996-07-08 2005-09-29 Burstein Technologies, Inc. Assay device and method
DE19629141A1 (en) * 1996-07-19 1998-04-16 Bayer Ag Method and device for screening molecules for their individual binding behavior to at least one predetermined ligand
US5731438A (en) * 1996-08-01 1998-03-24 Isis Pharmaceuticals, Inc. N-(aminoalkyl)-and/or N-(amidoalkyl)-dinitrogen heterocycles
US5922872A (en) * 1996-08-01 1999-07-13 Isis Pharmaceuticals, Inc. Meta-benzylic and alpha-amido compositions and methods for preparing same
US5798360A (en) * 1996-08-01 1998-08-25 Isis Pharmaceuticals, Inc. N-(aminoalkyl)- and/or N-(amidoalkyl)- dinitrogen heterocyclic compositions
US5817489A (en) 1996-08-01 1998-10-06 Isis Pharmaceuticals, Inc. Di-nitrogen heterocycle compositions
US5858666A (en) * 1996-08-29 1999-01-12 Biotechnology Research And Development Corporation Apparatus and method of detection employing an AC frequency sensor array
US6020047A (en) * 1996-09-04 2000-02-01 Kimberly-Clark Worldwide, Inc. Polymer films having a printed self-assembling monolayer
US6391550B1 (en) 1996-09-19 2002-05-21 Affymetrix, Inc. Identification of molecular sequence signatures and methods involving the same
US5965363A (en) 1996-09-19 1999-10-12 Genetrace Systems Inc. Methods of preparing nucleic acids for mass spectrometric analysis
US7094609B2 (en) * 1996-09-20 2006-08-22 Burstein Technologies, Inc. Spatially addressable combinatorial chemical arrays in encoded optical disk format
GB2321642B8 (en) 1996-10-01 2006-08-22 Geron Corp Human telomerase reverse transcriptase promoter
WO1998014641A1 (en) * 1996-10-02 1998-04-09 Symyx Technologies Potential masking systems and methods for combinatorial library synthesis
US5932546A (en) * 1996-10-04 1999-08-03 Glaxo Wellcome Inc. Peptides and compounds that bind to the thrombopoietin receptor
US6136274A (en) * 1996-10-07 2000-10-24 Irori Matrices with memories in automated drug discovery and units therefor
US6738529B1 (en) 1996-10-09 2004-05-18 Symyx Technologies, Inc. Analysis of chemical data from images
US5762881A (en) * 1996-10-29 1998-06-09 Bohdan Automation, Inc. Apparatus for multiple, simultaneous synthesis of organic compounds
US6875620B1 (en) * 1996-10-31 2005-04-05 Agilent Technologies, Inc. Tiling process for constructing a chemical array
US5780241A (en) * 1996-11-05 1998-07-14 Isis Pharmaceuticals, Inc. Complex chemical libraries
US6024925A (en) 1997-01-23 2000-02-15 Sequenom, Inc. Systems and methods for preparing low volume analyte array elements
ATE259056T1 (en) 1996-11-06 2004-02-15 Sequenom Inc METHOD FOR MASS SPECTROMETRY
US6133436A (en) 1996-11-06 2000-10-17 Sequenom, Inc. Beads bound to a solid support and to nucleic acids
US7285422B1 (en) 1997-01-23 2007-10-23 Sequenom, Inc. Systems and methods for preparing and analyzing low volume analyte array elements
US6140053A (en) * 1996-11-06 2000-10-31 Sequenom, Inc. DNA sequencing by mass spectrometry via exonuclease degradation
CA2270132A1 (en) 1996-11-06 1998-05-14 Sequenom, Inc. Dna diagnostics based on mass spectrometry
US6441172B1 (en) 1996-11-07 2002-08-27 Torrey Pines Institute For Molecular Studies Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
US6887665B2 (en) * 1996-11-14 2005-05-03 Affymetrix, Inc. Methods of array synthesis
EP0946286B1 (en) * 1996-11-14 2003-03-19 Affymetrix, Inc. Chemical amplification for the synthesis of patterned arrays
US5965719A (en) * 1996-11-15 1999-10-12 Sunsorb Biotech, Inc. Combinatorial synthesis of carbohydrate libraries
US5780603A (en) * 1996-11-15 1998-07-14 Synsorb Biotech, Inc. Combinatorial synthesis of carbohydrate libraries
US6706473B1 (en) * 1996-12-06 2004-03-16 Nanogen, Inc. Systems and devices for photoelectrophoretic transport and hybridization of oligonucleotides
AU5794498A (en) 1996-12-10 1998-07-03 Genetrace Systems, Inc. Releasable nonvolatile mass-label molecules
US5942397A (en) * 1996-12-11 1999-08-24 Tarlov; Michael J. Surface immobilization of biopolymers
AU741076B2 (en) 1996-12-12 2001-11-22 Prolume, Ltd. Apparatus and method for detecting and identifying infectious agents
WO1998027430A1 (en) * 1996-12-17 1998-06-25 Affymetrix Inc. Lithographic mask design and synthesis of diverse probes on a substrate
US6048623A (en) * 1996-12-18 2000-04-11 Kimberly-Clark Worldwide, Inc. Method of contact printing on gold coated films
US5922550A (en) * 1996-12-18 1999-07-13 Kimberly-Clark Worldwide, Inc. Biosensing devices which produce diffraction images
JP2002514913A (en) * 1996-12-19 2002-05-21 エール ユニバーシティ Bioreactive allosteric polynucleotide
JP4663824B2 (en) * 1996-12-31 2011-04-06 ハイ スループット ジェノミクス インコーポレイテッド Multiplexed molecular analyzer and method
US7670767B1 (en) * 1997-01-16 2010-03-02 The Regents Of The University Of California Genetic alterations associated with cancer
US6277563B1 (en) 1997-01-16 2001-08-21 The Regents Of The University Of California Genetic alterations associated with cancer
KR100566859B1 (en) 1997-01-21 2006-04-03 제너럴 하스피톨 코포레이션 Selection of proteins using rna-protein fusions
US5812272A (en) * 1997-01-30 1998-09-22 Hewlett-Packard Company Apparatus and method with tiled light source array for integrated assay sensing
US5837475A (en) * 1997-01-30 1998-11-17 Hewlett-Packard Co. Apparatus and method for scanning a chemical array
US6262269B1 (en) 1997-02-04 2001-07-17 Trega Biosciences, Inc. 4-Substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries
US5773308A (en) * 1997-02-10 1998-06-30 The United States Of America As Represented By The Secretary Of The Navy Photoactivatable o-nitrobenzyl polyethylene glycol-silane for the production of patterned biomolecular arrays
WO1998035012A2 (en) 1997-02-12 1998-08-13 Chan Eugene Y Methods and products for analyzing polymers
AU6659298A (en) 1997-02-18 1998-09-08 Thomas Jefferson University Compositions that bind to pancreatic cancer cells and methods of using the same
US7117098B1 (en) 1997-02-27 2006-10-03 Cellomics, Inc. Machine-readable storage medium for analyzing distribution of macromolecules between the cell membrane and the cell cytoplasm
US6727071B1 (en) 1997-02-27 2004-04-27 Cellomics, Inc. System for cell-based screening
EP0983498B1 (en) 1997-02-27 2004-05-26 Cellomics, Inc. A system for cell-based screening
US6165709A (en) 1997-02-28 2000-12-26 Fred Hutchinson Cancer Research Center Methods for drug target screening
US20030027126A1 (en) 1997-03-14 2003-02-06 Walt David R. Methods for detecting target analytes and enzymatic reactions
US7622294B2 (en) 1997-03-14 2009-11-24 Trustees Of Tufts College Methods for detecting target analytes and enzymatic reactions
AU751956B2 (en) 1997-03-20 2002-09-05 University Of Washington Solvent for biopolymer synthesis, solvent microdroplets and methods of use
US6419883B1 (en) 1998-01-16 2002-07-16 University Of Washington Chemical synthesis using solvent microdroplets
US6028189A (en) * 1997-03-20 2000-02-22 University Of Washington Solvent for oligonucleotide synthesis and methods of use
US6180288B1 (en) 1997-03-21 2001-01-30 Kimberly-Clark Worldwide, Inc. Gel sensors and method of use thereof
US6753161B2 (en) * 1997-03-27 2004-06-22 Oncosis Llc Optoinjection methods
JP2001521622A (en) 1997-04-04 2001-11-06 カリパー テクノロジーズ コーポレイション Closed-loop biochemical analyzer
US5772855A (en) * 1997-04-17 1998-06-30 Bend Research, Inc. Preparation of bioactive compounds by plasma synthesis
US6143496A (en) 1997-04-17 2000-11-07 Cytonix Corporation Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
US6558901B1 (en) * 1997-05-02 2003-05-06 Biomerieux Vitek Nucleic acid assays
US7101672B2 (en) 1998-05-05 2006-09-05 Third Wave Technologies, Inc. Target-dependent reactions using structure-bridging oligonucleotides
US6194149B1 (en) 1998-03-03 2001-02-27 Third Wave Technologies, Inc. Target-dependent reactions using structure-bridging oligonucleotides
US6214545B1 (en) 1997-05-05 2001-04-10 Third Wave Technologies, Inc Polymorphism analysis by nucleic acid structure probing
AU744369B2 (en) 1997-05-05 2002-02-21 Third Wave Technologies, Inc. Target-dependent reactions using structure-bridging oligonucleotides
US6210880B1 (en) 1997-09-19 2001-04-03 Third Wave Technologies, Inc. Polymorphism analysis by nucleic acid structure probing with structure-bridging oligonucleotides
US6159681A (en) * 1997-05-28 2000-12-12 Syntrix Biochip, Inc. Light-mediated method and apparatus for the regional analysis of biologic material
ATE464123T1 (en) * 1997-06-20 2010-04-15 Univ New York ELECTROSPRAYING SOLUTIONS FOR MASS PRODUCTION OF CHIPS AND MOLECULE LIBRARIES
NZ516848A (en) * 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US6368877B1 (en) * 1997-06-25 2002-04-09 Massachusetts Institute Of Technology Self-assembling peptide surfaces for cell patterning and interactions
EP0991930B1 (en) * 1997-06-26 2004-06-16 Perseptive Biosystems, Inc. High density sample holder for analysis of biological samples
IL121312A (en) * 1997-07-14 2001-09-13 Technion Res & Dev Foundation Microelectronic components, their fabrication and electronic networks comprising them
US6151123A (en) * 1997-07-14 2000-11-21 Symyx Technologies, Inc. Systems and methods for employing optical probes to characterize material properties
US6365349B1 (en) 1997-07-22 2002-04-02 Qiagen Genomics, Inc. Apparatus and methods for arraying solution onto a solid support
CA2297661A1 (en) 1997-07-22 1999-02-04 Darwin Molecular Corp. Amplification and other enzymatic reactions performed on nucleic acid arrays
CN1249252C (en) 1997-07-22 2006-04-05 佳根基因组学公司 Computer method and system for correlating sequencing data by MS
US6420108B2 (en) 1998-02-09 2002-07-16 Affymetrix, Inc. Computer-aided display for comparative gene expression
WO1999005324A1 (en) * 1997-07-25 1999-02-04 Affymetrix, Inc. System for providing a polymorphism database
US6826296B2 (en) 1997-07-25 2004-11-30 Affymetrix, Inc. Method and system for providing a probe array chip design database
US7068830B2 (en) * 1997-07-25 2006-06-27 Affymetrix, Inc. Method and system for providing a probe array chip design database
EP1046036A4 (en) * 1997-07-29 2003-08-27 James S Huston Methods for obtaining probes of peptide function
US6391655B1 (en) 1997-07-30 2002-05-21 Corning Incorporated Oxidized styrenic polymers for DNA binding
JP4313861B2 (en) * 1997-08-01 2009-08-12 キヤノン株式会社 Manufacturing method of probe array
US6375871B1 (en) 1998-06-18 2002-04-23 3M Innovative Properties Company Methods of manufacturing microfluidic articles
CA2244414A1 (en) * 1997-08-01 1999-02-01 Canon Kabushiki Kaisha Reaction site array, preparation process of it, reaction process using it and quantitative determination method of substance in sample solution using it
US6290685B1 (en) 1998-06-18 2001-09-18 3M Innovative Properties Company Microchanneled active fluid transport devices
US6326489B1 (en) 1997-08-05 2001-12-04 Howard Hughes Medical Institute Surface-bound, bimolecular, double-stranded DNA arrays
US6120995A (en) * 1997-08-07 2000-09-19 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
US7135333B1 (en) 1997-08-07 2006-11-14 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
US20090269814A1 (en) * 1998-05-22 2009-10-29 Murphy Patricia D Method of Analyzing a BRCA2 Gene in a Human Subject
EP2275575A3 (en) 1997-08-15 2012-07-11 Gene Logic Inc. Coding sequence haplotypes of the human BRCA2 gene
US6410342B1 (en) * 1997-08-19 2002-06-25 Pharmacopeia, Inc. Method and apparatus for controlled photoelution
US7252950B1 (en) * 1997-09-04 2007-08-07 The Regents Of The University Of California Assays for detecting modulators of cytoskeletal function
US6432639B1 (en) 1997-09-10 2002-08-13 Dna Sciences Laboratories, Inc. Isolated CYP3A4 nucleic acid molecules and detection methods
CN100367023C (en) * 1997-09-11 2008-02-06 生物风险公司 Method of making high density arrays
US7745142B2 (en) 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
DE19741715A1 (en) * 1997-09-22 1999-03-25 Hoechst Ag New pentopyranosyl nucleoside compounds
US7214298B2 (en) * 1997-09-23 2007-05-08 California Institute Of Technology Microfabricated cell sorter
US6492109B1 (en) 1997-09-23 2002-12-10 Gene Logic, Inc. Susceptibility mutation 6495delGC of BRCA2
US20030104481A1 (en) * 1997-09-30 2003-06-05 Symyx Technologies Potential masking systems and methods for combinatorial library synthesis
US6607878B2 (en) 1997-10-06 2003-08-19 Stratagene Collections of uniquely tagged molecules
US6548021B1 (en) 1997-10-10 2003-04-15 President And Fellows Of Harvard College Surface-bound, double-stranded DNA protein arrays
US6485944B1 (en) 1997-10-10 2002-11-26 President And Fellows Of Harvard College Replica amplification of nucleic acid arrays
US6511803B1 (en) 1997-10-10 2003-01-28 President And Fellows Of Harvard College Replica amplification of nucleic acid arrays
JP2001519538A (en) 1997-10-10 2001-10-23 プレジデント・アンド・フェローズ・オブ・ハーバード・カレッジ Replica amplification of nucleic acid arrays
US20020155495A1 (en) * 2000-04-17 2002-10-24 Millstein Larry S. Method for producing arrays and devices relating thereto
US6348322B1 (en) * 1997-10-17 2002-02-19 Duke University Method of screening for specific binding interactions
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
US7351578B2 (en) 1999-12-10 2008-04-01 Invitrogen Corp. Use of multiple recombination sites with unique specificity in recombinational cloning
US6156494A (en) * 1997-10-28 2000-12-05 Mosaic Technologies Serially directed combinatorial synthesis on fiber optic arrays
EP1032705B1 (en) * 1997-10-30 2011-12-14 Cold Spring Harbor Laboratory Probe arrays and methods of using probe arrays for distinguishing dna
US6322968B1 (en) 1997-11-21 2001-11-27 Orchid Biosciences, Inc. De novo or “universal” sequencing array
US6101946A (en) * 1997-11-21 2000-08-15 Telechem International Inc. Microarray printing device including printing pins with flat tips and exterior channel and method of manufacture
US6794133B1 (en) 1997-12-11 2004-09-21 The General Hospital Corporation Broad range PCR amplification techniques
US6274383B1 (en) 1997-12-15 2001-08-14 Sepracor Inc. Methods for synthesizing libraries of dihydro-quinazolinones
US20070166741A1 (en) * 1998-12-14 2007-07-19 Somalogic, Incorporated Multiplexed analyses of test samples
US6242246B1 (en) * 1997-12-15 2001-06-05 Somalogic, Inc. Nucleic acid ligand diagnostic Biochip
US6184377B1 (en) 1997-12-15 2001-02-06 Sepracor Inc. Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof
US20060057573A1 (en) * 2002-02-15 2006-03-16 Somalogic, Inc Methods and reagents for detecting target binding by nucleic acid ligands
US6060256A (en) * 1997-12-16 2000-05-09 Kimberly-Clark Worldwide, Inc. Optical diffraction biosensor
US6238869B1 (en) 1997-12-19 2001-05-29 High Throughput Genomics, Inc. High throughput assay system
US6458533B1 (en) 1997-12-19 2002-10-01 High Throughput Genomics, Inc. High throughput assay system for monitoring ESTs
US6232066B1 (en) 1997-12-19 2001-05-15 Neogen, Inc. High throughput assay system
US20030096232A1 (en) 1997-12-19 2003-05-22 Kris Richard M. High throughput assay system
US20100105572A1 (en) * 1997-12-19 2010-04-29 Kris Richard M High throughput assay system
US20030039967A1 (en) * 1997-12-19 2003-02-27 Kris Richard M. High throughput assay system using mass spectrometry
US6093302A (en) 1998-01-05 2000-07-25 Combimatrix Corporation Electrochemical solid phase synthesis
US6087102A (en) 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
US6265163B1 (en) 1998-01-09 2001-07-24 Lynx Therapeutics, Inc. Solid phase selection of differentially expressed genes
DE69930726T2 (en) * 1998-01-12 2007-01-25 Massachusetts Institute Of Technology, Cambridge METHOD AND DEVICE FOR MICROTEST PROCESSING
US6893877B2 (en) * 1998-01-12 2005-05-17 Massachusetts Institute Of Technology Methods for screening substances in a microwell array
US6201639B1 (en) 1998-03-20 2001-03-13 James W. Overbeck Wide field of view and high speed scanning microscopy
US6426185B1 (en) 1998-01-16 2002-07-30 Large Scale Biology Corporation Method of compiling a functional gene profile in a plant by transfecting a nucleic acid sequence of a donor plant into a different host plant in an anti-sense orientation
US6303848B1 (en) 1998-01-16 2001-10-16 Large Scale Biology Corporation Method for conferring herbicide, pest, or disease resistance in plant hosts
US20020164585A1 (en) * 1998-01-16 2002-11-07 Sean Chapman Method for enhancing RNA or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids
US20030166169A1 (en) * 1998-01-16 2003-09-04 Padgett Hal S. Method for constructing viral nucleic acids in a cell-free manner
US6289229B1 (en) 1998-01-20 2001-09-11 Scimed Life Systems, Inc. Readable probe array for in vivo use
AU2460399A (en) * 1998-01-20 1999-08-02 Packard Bioscience Company Gel pad arrays and methods and systems for making them
DE19802576B4 (en) * 1998-01-23 2004-10-28 Xerion Pharmaceuticals Ag Methods for the simultaneous identification of proteins and their binding partners
US6043294A (en) * 1998-01-29 2000-03-28 Gate Technologies International, Inc. Method of and apparatus for optically enhancing chemical reactions
US6741956B1 (en) 1998-02-03 2004-05-25 Lucent Technologies Inc. Analog computation using hybridization-capable oligomers
US6150102A (en) * 1998-02-03 2000-11-21 Lucent Technologies Inc. Method of generating nucleic acid oligomers of known composition
US6537747B1 (en) 1998-02-03 2003-03-25 Lucent Technologies Inc. Data transmission using DNA oligomers
EP0947246B1 (en) * 1998-02-04 2004-08-18 Corning Incorporated Substrate for array printing
ATE393912T1 (en) 1998-02-04 2008-05-15 Invitrogen Corp MICROARRAYS AND THEIR USES
US20040265838A1 (en) * 1998-02-06 2004-12-30 Affymetrix, Inc. Method of manufacturing
US5994079A (en) 1998-02-06 1999-11-30 Digene Corporation Direct detection of RNA mediated by reverse transcriptase lacking RNAse H function
US7399589B2 (en) * 1998-02-06 2008-07-15 Digene Corporation Immunological detection of RNA:DNA hybrids on microarrays
EP2332645A1 (en) * 1998-02-11 2011-06-15 The University Of Houston Apparatus for chemical and biochemical reactions using photo-generated reagents
US20040035690A1 (en) * 1998-02-11 2004-02-26 The Regents Of The University Of Michigan Method and apparatus for chemical and biochemical reactions using photo-generated reagents
AU772531B2 (en) * 1998-02-11 2004-04-29 University Of Houston, The Method and apparatus for chemical and biochemical reactions using photo-generated reagents
US6537505B1 (en) 1998-02-20 2003-03-25 Bio Dot, Inc. Reagent dispensing valve
EP1056882A4 (en) * 1998-02-21 2002-04-17 Technology Foundation Wisys One dimensional chemical compound arrays and methods for assaying them
WO1999042813A1 (en) * 1998-02-23 1999-08-26 Wisconsin Alumni Research Foundation Method and apparatus for synthesis of arrays of dna probes
US20020090639A1 (en) * 1998-02-26 2002-07-11 Mcginnis Ralph Evan Two dimensional linkage study methods and related inventions
US6087103A (en) * 1998-03-04 2000-07-11 Lifespan Biosciences, Inc. Tagged ligand arrays for identifying target-ligand interactions
EP1717249A1 (en) 1998-03-12 2006-11-02 Georgetown University Peptides containing a cholesterol recognition sequence and their uses
US6185030B1 (en) 1998-03-20 2001-02-06 James W. Overbeck Wide field of view and high speed scanning microscopy
US6361942B1 (en) * 1998-03-24 2002-03-26 Boston Probes, Inc. Method, kits and compositions pertaining to detection complexes
US6218114B1 (en) 1998-03-27 2001-04-17 Academia Sinica Methods for detecting differentially expressed genes
EP1064378A2 (en) * 1998-03-27 2001-01-03 The Board Of Trustees Of The Leland Stanford Junior University Hypoxia-inducible human genes, proteins, and uses thereof
WO1999049774A2 (en) 1998-03-31 1999-10-07 Genzyme Corporation Methods for the diagnosis and treatment of lung cancer
US6077673A (en) * 1998-03-31 2000-06-20 Clontech Laboratories, Inc. Mouse arrays and kits comprising the same
IL138668A0 (en) * 1998-04-03 2001-10-31 Phylos Inc Addressable protein arrays
US7108968B2 (en) * 1998-04-03 2006-09-19 Affymetrix, Inc. Mycobacterial rpoB sequences
US6284497B1 (en) 1998-04-09 2001-09-04 Trustees Of Boston University Nucleic acid arrays and methods of synthesis
US6376619B1 (en) 1998-04-13 2002-04-23 3M Innovative Properties Company High density, miniaturized arrays and methods of manufacturing same
AU3659199A (en) * 1998-04-20 1999-11-08 Affymetrix, Inc. Methods for reducing non-specific binding to a nucleic acid probe array
WO1999055886A1 (en) * 1998-04-24 1999-11-04 Genova Pharmaceuticals Corporation Function-based gene discovery
US6350618B1 (en) 1998-04-27 2002-02-26 Corning Incorporated Redrawn capillary imaging reservoir
DE69835342T2 (en) 1998-04-27 2007-08-23 Corning Inc. Method for storing biological samples with the aid of a redrawn capillary store
US6884626B1 (en) 1998-04-27 2005-04-26 Corning Incorporated Redrawn capillary imaging reservoir
US6355419B1 (en) 1998-04-27 2002-03-12 Hyseq, Inc. Preparation of pools of nucleic acids based on representation in a sample
US6780591B2 (en) 1998-05-01 2004-08-24 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US7875440B2 (en) 1998-05-01 2011-01-25 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US20080050836A1 (en) * 1998-05-01 2008-02-28 Isabelle Guyon Biomarkers for screening, predicting, and monitoring benign prostate hyperplasia
US7617163B2 (en) * 1998-05-01 2009-11-10 Health Discovery Corporation Kernels and kernel methods for spectral data
US6979728B2 (en) * 1998-05-04 2005-12-27 Baylor College Of Medicine Articles of manufacture and methods for array based analysis of biological molecules
US20030203394A1 (en) * 1998-05-04 2003-10-30 Yoav Eichen Detection of a target in a sample
US6130046A (en) * 1998-05-04 2000-10-10 Affymetrix, Inc. Techniques for synthesis integrity evaluation utilizing cycle fidelity probes
US6686163B2 (en) 1998-05-06 2004-02-03 Gene Logic Inc. Coding sequence haplotype of the human BRCA1 gene
US5992226A (en) * 1998-05-08 1999-11-30 The United States Of America As Represented By The Secretary Of The Navy Apparatus and method for measuring intermolecular interactions by atomic force microscopy
US6324479B1 (en) 1998-05-08 2001-11-27 Rosetta Impharmatics, Inc. Methods of determining protein activity levels using gene expression profiles
US5965352A (en) * 1998-05-08 1999-10-12 Rosetta Inpharmatics, Inc. Methods for identifying pathways of drug action
US20030153023A1 (en) * 1999-05-13 2003-08-14 Starzl Timothy W. Enumeration method of analyte detection
DE19823454A1 (en) * 1998-05-18 1999-11-25 Epigenomics Gmbh Photolithographic production of oligonucleotide array for manufacture of DNA chips
DE19823660C1 (en) * 1998-05-20 1999-10-07 Nanomont Ges Fuer Nanotechnolo Process and assembly to apply and fix biochemically-active micro- and nano- micro-spheres on a substrate, especially useful in biochemical analysis such as DNA, viral and genetic testing
WO1999061653A2 (en) * 1998-05-27 1999-12-02 Syntrix Biochip Light-mediated regional analysis of biologic material
US6268210B1 (en) * 1998-05-27 2001-07-31 Hyseq, Inc. Sandwich arrays of biological compounds
US6271957B1 (en) * 1998-05-29 2001-08-07 Affymetrix, Inc. Methods involving direct write optical lithography
US6086831A (en) * 1998-06-10 2000-07-11 Mettler-Toledo Bohdan, Inc. Modular reaction block assembly with thermoelectric cooling and heating
DE19826458A1 (en) * 1998-06-13 1999-12-16 Papst Motoren Gmbh & Co Kg Arrangement with an electric motor
US6872521B1 (en) 1998-06-16 2005-03-29 Beckman Coulter, Inc. Polymerase signaling assay
US6270730B1 (en) 1998-06-16 2001-08-07 Northwest Engineering Inc. Multi-well rotary synthesizer
US6251595B1 (en) 1998-06-18 2001-06-26 Agilent Technologies, Inc. Methods and devices for carrying out chemical reactions
US6132969A (en) * 1998-06-19 2000-10-17 Rosetta Inpharmatics, Inc. Methods for testing biological network models
US6218122B1 (en) * 1998-06-19 2001-04-17 Rosetta Inpharmatics, Inc. Methods of monitoring disease states and therapies using gene expression profiles
ATE313548T1 (en) * 1998-06-22 2006-01-15 Affymetrix Inc REAGENT AND METHOD FOR SOLID PHASE SYNTHESIS
US6235473B1 (en) 1998-07-02 2001-05-22 Orchid Biosciences, Inc. Gene pen devices for array printing
US6762061B1 (en) 1998-07-03 2004-07-13 Corning Incorporated Redrawn capillary imaging reservoir
US6593133B1 (en) 1998-07-06 2003-07-15 Nsgene A/S Neurotrophic factors
WO2000003037A1 (en) * 1998-07-10 2000-01-20 The Board Of Trustees Of The Leland Stanford Junior University Screening arrays of nucleotides to determine correspondence with both sequence and physical properties of a probe
US6171794B1 (en) 1998-07-13 2001-01-09 Rosetta Inpharmatics, Inc. Methods for determining cross-hybridization
US6576478B1 (en) * 1998-07-14 2003-06-10 Zyomyx, Inc. Microdevices for high-throughput screening of biomolecules
US20020119579A1 (en) * 1998-07-14 2002-08-29 Peter Wagner Arrays devices and methods of use thereof
US6897073B2 (en) * 1998-07-14 2005-05-24 Zyomyx, Inc. Non-specific binding resistant protein arrays and methods for making the same
US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
US6682942B1 (en) 1998-07-14 2004-01-27 Zyomyx, Inc. Microdevices for screening biomolecules
US6780582B1 (en) * 1998-07-14 2004-08-24 Zyomyx, Inc. Arrays of protein-capture agents and methods of use thereof
US20030138973A1 (en) * 1998-07-14 2003-07-24 Peter Wagner Microdevices for screening biomolecules
US6316229B1 (en) 1998-07-20 2001-11-13 Yale University Single molecule analysis target-mediated ligation of bipartite primers
JP2002521666A (en) * 1998-07-21 2002-07-16 バースタイン テクノロジーズ,インコーポレイティド Optical disc based assay device and method
US20040029159A1 (en) * 1998-08-03 2004-02-12 Dreyer William J. Nucleic acid switch patterns as cell or tissue type identifiers
AU5255199A (en) * 1998-08-03 2000-02-28 California Institute Of Technology Method of determining cell or tissue type by transmembrane receptor identifiers
US6306658B1 (en) 1998-08-13 2001-10-23 Symyx Technologies Parallel reactor with internal sensing
US6455316B1 (en) 1998-08-13 2002-09-24 Symyx Technologies, Inc. Parallel reactor with internal sensing and method of using same
US6864092B1 (en) 1998-08-13 2005-03-08 Symyx Technologies, Inc. Parallel reactor with internal sensing and method of using same
US6548026B1 (en) 1998-08-13 2003-04-15 Symyx Technologies, Inc. Parallel reactor with internal sensing and method of using same
US6528026B2 (en) 1998-08-13 2003-03-04 Symyx Technologies, Inc. Multi-temperature modular reactor and method of using same
DE19836882A1 (en) * 1998-08-14 2000-02-17 Papst Motoren Gmbh & Co Kg Electric motor has characteristic field stored as digital values for associating parameter and motor speed values, and microcontroller or microprocessor
US6291190B1 (en) 1998-08-25 2001-09-18 The Board Of Trustees Of The Leland Stanford Junior University Molecular differences between species of the M. tuberculosis complex
US6271042B1 (en) 1998-08-26 2001-08-07 Alpha Innotech Corporation Biochip detection system
DE69930328T2 (en) * 1998-08-27 2006-12-14 Spirogen Ltd., Ryde Dimer pyrrolobenzodiazepines
GB9818730D0 (en) * 1998-08-27 1998-10-21 Univ Portsmouth Collections of compounds
GB9818731D0 (en) * 1998-08-27 1998-10-21 Univ Portsmouth Compounds
GB9818732D0 (en) * 1998-08-27 1998-10-21 Univ Portsmouth Collection of compounds
US7640083B2 (en) 2002-11-22 2009-12-29 Monroe David A Record and playback system for aircraft
EP2273270A1 (en) * 1998-08-28 2011-01-12 febit holding GmbH Method and apparatus for the preparation and/or analysis of biochemical carriers
US6929912B2 (en) * 1998-08-31 2005-08-16 Genaissance Pharmaceuticals, Inc. Methods for evaluating the ability to metabolize pharmaceuticals
US6461812B2 (en) * 1998-09-09 2002-10-08 Agilent Technologies, Inc. Method and multiple reservoir apparatus for fabrication of biomolecular arrays
JP4028964B2 (en) * 1998-09-09 2008-01-09 日立ソフトウエアエンジニアリング株式会社 Biochip and method of using biochip
US6287824B1 (en) * 1998-09-15 2001-09-11 Yale University Molecular cloning using rolling circle amplification
EP1112385A1 (en) * 1998-09-15 2001-07-04 Yale University Artificial long terminal repeat vectors
US6475440B1 (en) 1998-09-16 2002-11-05 Clontech Laboratories, Inc. Applicator for use in deposition of fluid samples onto a substrate surface
US6185561B1 (en) 1998-09-17 2001-02-06 Affymetrix, Inc. Method and apparatus for providing and expression data mining database
KR100369694B1 (en) * 1998-09-17 2003-01-29 인터내셔널 비지네스 머신즈 코포레이션 Synthesis of Chemical Tags
US20070178475A1 (en) * 1998-09-17 2007-08-02 Nehls Michael C Novel human polynucleotides and polypeptides encoded thereby
US6821724B1 (en) * 1998-09-17 2004-11-23 Affymetrix, Inc. Methods of genetic analysis using nucleic acid arrays
US20040199544A1 (en) * 2000-11-02 2004-10-07 Affymetrix, Inc. Method and apparatus for providing an expression data mining database
US6146830A (en) 1998-09-23 2000-11-14 Rosetta Inpharmatics, Inc. Method for determining the presence of a number of primary targets of a drug
US6703228B1 (en) 1998-09-25 2004-03-09 Massachusetts Institute Of Technology Methods and products related to genotyping and DNA analysis
US20090119022A1 (en) * 1998-09-25 2009-05-07 Timberlake William E Emericella Nidulans Genome Sequence On Computer Readable Medium and Uses Thereof
EP1001037A3 (en) * 1998-09-28 2003-10-01 Whitehead Institute For Biomedical Research Pre-selection and isolation of single nucleotide polymorphisms
US6203989B1 (en) 1998-09-30 2001-03-20 Affymetrix, Inc. Methods and compositions for amplifying detectable signals in specific binding assays
US6682927B2 (en) * 1998-10-05 2004-01-27 Duke University Methods and apparatus for the high through-put detection of binding interactions in vivo
WO2000020859A1 (en) * 1998-10-05 2000-04-13 Duke University METHOD AND APPARATUS FOR DETECTING BINDING INTERACTIONS $i(IN VIVO)
US6593084B2 (en) 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
US6262216B1 (en) * 1998-10-13 2001-07-17 Affymetrix, Inc. Functionalized silicon compounds and methods for their synthesis and use
US7071324B2 (en) * 1998-10-13 2006-07-04 Brown University Research Foundation Systems and methods for sequencing by hybridization
US6489096B1 (en) 1998-10-15 2002-12-03 Princeton University Quantitative analysis of hybridization patterns and intensities in oligonucleotide arrays
AU6515899A (en) * 1998-10-16 2000-05-08 Larry S. Millstein Methods of making patterned arrays of analyte-binding molecules
US7199809B1 (en) 1998-10-19 2007-04-03 Symyx Technologies, Inc. Graphic design of combinatorial material libraries
FR2784751B1 (en) 1998-10-20 2001-02-02 Mesatronic HOUSING HOUSING OF AN ELECTRONIC CHIP WITH BIOLOGICAL PROBES
AU1218600A (en) * 1998-10-21 2000-05-08 Bios Group Lp Systems and methods for analysis of genetic networks
US7129043B1 (en) * 1998-10-22 2006-10-31 Duke University Methods of screening for risk of proliferative disease and methods for the treatment of proliferative disease
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
US6423493B1 (en) * 1998-10-26 2002-07-23 Board Of Regents The University Of Texas System Combinatorial selection of oligonucleotide aptamers
US6203987B1 (en) 1998-10-27 2001-03-20 Rosetta Inpharmatics, Inc. Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns
US6950752B1 (en) 1998-10-27 2005-09-27 Rosetta Inpharmatics Llc Methods for removing artifact from biological profiles
FR2785052B1 (en) * 1998-10-27 2000-12-01 Commissariat Energie Atomique DEVICE FOR DETERMINING THE CONCENTRATION OF A SUBSTANCE MIXED WITH A FLUOROPHORE AND METHOD OF IMPLEMENTING THE DEVICE
US6468476B1 (en) 1998-10-27 2002-10-22 Rosetta Inpharmatics, Inc. Methods for using-co-regulated genesets to enhance detection and classification of gene expression patterns
IL126776A (en) 1998-10-27 2001-04-30 Technion Res & Dev Foundation Method for gold depositions
EP1126035A4 (en) * 1998-10-30 2002-09-11 Takara Shuzo Co Method for detecting gene affected by endocrine disruptor
US6545264B1 (en) 1998-10-30 2003-04-08 Affymetrix, Inc. Systems and methods for high performance scanning
US6399299B1 (en) * 1998-11-02 2002-06-04 Perkinelmer Life Sciences, Inc. Amplified array analysis system
ES2308852T3 (en) * 1998-11-04 2008-12-01 Serono Genetics Inst Sa GENOMIC AND COMPLETE SEQUENCES OF CDNA OF HUMAN APM1 SPECIFIC FOR ADIPOCITOS AND BIALELIC MARKERS OF THE SAME.
US6187540B1 (en) 1998-11-09 2001-02-13 Identigene, Inc. Method of newborn identification and tracking
US20110014706A2 (en) * 1998-12-14 2011-01-20 Monsanto Technology Llc Arabidopsis thaliana Genome Sequence and Uses Thereof
US7135283B1 (en) 1998-11-17 2006-11-14 Nanogen, Inc. Topoisomerase type II gene polymorphisms and their use in identifying drug resistance and pathogenic strains of microorganisms
US6309828B1 (en) 1998-11-18 2001-10-30 Agilent Technologies, Inc. Method and apparatus for fabricating replicate arrays of nucleic acid molecules
DE19853640C2 (en) * 1998-11-20 2002-01-31 Molecular Machines & Ind Gmbh Multi-vessel arrangement with improved sensitivity for optical analysis, processes for its production and its use in optical analysis processes
DE19854946C2 (en) 1998-11-27 2002-01-03 Guenter Von Kiedrowski Cloning and copying on surfaces
DE69924034T2 (en) 1998-12-01 2006-04-06 Syntrix Biochip, Inc., Sammamish SOLVENT-RESISTANT LIGHT-SENSITIVE COMPOSITIONS
US6951682B1 (en) * 1998-12-01 2005-10-04 Syntrix Biochip, Inc. Porous coatings bearing ligand arrays and use thereof
JP2002531470A (en) * 1998-12-01 2002-09-24 シントリクス バイオチップ, インコーポレイテッド Methods and compositions for performing an array of chemical reactions on a support surface
WO2000032744A1 (en) * 1998-12-02 2000-06-08 Nanogen, Inc. Apparatus and methods for transport of charged biological materials
US6245518B1 (en) 1998-12-11 2001-06-12 Hyseq, Inc. Polynucleotide arrays and methods of making and using the same
US6221579B1 (en) 1998-12-11 2001-04-24 Kimberly-Clark Worldwide, Inc. Patterned binding of functionalized microspheres for optical diffraction-based biosensors
CN1357004A (en) * 1998-12-14 2002-07-03 德国癌症研究公共权益基金会 Method and devices for detecting optical properties, esp. luminescence reactions and refraction behavious of molecules which are directly or indirectly bound on support
US6579673B2 (en) 1998-12-17 2003-06-17 Kimberly-Clark Worldwide, Inc. Patterned deposition of antibody binding protein for optical diffraction-based biosensors
US20030032029A1 (en) * 1998-12-21 2003-02-13 Nanogen, Inc. Three dimensional apparatus and method for integrating sample preparation and multiplex assays
US6264891B1 (en) 1998-12-22 2001-07-24 Eos Biotechnology, Inc. Apparatus and method for concurrent chemical synthesis
US6801859B1 (en) 1998-12-23 2004-10-05 Rosetta Inpharmatics Llc Methods of characterizing drug activities using consensus profiles
DE19860547C1 (en) * 1998-12-23 2000-10-12 Genetrix B V I O Affinity sensor for the detection of specific molecular binding events and its use
US6453241B1 (en) 1998-12-23 2002-09-17 Rosetta Inpharmatics, Inc. Method and system for analyzing biological response signal data
US7510841B2 (en) * 1998-12-28 2009-03-31 Illumina, Inc. Methods of making and using composite arrays for the detection of a plurality of target analytes
US6351712B1 (en) * 1998-12-28 2002-02-26 Rosetta Inpharmatics, Inc. Statistical combining of cell expression profiles
US6222093B1 (en) * 1998-12-28 2001-04-24 Rosetta Inpharmatics, Inc. Methods for determining therapeutic index from gene expression profiles
US6429027B1 (en) 1998-12-28 2002-08-06 Illumina, Inc. Composite arrays utilizing microspheres
US6370478B1 (en) 1998-12-28 2002-04-09 Rosetta Inpharmatics, Inc. Methods for drug interaction prediction using biological response profiles
US6261431B1 (en) 1998-12-28 2001-07-17 Affymetrix, Inc. Process for microfabrication of an integrated PCR-CE device and products produced by the same
US20030180789A1 (en) * 1998-12-30 2003-09-25 Dale Roderic M.K. Arrays with modified oligonucleotide and polynucleotide compositions
US6087112A (en) 1998-12-30 2000-07-11 Oligos Etc. Inc. Arrays with modified oligonucleotide and polynucleotide compositions
US6570003B1 (en) * 2001-01-09 2003-05-27 Lexion Genetics Incorporated Human 7TM proteins and polynucleotides encoding the same
US20020103359A1 (en) * 1999-12-07 2002-08-01 Gregory Donoho Novel human membrane proteins and polynucleotides encoding the same
WO2000040590A2 (en) 1999-01-05 2000-07-13 Bio Merieux Functionalised polynucleotide compound, optionally marked and method for detecting a target nucleic acid
JP4355384B2 (en) 1999-01-14 2009-10-28 キヤノン株式会社 Pattern exposure method, exposure apparatus, nucleic acid array formation method, and peptide array formation method
AU2965500A (en) 1999-01-15 2000-08-01 Gene Logic, Inc. Immobilized nucleic acid hybridization reagent and method
US6232068B1 (en) 1999-01-22 2001-05-15 Rosetta Inpharmatics, Inc. Monitoring of gene expression by detecting hybridization to nucleic acid arrays using anti-heteronucleic acid antibodies
JP4970654B2 (en) * 1999-01-25 2012-07-11 ミクロナス ゲゼルシャフト ミット ベシュレンクテル ハフツング Immobilization of molecules on the surface via a polymer brush
US6320196B1 (en) 1999-01-28 2001-11-20 Agilent Technologies, Inc. Multichannel high dynamic range scanner
US6514768B1 (en) 1999-01-29 2003-02-04 Surmodics, Inc. Replicable probe array
US20030148360A1 (en) * 1999-01-29 2003-08-07 Surmodics, Inc. Replicable probe array
US6429302B1 (en) 1999-02-02 2002-08-06 Chiron Corporation Polynucleotides related to pancreatic disease
US20060234246A1 (en) * 1999-02-02 2006-10-19 Chiron Corporation Gene products differentially expressed in cancerous cells
US6605432B1 (en) * 1999-02-05 2003-08-12 Curators Of The University Of Missouri High-throughput methods for detecting DNA methylation
KR100497673B1 (en) * 1999-02-10 2005-07-01 주식회사 마크로젠 Method and Apparatus for Compound Library Preparation Using Optical Modulator
EP1180111A4 (en) * 1999-02-10 2003-03-26 Macrogen Inc Method and apparatus for compound library preparation using optical modulator
US6740875B1 (en) * 1999-02-11 2004-05-25 The Regents Of The University Of California Gamma watermarking
US6887431B1 (en) * 1999-02-16 2005-05-03 Applera Corporation Bead dispensing system
US7101510B2 (en) 1999-02-16 2006-09-05 Applera Corporation Matrix storage and dispensing system
US6432719B1 (en) 1999-02-16 2002-08-13 Pe Corporation (Ny) Matrix storage and dispensing system
US20030027214A1 (en) * 1999-02-17 2003-02-06 Kamb Carl Alexander Methods for substrate-ligand interaction screening
EP2175021B1 (en) * 1999-02-19 2013-06-19 Synthetic Genomics, Inc. Method for producing polymers
US6142681A (en) 1999-02-22 2000-11-07 Vialogy Corporation Method and apparatus for interpreting hybridized bioelectronic DNA microarray patterns using self-scaling convergent reverberant dynamics
US6136541A (en) * 1999-02-22 2000-10-24 Vialogy Corporation Method and apparatus for analyzing hybridized biochip patterns using resonance interactions employing quantum expressor functions
US20040111219A1 (en) * 1999-02-22 2004-06-10 Sandeep Gulati Active interferometric signal analysis in software
US6245511B1 (en) 1999-02-22 2001-06-12 Vialogy Corp Method and apparatus for exponentially convergent therapy effectiveness monitoring using DNA microarray based viral load measurements
EP1586645A3 (en) * 1999-02-25 2006-02-22 Ceres Incorporated Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
US6362907B1 (en) 1999-02-26 2002-03-26 Nec Research Institute, Inc. Apparatus and method for transmitting data between VLSI chips
US6787368B1 (en) 1999-03-02 2004-09-07 Helix Biopharma Corporation Biosensor method for detecting analytes in a liquid
US6300141B1 (en) * 1999-03-02 2001-10-09 Helix Biopharma Corporation Card-based biosensor device
CA2365780C (en) 1999-03-05 2012-01-31 Mitsubishi Rayon Co., Ltd. Carriers having biological substance
US6716578B1 (en) 1999-03-08 2004-04-06 Bioforce Nanosciences, Inc. Method for solid state genome analysis
US7005256B1 (en) * 1999-03-10 2006-02-28 Cold Spring Harbor Laboratory Gene chip technology for determining memory genes
EP1185363B1 (en) * 1999-03-11 2005-06-15 Combimatrix Corporation Self assembling arrays
CN1185492C (en) 1999-03-15 2005-01-19 清华大学 Single-point strobed micro electromagnetic units array chip or electromagnetic biologic chip and application thereof
TW496775B (en) 1999-03-15 2002-08-01 Aviva Bioscience Corp Individually addressable micro-electromagnetic unit array chips
US6296702B1 (en) 1999-03-15 2001-10-02 Pe Corporation (Ny) Apparatus and method for spotting a substrate
US6403309B1 (en) 1999-03-19 2002-06-11 Valigen (Us), Inc. Methods for detection of nucleic acid polymorphisms using peptide-labeled oligonucleotides and antibody arrays
US7014994B1 (en) 1999-03-19 2006-03-21 Cornell Research Foundation,Inc. Coupled polymerase chain reaction-restriction-endonuclease digestion-ligase detection reaction process
AU3867400A (en) * 1999-03-19 2000-10-09 Duke University Methods of using bioelastomers
EP1165235B1 (en) * 1999-03-19 2011-09-28 Life Technologies Corporation Method of screening mutated cells
US6506594B1 (en) 1999-03-19 2003-01-14 Cornell Res Foundation Inc Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US6764820B2 (en) 1999-03-26 2004-07-20 Ludwig Institute For Cancer Research Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3)
WO2000058511A1 (en) 1999-03-26 2000-10-05 Ludwig Institute For Cancer Research Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3)
EP1041385A3 (en) * 1999-03-30 2004-01-02 Fuji Photo Film Co., Ltd. Method and apparatus for detecting an organism-originated substance
CN1192116C (en) * 1999-03-30 2005-03-09 内诺金有限公司 Single nucleotide polymorphic discrimination by electronic dot blot assay on semiconductor microchips
AU4057600A (en) * 1999-03-31 2000-10-16 Rosetta Inpharmatics, Inc. Methods for the identification of reporter and target molecules using comprehensive gene expression profiles
US6582906B1 (en) 1999-04-05 2003-06-24 Affymetrix, Inc. Proportional amplification of nucleic acids
EP1196629A2 (en) 1999-04-07 2002-04-17 Dennis Michael Connolly High resolution dna detection methods and devices
US6824866B1 (en) 1999-04-08 2004-11-30 Affymetrix, Inc. Porous silica substrates for polymer synthesis and assays
JP2002541820A (en) * 1999-04-09 2002-12-10 ゲーペーツェー バイオテック アーゲー A novel method for identifying antimicrobial compounds
US20030133009A1 (en) * 1999-04-09 2003-07-17 Carl S Brown System and method for detecting with high resolution a large, high content field
EP1177423A4 (en) * 1999-04-12 2004-10-27 Nanogen Becton Dickinson Partn Amplification and separation of nucleic acid sequences using strand displacement amplification and bioelectronic microchip technology
US6326173B1 (en) * 1999-04-12 2001-12-04 Nanogen/Becton Dickinson Partnership Electronically mediated nucleic acid amplification in NASBA
US6531302B1 (en) * 1999-04-12 2003-03-11 Nanogen/Becton Dickinson Partnership Anchored strand displacement amplification on an electronically addressable microchip
US6238868B1 (en) * 1999-04-12 2001-05-29 Nanogen/Becton Dickinson Partnership Multiplex amplification and separation of nucleic acid sequences using ligation-dependant strand displacement amplification and bioelectronic chip technology
US6235479B1 (en) 1999-04-13 2001-05-22 Bio Merieux, Inc. Methods and devices for performing analysis of a nucleic acid sample
DE19916867A1 (en) * 1999-04-14 2000-10-19 Fraunhofer Ges Forschung Making a molecular array on which molecules are immobilized, using micro-compartments or microcapillary reactors on planar substrates with sensor elements employs microelectronic production techniques
US20030129654A1 (en) * 1999-04-15 2003-07-10 Ilya Ravkin Coded particles for multiplexed analysis of biological samples
US20030134330A1 (en) * 1999-04-15 2003-07-17 Ilya Ravkin Chemical-library composition and method
US6908737B2 (en) * 1999-04-15 2005-06-21 Vitra Bioscience, Inc. Systems and methods of conducting multiplexed experiments
US7253435B2 (en) 1999-04-15 2007-08-07 Millipore Corporation Particles with light-polarizing codes
CA2366093A1 (en) * 1999-04-15 2000-10-26 Ilya Ravkin Combinatorial chemical library supports having indicia at coding positions and methods of use
US20030166015A1 (en) * 1999-04-15 2003-09-04 Zarowitz Michael A. Multiplexed analysis of cell-substrate interactions
US20030207249A1 (en) * 1999-04-15 2003-11-06 Beske Oren E. Connection of cells to substrates using association pairs
US6171793B1 (en) 1999-04-19 2001-01-09 Affymetrix, Inc. Method for scanning gene probe array to produce data having dynamic range that exceeds that of scanner
US20030207295A1 (en) * 1999-04-20 2003-11-06 Kevin Gunderson Detection of nucleic acid reactions on bead arrays
US20060275782A1 (en) 1999-04-20 2006-12-07 Illumina, Inc. Detection of nucleic acid reactions on bead arrays
US20020177135A1 (en) * 1999-07-27 2002-11-28 Doung Hau H. Devices and methods for biochip multiplexing
US6174683B1 (en) 1999-04-26 2001-01-16 Biocept, Inc. Method of making biochips and the biochips resulting therefrom
DE19918956A1 (en) * 1999-04-27 2000-11-02 Studiengesellschaft Kohle Mbh Process for the automated investigation of catalytic and spectroscopic properties of the components of combinatorial libraries
US6518056B2 (en) * 1999-04-27 2003-02-11 Agilent Technologies Inc. Apparatus, systems and method for assaying biological materials using an annular format
US6300137B1 (en) * 1999-04-28 2001-10-09 Agilent Technologies Inc. Method for synthesizing a specific, surface-bound polymer uniformly over an element of a molecular array
US20020110809A1 (en) * 1999-04-30 2002-08-15 Nehls Michael C. Novel human polynucleotides and polypeptides encoded thereby
US20020095031A1 (en) * 1999-05-04 2002-07-18 Nehls Michael C. Novel human polynucleotides and polypeptides encoded thereby
BR0010222A (en) 1999-05-04 2002-03-19 Large Scale Biology Corp Viral Expression Vectors
US6395559B1 (en) * 1999-05-04 2002-05-28 Orchid Biosciences, Inc. Multiple fluid sample processor with single well addressability
AU4698600A (en) * 1999-05-05 2000-11-17 Ut-Battelle, Llc Method and apparatus for combinatorial chemistry
DE19922941A1 (en) * 1999-05-14 2000-11-30 Epigenomics Gmbh Device and method for the photolithographic exposure of biological substances
JP3957118B2 (en) * 1999-05-18 2007-08-15 富士フイルム株式会社 Test piece and image information reading device from the test piece
US20030096321A1 (en) * 1999-05-19 2003-05-22 Jose Remacle Method for the identification and/or the quantification of a target compound obtained from a biological sample upon chips
US6638717B2 (en) 1999-05-19 2003-10-28 Aventis Pharmaceuticals, Inc. Microarray-based subtractive hybridzation
CA2371658C (en) 1999-05-19 2012-01-31 Advanced Array Technologies S.A. Method for the identification and/or the quantification of a target compound
US20030186311A1 (en) * 1999-05-21 2003-10-02 Bioforce Nanosciences, Inc. Parallel analysis of molecular interactions
CN1159454C (en) * 1999-05-21 2004-07-28 陆祖宏 Compound micro-array chip preparing process and the micro-array chip using the same
US6472141B2 (en) * 1999-05-21 2002-10-29 Caliper Technologies Corp. Kinase assays using polycations
US6287774B1 (en) * 1999-05-21 2001-09-11 Caliper Technologies Corp. Assay methods and system
US6573369B2 (en) 1999-05-21 2003-06-03 Bioforce Nanosciences, Inc. Method and apparatus for solid state molecular analysis
JP2003500070A (en) 1999-05-21 2003-01-07 インビトロゲン・コーポレーション Compositions and methods for labeling nucleic acid molecules
US20020042081A1 (en) * 2000-10-10 2002-04-11 Eric Henderson Evaluating binding affinities by force stratification and force panning
US20030073250A1 (en) * 1999-05-21 2003-04-17 Eric Henderson Method and apparatus for solid state molecular analysis
US6371370B2 (en) * 1999-05-24 2002-04-16 Agilent Technologies, Inc. Apparatus and method for scanning a surface
US6502039B1 (en) 2000-05-24 2002-12-31 Aventis Pharmaceuticals Mathematical analysis for the estimation of changes in the level of gene expression
BR0010937A (en) 1999-05-25 2002-02-26 Aventis Pharma Inc Mathematical analysis to estimate changes in the level of gene expression
US6485690B1 (en) 1999-05-27 2002-11-26 Orchid Biosciences, Inc. Multiple fluid sample processor and system
US6132686A (en) * 1999-05-28 2000-10-17 Mettler-Toledo Bohdan, Inc. Pressurized reaction block
AU5526500A (en) * 1999-06-05 2000-12-28 Zeptosens Ag Sensor platform and method for analysing multiple analytes
KR20010001577A (en) * 1999-06-07 2001-01-05 윤종용 Process for Preparing Oligopeptidenucleotide Probe Using Polymeric Photoacid Generator
US6660479B2 (en) 1999-06-07 2003-12-09 Samsung Electronics Co., Ltd. Process for preparing peptide nucleic acid probe using polymeric photoacid generator
US6716579B1 (en) 1999-06-11 2004-04-06 Narayan Baidya Gene specific arrays, preparation and use
US7485715B2 (en) * 1999-06-18 2009-02-03 Ceres, Inc. Sequence-determined DNA encoding AP2 domain polypeptides
NZ516278A (en) 1999-06-22 2004-03-26 Invitrogen Corp Improved primers and methods for the detection and discrimination of nucleic acids
KR100379411B1 (en) 1999-06-28 2003-04-10 엘지전자 주식회사 biochip and method for patterning and measuring biomaterial of the same
US7501245B2 (en) 1999-06-28 2009-03-10 Helicos Biosciences Corp. Methods and apparatuses for analyzing polynucleotide sequences
US6818395B1 (en) 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
US6258593B1 (en) 1999-06-30 2001-07-10 Agilent Technologies Inc. Apparatus for conducting chemical or biochemical reactions on a solid surface within an enclosed chamber
US6399394B1 (en) 1999-06-30 2002-06-04 Agilent Technologies, Inc. Testing multiple fluid samples with multiple biopolymer arrays
AU5785400A (en) 1999-07-02 2001-01-22 Symyx Technologies, Inc. Polymer brushes for immobilizing molecules to a surface or substrate, where the polymers have water-soluble or water-dispersible segments and probes bonded thereto
US6830902B1 (en) 1999-07-02 2004-12-14 Invitrogen Corporation Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
JP4684507B2 (en) 1999-07-05 2011-05-18 ノバルティス アーゲー How to use the sensor platform
US6771376B2 (en) * 1999-07-05 2004-08-03 Novartis Ag Sensor platform, apparatus incorporating the platform, and process using the platform
US7223364B1 (en) 1999-07-07 2007-05-29 3M Innovative Properties Company Detection article having fluid control film
US6964847B1 (en) 1999-07-14 2005-11-15 Packard Biosciences Company Derivative nucleic acids and uses thereof
US7013221B1 (en) 1999-07-16 2006-03-14 Rosetta Inpharmatics Llc Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays
US7371516B1 (en) 1999-07-16 2008-05-13 Rosetta Inpharmatics Llc Methods for determining the specificity and sensitivity of oligonucleo tides for hybridization
US6346423B1 (en) 1999-07-16 2002-02-12 Agilent Technologies, Inc. Methods and compositions for producing biopolymeric arrays
US7479555B2 (en) * 1999-07-21 2009-01-20 Ceres, Inc. Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity
US6692915B1 (en) 1999-07-22 2004-02-17 Girish N. Nallur Sequencing a polynucleotide on a generic chip
US7144700B1 (en) * 1999-07-23 2006-12-05 Affymetrix, Inc. Photolithographic solid-phase polymer synthesis
DE19935749C2 (en) * 1999-07-28 2003-06-26 Epigenomics Ag Process for the characterization of nucleic acid fragments
US6864050B2 (en) 1999-07-30 2005-03-08 Affymetrix, Inc. Single-phase amplification of nucleic acids
US7604996B1 (en) 1999-08-18 2009-10-20 Illumina, Inc. Compositions and methods for preparing oligonucleotide solutions
US6909006B1 (en) 1999-08-27 2005-06-21 Spirogen Limited Cyclopropylindole derivatives
EP1212599A2 (en) 1999-08-30 2002-06-12 Illumina, Inc. Methods for improving signal detection from an array
US20050118618A1 (en) * 1999-08-30 2005-06-02 Dale Roderic M. Method for detecting nucleic acid sequences
EP1214331B1 (en) 1999-08-30 2006-10-11 Roche Diagnostics GmbH 2-azapurine compounds and their use
CA2317179A1 (en) * 1999-09-01 2001-03-01 Affymetrix, Inc. Macromolecular arrays on polymeric brushes and methods for preparing the same
US20030050464A1 (en) * 2000-07-28 2003-03-13 Yi Hu Novel human proteases and polynucleotides encoding the same
US20080003673A1 (en) * 1999-09-02 2008-01-03 Alejandro Abuin Novel human proteases and polynucleotides encoding the same
US6395483B1 (en) 1999-09-02 2002-05-28 3M Innovative Properties Company Arrays with mask layers
US20020049312A1 (en) * 2000-05-23 2002-04-25 Turner C. Alexander Noel human thrombospondin-like proteins and polynucleotides encoding the same
US20050153323A1 (en) * 2000-07-28 2005-07-14 Yi Hu Novel human proteases and polynucleotides encoding the same
US6716614B1 (en) 1999-09-02 2004-04-06 Lexicon Genetics Incorporated Human calcium dependent proteases, polynucleotides encoding the same, and uses thereof
US20020165376A1 (en) * 1999-12-22 2002-11-07 Walke D. Wade Novel human proteases and polynucleotides encoding the same
US6448388B1 (en) 2000-08-16 2002-09-10 Lexicon Genetics Incorporated Human proteases and polynucleotides encoding the same
US20010034437A1 (en) * 2000-01-06 2001-10-25 Walke D. Wade Novel human proteases and polynucleotides encoding the same
JP4267233B2 (en) 1999-09-10 2009-05-27 ジェロン・コーポレーション Oligonucleotides N3 '→ P5' thiophosphoramidates: their synthesis and use
US6358557B1 (en) * 1999-09-10 2002-03-19 Sts Biopolymers, Inc. Graft polymerization of substrate surfaces
US6692918B2 (en) 1999-09-13 2004-02-17 Nugen Technologies, Inc. Methods and compositions for linear isothermal amplification of polynucleotide sequences
FR2798392B1 (en) * 1999-09-13 2005-07-15 Exonhit Therapeutics Sa GENETIC MARKERS OF TOXICITY, PREPARATION AND USES
US7211390B2 (en) 1999-09-16 2007-05-01 454 Life Sciences Corporation Method of sequencing a nucleic acid
FR2798673B1 (en) * 1999-09-16 2004-05-28 Exonhit Therapeutics Sa METHODS AND COMPOSITIONS FOR DETECTION OF PATHOLOGICAL EVENTS
US6319674B1 (en) 1999-09-16 2001-11-20 Agilent Technologies, Inc. Methods for attaching substances to surfaces
US6743585B2 (en) 1999-09-16 2004-06-01 Agilent Technologies, Inc. Methods for preparing conjugates
US6274320B1 (en) 1999-09-16 2001-08-14 Curagen Corporation Method of sequencing a nucleic acid
US7244559B2 (en) * 1999-09-16 2007-07-17 454 Life Sciences Corporation Method of sequencing a nucleic acid
US7078167B2 (en) * 1999-09-17 2006-07-18 Agilent Technologies, Inc. Arrays having background features and methods for using the same
US20020006664A1 (en) * 1999-09-17 2002-01-17 Sabatini David M. Arrayed transfection method and uses related thereto
EP1218529B1 (en) 1999-09-17 2006-11-22 Whitehead Institute For Biomedical Research Reverse transfection method
US7122303B2 (en) 1999-09-17 2006-10-17 Agilent Technologies, Inc. Arrays comprising background features that provide for a measure of a non-specific binding and methods for using the same
US6790660B1 (en) * 2001-09-18 2004-09-14 Lexicon Genetics Incorporated Human kielin-like proteins and polynucleotides encoding the same
US6867291B1 (en) * 2000-09-15 2005-03-15 Lexicon Genetics Incorporated Human hemicentin proteins and polynucleotides encoding the same
US20020107382A1 (en) * 2000-09-27 2002-08-08 Friddle Carl Johan Novel human protease inhibitor proteins and polynucleotides encoding the same
US20030166883A1 (en) * 2000-11-15 2003-09-04 Walke D. Wade Novel human secreted proteins and polynucleotides encoding the same
US6511840B1 (en) 2000-06-15 2003-01-28 Lexicon Genetics Incorporated Human kinase proteins and polynucleotides encoding the same
US20080050809A1 (en) * 1999-09-28 2008-02-28 Alejandro Abuin Novel human kinases and polynucleotides encoding the same
US6797510B1 (en) 2001-05-24 2004-09-28 Lexicon Genetics Incorporated Human kinases and polynucleotides encoding the same
US6759527B2 (en) 2001-03-20 2004-07-06 Lexicon Genetics Incorporated Human kinase and polynucleotides encoding the same
US6586230B1 (en) * 2000-10-27 2003-07-01 Lexicon Genetics Incorporated Human kinase and polynucleotides encoding the same
US6841377B1 (en) * 2001-06-13 2005-01-11 Lexicon Genetics Incorporated Human kinase and polynucleotides encoding the same
US6900045B2 (en) * 2000-08-31 2005-05-31 Lexicon Genetics Incorporated Human kinase proteins and polynucleotides encoding the same
US6541252B1 (en) 2000-05-19 2003-04-01 Lexicon Genetics Incorporated Human kinases and polynucleotides encoding the same
US6734010B2 (en) * 2001-05-09 2004-05-11 Lexicon Genetics Incorporated Human kinases and polynucleotides encoding the same
US6844151B1 (en) 1999-09-29 2005-01-18 Oligos Etc. Inc. Methods for production of arrays with modified oligonucleotide and polynucleotide compositions
US6673536B1 (en) 1999-09-29 2004-01-06 Rosetta Inpharmatics Llc. Methods of ranking oligonucleotides for specificity using wash dissociation histories
AU7748200A (en) * 1999-09-30 2001-04-30 Varian Associates, Inc. Hypoxia-related human genes, proteins, and uses thereof
WO2001023082A2 (en) * 1999-09-30 2001-04-05 Nanogen, Inc. Biomolecular attachment sites on microelectronic arrays
US7217573B1 (en) 1999-10-05 2007-05-15 Hitachi, Ltd. Method of inspecting a DNA chip
WO2001027327A2 (en) * 1999-10-08 2001-04-19 Protogene Laboratories, Inc. Method and apparatus for performing large numbers of reactions using array assembly
US20080213878A1 (en) * 1999-10-19 2008-09-04 Gregory Donoho Novel human membrane proteins and polynucleotides encoding the same
US6750054B2 (en) 2000-05-18 2004-06-15 Lexicon Genetics Incorporated Human semaphorin homologs and polynucleotides encoding the same
US6171797B1 (en) 1999-10-20 2001-01-09 Agilent Technologies Inc. Methods of making polymeric arrays
US6958225B2 (en) 1999-10-27 2005-10-25 Affymetrix, Inc. Complexity management of genomic DNA
US7364920B2 (en) * 1999-10-27 2008-04-29 Technion Research And Development Foundation Ltd. Method for gold deposition
WO2001031580A2 (en) 1999-10-27 2001-05-03 Biowulf Technologies, Llc Methods and devices for identifying patterns in biological systems
US6329210B1 (en) * 1999-10-29 2001-12-11 Agilent Technologies, Inc. Method and apparatus for high volume polymer synthesis
KR100339379B1 (en) 1999-10-29 2002-06-03 구자홍 biochip and apparatus and method for measuring biomaterial of the same
US8153367B2 (en) * 1999-10-29 2012-04-10 Perkinelmer Las, Inc. Amplified array analysis system
US6689319B1 (en) 1999-10-29 2004-02-10 Agilent Technologies, Ind. Apparatus for deposition and inspection of chemical and biological fluids
JP2003517589A (en) * 1999-11-02 2003-05-27 セリーヌ フー, Molecular microarrays and methods for their production and use
US7167615B1 (en) 1999-11-05 2007-01-23 Board Of Regents, The University Of Texas System Resonant waveguide-grating filters and sensors and methods for making and using same
US6589778B1 (en) 1999-12-15 2003-07-08 Amersham Biosciences Ab Method and apparatus for performing biological reactions on a substrate surface
US6642046B1 (en) * 1999-12-09 2003-11-04 Motorola, Inc. Method and apparatus for performing biological reactions on a substrate surface
US6569674B1 (en) 1999-12-15 2003-05-27 Amersham Biosciences Ab Method and apparatus for performing biological reactions on a substrate surface
US7041445B2 (en) * 1999-11-15 2006-05-09 Clontech Laboratories, Inc. Long oligonucleotide arrays
CA2392218A1 (en) * 1999-11-17 2001-05-25 Jiuping Ji Simultaneous detection of hbv, hcv and hiv in plasma samples using a multiplex capture assay
US6446642B1 (en) 1999-11-22 2002-09-10 Agilent Technologies, Inc. Method and apparatus to clean an inkjet reagent deposition device
US6583399B1 (en) 1999-11-22 2003-06-24 California Institute Of Technology Optical resonator microsphere sensor with altering Q-factor
WO2001038585A2 (en) * 1999-11-24 2001-05-31 The Regents Of The University Of California Polymer arrays and methods of using labeled probe molecules to identify and quantify target molecule expression
US6423535B1 (en) 1999-11-24 2002-07-23 Incyte Genomics, Inc. Normalization control for hybridization reactions
US6703480B1 (en) * 1999-11-24 2004-03-09 Palani Balu Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use
WO2001042512A2 (en) 1999-11-24 2001-06-14 Incyte Genomics, Inc. Normalization controls and duplex probes for quantitative hybridization reactions
WO2001040454A1 (en) 1999-11-30 2001-06-07 Oncosis Method and apparatus for selectively targeting specific cells within a cell population
GB9928787D0 (en) * 1999-12-03 2000-02-02 Medical Res Council Direct screening method
GB9928789D0 (en) * 1999-12-03 2000-02-02 Medical Res Council Naive screening method
EP1240187A2 (en) 1999-12-07 2002-09-18 Lexicon Genetics Incorporated Novel human kinase proteins and polynucleotides encoding the same
US6716588B2 (en) 1999-12-09 2004-04-06 Cellomics, Inc. System for cell-based screening
CA2393723A1 (en) 1999-12-09 2001-06-14 Lexicon Genetics Incorporated Human adam-ts proteases and polynucleotides encoding the same
US6482638B1 (en) * 1999-12-09 2002-11-19 3M Innovative Properties Company Heat-relaxable substrates and arrays
ATE391789T1 (en) 1999-12-10 2008-04-15 Invitrogen Corp USE OF A VARIETY OF RECOMBINATION SITE WITH UNIQUE SPECIFICITY IN RECOMBINATORY CLONING
EP1263966A1 (en) * 1999-12-13 2002-12-11 Lexicon Genetics Incorporated Novel human transferase proteins and polynucleotides encoding the same
US6303082B1 (en) * 1999-12-15 2001-10-16 Nanogen, Inc. Permeation layer attachment chemistry and method
US7109299B1 (en) 1999-12-16 2006-09-19 Affymax, Inc. Peptides and compounds that bind to the IL-5 receptor
US20020197656A1 (en) * 1999-12-17 2002-12-26 Ronghao Li Cell arrays and the uses thereof
US6902891B2 (en) 1999-12-17 2005-06-07 Bio Merieux Process for labeling a nucleic acid
US6399295B1 (en) 1999-12-17 2002-06-04 Kimberly-Clark Worldwide, Inc. Use of wicking agent to eliminate wash steps for optical diffraction-based biosensors
US6489114B2 (en) 1999-12-17 2002-12-03 Bio Merieux Process for labeling a ribonucleic acid, and labeled RNA fragments which are obtained thereby
US6406840B1 (en) 1999-12-17 2002-06-18 Biomosaic Systems, Inc. Cell arrays and the uses thereof
US6670124B1 (en) 1999-12-20 2003-12-30 Stemcyte, Inc. High throughput methods of HLA typing
US7754439B2 (en) * 2003-06-12 2010-07-13 Accupath Diagnostic Laboratories, Inc. Method and system for the analysis of high density cells samples
CA2395247A1 (en) * 1999-12-22 2001-06-28 Lexicon Genetics Incorporated Novel human membrane proteins and polynucleotides encoding the same
DE19962803A1 (en) * 1999-12-23 2001-07-05 Basf Ag Process and device for mask-free production of biopolymers
US6929907B2 (en) 1999-12-31 2005-08-16 North Carolina State University Methods and compositions for determining the purity of chemically synthesized nucleic acids
US6800439B1 (en) 2000-01-06 2004-10-05 Affymetrix, Inc. Methods for improved array preparation
US20050095696A9 (en) * 2000-01-07 2005-05-05 Lemmo Anthony V. Apparatus and method for high-throughput preparation and characterization of compositions
US6977723B2 (en) * 2000-01-07 2005-12-20 Transform Pharmaceuticals, Inc. Apparatus and method for high-throughput preparation and spectroscopic classification and characterization of compositions
US20070020662A1 (en) * 2000-01-07 2007-01-25 Transform Pharmaceuticals, Inc. Computerized control of high-throughput experimental processing and digital analysis of comparative samples for a compound of interest
US20070021929A1 (en) * 2000-01-07 2007-01-25 Transform Pharmaceuticals, Inc. Computing methods for control of high-throughput experimental processing, digital analysis, and re-arraying comparative samples in computer-designed arrays
CA2396079A1 (en) * 2000-01-07 2001-07-19 Transform Pharmaceuticals, Inc. High-throughput formation, identification, and analysis of diverse solid-forms
US20050118637A9 (en) * 2000-01-07 2005-06-02 Levinson Douglas A. Method and system for planning, performing, and assessing high-throughput screening of multicomponent chemical compositions and solid forms of compounds
US20050089923A9 (en) * 2000-01-07 2005-04-28 Levinson Douglas A. Method and system for planning, performing, and assessing high-throughput screening of multicomponent chemical compositions and solid forms of compounds
US7108970B2 (en) * 2000-01-07 2006-09-19 Transform Pharmaceuticals, Inc. Rapid identification of conditions, compounds, or compositions that inhibit, prevent, induce, modify, or reverse transitions of physical state
DE10000629C5 (en) * 2000-01-10 2010-06-02 november Aktiengesellschaft, Gesellschaft für Molekulare Medizin Method of identifying a label applied to a solid
AU2001229318A1 (en) * 2000-01-12 2001-07-24 Lexicon Genetics Incorporated Human olfactory receptor and polynucleotides encoding the same
US20020009728A1 (en) * 2000-01-18 2002-01-24 Quantum Dot Corporation Oligonucleotide-tagged semiconductor nanocrystals for microarray and fluorescence in situ hybridization
US6586582B2 (en) 2000-01-18 2003-07-01 Lexicon Genetics Incorporated Human GABA receptor proteins and polynucleotides encoding the same
WO2001053493A2 (en) 2000-01-18 2001-07-26 Lexicon Genetics Incorporated Human kinase protein and polynucleotides encoding the same
US6728641B1 (en) 2000-01-21 2004-04-27 General Electric Company Method and system for selecting a best case set of factors for a chemical reaction
US8143195B2 (en) * 2000-01-24 2012-03-27 Yingjian Wang Arrays for bringing two or more reagents in contact with one or more biological targets and methods for making and using the arrays
US7429466B2 (en) * 2000-01-24 2008-09-30 Hypromatrix, Inc Methods and arrays for detecting biological molecules
US20030097222A1 (en) * 2000-01-25 2003-05-22 Craford David M. Method, system, and computer software for providing a genomic web portal
AU2001253117B8 (en) * 2000-01-26 2006-08-03 Lexicon Pharmaceuticals, Inc. Human neurexin-like proteins and polynucleotides encoding the same
AU2001233043A1 (en) 2000-01-28 2001-08-07 Linden Technologies, Inc. C-3' protected monomeric nucleotides and synthesis of oligonucleotides on solid support
AU9256001A (en) * 2000-01-28 2001-12-17 Lexicon Genetics Incorporated Novel human enzymes and polynucleotides encoding the same
US20020115837A1 (en) * 2000-01-28 2002-08-22 Turner C. Alexander Novel human membrane proteins and polynucleotides encoding the same
US6618679B2 (en) 2000-01-28 2003-09-09 Althea Technologies, Inc. Methods for analysis of gene expression
GB0002389D0 (en) * 2000-02-02 2000-03-22 Solexa Ltd Molecular arrays
WO2001057523A1 (en) * 2000-02-03 2001-08-09 Nanoscale Combinatorial Synthesis, Inc. Structure identification methods using mass measurements
AU3665901A (en) * 2000-02-04 2001-08-14 Lexicon Genetics Incorporated Novel human enzymes and polynucleotides encoding the same
WO2001057086A2 (en) * 2000-02-04 2001-08-09 Lexicon Genetics Incorporated Novel human g protein coupled receptor proteins and polynucleotides encoding the same
US7582420B2 (en) 2001-07-12 2009-09-01 Illumina, Inc. Multiplex nucleic acid reactions
US8076063B2 (en) 2000-02-07 2011-12-13 Illumina, Inc. Multiplexed methylation detection methods
US7611869B2 (en) 2000-02-07 2009-11-03 Illumina, Inc. Multiplexed methylation detection methods
US20050214825A1 (en) * 2000-02-07 2005-09-29 John Stuelpnagel Multiplex sample analysis on universal arrays
US7955794B2 (en) * 2000-09-21 2011-06-07 Illumina, Inc. Multiplex nucleic acid reactions
US20020006617A1 (en) * 2000-02-07 2002-01-17 Jian-Bing Fan Nucleic acid detection methods using universal priming
US6693033B2 (en) 2000-02-10 2004-02-17 Motorola, Inc. Method of removing an amorphous oxide from a monocrystalline surface
US6770441B2 (en) * 2000-02-10 2004-08-03 Illumina, Inc. Array compositions and methods of making same
JP2003522530A (en) * 2000-02-11 2003-07-29 レキシコン・ジェネティクス・インコーポレーテッド Novel human protease and polynucleotide encoding the protease
US20030176385A1 (en) * 2000-02-15 2003-09-18 Jingfang Ju Antisense modulation of protein expression
AU2001238503A1 (en) * 2000-02-17 2001-08-27 Lexicon Genetics Incorporated Novel human thrombospondin repeat proteins and polynucleotides encoding the same
US20020110901A1 (en) * 2000-02-18 2002-08-15 Aspira Biosystems, Inc. Compositions and methods for surface imprinting
CA2400644C (en) * 2000-02-18 2009-07-14 Board Of Trustees Of The Leland Stanford Junior University Apparatus and methods for parallel processing of micro-volume liquid reactions
US20020151040A1 (en) 2000-02-18 2002-10-17 Matthew O' Keefe Apparatus and methods for parallel processing of microvolume liquid reactions
KR20030003686A (en) 2000-02-22 2003-01-10 제노스펙트라 인코포레이티드 Microarray fabrication techniques and apparatus
US6594432B2 (en) 2000-02-22 2003-07-15 Genospectra, Inc. Microarray fabrication techniques and apparatus
EP1265641A2 (en) 2000-02-22 2002-12-18 Biostream, Inc. Imaging agents for diagnosis of parkinson's disease
US20040014102A1 (en) * 2000-02-22 2004-01-22 Shiping Chen High density parallel printing of microarrays
WO2001062887A1 (en) 2000-02-23 2001-08-30 Zyomyx, Inc. Chips having elevated sample surfaces
US6555669B2 (en) * 2000-02-29 2003-04-29 Lexicon Genetics Incorporated Human transferase proteins and polynucleotides encoding the same
EP1259610A2 (en) 2000-02-29 2002-11-27 Lexicon Genetics Incorporated Human transporter proteins and polynucleotides encoding the same
US6627571B1 (en) 2000-03-01 2003-09-30 Symyx Technologies, Inc. Method and system for the situ synthesis of a combinatorial library of supported catalyst materials
US20030129724A1 (en) * 2000-03-03 2003-07-10 Grozinger Christina M. Class II human histone deacetylases, and uses related thereto
AU2001240040A1 (en) * 2000-03-03 2001-09-17 California Institute Of Technology Combinatorial array for nucleic acid analysis
US20020082405A1 (en) * 2000-03-06 2002-06-27 Gregory Donoho Novel human transporter proteins and polynucleotides encoding the same
DE10011022A1 (en) * 2000-03-07 2001-09-27 Meinhard Knoll Apparatus for performing synthesis, analysis or transport processes with a process fluid has a reaction zone with controlled delivery of a process fluid and control fluids with inner analysis and reaction interfaces at the side walls
US6897015B2 (en) * 2000-03-07 2005-05-24 Bioforce Nanosciences, Inc. Device and method of use for detection and characterization of pathogens and biological materials
WO2001068869A2 (en) * 2000-03-10 2001-09-20 Lexicon Genetics Incorporated Human g-coupled protein receptor kinsaes and polynucleotides encoding the same
WO2001068871A2 (en) * 2000-03-13 2001-09-20 Lexicon Genetics Incorporated Human phospholipases and polynucleotides encoding the same
EP1134294A3 (en) 2000-03-16 2004-06-30 Kabushiki Kaisha Toshiba Method for producing immobilized nucleic acid strand
US6806361B1 (en) 2000-03-17 2004-10-19 Affymetrix, Inc. Methods of enhancing functional performance of nucleic acid arrays
US20050119473A1 (en) * 2000-03-17 2005-06-02 Affymetrix, Inc. Phosphite ester oxidation in nucleic acid array preparation
US6833450B1 (en) 2000-03-17 2004-12-21 Affymetrix, Inc. Phosphite ester oxidation in nucleic acid array preparation
WO2001070806A2 (en) * 2000-03-20 2001-09-27 Lexicon Genetics Incorporated Human secreted proteins and polynucleotides encoding the same
US6500622B2 (en) 2000-03-22 2002-12-31 Quantum Dot Corporation Methods of using semiconductor nanocrystals in bead-based nucleic acid assays
US6413722B1 (en) 2000-03-22 2002-07-02 Incyte Genomics, Inc. Polymer coated surfaces for microarray applications
US7202026B2 (en) * 2000-03-24 2007-04-10 Eppendorf Array Technologies Sa (Eat) Identification of a large number of biological (micro)organisms groups at different levels by their detection on a same array
US7244572B1 (en) 2000-03-24 2007-07-17 Wisys Technology Foundation, Inc. One-dimensional arrays on optical fibers
US7875442B2 (en) * 2000-03-24 2011-01-25 Eppendorf Array Technologies Identification and quantification of a plurality of biological (micro)organisms or their components
US7205104B2 (en) 2000-03-24 2007-04-17 Eppendorf Array Technologies Sa (Eat) Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays
US7829313B2 (en) * 2000-03-24 2010-11-09 Eppendorf Array Technologies Identification and quantification of a plurality of biological (micro)organisms or their components
US20080085515A1 (en) * 2000-03-24 2008-04-10 Eppendorf Array Technologies Sa (Eat) Identification of multiple biological (micro) organisms by detection of their nucleotide sequences on arrays
EP1274861B1 (en) 2000-03-27 2009-12-23 Thomas Jefferson University Compositions and methods for identifying and targeting cancer cells
CA2402525A1 (en) * 2000-03-31 2001-10-11 Genentech, Inc. Compositions and methods for detecting and quantifying gene expression
US6884578B2 (en) 2000-03-31 2005-04-26 Affymetrix, Inc. Genes differentially expressed in secretory versus proliferative endometrium
JP2004505610A (en) * 2000-04-03 2004-02-26 レキシコン・ジェネティクス・インコーポレーテッド Novel human ion channel protein and polynucleotide encoding the same
US7157564B1 (en) 2000-04-06 2007-01-02 Affymetrix, Inc. Tag nucleic acids and probe arrays
GB0008563D0 (en) * 2000-04-07 2000-05-24 Cambridge Discovery Chemistry Investigating different physical and/or chemical forms of materials
EP1272644A1 (en) * 2000-04-12 2003-01-08 Lexicon Genetics Incorporated Human metalloprotease and polynucleotides encoding the same
JP2003530130A (en) 2000-04-14 2003-10-14 メタボロン インコーポレイテッド Methods for drug discovery, disease treatment and diagnosis using metabolomics
WO2001079821A1 (en) * 2000-04-14 2001-10-25 Zeptosens Ag Grid-waveguide structure for reinforcing an excitation field and use thereof
AU2001293366A1 (en) 2000-04-14 2001-10-30 Cornell Research Foundation, Inc. Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction
US6983233B1 (en) 2000-04-19 2006-01-03 Symyx Technologies, Inc. Combinatorial parameter space experiment design
US6667287B2 (en) * 2000-04-20 2003-12-23 Colgate-Palmolive Company Light duty cleaning composition comprising an amine oxide and polyacrylic acid homopolymer
WO2001081557A2 (en) 2000-04-25 2001-11-01 Lexicon Genetics Incorporated Human kinase proteins and polynucleotides encoding the same
US6458589B1 (en) 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
ATE503209T1 (en) 2000-05-03 2011-04-15 Caliper Life Sciences Inc MANUFACTURING PROCESSES FOR MULTIPLE DEPTH SUBSTRATES
CN1654956A (en) 2000-05-04 2005-08-17 耶鲁大学 High density protein arrays for screening of protein activity
US6690467B1 (en) 2000-05-05 2004-02-10 Pe Corporation Optical system and method for optically analyzing light from a sample
WO2001086591A2 (en) * 2000-05-08 2001-11-15 General Electric Company High throughput screening method and system
US7019129B1 (en) 2000-05-09 2006-03-28 Biosearch Technologies, Inc. Dark quenchers for donor-acceptor energy transfer
US6709840B1 (en) 2000-05-11 2004-03-23 The Board Of Trustees Of The Leland Stanford Junior University Anergy associated genes
US20020107375A1 (en) * 2000-05-12 2002-08-08 Brian Mathur Novel human lipocalin homologs and polynucleotides encoding the same
US20020110843A1 (en) * 2000-05-12 2002-08-15 Dumas David P. Compositions and methods for epitope mapping
US6492458B1 (en) 2000-05-16 2002-12-10 Arizona Chemical Company Polyalkyleneoxydiamine polyamides useful for formulating inks for phase-change jet printing
US6686188B2 (en) * 2000-05-26 2004-02-03 Amersham Plc Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
US6656700B2 (en) * 2000-05-26 2003-12-02 Amersham Plc Isoforms of human pregnancy-associated protein-E
US6790667B1 (en) 2000-05-30 2004-09-14 Lexicon Genetics Incorporated Human mitochondrial proteins and polynucleotides encoding the same
US20020155471A1 (en) * 2000-05-31 2002-10-24 Nicolette Charles A. Compounds for therapy and diagnosis and methods for using same
US7005259B1 (en) 2000-06-01 2006-02-28 Affymetrix, Inc. Methods for array preparation using substrate rotation
JP4644914B2 (en) * 2000-06-02 2011-03-09 株式会社村田製作所 Solid phase substrate for probe array and probe array
US6994827B2 (en) 2000-06-03 2006-02-07 Symyx Technologies, Inc. Parallel semicontinuous or continuous reactors
US7351376B1 (en) * 2000-06-05 2008-04-01 California Institute Of Technology Integrated active flux microfluidic devices and methods
EP1162450A1 (en) * 2000-06-07 2001-12-12 F. Hoffmann-La Roche Ag Reference device for evaluating the performance of a confocal laser scanning microscope, and a method and system for performing that evaluation
WO2001094583A2 (en) * 2000-06-07 2001-12-13 Lexicon Genetics Incorporated Human transporter proteins and polynucleotides encoding the same
US20040168209A1 (en) * 2000-06-12 2004-08-26 Alejandro Abuin Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
US6455007B1 (en) * 2000-06-13 2002-09-24 Symyx Technologies, Inc. Apparatus and method for testing compositions in contact with a porous medium
DE60137722D1 (en) 2000-06-13 2009-04-02 Univ Boston USE OF MASS-MATCHED NUCLEOTIDES IN THE ANALYSIS OF OLIGONUCLEOTIDE MIXTURES AND IN THE HIGH-MULTIPLEXIC NUCLEIC ACID SEQUENCING
EP1164201A1 (en) * 2000-06-14 2001-12-19 Facultés Universitaires Notre-Dame de la Paix Reverse detection for identification and/or quantification of nucleotide target sequences on biochips
US20060166227A1 (en) * 2000-06-20 2006-07-27 Stephen Kingsmore Protein expression profiling
ES2259666T3 (en) 2000-06-21 2006-10-16 Bioarray Solutions Ltd MOLECULAR ANALYSIS OF MULTIPLE ANALYTICS USING SERIES OF RANDOM PARTICLES WITH APPLICATION SPECIFICITY.
US9709559B2 (en) 2000-06-21 2017-07-18 Bioarray Solutions, Ltd. Multianalyte molecular analysis using application-specific random particle arrays
US7846733B2 (en) * 2000-06-26 2010-12-07 Nugen Technologies, Inc. Methods and compositions for transcription-based nucleic acid amplification
JP2004513617A (en) * 2000-06-26 2004-05-13 ニューゲン テクノロジーズ, インコーポレイテッド Methods and compositions for transcription-based nucleic acid amplification
EP1297134A2 (en) * 2000-06-27 2003-04-02 Lexicon Genetics Incorporated Novel human gaba receptors and polynucleotides encoding the same
US6323009B1 (en) * 2000-06-28 2001-11-27 Molecular Staging, Inc. Multiply-primed amplification of nucleic acid sequences
DE10031587A1 (en) * 2000-06-29 2002-01-10 Basf Ag Dosing of microscale suspensions for the production of material samples in combinatorial materials research and their testing
US20030118486A1 (en) * 2000-07-03 2003-06-26 Xeotron Corporation Fluidic methods and devices for parallel chemical reactions
AU2001273156A1 (en) * 2000-07-03 2002-01-14 Xeotron Corporation Devices and methods for carrying out chemical reactions using photogenerated reagents
US20030219816A1 (en) * 2001-07-02 2003-11-27 Keith Solomon Composite microarray slides
US7657379B2 (en) * 2000-07-05 2010-02-02 Microsoft Corporation Methods and systems for determining the biological function of cell constituents using response profiles
AU2001271893A1 (en) * 2000-07-07 2002-01-21 Nimblegen Systems, Inc. Method and apparatus for synthesis of arrays of dna probes
US6913879B1 (en) 2000-07-10 2005-07-05 Telechem International Inc. Microarray method of genotyping multiple samples at multiple LOCI
US6511277B1 (en) * 2000-07-10 2003-01-28 Affymetrix, Inc. Cartridge loader and methods
US6596490B2 (en) 2000-07-14 2003-07-22 Applied Gene Technologies, Inc. Nucleic acid hairpin probes and uses thereof
US6380377B1 (en) 2000-07-14 2002-04-30 Applied Gene Technologies, Inc. Nucleic acid hairpin probes and uses thereof
US7052659B1 (en) 2000-07-18 2006-05-30 General Electric Company Sequential high throughput screening method and system
EP1409718A2 (en) * 2000-07-21 2004-04-21 Phase-1 Molecular Toxicology Canine toxicity genes
JP2004515220A (en) * 2000-07-21 2004-05-27 インサイト・ゲノミックス・インコーポレイテッド Protease
US6590236B1 (en) 2000-07-24 2003-07-08 Motorola, Inc. Semiconductor structure for use with high-frequency signals
US6555946B1 (en) 2000-07-24 2003-04-29 Motorola, Inc. Acoustic wave device and process for forming the same
DE10036174B4 (en) * 2000-07-25 2006-12-07 Axaron Bioscience Ag Method and apparatus for analyzing chemical or biological samples
US6887685B1 (en) 2000-07-25 2005-05-03 Lexicon Genetics Incorporated Human thymosin protein and polynucleotides encoding the same
DE10036457A1 (en) * 2000-07-26 2002-02-14 Giesing Michael Use of an imaging photoelectric area sensor for evaluating biochips and imaging processes therefor
AU2001279135A1 (en) * 2000-07-31 2002-02-13 Maxygen, Inc. Biosensors, reagents and diagnostic applications of directed evolution
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
DE60132596T2 (en) * 2000-08-03 2009-02-19 Roche Diagnostics Gmbh NUCLEIC ACID BINDING COMPOUNDS WITH PYRAZOLOi3,4-D PYRIMIDINE ANALOGUE OF PURINE-2,6-DIAMINE AND THEIR USE
EP1356266A2 (en) 2000-08-03 2003-10-29 Perlegen Sciences, Inc. Substrate scanning apparatus
US20050181421A1 (en) * 2000-08-03 2005-08-18 Affymetrix, Inc. Methods of array synthesis
US8463718B2 (en) * 2000-08-07 2013-06-11 Health Discovery Corporation Support vector machine-based method for analysis of spectral data
US6422249B1 (en) 2000-08-10 2002-07-23 Affymetrix Inc. Cartridge washing system and methods
AU2001284896A1 (en) 2000-08-14 2002-02-25 Surface Logix, Inc. Deformable stamp for patterning three-dimensional surfaces
CA2419144A1 (en) * 2000-08-15 2002-07-25 Bioforce Nanosciences, Inc. Nanoscale molecular arrayer
US6902702B1 (en) 2000-08-16 2005-06-07 University Health Network Devices and methods for producing microarrays of biological samples
US20050106621A1 (en) * 2000-08-16 2005-05-19 Winegarden Neil A. Devices and methods for producing microarrays of biological samples
US20020076780A1 (en) * 2000-08-16 2002-06-20 Turner C. Alexander Novel human ion channel proteins and polynucleotides encoding the same
US6680059B2 (en) * 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
EP2332574A1 (en) 2000-08-17 2011-06-15 Tripep Ab HCV NS3/4A Sequences
RU2286172C2 (en) * 2000-08-17 2006-10-27 Трипеп Аб Ribavirin-containing vaccines and methods for their application
US7022830B2 (en) * 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
AU3511802A (en) 2000-08-22 2002-05-06 Affymetrix, Inc. System method, and computer software product for controlling biological microarray scanner
US7062092B2 (en) 2000-08-22 2006-06-13 Affymetrix, Inc. System, method, and computer software product for gain adjustment in biological microarray scanner
EP1311690B1 (en) * 2000-08-22 2006-07-26 Lexicon Genetics Incorporated Human proteases and polynucleotides encoding the same
WO2002016435A2 (en) * 2000-08-22 2002-02-28 Lexicon Genetics Incorporated Human 7tm proteins and polynucleotides encoding the same
US6900013B1 (en) 2000-08-25 2005-05-31 Aviva Biosciences Corporation Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization
WO2002016647A1 (en) * 2000-08-24 2002-02-28 Aviva Biosciences Corporation Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization
US6713257B2 (en) 2000-08-25 2004-03-30 Rosetta Inpharmatics Llc Gene discovery using microarrays
US7807447B1 (en) 2000-08-25 2010-10-05 Merck Sharp & Dohme Corp. Compositions and methods for exon profiling
US20020164634A1 (en) * 2000-08-26 2002-11-07 Perlegen Sciences, Inc. Methods for reducing complexity of nucleic acid samples
US20020055112A1 (en) * 2000-08-26 2002-05-09 Nila Patil Methods for reducing complexity of nucleic acid samples
JP3467004B2 (en) * 2000-08-31 2003-11-17 キヤノン株式会社 Analysis method of nucleic acid base sequence
JP2002071687A (en) * 2000-08-31 2002-03-12 Canon Inc Screening method for variant gene
US20030190612A1 (en) * 2000-08-31 2003-10-09 Nobuko Yamamoto Detecting method and detection substrate for use therein
WO2002020753A2 (en) * 2000-09-01 2002-03-14 Lexicon Genetics Incorporated Human gaba transporter protein and polynucleotides encoding the same
US7879598B2 (en) * 2000-09-04 2011-02-01 Bayer Technology Services Gmbh Multianalyte determination system and methods
US7108969B1 (en) 2000-09-08 2006-09-19 Affymetrix, Inc. Methods for detecting and diagnosing oral cancer
AU2001292142A1 (en) * 2000-09-11 2002-03-22 Affymetrix, Inc. Photocleavable protecting groups
US20030176344A1 (en) * 2000-09-14 2003-09-18 Decode Genetics Ehf. Human osteoporosis gene
US20040185464A1 (en) * 2000-09-15 2004-09-23 Kris Richard M. High throughput assay system
US7057704B2 (en) * 2000-09-17 2006-06-06 Bioarray Solutions Ltd. System and method for programmable illumination pattern generation
AU2001292728A1 (en) * 2000-09-18 2002-03-26 Thomas Jefferson University Compositions and methods for identifying and targeting stomach and esophageal cancer cells
AU2001293297A1 (en) 2000-09-20 2002-04-02 Case Western Reserve University Phyisological profiling
US6780648B1 (en) 2000-09-20 2004-08-24 General Electric Company Method and system for selectively distributing luminescence material precursors
US6420178B1 (en) 2000-09-20 2002-07-16 General Electric Company High throughput screening method, array assembly and system
US20020115058A1 (en) * 2000-09-22 2002-08-22 Pedersen Finn Skou Methods for diagnosis and treatment of diseases associated with altered expression of Pik3r1
US20020164576A1 (en) * 2000-09-22 2002-11-07 Pedersen Finn Skou Methods for diagnosis and treatment of diseases associated with altered expression of Nrf2
US20030044803A1 (en) * 2000-09-22 2003-03-06 Pedersen Finn Skou Methods for diagnosis and treatment of diseases associated with altered expression of JAK1
AU2001292959A1 (en) * 2000-09-22 2002-04-02 Clontech Laboratories, Inc. Highly sensitive proteomic analysis methods and kits and systems for practicing the same
US6808934B2 (en) 2000-09-25 2004-10-26 Picoliter Inc. High-throughput biomolecular crystallization and biomolecular crystal screening
US20020037359A1 (en) * 2000-09-25 2002-03-28 Mutz Mitchell W. Focused acoustic energy in the preparation of peptide arrays
WO2002024325A2 (en) 2000-09-25 2002-03-28 Picoliter, Inc. Acoustic ejection of fluids from a plurality of reservoirs
US6613285B1 (en) 2000-09-25 2003-09-02 General Electric Company Reactor plate and method
US6806051B2 (en) * 2000-09-25 2004-10-19 Picoliter Inc. Arrays of partially nonhybridizing oligonucleotides and preparation thereof using focused acoustic energy
US6493497B1 (en) 2000-09-26 2002-12-10 Motorola, Inc. Electro-optic structure and process for fabricating same
ATE326533T1 (en) 2000-09-27 2006-06-15 Lexicon Genetics Inc HUMAN ION EXCHANGE PROTEINS AND POLYNUcleotides Encoding Therefor
US6780584B1 (en) * 2000-09-27 2004-08-24 Nanogen, Inc. Electronic systems and component devices for macroscopic and microscopic molecular biological reactions, analyses and diagnostics
US6496250B1 (en) 2000-09-29 2002-12-17 General Electric Company Combinatorial method foe development of optical ceramics
CN100495030C (en) * 2000-09-30 2009-06-03 清华大学 Multi-force operator and use thereof
US6777232B1 (en) * 2000-10-02 2004-08-17 Lexicon Genetics Incorporated Human membrane proteins and polynucleotides encoding the same
US6638838B1 (en) 2000-10-02 2003-10-28 Motorola, Inc. Semiconductor structure including a partially annealed layer and method of forming the same
US20040091602A1 (en) * 2000-10-04 2004-05-13 Hwang Hyun Jin Method for immobilizing biologically active molecules
US20020123474A1 (en) * 2000-10-04 2002-09-05 Shannon Mark E. Human GTP-Rho binding protein2
US20100261159A1 (en) * 2000-10-10 2010-10-14 Robert Hess Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof
AU2002213183A1 (en) 2000-10-12 2002-04-22 Lexicon Genetics Incorporated Human kinases and polynucleotides encoding the same
US6849409B2 (en) * 2000-10-16 2005-02-01 Axxima Pharmaceuticals Ag Cellular kinases involved in Cytomegalovirus infection and their inhibition
US20030045005A1 (en) * 2000-10-17 2003-03-06 Michael Seul Light-controlled electrokinetic assembly of particles near surfaces
US7001763B1 (en) 2000-10-17 2006-02-21 Lexicon Genetics Incorporated Human semaphorin proteins and polynucleotides encoding the same
DE10051396A1 (en) 2000-10-17 2002-04-18 Febit Ferrarius Biotech Gmbh An integrated synthesis and identification of an analyte, comprises particles immobilized at a carrier to be coupled to receptors in a structured pattern to give receptor arrays for biochemical reactions
JPWO2002033068A1 (en) * 2000-10-18 2004-02-26 キヤノン株式会社 Analysis method of nucleic acid base sequence
JP2004537712A (en) * 2000-10-18 2004-12-16 バーチャル・アレイズ・インコーポレーテッド Multiple cell analysis system
US20020155476A1 (en) * 2000-10-20 2002-10-24 Nader Pourmand Transient electrical signal based methods and devices for characterizing molecular interaction and/or motion in a sample
US6861214B1 (en) * 2000-10-23 2005-03-01 Beckman Coulter, Inc. Immobilization of biopolymers to aminated substrates by direct adsorption
DE10052823B4 (en) * 2000-10-24 2014-11-20 Ruprecht-Karls-Universität Heidelberg Method for light microscopic analysis of the topology of molecular structures in grid arrangements
US6491967B1 (en) 2000-10-24 2002-12-10 General Electric Company Plasma spray high throughput screening method and system
US6804385B2 (en) 2000-10-24 2004-10-12 Oncosis Method and device for selectively targeting cells within a three-dimensional specimen
US7118908B2 (en) * 2000-10-25 2006-10-10 Bor-Iuan Jan On-spot selectively activated hydrophobic slide and preparation thereof
DE60125312T2 (en) * 2000-10-26 2007-06-06 Agilent Technologies, Inc. (n.d. Ges. d. Staates Delaware), Santa Clara microarray
EP1409674A2 (en) * 2000-10-27 2004-04-21 Lexicon Genetics Incorporated Human 7tm proteins and polynucleotides encoding them
CA2427701A1 (en) * 2000-10-30 2002-05-10 Lexicon Genetics Incorporated Human 7tm proteins and polynucleotides encoding the same
AU2002245047A1 (en) 2000-10-30 2002-07-24 Sequenom, Inc. Method and apparatus for delivery of submicroliter volumes onto a substrate
WO2002036759A2 (en) * 2000-11-01 2002-05-10 Lexicon Genetics Incorporated Polynucleotides encoding human meltrin beta (adam19) metalloendopeptidases
US6567751B1 (en) 2000-11-03 2003-05-20 General Electric Company Methods and computer system for combinatorial analysis of lighting phosphors
US6844184B2 (en) * 2000-11-08 2005-01-18 Surface Logix, Inc. Device for arraying biomolecules and for monitoring cell motility in real-time
US6893851B2 (en) 2000-11-08 2005-05-17 Surface Logix, Inc. Method for arraying biomolecules and for monitoring cell motility in real-time
US7374906B2 (en) 2000-11-08 2008-05-20 Surface Logix, Inc. Biological assays using gradients formed in microfluidic systems
US6937323B2 (en) * 2000-11-08 2005-08-30 Burstein Technologies, Inc. Interactive system for analyzing biological samples and processing related information and the use thereof
US6967074B2 (en) * 2000-11-08 2005-11-22 Surface Logix, Inc. Methods of detecting immobilized biomolecules
US7033821B2 (en) * 2000-11-08 2006-04-25 Surface Logix, Inc. Device for monitoring cell motility in real-time
US7439056B2 (en) 2000-11-08 2008-10-21 Surface Logix Inc. Peelable and resealable devices for arraying materials
US7371563B2 (en) * 2000-11-08 2008-05-13 Surface Logix, Inc. Peelable and resealable devices for biochemical assays
US7351575B2 (en) * 2000-11-08 2008-04-01 Surface Logix, Inc. Methods for processing biological materials using peelable and resealable devices
US7001740B2 (en) * 2000-11-08 2006-02-21 Surface Logix, Inc. Methods of arraying biological materials using peelable and resealable devices
US7033819B2 (en) 2000-11-08 2006-04-25 Surface Logix, Inc. System for monitoring cell motility in real-time
US6699665B1 (en) * 2000-11-08 2004-03-02 Surface Logix, Inc. Multiple array system for integrating bioarrays
US7326563B2 (en) 2000-11-08 2008-02-05 Surface Logix, Inc. Device and method for monitoring leukocyte migration
US6864065B2 (en) * 2000-11-08 2005-03-08 Surface Logix, Inc. Assays for monitoring cell motility in real-time
US6803205B2 (en) * 2000-11-08 2004-10-12 Surface Logix, Inc. Methods of measuring enzyme activity using peelable and resealable devices
AU2002228872A1 (en) * 2000-11-09 2002-05-21 Burstein Technologies, Inc. Disc drive system and methods for use with bio-discs
US20020150887A1 (en) * 2000-11-09 2002-10-17 National Institute Of Advanced Industrial Science And Technology Methods and nucleic acid probes for molecular genetic analysis of polluted environments and environmental samples
WO2002044695A1 (en) * 2000-11-16 2002-06-06 Burstein Technologies, Inc. Methods and apparatus for detecting and quantifying lymphocytes with optical biodiscs
WO2002040874A1 (en) 2000-11-16 2002-05-23 California Institute Of Technology Apparatus and methods for conducting assays and high throughput screening
US7026131B2 (en) * 2000-11-17 2006-04-11 Nagaoka & Co., Ltd. Methods and apparatus for blood typing with optical bio-discs
US7087203B2 (en) * 2000-11-17 2006-08-08 Nagaoka & Co., Ltd. Methods and apparatus for blood typing with optical bio-disc
AU2002228633A1 (en) * 2000-11-20 2002-06-03 Lexicon Genetics Incorporated Human kinases and polynucleotides encoding the same
US6905816B2 (en) 2000-11-27 2005-06-14 Intelligent Medical Devices, Inc. Clinically intelligent diagnostic devices and methods
US7211414B2 (en) 2000-12-01 2007-05-01 Visigen Biotechnologies, Inc. Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
US7635571B2 (en) * 2000-12-07 2009-12-22 Siemens Healthcare Diagnostics Products Gmbh Amplified signal in binding assays
WO2002046477A2 (en) 2000-12-07 2002-06-13 Chiron Corporation Endogenous retroviruses up-regulated in prostate cancer
JP3778041B2 (en) * 2000-12-08 2006-05-24 コニカミノルタホールディングス株式会社 Particle separation mechanism and particle separation apparatus
US6760298B2 (en) * 2000-12-08 2004-07-06 Nagaoka & Co., Ltd. Multiple data layer optical discs for detecting analytes
AU2002239552A1 (en) * 2000-12-08 2002-06-18 Burstein Technologies, Inc. Multiple data layer optical discs for detecting analytes
CA2431007A1 (en) * 2000-12-11 2002-07-18 Lexicon Genetics Incorporated Novel human kinase and polynucleotides encoding the same
WO2002048333A2 (en) * 2000-12-12 2002-06-20 Lexicon Genetics Incorporated Novel human kinases and uses thereof
US6596239B2 (en) * 2000-12-12 2003-07-22 Edc Biosystems, Inc. Acoustically mediated fluid transfer methods and uses thereof
AU2002228974A1 (en) 2000-12-13 2002-06-24 Nugen Technologies, Inc Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof
AU2002230981A1 (en) * 2000-12-15 2002-06-24 Symyx Technologies, Inc. Methods and apparatus for designing high-dimensional combinatorial experiments
US6583269B1 (en) 2000-12-18 2003-06-24 Lexicon Genetics Incorporated Human protease inhibitor and polynucleotides encoding the same
US6448387B1 (en) * 2000-12-18 2002-09-10 Monsanto Technology, Llc Polymeric arrays adapted for high expressing polynucleotides
US6852844B1 (en) 2000-12-20 2005-02-08 Lexicon Genetics Incorporated Human protocadherin proteins and polynucleotides encoding the same
CA2432737A1 (en) * 2000-12-20 2002-06-27 Lexicon Genetics Incorporated Human ion channel protein and polynucleotides encoding the same
US7645441B2 (en) * 2000-12-22 2010-01-12 Sagres Discovery Inc. Compositions and methods in cancer associated with altered expression of PRLR
US7892730B2 (en) * 2000-12-22 2011-02-22 Sagres Discovery, Inc. Compositions and methods for cancer
US20030087252A1 (en) * 2000-12-22 2003-05-08 Morris David W. Novel compositions and methods in cancer associated with altered expression of PRDM11
US20030165878A1 (en) * 2000-12-22 2003-09-04 Morris David W. Novel compositions and methods in cancer associated with altered expression of MCM3AP
US7700274B2 (en) * 2000-12-22 2010-04-20 Sagres Discovery, Inc. Compositions and methods in cancer associated with altered expression of KCNJ9
US20030099963A1 (en) * 2000-12-22 2003-05-29 Morris David W. Novel compositions and methods in cancer associated with altered expression of TBX21
US20030232334A1 (en) * 2000-12-22 2003-12-18 Morris David W. Novel compositions and methods for cancer
US7820447B2 (en) 2000-12-22 2010-10-26 Sagres Discovery Inc. Compositions and methods for cancer
WO2002052045A1 (en) * 2000-12-26 2002-07-04 Aviva Biosciences Active and biocompatible platforms prepared by polymerization of surface coating films
AU2002246858A1 (en) * 2000-12-27 2002-08-06 Lexicon Genetics Incorporated Human kinases and polynucleotides encoding the same
US20020115844A1 (en) * 2001-01-05 2002-08-22 Yu Xuanchuan Sean Novel human lipase and polynucleotides encoding the same
WO2002053754A2 (en) * 2001-01-08 2002-07-11 Lexicon Genetics Incorporated Human protease and polynucleotides encoding the same
WO2002056021A2 (en) * 2001-01-10 2002-07-18 Symyx Technologies Inc Polymer brushes for immobilizing molecules to a surface
WO2002056311A2 (en) * 2001-01-11 2002-07-18 Burstein Technologies Inc Optical disc analysis system including related methods for biological and medical imaging
US20020150935A1 (en) * 2001-01-12 2002-10-17 Zheng-Zheng Zhou Dotted micro-array data extraction method
JP2004533228A (en) * 2001-01-19 2004-11-04 エジー バイオサイエンシーズ, インコーポレイテッド Computer-based assembly of a polynucleotide encoding a target polypeptide
EP1407029A2 (en) * 2001-01-23 2004-04-14 Lexicon Genetics Incorporated Novel human kinases and polynucleotides encoding the same
CA2434139C (en) * 2001-01-23 2014-05-27 President And Fellows Of Harvard College Nucleic-acid programmable protein arrays
US6870011B2 (en) * 2001-01-24 2005-03-22 Arizona Chemical Company Hydrocarbon-terminated polyether-polyamide block copolymers and uses thereof
US6399713B1 (en) 2001-01-24 2002-06-04 Arizona Chemical Company Hydrocarbon-terminated polyether-polyamide block copolymers and uses thereof
JP2005502311A (en) * 2001-01-24 2005-01-27 レキシコン・ジェネティクス・インコーポレーテッド Novel human lipase and polynucleotide encoding the lipase
US20090226915A1 (en) * 2001-01-24 2009-09-10 Health Discovery Corporation Methods for Screening, Predicting and Monitoring Prostate Cancer
US20020169562A1 (en) * 2001-01-29 2002-11-14 Gregory Stephanopoulos Defining biological states and related genes, proteins and patterns
GB0102357D0 (en) * 2001-01-30 2001-03-14 Randox Lab Ltd Imaging method
US7166258B2 (en) * 2001-01-31 2007-01-23 Agilent Technologies, Inc. Automation-optimized microarray package
US7112305B2 (en) 2001-01-31 2006-09-26 Agilent Technologies, Inc. Automation-optimized microarray package
US20030170148A1 (en) * 2001-01-31 2003-09-11 Mcentee John F. Reaction chamber roll pump
US7442370B2 (en) 2001-02-01 2008-10-28 Biogen Idec Ma Inc. Polymer conjugates of mutated neublastin
US20020127674A1 (en) * 2001-02-02 2002-09-12 Xuanchuan Yu Novel human transporter protein and polynucleotides encoding the same
WO2002063270A2 (en) * 2001-02-05 2002-08-15 Board Of Regents, The University Of Texas System The use of mesoscale self-assembly and recognition to effect delivery of sensing reagent for arrayed sensors
JPWO2002062993A1 (en) * 2001-02-06 2004-06-10 タカラバイオ株式会社 Amplified nucleic acid and immobilized product thereof
WO2002062957A2 (en) * 2001-02-07 2002-08-15 Invitrogen Corporation Ter sites and ter binding proteins
US6832163B2 (en) * 2001-02-09 2004-12-14 Agilent Technologies, Inc. Methods of identifying heterogeneous features in an image of an array
WO2002066624A2 (en) * 2001-02-20 2002-08-29 Lexicon Genetics Incorporated Novel human protease and polynucleotides encoding the same
US20020160527A1 (en) * 2001-02-26 2002-10-31 3M Innovative Properties Company Combinatorial library comprising pouches as packages for library members and method therefor
US6673646B2 (en) 2001-02-28 2004-01-06 Motorola, Inc. Growth of compound semiconductor structures on patterned oxide films and process for fabricating same
EP1236804A1 (en) 2001-03-02 2002-09-04 Boehringer Mannheim Gmbh A method for determination of a nucleic acid using a control
ES2360205T3 (en) 2001-03-02 2011-06-01 Agennix Ag THREE HYBRID TEST SYSTEM.
AU2002258100B2 (en) 2001-03-02 2007-03-01 University Of Western Ontario Polymer precursors of radiolabeled compounds, and methods of making and using the same
US20050196785A1 (en) * 2001-03-05 2005-09-08 California Institute Of Technology Combinational array for nucleic acid analysis
GB0105787D0 (en) * 2001-03-08 2001-04-25 Expresson Biosystems Ltd Complex element micro-array and methods of use
JP3929250B2 (en) * 2001-03-08 2007-06-13 株式会社ルネサステクノロジ Semiconductor device
WO2002073158A2 (en) * 2001-03-09 2002-09-19 Apollo Biotechnology, Inc. Conjugate probes and optical detection of analytes
MXPA02012739A (en) * 2001-03-09 2004-04-20 Nugen Technologies Inc Methods and compositions for amplification of rna sequences.
JP2005508135A (en) * 2001-03-09 2005-03-31 ニューゲン テクノロジーズ, インコーポレイテッド Methods and compositions for amplification of RNA sequences
WO2002072783A2 (en) * 2001-03-12 2002-09-19 Irm, Llc Identification of cellular targets for biologically active molecules
EP1385829A4 (en) * 2001-03-12 2005-10-19 Affymetrix Inc Nucleic acid labeling compounds
US7276580B2 (en) * 2001-03-12 2007-10-02 Biogen Idec Ma Inc. Neurotrophic factors
AU2002252296A1 (en) * 2001-03-12 2002-09-24 Lexicon Genetics Incorporated Novel human transporter proteins and polynucleotides encoding the same
US20040076954A1 (en) * 2001-03-12 2004-04-22 Irm, Llc Genomics-driven high speed cellular assays, development thereof, and collections of cellular reporters
AU2002245593A1 (en) * 2001-03-12 2002-09-24 Lexicon Genetics Incorporated Novel human dectin proteins and polynucleotides encoding the same
US7297518B2 (en) 2001-03-12 2007-11-20 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension
JP2004535781A (en) * 2001-03-12 2004-12-02 レキシコン・ジェネティクス・インコーポレーテッド Novel human EFG family protein and polynucleotide encoding the same
US7280014B2 (en) 2001-03-13 2007-10-09 Rochester Institute Of Technology Micro-electro-mechanical switch and a method of using and making thereof
US7211654B2 (en) * 2001-03-14 2007-05-01 Regents Of The University Of Michigan Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports
US6994995B1 (en) 2001-03-16 2006-02-07 Lexicon Genetics Incorporated Human synaptotagmin and polynucleotides encoding the same
US20030104410A1 (en) * 2001-03-16 2003-06-05 Affymetrix, Inc. Human microarray
AU2002306768A1 (en) * 2001-03-20 2002-10-03 Ortho-Clinical Diagnostics, Inc. Expression profiles and methods of use
FR2822476B1 (en) 2001-03-23 2004-04-02 Aventis Pharma Sa METHODS OF PURIFICATION AND DETECTION OF TARGET SEQUENCES OF DOUBLE-STRANDED DNA BY TRIPLE-HELICE INTERACTION
US20020136772A1 (en) * 2001-03-26 2002-09-26 Tai-Nang Huang Polymer synthesis
WO2002077194A2 (en) * 2001-03-26 2002-10-03 Linden Technologies, Inc. Polymer synthesis
CA2441893C (en) 2001-03-26 2015-01-20 Dana-Farber Cancer Institute, Inc. Method of attenuating reactions to skin irritants
US6596489B2 (en) 2001-03-30 2003-07-22 Applied Gene Technologies Methods and compositions for analyzing nucleotide sequence mismatches using RNase H
AU785425B2 (en) * 2001-03-30 2007-05-17 Genetic Technologies Limited Methods of genomic analysis
US7115726B2 (en) * 2001-03-30 2006-10-03 Perlegen Sciences, Inc. Haplotype structures of chromosome 21
US7514263B2 (en) 2001-04-02 2009-04-07 3M Innovative Properties Company Continuous process for the production of combinatorial libraries of materials
JP2004530125A (en) * 2001-04-02 2004-09-30 ツェプトゼンス アクチエンゲゼルシャフト Optical structures and their use for multiphoton excitation
EP1384022A4 (en) 2001-04-06 2004-08-04 California Inst Of Techn Nucleic acid amplification utilizing microfluidic devices
WO2002081670A1 (en) * 2001-04-06 2002-10-17 Lexicon Genetics Incorporated Novel human kinases and polynucleotides encoding the same
EP1383880A1 (en) * 2001-04-06 2004-01-28 Lexicon Genetics Incorporated Novel human kinase and polynucleotides encoding the same
US20060129329A1 (en) * 2001-04-09 2006-06-15 Kobylecki Ryszard J Investigating different physical and/or chemical forms of materials
US6911339B2 (en) * 2001-04-09 2005-06-28 David P. Dumas Transparent polymer support for organic synthesis
EP1493014A2 (en) 2001-04-11 2005-01-05 Burstein Technologies, Inc. Multi-parameter assays including analysis discs and methods relating thereto
JP3885511B2 (en) * 2001-04-11 2007-02-21 ソニー株式会社 Laser light generating apparatus and method
US6644173B2 (en) * 2001-04-11 2003-11-11 Keuring, Incorporated Beverage filter cartridge holder
US6607895B2 (en) 2001-04-16 2003-08-19 Lexicon Genetics Incorporated Human adenylsuccinate synthetase and polynucleotides encoding the same
WO2002086164A1 (en) 2001-04-18 2002-10-31 Perlegen Sciences, Inc. Methods for identifying the evolutionarily conserved sequences
US7258974B2 (en) * 2001-04-23 2007-08-21 Michael F. Chou Transcription factor network discovery methods
US6490533B2 (en) 2001-04-26 2002-12-03 Affymetrix, Inc. System, method, and product for dynamic noise reduction in scanning of biological materials
US6650411B2 (en) 2001-04-26 2003-11-18 Affymetrix, Inc. System, method, and product for pixel clocking in scanning of biological materials
US6643015B2 (en) 2001-04-26 2003-11-04 Affymetrix, Inc. System, method, and product for symmetrical filtering in scanning of biological materials
US20020160427A1 (en) * 2001-04-27 2002-10-31 Febit Ag Methods and apparatuses for electronic determination of analytes
US20030166893A1 (en) * 2001-04-30 2003-09-04 Yi Hu Novel human nuclear transporters and polynucleotides encoding the same
US6933117B2 (en) * 2001-04-30 2005-08-23 Ventana Medical Systems, Inc. Reagents and methods for automated hybridization
US7138506B2 (en) * 2001-05-09 2006-11-21 Genetic Id, Na, Inc. Universal microarray system
US7244853B2 (en) 2001-05-09 2007-07-17 President And Fellows Of Harvard College Dioxanes and uses thereof
USRE46351E1 (en) 2001-05-10 2017-03-28 Battelle Energy Alliance, Llc Antibody profiling sensitivity through increased reporter antibody layering
US6989276B2 (en) * 2001-05-10 2006-01-24 Battelle Energy Alliance, Llc Rapid classification of biological components
US7695919B2 (en) * 2001-05-10 2010-04-13 Battelle Energy Alliance, Llc Antibody profiling sensitivity through increased reporter antibody layering
USRE44031E1 (en) 2001-05-10 2013-02-26 Battelle Energy Alliance, Llc Antibody profiling sensitivity through increased reporter antibody layering
US20030119015A1 (en) * 2001-05-10 2003-06-26 Perlegen Sciences, Inc. Methods for nucleic acid analysis
US6552160B2 (en) 2001-05-14 2003-04-22 Arizona Chemical Company Ester-terminated poly(ester-amides) useful for formulating transparent gels in low polarity fluids
US7183116B2 (en) 2001-05-14 2007-02-27 The Institute For Systems Biology Methods for isolation and labeling of sample molecules
US7858385B2 (en) * 2001-05-16 2010-12-28 Los Alamos National Security, Llc Method for detecting binding events using micro-X-ray fluorescence spectrometry
US20080220441A1 (en) 2001-05-16 2008-09-11 Birnbaum Eva R Advanced drug development and manufacturing
WO2004010099A2 (en) * 2001-05-16 2004-01-29 Burstein Technologies, Inc. Variable sampling for rendering pixelization of analysis results in optical bio-disc assembly
US9157875B2 (en) * 2001-05-16 2015-10-13 Benjamin P. Warner Drug development and manufacturing
US20050009101A1 (en) * 2001-05-17 2005-01-13 Motorola, Inc. Microfluidic devices comprising biochannels
US7083920B2 (en) * 2001-05-18 2006-08-01 Nagaoka & Co. Ltd. Surface assembly for immobilizing DNA capture probes in genetic assays using enzymatic reactions to generate signal in optical bio-discs and methods relating thereto
TW490783B (en) * 2001-05-22 2002-06-11 Hi Max Optoelectronics Corp Testing device and method built in the wafer scribe line
US20020177157A1 (en) * 2001-05-24 2002-11-28 Yuling Luo Pairs of nucleic acid probes with interactive signaling moieties and nucleic acid probes with enhanced hybridization efficiency and specificity
WO2002097095A1 (en) * 2001-05-25 2002-12-05 Lexicon Genetics Incorporated Novel human transporter proteins and polynucleotides encoding the same
US20070015144A9 (en) * 2001-05-25 2007-01-18 Genset, S.A. Human cDNAs and proteins and uses thereof
US20030129607A1 (en) * 2001-05-25 2003-07-10 Invitrogen Corporation Compositions and methods for extension of nucleic acids
AU2002303879B2 (en) 2001-05-29 2007-08-09 Lexicon Pharmaceuticals, Inc. Novel human hydroxylases and polynucleotides encoding the same
AU2002303933A1 (en) 2001-05-31 2002-12-09 Rochester Institute Of Technology Fluidic valves, agitators, and pumps and methods thereof
US7294478B1 (en) 2001-06-06 2007-11-13 Rosetta Inpharmatics Llc Microarray reaction cartridge
US20070184436A1 (en) * 2001-06-07 2007-08-09 Joel Myerson Generic capture probe arrays
WO2002099386A2 (en) * 2001-06-07 2002-12-12 Proligo Llc Microcalorimetric detection of analytes and binding events
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US20040048241A1 (en) * 2001-06-11 2004-03-11 Freeman Beverly Annette Methods for attaching molecules
US6824974B2 (en) * 2001-06-11 2004-11-30 Genorx, Inc. Electronic detection of biological molecules using thin layers
WO2002102986A2 (en) * 2001-06-14 2002-12-27 Lexicon Genetics Incorporated Novel human transporter proteins and polynucleotides encoding the same
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
EP1410011B1 (en) 2001-06-18 2011-03-23 Rosetta Inpharmatics LLC Diagnosis and prognosis of breast cancer patients
US20030096264A1 (en) * 2001-06-18 2003-05-22 Psychiatric Genomics, Inc. Multi-parameter high throughput screening assays (MPHTS)
US20030104426A1 (en) * 2001-06-18 2003-06-05 Linsley Peter S. Signature genes in chronic myelogenous leukemia
US20020198666A1 (en) * 2001-06-20 2002-12-26 Kabushikigaisha Dynacom System and method for computer-designing optimum oligo-nucleic acid sequences from nucleic acid base sequences, and oligo-nucleic acid array mounted with the designed oligo-nucleic acid sequences
US7262063B2 (en) 2001-06-21 2007-08-28 Bio Array Solutions, Ltd. Directed assembly of functional heterostructures
US6709989B2 (en) 2001-06-21 2004-03-23 Motorola, Inc. Method for fabricating a semiconductor structure including a metal oxide interface with silicon
US20040166593A1 (en) * 2001-06-22 2004-08-26 Nolte David D. Adaptive interferometric multi-analyte high-speed biosensor
CN1665920A (en) 2001-06-22 2005-09-07 干细胞股份有限公司 Liver engrafting cells, assays, and uses thereof
EP1925672A1 (en) 2001-06-22 2008-05-28 Syngeta Participations AG Abiotic stress responsive polynucleotides and polypeptides
US6855538B2 (en) * 2001-06-27 2005-02-15 The Regents Of The University Of California High-efficiency microarray printing device
AU2002345174A1 (en) 2001-06-27 2003-03-03 Cancer Research Technology Limited Methods for the diagnosis of cancer based on the obcam and ntm genes
US7402286B2 (en) * 2001-06-27 2008-07-22 The Regents Of The University Of California Capillary pins for high-efficiency microarray printing device
CA2452690C (en) * 2001-06-29 2016-08-16 Veri-Q, Inc. Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US9777312B2 (en) * 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US6691042B2 (en) 2001-07-02 2004-02-10 Rosetta Inpharmatics Llc Methods for generating differential profiles by combining data obtained in separate measurements
EP1412535A4 (en) * 2001-07-02 2007-08-22 Univ Leland Stanford Junior Microarrays for cell phenotyping and manipulation
WO2003004609A2 (en) * 2001-07-03 2003-01-16 Lexicon Genetics Incorporated Novel human kielin-like proteins and polynucleotides encoding the same
JP2005520484A (en) * 2001-07-06 2005-07-14 454 コーポレイション Method for isolating independent parallel chemical microreactions using a porous filter
US7221632B2 (en) * 2001-07-12 2007-05-22 Burstein Technologies, Inc. Optical disc system and related detecting methods for analysis of microscopic structures
US20030013208A1 (en) * 2001-07-13 2003-01-16 Milagen, Inc. Information enhanced antibody arrays
US7297553B2 (en) * 2002-05-28 2007-11-20 Nanosphere, Inc. Method for attachment of silylated molecules to glass surfaces
US20050287560A1 (en) * 2001-07-13 2005-12-29 Nanosphere, Inc. Method for preparing substrates having immobilized molecules and substrates
US7687437B2 (en) 2001-07-13 2010-03-30 Nanosphere, Inc. Method for immobilizing molecules onto surfaces
CA2453434C (en) * 2001-07-16 2009-04-14 Hk Pharmaceuticals, Inc. Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
US20030068691A1 (en) * 2001-07-16 2003-04-10 Applera Corporation Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
US20030134273A1 (en) * 2001-07-17 2003-07-17 Eric Henderson Combined molecular binding detection through force microscopy and mass spectrometry
US20030143612A1 (en) * 2001-07-18 2003-07-31 Pointilliste, Inc. Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening
US6646293B2 (en) 2001-07-18 2003-11-11 Motorola, Inc. Structure for fabricating high electron mobility transistors utilizing the formation of complaint substrates
US6893822B2 (en) 2001-07-19 2005-05-17 Nanogen Recognomics Gmbh Enzymatic modification of a nucleic acid-synthetic binding unit conjugate
US6693298B2 (en) 2001-07-20 2004-02-17 Motorola, Inc. Structure and method for fabricating epitaxial semiconductor on insulator (SOI) structures and devices utilizing the formation of a compliant substrate for materials used to form same
WO2003009107A2 (en) * 2001-07-20 2003-01-30 Burstein Technologies, Inc. Optical analysis disc and related drive assembly for performing interactive centrifugation
US20030022150A1 (en) * 2001-07-24 2003-01-30 Sampson Jeffrey R. Methods for detecting a target molecule
JP2005511009A (en) * 2001-07-24 2005-04-28 セローノ ジェネティクス インスティテュート ソシエテ アノニム Novel mutants and exons of GLYT1 transporter
US7348140B1 (en) 2001-07-25 2008-03-25 Acadia Pharmaceuticals, Inc. Clinical indications for genotyping polymorphic variants of G-protein coupled receptors
JP4265149B2 (en) * 2001-07-25 2009-05-20 セイコーエプソン株式会社 Electro-optical device and method for manufacturing electro-optical device
US6667196B2 (en) 2001-07-25 2003-12-23 Motorola, Inc. Method for real-time monitoring and controlling perovskite oxide film growth and semiconductor structure formed using the method
US20030022394A1 (en) * 2001-07-27 2003-01-30 Dumas David P. Biochips and methods of making same
US20050042612A1 (en) * 2001-07-30 2005-02-24 Hubbard Michael Anthony Graft polymer martrices
US6833441B2 (en) 2001-08-01 2004-12-21 Abmaxis, Inc. Compositions and methods for generating chimeric heteromultimers
US20030027258A1 (en) * 2001-08-02 2003-02-06 Chang Fang-Tseh Frank Methods and compositions for pearl oyster cultivation
US6589856B2 (en) 2001-08-06 2003-07-08 Motorola, Inc. Method and apparatus for controlling anti-phase domains in semiconductor structures and devices
US6639249B2 (en) 2001-08-06 2003-10-28 Motorola, Inc. Structure and method for fabrication for a solid-state lighting device
US20030082596A1 (en) * 2001-08-08 2003-05-01 Michael Mittmann Methods of genetic analysis of probes: test3
WO2003014151A2 (en) 2001-08-10 2003-02-20 Genset S.A. Human secreted proteins, their encoding polynucleotides, and uses thereof
EP1425382A4 (en) * 2001-08-14 2004-10-06 Lexicon Genetics Inc Novel human collagen proteins and polynucleotides encoding the same
KR100455284B1 (en) * 2001-08-14 2004-11-12 삼성전자주식회사 High-throughput sensor for detecting biomolecules using carbon nanotubes
US6673667B2 (en) 2001-08-15 2004-01-06 Motorola, Inc. Method for manufacturing a substantially integral monolithic apparatus including a plurality of semiconductor materials
US7189509B2 (en) * 2001-08-16 2007-03-13 Zhifeng Shao Analysis of gene expression profiles using sequential hybridization
US20080026367A9 (en) * 2001-08-17 2008-01-31 Perlegen Sciences, Inc. Methods for genomic analysis
AU2002332598A1 (en) * 2001-08-22 2003-03-10 Shengfeng Li Compositions and methods for generating antigen-binding units
US20050009026A1 (en) * 2001-08-27 2005-01-13 Abel Andreas Peter Surface for the immobilisation of nucleic acids
US20030129665A1 (en) * 2001-08-30 2003-07-10 Selvan Gowri Pyapali Methods for qualitative and quantitative analysis of cells and related optical bio-disc systems
US10539561B1 (en) 2001-08-30 2020-01-21 Customarray, Inc. Enzyme-amplified redox microarray detection process
DE10142643A1 (en) * 2001-08-31 2003-04-24 Clondiag Chip Tech Gmbh Detection of interactions on probe arrays
US20050032060A1 (en) * 2001-08-31 2005-02-10 Shishir Shah Arrays comprising pre-labeled biological molecules and methods for making and using these arrays
US20030143637A1 (en) * 2001-08-31 2003-07-31 Selvan Gowri Pyapali Capture layer assemblies for cellular assays including related optical analysis discs and methods
US20030044798A1 (en) * 2001-08-31 2003-03-06 Lefkowitz Steven M. Methods for generating ligand arrays via deposition of ligands onto olefin displaying substrates, and arrays produced thereby
US20050147984A1 (en) * 2001-08-31 2005-07-07 Clondiag Chip Technologies Gmbh Interaction detection on several probe arrays
US20030108972A1 (en) * 2001-12-06 2003-06-12 Zweig Stephen Eliot Tethered receptor-ligand reagent and assay
US20030054396A1 (en) * 2001-09-07 2003-03-20 Weiner Michael P. Enzymatic light amplification
AU2002335715A1 (en) * 2001-09-07 2003-03-24 Burstein Technologies, Inc. Optical bio-disc systems for nuclear morphology based identification
AU2002336457A1 (en) * 2001-09-07 2003-03-24 Transform Pharmaceuticals, Inc. Apparatus and method for high-throughput preparation and characterization of compositions
AU2002333589A1 (en) * 2001-09-12 2003-03-24 Burstein Technologies, Inc. Methods for differential cell counts including related apparatus and software for performing same
US6974671B1 (en) 2001-09-12 2005-12-13 Salk Institute For Biological Studies Methods for indentifying compounds that modulate gluconeogenesis through the binding of CREB to the PGC-1 promoter
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
US20070082337A1 (en) * 2004-01-27 2007-04-12 Compugen Ltd. Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby
WO2003024923A1 (en) * 2001-09-14 2003-03-27 Axys Pharmaceuticals, Inc. Sulfonamide compounds as protease inhibitors
US20060188875A1 (en) * 2001-09-18 2006-08-24 Perlegen Sciences, Inc. Human genomic polymorphisms
US20070098728A1 (en) * 2001-09-24 2007-05-03 Pedersen Finn S Novel compositions and methods in cancer
US7202028B2 (en) * 2001-09-24 2007-04-10 The University Of North Carolina At Chapel Hill Methods for the electrochemical detection of multiple target compounds
US7042488B2 (en) 2001-09-27 2006-05-09 Fujinon Corporation Electronic endoscope for highlighting blood vessel
JP4754746B2 (en) * 2001-09-28 2011-08-24 オリンパス株式会社 Rod-shaped carrier and cylinder reaction vessel equipped with the same
US20030068621A1 (en) * 2001-10-04 2003-04-10 Jonathan Briggs Method and device for producing oligonucleotide arrays
US20040053232A1 (en) * 2001-10-05 2004-03-18 Perlegen Sciences, Inc. Haplotype structures of chromosome 21
DE10149684B4 (en) * 2001-10-09 2005-02-17 Clondiag Chip Technologies Gmbh Device for holding a substance library carrier
CA2463725A1 (en) 2001-10-12 2003-11-06 Spectral Genomics, Inc. Compilations of nucleic acids and arrays and methods of using them
US20030087289A1 (en) * 2001-10-12 2003-05-08 Harry Zuzan Image analysis of high-density synthetic DNA microarrays
WO2003033128A2 (en) * 2001-10-12 2003-04-24 Duke University Methods for image analysis of high-density synthetic dna microarrays
US7439346B2 (en) 2001-10-12 2008-10-21 Perkinelmer Las Inc. Nucleic acids arrays and methods of use therefor
CA2741049C (en) 2001-10-15 2019-02-05 Bioarray Solutions, Ltd. Multiplexed analysis of polymorphic loci by probe elongation-mediated detection
WO2003033718A1 (en) * 2001-10-17 2003-04-24 Global Genomics Ab Synthesis of oligonucleotides on solid support and assembly into doublestranded polynucleotides
US20030219800A1 (en) * 2001-10-18 2003-11-27 Beske Oren E. Multiplexed cell transfection using coded carriers
US20040126762A1 (en) * 2002-12-17 2004-07-01 Morris David W. Novel compositions and methods in cancer
US20040166490A1 (en) * 2002-12-17 2004-08-26 Morris David W. Novel therapeutic targets in cancer
US20030165859A1 (en) * 2001-10-23 2003-09-04 Invitrogen Corporation Primers and methods for the detection and discrimination of nucleic acids
ITMI20010566U1 (en) * 2001-10-25 2003-04-25 Troletti Adriano HAIR DRYER, WITH HIGH PRACTICALITY OF USE
ES2401425T3 (en) 2001-10-25 2013-04-19 Medical Research Council Molecules
WO2003036225A1 (en) * 2001-10-26 2003-05-01 University Of Rochester Method for biomolecular sensing and system thereof
US7378775B2 (en) 2001-10-26 2008-05-27 Nth Tech Corporation Motion based, electrostatic power source and methods thereof
US7211923B2 (en) 2001-10-26 2007-05-01 Nth Tech Corporation Rotational motion based, electrostatic power source and methods thereof
WO2003098661A2 (en) * 2001-10-26 2003-11-27 Integrated Nano-Technologies, Llc Chemical and biological hazard sensor system and methods thereof
US20030082560A1 (en) * 2001-10-29 2003-05-01 Yingjian Wang Method of making interactive protein arrays
US6956114B2 (en) 2001-10-30 2005-10-18 '454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
WO2003053855A2 (en) * 2001-10-30 2003-07-03 University Of Delaware Rapid high-throughput screen for detecting biological species in ballast water
US6902921B2 (en) * 2001-10-30 2005-06-07 454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US20050124022A1 (en) * 2001-10-30 2005-06-09 Maithreyan Srinivasan Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US20040014064A1 (en) * 2001-10-31 2004-01-22 Brissette William H. Therapeutics and diagnostics for disorders of erythropoiesis
US7175983B2 (en) * 2001-11-02 2007-02-13 Abmaxis, Inc. Adapter-directed display systems
AU2002367965A1 (en) * 2001-11-06 2003-12-31 Dermal Systems International Inc. High throughput methods and devices for assaying analytes in a fluid sample
US7498407B2 (en) 2001-11-09 2009-03-03 Georgetown University Vascular endothelial cell growth inhibitor, VEGI-192a
US20030162202A1 (en) * 2001-11-09 2003-08-28 Becker Kenneth David Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
US7195872B2 (en) * 2001-11-09 2007-03-27 3D Biosurfaces, Inc. High surface area substrates for microarrays and methods to make same
US20040067512A1 (en) * 2001-11-09 2004-04-08 Neurogenetics, Inc. Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
US20080094974A1 (en) * 2001-11-09 2008-04-24 Burstein Technologies, Inc. Optical disc system and related detecting methods for analysis of microscopic structures
WO2003042697A1 (en) * 2001-11-14 2003-05-22 Genospectra, Inc. Biochemical analysis system with combinatorial chemistry applications
DE10156467A1 (en) * 2001-11-16 2003-06-05 Micronas Gmbh Carriers for synthesis and processes for the production of biopolymers
US7157049B2 (en) * 2001-11-20 2007-01-02 Nagaoka & Co., Ltd. Optical bio-discs and fluidic circuits for analysis of cells and methods relating thereto
US20040023237A1 (en) * 2001-11-26 2004-02-05 Perelegen Sciences Inc. Methods for genomic analysis
AU2002351164A1 (en) * 2001-11-26 2003-06-10 Molecular Reflections, Inc. Microscale immobilization of molecules using a hydrogel and methods of use thereof
US20040180344A1 (en) * 2003-03-14 2004-09-16 Morris David W. Novel therapeutic targets in cancer
ES2403560T3 (en) 2001-11-30 2013-05-20 Fluidigm Corporation Microfluidic device and procedures for its use
US20040197778A1 (en) * 2002-12-26 2004-10-07 Sagres Discovery, Inc. Novel compositions and methods in cancer
US20060040262A1 (en) * 2002-12-27 2006-02-23 Morris David W Novel compositions and methods in cancer
EP1521594B1 (en) * 2001-12-07 2013-10-02 Novartis Vaccines and Diagnostics, Inc. Endogenous retrovirus polypeptides linked to oncogenic transformation
PT1458888E (en) * 2001-12-10 2011-06-01 Novartis Ag Methods of treating psychosis and schizophrenia based on polymorphisms in the cntf gene
US6960298B2 (en) * 2001-12-10 2005-11-01 Nanogen, Inc. Mesoporous permeation layers for use on active electronic matrix devices
US7098041B2 (en) 2001-12-11 2006-08-29 Kimberly-Clark Worldwide, Inc. Methods to view and analyze the results from diffraction-based diagnostics
US7102752B2 (en) 2001-12-11 2006-09-05 Kimberly-Clark Worldwide, Inc. Systems to view and analyze the results from diffraction-based diagnostics
US7858297B2 (en) * 2001-12-18 2010-12-28 Centre National De La Recherche Scientifique Cnrs Chemokine-binding protein and methods of use
EP1321768A1 (en) * 2001-12-18 2003-06-25 Roche Diagnostics GmbH Diagnosis of endometriosis from menstrual blood
DE60234713D1 (en) * 2001-12-18 2010-01-21 Endocube Sas NEW PROTEINS ASSOCIATED WITH CELL-DATE FROM THE THAP FAMILY AND PAR4 RELATED SIGNALING PATHS INVOLVED IN THE CONTROL OF APOPTOSIS
CN1927466A (en) * 2001-12-19 2007-03-14 阿菲梅特里克斯公司 Array plate and manufacturing process for array plate assembly
KR20050008644A (en) * 2001-12-21 2005-01-21 엘지 바이오메디컬 인스티튜트 Gene expression profiles in stomach cancer
US20030119203A1 (en) 2001-12-24 2003-06-26 Kimberly-Clark Worldwide, Inc. Lateral flow assay devices and methods for conducting assays
US8367013B2 (en) 2001-12-24 2013-02-05 Kimberly-Clark Worldwide, Inc. Reading device, method, and system for conducting lateral flow assays
EP1486561B1 (en) * 2001-12-26 2013-12-04 Canon Kabushiki Kaisha Probe medium
US7335153B2 (en) 2001-12-28 2008-02-26 Bio Array Solutions Ltd. Arrays of microparticles and methods of preparation thereof
AU2002361908A1 (en) * 2001-12-31 2003-07-24 Quark Biotech, Inc. Methods for identifying marker genes for cancer
US6897025B2 (en) * 2002-01-07 2005-05-24 Perlegen Sciences, Inc. Genetic analysis systems and methods
US20030188343A1 (en) * 2002-01-09 2003-10-02 Lynx Therapeutics, Inc. Identification of genes associated with growth in plants
FR2834521B1 (en) * 2002-01-10 2004-12-17 Bio Merieux METHOD FOR DETECTION AND / OR IDENTIFICATION OF THE ORIGINAL ANIMAL SPECIES OF THE ANIMAL MATERIAL CONTAINED IN A SAMPLE
WO2003060668A2 (en) * 2002-01-14 2003-07-24 Burstein Technologies, Inc. Method and apparatus for visualizing data
DE10201463B4 (en) 2002-01-16 2005-07-21 Clondiag Chip Technologies Gmbh Reaction vessel for performing array method
US8008012B2 (en) 2002-01-24 2011-08-30 Health Discovery Corporation Biomarkers downregulated in prostate cancer
US20030148391A1 (en) * 2002-01-24 2003-08-07 Salafsky Joshua S. Method using a nonlinear optical technique for detection of interactions involving a conformational change
CA2471018A1 (en) * 2002-01-28 2003-08-07 Burstein Technologies, Inc. Methods and apparatus for logical triggering of an optical bio-disc
US20050002827A1 (en) * 2002-01-29 2005-01-06 Mcintyre Kevin Robert Optical discs including equi-radial and/or spiral analysis zones and related disc drive systems and methods
US20050019901A1 (en) * 2002-01-31 2005-01-27 Evgenia Matveeva Methods for synthesis of bio-active nanoparticles and nanocapsules for use in optical bio-disc assays and disc assembly including same
US7418351B2 (en) * 2002-01-31 2008-08-26 Rosetta Inpharmatics Llc Methods for analysis of measurement errors in measured signals
CA2474982A1 (en) * 2002-02-01 2003-08-07 Rosetta Inpharmatics Llc Computer systems and methods for identifying genes and determining pathways associated with traits
US7083975B2 (en) * 2002-02-01 2006-08-01 Roland Green Microarray synthesis instrument and method
US20030149933A1 (en) * 2002-02-01 2003-08-07 Marco Falcioni Graphical design of chemical discovery processes
US6887362B2 (en) * 2002-02-06 2005-05-03 Nanogen, Inc. Dielectrophoretic separation and immunoassay methods on active electronic matrix devices
US7553619B2 (en) * 2002-02-08 2009-06-30 Qiagen Gmbh Detection method using dissociated rolling circle amplification
US6861523B2 (en) 2002-02-08 2005-03-01 Torrey Pines Institute For Molecular Studies 1,3,5- trisubstituted-1,3,5-triazine-2,4,6-trione compounds and libraries
US20030156136A1 (en) * 2002-02-15 2003-08-21 Cattell Herbert F. Method and system for visualization of results of feature extraction from molecular array data
US20030162178A1 (en) * 2002-02-25 2003-08-28 O'hagan David Variable microarray and methods of detecting one or more anlaytes in a sample
NL1020066C2 (en) * 2002-02-26 2003-08-27 Dutch Space B V Device for manufacturing a DNA test array.
US6914229B2 (en) * 2002-02-28 2005-07-05 Agilent Technologies, Inc. Signal offset for prevention of data clipping in a molecular array scanner
US6770892B2 (en) 2002-02-28 2004-08-03 Agilent Technologies, Inc. Method and system for automated focus-distance determination for molecular array scanners
US6929951B2 (en) * 2002-02-28 2005-08-16 Agilent Technologies, Inc. Method and system for molecular array scanner calibration
US20030161761A1 (en) * 2002-02-28 2003-08-28 Williams Roger O. Apparatus and method for composing high density materials onto target substrates by a rapid sequence
US7504364B2 (en) * 2002-03-01 2009-03-17 Receptors Llc Methods of making arrays and artificial receptors
US20030203384A1 (en) * 2002-03-08 2003-10-30 Chafin David R. Multiplex detection of biological materials in a sample
ATE421088T1 (en) * 2002-03-11 2009-01-15 Caprotec Bioanalytics Gmbh COMPOUNDS AND METHODS FOR ANALYZING THE PROTEOME
WO2003077727A2 (en) 2002-03-11 2003-09-25 Biostream, Inc. Technetium-dipyridine complexes, and methods of use thereof
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
AU2003214558A1 (en) 2002-03-13 2003-09-22 Bayer Cropscience Sa Mutagenesis of aspergillus fungi and identification of genes essential for growth
CA2422224A1 (en) 2002-03-15 2003-09-15 Affymetrix, Inc. System, method, and product for scanning of biological materials
SE0200817D0 (en) * 2002-03-15 2002-03-15 Ulf Gyllensten Method and kit for detection of mutations in mitochondrial DNA
US20030177380A1 (en) * 2002-03-18 2003-09-18 Woods Stanley P. Devices for storing array data and methods of using the same
US20030233197A1 (en) * 2002-03-19 2003-12-18 Padilla Carlos E. Discrete bayesian analysis of data
WO2003080649A2 (en) * 2002-03-20 2003-10-02 Regents Of The University Of Minnesota Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors
CA2479730A1 (en) * 2002-03-21 2003-10-02 Sagres Discovery, Inc. Novel compositions and methods in cancer
US20040006431A1 (en) * 2002-03-21 2004-01-08 Affymetrix, Inc., A Corporation Organized Under The Laws Of Delaware System, method and computer software product for grid placement, alignment and analysis of images of biological probe arrays
US7193069B2 (en) * 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
AU2003233451A1 (en) 2002-03-26 2003-10-13 Massachusetts Institute Of Technology Targets, methods, and reagents for diagnosis and treatment of schizophrenia
PE20040015A1 (en) * 2002-03-26 2004-01-29 Derhsing Lai NEW CHIP OF INTEGRATED CIRCUITS FOR BIOLOGICAL TESTS
US6916621B2 (en) 2002-03-27 2005-07-12 Spectral Genomics, Inc. Methods for array-based comparitive binding assays
US20030186279A1 (en) * 2002-03-28 2003-10-02 Affymetrix, Inc. Large scale genotyping methods
US20030186302A1 (en) * 2002-03-29 2003-10-02 Yixin Wang Colorectal cancer diagnostics
EP2666849A3 (en) 2002-04-01 2014-05-28 Fluidigm Corporation Microfluidic particle-analysis systems
NZ573064A (en) 2002-04-04 2011-02-25 Coley Pharm Gmbh Immunostimulatory G,U-containing oligoribonucleotides
US6773888B2 (en) * 2002-04-08 2004-08-10 Affymetrix, Inc. Photoactivatable silane compounds and methods for their synthesis and use
US20030194709A1 (en) * 2002-04-10 2003-10-16 Xing Yang Hydrophobic zone device
AU2003221884A1 (en) * 2002-04-10 2003-10-27 Transtech Pharma, Inc. System and method for data analysis, manipulation, and visualization
US20030195431A1 (en) * 2002-04-10 2003-10-16 Sukhatme Vikas P. Observation of effects of body fluids on indicator cells for disease diagnosis
US7687256B2 (en) 2002-04-11 2010-03-30 Spire Corporation Surface activated biochip
WO2003087774A2 (en) 2002-04-12 2003-10-23 Curators Of The University Of Missouri Ecist microarrays for dual screening of dna hypermethylation and gene silencing
US7531305B2 (en) * 2002-04-16 2009-05-12 Autogenomics, Inc. Human Papilloma Virus detection with DNA microarray
DK1355152T3 (en) 2002-04-17 2010-06-14 Deutsches Krebsforsch Method of identifying a connection for modulating the wnt signal cascade
US7226771B2 (en) 2002-04-19 2007-06-05 Diversa Corporation Phospholipases, nucleic acids encoding them and methods for making and using them
CN1659276A (en) 2002-04-19 2005-08-24 戴弗萨公司 Phospholipases, nucleic acids encoding them and methods for making and using them
DE10217569A1 (en) * 2002-04-19 2003-11-13 Infineon Technologies Ag Device based on partially oxidized porous silicon
US7425749B2 (en) * 2002-04-23 2008-09-16 Sharp Laboratories Of America, Inc. MEMS pixel sensor
EP1501871A4 (en) * 2002-04-23 2006-05-03 Applera Corp Isolated human proteins that show high homology to human disease proteins, nucleic acid molecules encoding these human proteins, and uses thereof
US20030198967A1 (en) * 2002-04-23 2003-10-23 Matson Robert S. Multi-functional microarrays and methods
US6946285B2 (en) * 2002-04-29 2005-09-20 Agilent Technologies, Inc. Arrays with elongated features
US20040023275A1 (en) * 2002-04-29 2004-02-05 Perlegen Sciences, Inc. Methods for genomic analysis
CN1202266C (en) * 2002-04-30 2005-05-18 欧姆龙株式会社 Biological chip fitted with optical scanning device and reading method of said biological chip
US6791690B2 (en) * 2002-04-30 2004-09-14 Agilent Technologies, Inc. Reading dry chemical arrays
AU2003245269A1 (en) * 2002-05-03 2003-11-17 Vialogy Corporation System and method for characterizing microarray output data
US7223368B2 (en) 2002-05-03 2007-05-29 Kimberly-Clark Worldwide, Inc. Diffraction-based diagnostic devices
US7118855B2 (en) * 2002-05-03 2006-10-10 Kimberly-Clark Worldwide, Inc. Diffraction-based diagnostic devices
US7485453B2 (en) * 2002-05-03 2009-02-03 Kimberly-Clark Worldwide, Inc. Diffraction-based diagnostic devices
US7223534B2 (en) 2002-05-03 2007-05-29 Kimberly-Clark Worldwide, Inc. Diffraction-based diagnostic devices
US7771922B2 (en) 2002-05-03 2010-08-10 Kimberly-Clark Worldwide, Inc. Biomolecule diagnostic device
US7214530B2 (en) 2002-05-03 2007-05-08 Kimberly-Clark Worldwide, Inc. Biomolecule diagnostic devices and method for producing biomolecule diagnostic devices
WO2003094841A2 (en) * 2002-05-06 2003-11-20 Functional Genetics, Inc. Mammalian genes involed in rapamycin resistance and tumorgenesis: annexin xiii genes
US20030216870A1 (en) * 2002-05-07 2003-11-20 Wolber Paul K. Method and system for normalization of micro array data based on local normalization of rank-ordered, globally normalized data
KR20120004544A (en) 2002-05-08 2012-01-12 노쓰웨스트 바이오써라퓨틱스, 인크. Quality assays for antigen presenting cells
US7217512B2 (en) * 2002-05-09 2007-05-15 Corning Incorporated Reagent and method for attaching target molecules to a surface
US20040018527A1 (en) * 2002-05-17 2004-01-29 Chang Jenny C. Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemo resistance
EP1573056A4 (en) * 2002-05-17 2007-11-28 Nugen Technologies Inc Methods for fragmentation, labeling and immobilization of nucleic acids
WO2003100557A2 (en) * 2002-05-20 2003-12-04 Rosetta Inpharmatics Llc Computer systems and methods for subdividing a complex disease into component diseases
US20030220746A1 (en) * 2002-05-21 2003-11-27 Srinka Ghosh Method and system for computing and applying a global, multi-channel background correction to a feature-based data set obtained from scanning a molecular array
US7221785B2 (en) * 2002-05-21 2007-05-22 Agilent Technologies, Inc. Method and system for measuring a molecular array background signal from a continuous background region of specified size
TWI221523B (en) * 2002-05-21 2004-10-01 Sony Corp Bioassay method, bioassay device, and bioassay substrate
US20050033525A1 (en) * 2002-05-21 2005-02-10 Corson John F. Method and system for computing and applying a user-defined, global, multi-channel background correction to a feature-based data set obtained from reading a microarray
US20040126773A1 (en) * 2002-05-23 2004-07-01 Beske Oren E. Assays with coded sensor particles to sense assay conditions
US20030219755A1 (en) * 2002-05-24 2003-11-27 Nanibhushan Dattagupta Compositions and methods for performing hybridization assays using target enhanced signal amplification (TESA)
US6763308B2 (en) 2002-05-28 2004-07-13 Sas Institute Inc. Statistical outlier detection for gene expression microarray data
US20050239193A1 (en) * 2002-05-30 2005-10-27 Bioforce Nanosciences, Inc. Device and method of use for detection and characterization of microorganisms and microparticles
US6806460B2 (en) * 2002-05-31 2004-10-19 Agilent Technologies, Inc. Fluorescence detection with increased dynamic range
US7537936B2 (en) * 2002-05-31 2009-05-26 Agilent Technologies, Inc. Method of testing multiple fluid samples with multiple biopolymer arrays
JP4193421B2 (en) * 2002-06-06 2008-12-10 ソニー株式会社 Bioassay device, manufacturing method thereof, and bioassay method
AU2003239283A1 (en) * 2002-06-13 2003-12-31 Millenium Biologix Ag Reaction chamber
AU2003276679A1 (en) * 2002-06-13 2003-12-31 Chiron Corporation Vectors for expression of hml-2 polypeptides
US9388459B2 (en) * 2002-06-17 2016-07-12 Affymetrix, Inc. Methods for genotyping
US7108976B2 (en) * 2002-06-17 2006-09-19 Affymetrix, Inc. Complexity management of genomic DNA by locus specific amplification
US20030231986A1 (en) * 2002-06-18 2003-12-18 Eastman Kodak Company Micro-array identification means
EP1534857B1 (en) 2002-06-20 2010-08-04 The Regents of The University of California Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores
US7332273B2 (en) 2002-06-20 2008-02-19 Affymetrix, Inc. Antireflective coatings for high-resolution photolithographic synthesis of DNA arrays
US7144950B2 (en) 2003-09-17 2006-12-05 The Regents Of The University Of California Conformationally flexible cationic conjugated polymers
US7091049B2 (en) 2002-06-26 2006-08-15 Kimberly-Clark Worldwide, Inc. Enhanced diffraction-based biosensor devices
WO2004003551A1 (en) * 2002-06-28 2004-01-08 Canon Kabushiki Kaisha Probe support, method of constructing probe support, method of evaluating probe support and method of detecting target nucleic acid using the same
CN1688716A (en) * 2002-06-28 2005-10-26 罗斯塔英法美蒂克斯有限责任公司 Methods to assess quality of microarrays
JP3658397B2 (en) * 2002-06-28 2005-06-08 キヤノン株式会社 Device information acquisition method and information acquisition device by time-of-flight secondary ion mass spectrometry
US20040137491A1 (en) * 2002-06-28 2004-07-15 Tadashi Okamoto Method of analyzing probe carrier using time-of-flight secondary ion mass spectrometry
JP2004024203A (en) * 2002-06-28 2004-01-29 Canon Inc Method for analysis of rna by time-of-flight secondary ion mass spectrometry
US20040005769A1 (en) * 2002-07-03 2004-01-08 Cabot Microelectronics Corp. Method and apparatus for endpoint detection
DE10230320A1 (en) * 2002-07-05 2004-02-05 Marcel Rogalla Programmable illumination device for high resolution, massively parallel, spatial Systhese and analysis of microarrays
US20040009574A1 (en) * 2002-07-09 2004-01-15 Nanibhushan Dattagupta Compositions and methods for detecting streptococcus agalactiae capsular polysaccharide synthesis genes
USH2223H1 (en) 2002-07-11 2008-09-02 The United States Of America As Represented By The Secretary Of The Navy Patterned, micrometer-sized antibody features
US7504215B2 (en) 2002-07-12 2009-03-17 Affymetrix, Inc. Nucleic acid labeling methods
US20050185175A1 (en) * 2002-07-16 2005-08-25 Canos Avelino C. Rotary support and apparatus used for the multiple spectroscopic characterisation of samples of solid materials
AU2003261168A1 (en) * 2002-07-19 2004-02-09 Althea Technologies, Inc. Strategies for gene expression analysis
AU2003258472A1 (en) * 2002-07-23 2004-02-25 Universitat Leipzig Method for selective peptide labeling
CA2492463A1 (en) * 2002-07-25 2004-02-05 Archemix Corporation Regulated aptamer therapeutics
US7601493B2 (en) * 2002-07-26 2009-10-13 Nanogen, Inc. Methods and apparatus for screening and detecting multiple genetic mutations
US20040018497A1 (en) * 2002-07-26 2004-01-29 Warden Craig H Human obesity LIPIN3 polynucleotide and polypeptide sequences and methods of use thereof
US20040118688A1 (en) * 2002-07-29 2004-06-24 Dumas David P. Transparent polymer support for electrophoresis and electrochromatography and related methods
WO2004013628A1 (en) * 2002-08-02 2004-02-12 Applera Corporation Fluorescence polarization assay
WO2004013727A2 (en) * 2002-08-02 2004-02-12 Rosetta Inpharmatics Llc Computer systems and methods that use clinical and expression quantitative trait loci to associate genes with traits
US7632916B2 (en) * 2002-08-02 2009-12-15 3M Innovative Properties Company Process to modify polymeric materials and resulting compositions
AU2003257109A1 (en) * 2002-08-05 2004-02-23 Invitrogen Corporation Compositions and methods for molecular biology
US20060073475A1 (en) * 2002-08-09 2006-04-06 Nanibhushan Dattagupta Compositions and methods for detecting pathogenic bacteria expressing chaperonin proteins
US20060099676A1 (en) * 2002-08-15 2006-05-11 Limin Li Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes
WO2004020581A2 (en) * 2002-08-15 2004-03-11 Functional Genetics, Inc. Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr7 genes
US20050118616A1 (en) * 2002-08-16 2005-06-02 Kawashima Tadashi R. Amplification of target nucleotide sequence without polymerase chain reaction
US20050233473A1 (en) * 2002-08-16 2005-10-20 Zyomyx, Inc. Methods and reagents for surface functionalization
US7118865B2 (en) * 2002-08-16 2006-10-10 Regents Of The University Of Minnesota Methods for diagnosing severe systemic lupus erythematosus
US7267751B2 (en) * 2002-08-20 2007-09-11 Nanogen, Inc. Programmable multiplexed active biologic array
US7508608B2 (en) 2004-11-17 2009-03-24 Illumina, Inc. Lithographically fabricated holographic optical identification element
US7923260B2 (en) 2002-08-20 2011-04-12 Illumina, Inc. Method of reading encoded particles
US7473535B2 (en) * 2002-08-20 2009-01-06 The Institute For Systems Biology Chemical reagents and methods for detection and quantification of proteins in complex mixtures
US7901630B2 (en) 2002-08-20 2011-03-08 Illumina, Inc. Diffraction grating-based encoded microparticle assay stick
US7164533B2 (en) 2003-01-22 2007-01-16 Cyvera Corporation Hybrid random bead/chip based microarray
US7619819B2 (en) 2002-08-20 2009-11-17 Illumina, Inc. Method and apparatus for drug product tracking using encoded optical identification elements
US7872804B2 (en) 2002-08-20 2011-01-18 Illumina, Inc. Encoded particle having a grating with variations in the refractive index
US7900836B2 (en) 2002-08-20 2011-03-08 Illumina, Inc. Optical reader system for substrates having an optically readable code
US20040038214A1 (en) * 2002-08-23 2004-02-26 Corson John F. Method and system for reading a molecular array
US8277753B2 (en) * 2002-08-23 2012-10-02 Life Technologies Corporation Microfluidic transfer pin
EA007653B1 (en) 2002-08-26 2006-12-29 Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores
US7314763B2 (en) 2002-08-27 2008-01-01 Kimberly-Clark Worldwide, Inc. Fluidics-based assay devices
US7432105B2 (en) 2002-08-27 2008-10-07 Kimberly-Clark Worldwide, Inc. Self-calibration system for a magnetic binding assay
US7285424B2 (en) 2002-08-27 2007-10-23 Kimberly-Clark Worldwide, Inc. Membrane-based assay devices
AU2003258683A1 (en) * 2002-09-03 2004-03-29 Zeptosens Ag Analytical platform and detection method with analytes which are to be detected in a sample in the form of immobilized specific binding partners
AU2003298412A1 (en) * 2002-09-03 2004-03-29 Zeptosens Ag Analytical platform and identification method
CA2497792C (en) * 2002-09-06 2014-08-05 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
EP2161276A3 (en) * 2002-09-08 2010-05-26 Applera Corporation Methods, compositions and libraries pertaining PNA dimer and PNA oligomer systhesis
WO2004024314A2 (en) * 2002-09-11 2004-03-25 Exiqon A/S A population of nucleic acids including a subpopulation of lna oligomers
US7563600B2 (en) 2002-09-12 2009-07-21 Combimatrix Corporation Microarray synthesis and assembly of gene-length polynucleotides
US20100255603A9 (en) 2002-09-12 2010-10-07 Putnam Martin A Method and apparatus for aligning microbeads in order to interrogate the same
US7092160B2 (en) 2002-09-12 2006-08-15 Illumina, Inc. Method of manufacturing of diffraction grating-based optical identification element
US6889143B2 (en) * 2002-09-12 2005-05-03 Intergrated Dna Technologies, Inc. Methods and systems for estimating the melting temperature (TM) for polynucleotide molecules
US7595883B1 (en) 2002-09-16 2009-09-29 The Board Of Trustees Of The Leland Stanford Junior University Biological analysis arrangement and approach therefor
US7469076B2 (en) * 2003-09-03 2008-12-23 Receptors Llc Sensors employing combinatorial artificial receptors
US20050170385A1 (en) * 2002-09-16 2005-08-04 Receptors Llc Artificial receptors including gradients
US20050037381A1 (en) * 2002-09-16 2005-02-17 Receptors Llc Artificial receptors, building blocks, and methods
AU2003272548A1 (en) * 2002-09-16 2004-04-30 Plexxikon, Inc. Crystal structure of pim-1 kinase
US20040137481A1 (en) * 2002-09-16 2004-07-15 Receptors Llc Artificial receptor building blocks, components, and kits
US20050136483A1 (en) * 2003-09-03 2005-06-23 Receptors Llc Nanodevices employing combinatorial artificial receptors
US20050037429A1 (en) * 2003-03-28 2005-02-17 Receptors Llc Artificial receptors including reversibly immobilized building blocks and methods
US20060057625A1 (en) * 2002-09-16 2006-03-16 Carlson Robert E Scaffold-based artificial receptors and methods
US20050037428A1 (en) * 2002-09-16 2005-02-17 Receptors Llc Artificial receptors including reversibly immobilized building blocks, the building blocks, and methods
AU2003275077B2 (en) 2002-09-18 2010-02-04 Ortho-Mcneil Pharmaceutical, Inc. Methods of increasing platelet and hematopoietic stem cell production
US7143785B2 (en) 2002-09-25 2006-12-05 California Institute Of Technology Microfluidic large scale integration
US7169550B2 (en) * 2002-09-26 2007-01-30 Kimberly-Clark Worldwide, Inc. Diffraction-based diagnostic devices
DE10245432A1 (en) 2002-09-27 2004-04-08 Micronas Gmbh Method and device for detecting at least one luminescent substance
US7135288B2 (en) 2002-09-27 2006-11-14 Ut-Battelle, Llc Combinatorial synthesis of ceramic materials
AU2003270898A1 (en) * 2002-09-27 2004-04-19 Nimblegen Systems, Inc. Microarray with hydrophobic barriers
DE10393406T5 (en) 2002-09-30 2005-12-22 Nimblegen Systems, Inc., Madison Parallel loading of arrays
US20040110212A1 (en) * 2002-09-30 2004-06-10 Mccormick Mark Microarrays with visual alignment marks
US20040101894A1 (en) * 2002-10-01 2004-05-27 Thomas Albert Microarrays having multiple oligonucleotides in single array features
WO2004040001A2 (en) 2002-10-02 2004-05-13 California Institute Of Technology Microfluidic nucleic acid analysis
US20040259105A1 (en) * 2002-10-03 2004-12-23 Jian-Bing Fan Multiplex nucleic acid analysis using archived or fixed samples
US7459273B2 (en) * 2002-10-04 2008-12-02 Affymetrix, Inc. Methods for genotyping selected polymorphism
US20040067492A1 (en) * 2002-10-04 2004-04-08 Allan Peng Reverse transcription on microarrays
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
US20050003369A1 (en) * 2002-10-10 2005-01-06 Affymetrix, Inc. Method for depleting specific nucleic acids from a mixture
US20040120861A1 (en) * 2002-10-11 2004-06-24 Affymetrix, Inc. System and method for high-throughput processing of biological probe arrays
KR100508108B1 (en) * 2002-10-14 2005-08-18 학교법인 포항공과대학교 Method for formation of polymer pattern
US20080293750A1 (en) * 2002-10-17 2008-11-27 Anna Helgadottir Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
AU2003301353A1 (en) * 2002-10-18 2004-05-04 Cylene Pharmaceuticals Processes for identifying quadruplex-targeted antiviral molecules
KR20050056250A (en) 2002-10-18 2005-06-14 주식회사 엘지생명과학 Gene families associated with cancers
US20040219565A1 (en) * 2002-10-21 2004-11-04 Sakari Kauppinen Oligonucleotides useful for detecting and analyzing nucleic acids of interest
US20040076961A1 (en) * 2002-10-21 2004-04-22 Lewis Mark A. Biomolecule retaining material and methods for attaching biomolecules to a surface
CA2429101A1 (en) * 2002-10-24 2004-04-24 Ben Gao Method and equipment to monitor nucleic acid hybridization on a dna chip using four-dimensional parameters
US7635564B2 (en) * 2002-10-25 2009-12-22 Agilent Technologies, Inc. Biopolymeric arrays having replicate elements
US20040115722A1 (en) * 2002-10-25 2004-06-17 Mel Kronick Biopolymeric arrays and methods of producing the same
US6742843B2 (en) * 2002-10-25 2004-06-01 Knoll, Inc. Cable control with overload protection device
WO2004039953A2 (en) * 2002-10-28 2004-05-13 Xeotron Corporation Array oligomer synthesis and use.
JP3447009B1 (en) * 2002-10-29 2003-09-16 實 平垣 Construct structure and method for producing the same
US7195908B2 (en) 2002-10-31 2007-03-27 Corning Incorporated Supports treated with triamine for immobilizing biomolecules
US20050037369A1 (en) * 2002-10-31 2005-02-17 Neote Kuldeep Singh Panels of molecular targets differentially expressed during CD8+ T cell priming, and methods for therapy and diagnosis utilizing the same
JP4571776B2 (en) * 2002-11-05 2010-10-27 Jx日鉱日石エネルギー株式会社 Lubricating oil composition
US20040086892A1 (en) * 2002-11-06 2004-05-06 Crothers Donald M. Universal tag assay
GB0226593D0 (en) * 2002-11-14 2002-12-24 Consultants Ltd Compounds
AU2002952696A0 (en) 2002-11-14 2002-11-28 Genomics Research Partners Pty Ltd Status determination
WO2004046387A1 (en) * 2002-11-15 2004-06-03 Sangamo Biosciences, Inc. Methods and compositions for analysis of regulatory sequences
US7526114B2 (en) 2002-11-15 2009-04-28 Bioarray Solutions Ltd. Analysis, secure access to, and transmission of array images
EP1420248A3 (en) * 2002-11-18 2004-05-26 Schott Glas Validated design for microarrays
WO2004046691A2 (en) * 2002-11-18 2004-06-03 Genospectra, Inc. Uncaging devices
US7250289B2 (en) * 2002-11-20 2007-07-31 Affymetrix, Inc. Methods of genetic analysis of mouse
US7314750B2 (en) * 2002-11-20 2008-01-01 Affymetrix, Inc. Addressable oligonucleotide array of the rat genome
EP1897959A1 (en) * 2002-11-22 2008-03-12 The Johns Hopkins University Target for therapy of cognitive impairment
EP2112229A3 (en) 2002-11-25 2009-12-02 Sequenom, Inc. Methods for identifying risk of breast cancer and treatments thereof
US20040101861A1 (en) * 2002-11-27 2004-05-27 Little Roger G. Resonant cavity photodiode array for rapid DNA microarray readout
TWI255971B (en) * 2002-11-29 2006-06-01 Asml Netherlands Bv Lithographic apparatus and device manufacturing method
EP1424599B1 (en) * 2002-11-29 2008-03-12 ASML Netherlands B.V. Lithographic apparatus and device manufacturing method
US20040109045A1 (en) * 2002-12-06 2004-06-10 Eastman Kodak Company Print head for micro-deposition of bio-molecules
DK1581467T3 (en) 2002-12-09 2016-11-28 Massachusetts Inst Technology LIGANDS FOR METALS AND IMPROVED METAL CATALYZED PROCEDURES BASED ON THERE
US20040259111A1 (en) * 2002-12-10 2004-12-23 Rosetta Inpharmatics Llc Automated system and method for preparing an assay ready biological sample
US20040115654A1 (en) * 2002-12-16 2004-06-17 Intel Corporation Laser exposure of photosensitive masks for DNA microarray fabrication
WO2004056868A2 (en) * 2002-12-19 2004-07-08 Endocube Sas Nf-hev compositions and methods of use
US7247500B2 (en) 2002-12-19 2007-07-24 Kimberly-Clark Worldwide, Inc. Reduction of the hook effect in membrane-based assay devices
US9487823B2 (en) 2002-12-20 2016-11-08 Qiagen Gmbh Nucleic acid amplification
US20060094108A1 (en) * 2002-12-20 2006-05-04 Karl Yoder Thermal cycler for microfluidic array assays
US20040120859A1 (en) * 2002-12-20 2004-06-24 Kocher Thomas E. Biomolecular micro-deposition system
EP1608952B1 (en) * 2002-12-20 2016-08-10 Life Technologies Corporation Assay apparatus and method using microfluidic arrays
EP1583816A4 (en) * 2002-12-22 2007-06-13 Scripps Research Inst Protein arrays
US20040180368A1 (en) * 2002-12-23 2004-09-16 Affymetrix, Inc. Method for producing a high density nucleic acid array using activators
US7541152B2 (en) * 2002-12-24 2009-06-02 Agilent Technologies, Inc. Integrated light source for diagnostic arrays
US20040126766A1 (en) * 2002-12-26 2004-07-01 Amorese Douglas A. Breakaway seal for processing a subarray of an array
US8843356B2 (en) 2002-12-27 2014-09-23 Merck Sharp & Dohme Corp. Computer systems and methods for associating genes with traits using cross species data
US6977153B2 (en) * 2002-12-31 2005-12-20 Qiagen Gmbh Rolling circle amplification of RNA
US7344832B2 (en) * 2003-01-02 2008-03-18 Bioforce Nanosciences, Inc. Method and apparatus for molecular analysis in small sample volumes
EP1587840B1 (en) * 2003-01-13 2008-08-20 The Regents Of The University Of Michigan Method to form a protein microarray system
WO2004064972A2 (en) * 2003-01-16 2004-08-05 Hk Pharmaceuticals, Inc. Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
KR100994566B1 (en) * 2003-01-20 2010-11-15 삼성전자주식회사 An array device comprising a photoresist film having immobilization regions and a method using the same
US7996155B2 (en) 2003-01-22 2011-08-09 Microsoft Corporation ANOVA method for data analysis
WO2004067191A2 (en) 2003-01-29 2004-08-12 President And Fellows Of Harward College Alteration of surface affinities
US7575865B2 (en) * 2003-01-29 2009-08-18 454 Life Sciences Corporation Methods of amplifying and sequencing nucleic acids
ES2396245T3 (en) 2003-01-29 2013-02-20 454 Life Sciences Corporation Nucleic Acid Amplification and Sequencing Method
US20050048573A1 (en) * 2003-02-03 2005-03-03 Plexxikon, Inc. PDE5A crystal structure and uses
US20040157220A1 (en) 2003-02-10 2004-08-12 Purnima Kurnool Methods and apparatus for sample tracking
US8206704B2 (en) 2003-02-10 2012-06-26 Thomas Jefferson University Use of GCC ligands
EP2351856A1 (en) 2003-02-13 2011-08-03 The Regents Of the University of California Methods and compositions for detection and analysis of polynucleotide-binding protein interactions using light harvesting multichromophores
US7192703B2 (en) * 2003-02-14 2007-03-20 Intel Corporation, Inc. Biomolecule analysis by rolling circle amplification and SERS detection
US7767387B2 (en) * 2003-06-13 2010-08-03 Sagres Discovery, Inc. Therapeutic targets in cancer
US20040170982A1 (en) 2003-02-14 2004-09-02 Morris David W. Novel therapeutic targets in cancer
US20070218071A1 (en) * 2003-09-15 2007-09-20 Morris David W Novel therapeutic targets in cancer
JP2007524362A (en) 2003-02-14 2007-08-30 サイグレス ディスカバリー, インコーポレイテッド Therapeutic GPCR targets in cancer
US7759513B2 (en) * 2003-02-21 2010-07-20 Nigu Chemie Gmbh Photolabile protective groups for improved processes to prepare oligonucleotide arrays
US20050014249A1 (en) * 2003-02-21 2005-01-20 Norbert Staimer Chromatographic analysis on optical bio-discs and methods relating thereto
US20040166495A1 (en) * 2003-02-24 2004-08-26 Greinwald John H. Microarray-based diagnosis of pediatric hearing impairment-construction of a deafness gene chip
US20060183132A1 (en) * 2005-02-14 2006-08-17 Perlegen Sciences, Inc. Selection probe amplification
EP2365095A1 (en) * 2003-02-26 2011-09-14 Callida Genomics, Inc. Random array DNA analysis by hybridization
US20090124514A1 (en) * 2003-02-26 2009-05-14 Perlegen Sciences, Inc. Selection probe amplification
EP1627045A2 (en) * 2003-02-28 2006-02-22 Plexxikon, Inc. Pyk2 crystal structure and uses
CA2920416A1 (en) 2003-03-06 2004-10-28 Basf Enzymes Llc Amylases, nucleic acids encoding them and methods for making and using them
US20040235019A1 (en) * 2003-03-06 2004-11-25 Agouron Pharmaceuticals, Inc. Diagnostics and therapeutics for the gene expression signature of PPAR-gamma receptor ligand
WO2005032496A2 (en) 2003-03-07 2005-04-14 Diversa Corporation Hydrolases, nucleic acids encoding them and mehods for making and using them
US6970240B2 (en) * 2003-03-10 2005-11-29 Applera Corporation Combination reader
FR2852317B1 (en) 2003-03-13 2006-08-04 PROBE BIOPUCES AND METHODS OF USE
JP2004279196A (en) * 2003-03-14 2004-10-07 Dainippon Printing Co Ltd Substrate for bio-micro-array and bio-micro-array
US20040235022A1 (en) * 2003-03-19 2004-11-25 Ralf Mauritz Quality control method for manufacturing biopolymer arrays
WO2004087323A1 (en) * 2003-03-28 2004-10-14 Mergen Ltd. Multi-array systems and methods of use thereof
EP1613737A4 (en) * 2003-03-28 2008-12-03 Receptors Llc Artificial receptors including reversibly immobilized building blocks and methods
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20040223874A1 (en) * 2003-03-31 2004-11-11 Canon Kabushiki Kaisha Biochemical reaction cartridge
US8043834B2 (en) 2003-03-31 2011-10-25 Qiagen Gmbh Universal reagents for rolling circle amplification and methods of use
US20040191782A1 (en) * 2003-03-31 2004-09-30 Yixin Wang Colorectal cancer prognostics
EP1473085B1 (en) * 2003-03-31 2015-07-22 Canon Kabushiki Kaisha Biochemical reaction cartridge
DE10315074A1 (en) 2003-04-02 2004-10-14 Clondiag Chip Technologies Gmbh Device for the duplication and detection of nucleic acids
WO2006102264A1 (en) 2005-03-18 2006-09-28 Fluidigm Corporation Thermal reaction device and method for using the same
US20040197819A1 (en) 2003-04-03 2004-10-07 Kimberly-Clark Worldwide, Inc. Assay devices that utilize hollow particles
US7604965B2 (en) 2003-04-03 2009-10-20 Fluidigm Corporation Thermal reaction device and method for using the same
US7666361B2 (en) 2003-04-03 2010-02-23 Fluidigm Corporation Microfluidic devices and methods of using same
US7851209B2 (en) 2003-04-03 2010-12-14 Kimberly-Clark Worldwide, Inc. Reduction of the hook effect in assay devices
EP2341136B1 (en) 2003-04-04 2016-06-08 BASF Enzymes LLC Pectate lyases, Nucleic Acids encoding them and methods for making and using them
CA2463719A1 (en) * 2003-04-05 2004-10-05 F. Hoffmann-La Roche Ag Nucleotide analogs with six membered rings
US7833714B1 (en) 2003-04-11 2010-11-16 Affymetrix, Inc. Combinatorial affinity selection
EP1613778B1 (en) * 2003-04-14 2014-11-26 Nugen Technologies, Inc. Global amplification using a randomly primed composite primer
EP1616026A1 (en) 2003-04-14 2006-01-18 Novartis AG Gene expression associated with osteoblast differentiation
US20040210036A1 (en) * 2003-04-15 2004-10-21 Nanogen, Inc. Peptide substrate libraries
US8652774B2 (en) * 2003-04-16 2014-02-18 Affymetrix, Inc. Automated method of manufacturing polyer arrays
EP1618179B1 (en) 2003-04-18 2014-05-07 Biogen Idec MA Inc. Polymer-conjugated glycosylated neublastin
US7892745B2 (en) 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
WO2004096985A2 (en) * 2003-04-24 2004-11-11 Mayo Foundation For Medical Education And Research Methods for assessing biologic diversity
US20050064452A1 (en) * 2003-04-25 2005-03-24 Schmid Matthew J. System and method for the detection of analytes
EP1623010A4 (en) * 2003-04-25 2007-12-26 Janssen Pharmaceutica Nv Preservation of rna in a biological sample
EP1624901B1 (en) 2003-05-02 2012-07-25 The University Of Western Ontario Prosthetic groups attached to stannylated polymers for the synthesis of radiopharmaceuticals
GB0310270D0 (en) * 2003-05-03 2003-06-11 Univ Edinburgh Biomolecular devices
US7709610B2 (en) 2003-05-08 2010-05-04 Facet Biotech Corporation Therapeutic use of anti-CS1 antibodies
US20050136395A1 (en) * 2003-05-08 2005-06-23 Affymetrix, Inc Methods for genetic analysis of SARS virus
US20050025763A1 (en) 2003-05-08 2005-02-03 Protein Design Laboratories, Inc. Therapeutic use of anti-CS1 antibodies
EP1625228A4 (en) * 2003-05-09 2007-05-02 Capitalbio Corp Methods and compositions for detecting sars virus
EP1623020A4 (en) * 2003-05-09 2007-05-09 Sigma Aldrich Co Genomic and proteomic approaches for the development of cell culture medium
US20090005257A1 (en) 2003-05-14 2009-01-01 Jespers Laurent S Process for Recovering Polypeptides that Unfold Reversibly from a Polypeptide Repertoire
WO2004104922A2 (en) * 2003-05-16 2004-12-02 Board Of Regents, The University Of Texas System Image and part recognition technology
JP2006525811A (en) * 2003-05-16 2006-11-16 ロゼッタ インファーマティクス エルエルシー Methods and compositions for RNA interference
US9317922B2 (en) 2003-05-16 2016-04-19 Board Of Regents The University Of Texas System Image and part recognition technology
SE527896C2 (en) * 2003-05-20 2006-07-04 Aamic Ab Optical test device for biological samples, as well as a microarray for the device and the method for its use
JP3898198B2 (en) * 2003-05-22 2007-03-28 韓国科学技術院 Nanoarray fabrication method using organic supramolecular self-assembly and metal chemisorption
RU2390561C2 (en) * 2003-05-23 2010-05-27 Колд Спринг Харбор Лэборетери Virtual sets of fragments of nucleotide sequences
WO2005020784A2 (en) * 2003-05-23 2005-03-10 Mount Sinai School Of Medicine Of New York University Surrogate cell gene expression signatures for evaluating the physical state of a subject
US20040241657A1 (en) * 2003-05-28 2004-12-02 Perlegen Sciences, Inc. Liver related disease compositions and methods
WO2004109447A2 (en) 2003-05-30 2004-12-16 Rosetta Inpharmatics Llc Computer systems and methods for identifying surrogate markers
US20040241659A1 (en) * 2003-05-30 2004-12-02 Applera Corporation Apparatus and method for hybridization and SPR detection
FR2855832B1 (en) * 2003-06-03 2007-09-14 Biomerieux Sa DIAGNOSTIC AND / OR PROGNOSTIC METHOD OF SEPTIC SYNDROME
KR100549103B1 (en) * 2003-06-05 2006-02-06 한국과학기술원 Method for Fabricating a Carbon Nanotube Array
US20040248323A1 (en) 2003-06-09 2004-12-09 Protometrix, Inc. Methods for conducting assays for enzyme activity on protein microarrays
WO2005000098A2 (en) 2003-06-10 2005-01-06 The Trustees Of Boston University Detection methods for disorders of the lung
US8133670B2 (en) 2003-06-13 2012-03-13 Cold Spring Harbor Laboratory Method for making populations of defined nucleic acid molecules
WO2005003301A2 (en) * 2003-06-17 2005-01-13 Signal Pharmaceuticals, Inc. Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms
US20040259100A1 (en) 2003-06-20 2004-12-23 Illumina, Inc. Methods and compositions for whole genome amplification and genotyping
JP4367901B2 (en) * 2003-06-20 2009-11-18 キヤノン株式会社 Spotter with spot pattern encryption function and detection device that supports spot pattern encryption
ES2330441T3 (en) * 2003-06-24 2009-12-10 Ventana Medical Systems, Inc. METAL DEPOSIT CATALYZED BY AN ENZYME FOR IMPROVED IN SITU DETECTION OF IMMUNOHISTOCHEMICAL EPITHOPES AND NUCLEIC ACID SEQUENCES.
US7642064B2 (en) * 2003-06-24 2010-01-05 Ventana Medical Systems, Inc. Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest
WO2005001429A2 (en) * 2003-06-27 2005-01-06 Nagaoka & Co., Ltd. Fluidic circuits, methods and apparatus for use of whole blood samples in colorimetric assays
US7534563B2 (en) * 2003-06-30 2009-05-19 Agilent Technologies, Inc. Methods for producing ligand arrays
WO2005004702A2 (en) * 2003-06-30 2005-01-20 Massachusetts Institute Of Technology Egr genes as targets for the diagnosis and treatment of schizophrenia
CN100494399C (en) * 2003-06-30 2009-06-03 清华大学 Genotype typing method based on DNA chip and use thereof
CN108486086A (en) 2003-07-02 2018-09-04 维莱尼姆公司 Dextranase, encode they nucleic acid and preparation and use their method
US20050079548A1 (en) * 2003-07-07 2005-04-14 Plexxikon, Inc. Ligand development using PDE4B crystal structures
FR2857375B1 (en) * 2003-07-10 2007-11-09 Biomerieux Sa PROCESS FOR THE DETECTION AND / OR IDENTIFICATION OF STAPHYLOCOCCUS GENE BACTERIA
US7341841B2 (en) * 2003-07-12 2008-03-11 Accelr8 Technology Corporation Rapid microbial detection and antimicrobial susceptibility testing
AU2004273783A1 (en) 2003-07-12 2005-03-31 Accelr8 Technology Corporation Sensitive and rapid biodetection
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
US20050153306A1 (en) * 2003-07-14 2005-07-14 Irm Llc Fluorogenic enzyme substrates and uses thereof
US20050113584A1 (en) * 2003-07-14 2005-05-26 Irm Llc Methods for the preparation of rhodamine
US20050019944A1 (en) * 2003-07-23 2005-01-27 Eastman Kodak Company Colorable microspheres for DNA and protein microarray
US7545494B2 (en) * 2003-07-23 2009-06-09 Bayer Technology Services Gmbh Analytical system and method for analyzing nonlinear optical signals
US20050059024A1 (en) 2003-07-25 2005-03-17 Ambion, Inc. Methods and compositions for isolating small RNA molecules
CN1882688B (en) 2003-07-25 2014-07-16 安比恩股份有限公司 Methods and compositions for isolating small RNA molecules
US8114978B2 (en) * 2003-08-05 2012-02-14 Affymetrix, Inc. Methods for genotyping selected polymorphism
US20070038386A1 (en) * 2003-08-05 2007-02-15 Schadt Eric E Computer systems and methods for inferring casuality from cellular constituent abundance data
US20050100911A1 (en) * 2003-08-06 2005-05-12 Perlegen Sciences, Inc. Methods for enriching populations of nucleic acid samples
US7317415B2 (en) 2003-08-08 2008-01-08 Affymetrix, Inc. System, method, and product for scanning of biological materials employing dual analog integrators
EP1668113B1 (en) 2003-08-11 2013-06-19 Verenium Corporation Laccases, nucleic acids encoding them and methods for making and using them
CN1580283A (en) * 2003-08-13 2005-02-16 清华大学 Method for detecting nucleic acid molecule
US20070026406A1 (en) * 2003-08-13 2007-02-01 Iconix Pharmaceuticals, Inc. Apparatus and method for classifying multi-dimensional biological data
KR100561842B1 (en) * 2003-08-25 2006-03-16 삼성전자주식회사 A composition containing a photoacid generator monomer, a substrate coated with the composition, method for synthesizing a compound on a substrate using the composition and a microarray produced by the method
HUE032370T2 (en) * 2003-08-28 2017-09-28 Janssen Pharmaceuticals Inc Peptides and compounds that bind to thrombopoietin receptors
US7723295B2 (en) * 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor
US7217582B2 (en) 2003-08-29 2007-05-15 Rochester Institute Of Technology Method for non-damaging charge injection and a system thereof
US7287328B2 (en) 2003-08-29 2007-10-30 Rochester Institute Of Technology Methods for distributed electrode injection
JP3824233B2 (en) * 2003-09-01 2006-09-20 セイコーエプソン株式会社 Biosensor and biosensor manufacturing method
EP1664762A4 (en) 2003-09-03 2008-08-13 Us Gov Health & Human Serv Methods for identifying, diagnosing, and predicting survival of lymphomas
WO2005074417A2 (en) * 2003-09-03 2005-08-18 Salk Institute For Biological Studies Multiple antigen detection assays and reagents
US8131475B2 (en) 2003-09-03 2012-03-06 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Methods for identifying, diagnosing, and predicting survival of lymphomas
US7269517B2 (en) * 2003-09-05 2007-09-11 Rosetta Inpharmatics Llc Computer systems and methods for analyzing experiment design
US20050053949A1 (en) * 2003-09-08 2005-03-10 Silin Vitalii Ivanovich Biochip for proteomics applications
EP2325339A3 (en) 2003-09-09 2011-11-02 Integrigen, Inc. Methods and compositions for generation of germline human antibody genes
WO2005026686A2 (en) * 2003-09-09 2005-03-24 Compass Genetics, Llc Multiplexed analytical platform
CA2536565A1 (en) * 2003-09-10 2005-05-12 Althea Technologies, Inc. Expression profiling using microarrays
GB0321295D0 (en) * 2003-09-11 2003-10-15 Spirogen Ltd Synthesis of protected pyrrolobenzodiazepines
US20050084914A1 (en) * 2003-09-15 2005-04-21 Foulkes J. G. Assays with primary cells
US20050164300A1 (en) * 2003-09-15 2005-07-28 Plexxikon, Inc. Molecular scaffolds for kinase ligand development
US7488451B2 (en) * 2003-09-15 2009-02-10 Millipore Corporation Systems for particle manipulation
WO2005029040A2 (en) * 2003-09-18 2005-03-31 Parallele Biosciences, Inc. System and methods for enhancing signal-to-noise ratios of microarray-based measurements
US7317521B2 (en) * 2003-09-18 2008-01-08 Micron Technology, Inc. Particle detection method
WO2005029705A2 (en) 2003-09-18 2005-03-31 Bioarray Solutions, Ltd. Number coding for identification of subtypes of coded types of solid phase carriers
EP1680518A2 (en) * 2003-09-19 2006-07-19 Decode Genetics EHF. Inversion on chromosome 8p23 is a risk factor for anxiety disorders, depression and bipolar
US20050226771A1 (en) * 2003-09-19 2005-10-13 Lehto Dennis A High speed microplate transfer
US20050233472A1 (en) * 2003-09-19 2005-10-20 Kao H P Spotting high density plate using a banded format
ES2375962T3 (en) 2003-09-22 2012-03-07 Bioarray Solutions Ltd IMMOBILIZED SURFACE POLYELECTROLYTE WITH MULTIPLE FUNCTIONAL GROUPS ABLE TO JOIN COVALENTLY TO BIOMOLECULES.
JP4111223B2 (en) * 2003-09-26 2008-07-02 株式会社ニコン Environmental maintenance device and environmental control analyzer
WO2005031335A1 (en) * 2003-09-26 2005-04-07 Mitsubishi Rayon Co., Ltd. Cataphoresis apparatus, cataphoresis method, and detection method for organism-related material using the apparatus and the method
ATE517091T1 (en) * 2003-09-26 2011-08-15 Exelixis Inc C-MET MODULATORS AND METHODS OF USE
AU2004285103A1 (en) 2003-09-29 2005-05-12 Pathwork Diagnostics, Inc. Systems and methods for detecting biological features
US20070281896A1 (en) * 2003-09-30 2007-12-06 Morris David W Novel compositions and methods in cancer
FR2860518B1 (en) * 2003-10-01 2006-02-17 Biomerieux Sa METHOD FOR THE DIAGNOSIS / PROGNOSIS OF NEUROBLASTOMA
DE10346286B3 (en) 2003-10-06 2005-04-14 J. Eberspächer GmbH & Co. KG The exhaust purification device
US9081011B2 (en) 2003-10-10 2015-07-14 Deutsches Krebsforschungszentrum Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-spondins) and/or Wnt
US20070274988A1 (en) * 2003-10-10 2007-11-29 Five Prime Therapeautics, Inc. Kiaa0779, Splice Variants Thereof, and Methods of Their Use
US20050227251A1 (en) 2003-10-23 2005-10-13 Robert Darnell Method of purifying RNA binding protein-RNA complexes
WO2005040163A1 (en) * 2003-10-28 2005-05-06 Dr. Reddy's Laboratories Ltd Heterocyclic compounds that block the effects of advanced glycation end products (age)
CA2899287A1 (en) 2003-10-28 2005-05-12 Bioarray Solutions Ltd. Optimization of gene expression analysis using immobilized capture probes
AU2004287069B2 (en) 2003-10-29 2009-07-16 Bioarray Solutions, Ltd. Multiplexed nucleic acid analysis by fragmentation of double-stranded DNA
US20070212689A1 (en) * 2003-10-30 2007-09-13 Bianchi Diana W Prenatal Diagnosis Using Cell-Free Fetal DNA in Amniotic Fluid
US20050095600A1 (en) * 2003-10-31 2005-05-05 Xiang Yu Methods of generating gene-specific probes for nucleic acid array detection
US20050095578A1 (en) * 2003-10-31 2005-05-05 Koller Manfred R. Method and apparatus for cell permeabilization
WO2005042716A2 (en) * 2003-10-31 2005-05-12 President And Fellows Of Harvard College Nucleic acid binding oligonucleotides
US20070207459A1 (en) * 2003-11-04 2007-09-06 Martin Dugas Method For Distinguishing Immunologically Defined All Subtype
EP1530046A1 (en) * 2003-11-04 2005-05-11 Ludwig-Maximilians-Universität München Method for distinguishing AML subtypes with aberrant and prognostically intermediate karyotypes
EP1682903A2 (en) * 2003-11-04 2006-07-26 Roche Diagnostics GmbH Method for distinguishing aml-specific flt3 length mutations from tkd mutations
US20070212687A1 (en) * 2003-11-04 2007-09-13 Martin Dugas Method For Distinguishing Mll-Ptd-Positive Aml From Other Aml Subtypes
US20050287668A1 (en) * 2003-11-04 2005-12-29 Cell Therapeutics, Inc. (Cti) RNA interference compositions and screening methods for the identification of novel genes and biological pathways
EP1682901A2 (en) * 2003-11-04 2006-07-26 Roche Diagnostics GmbH Method for distinguishing leukemia subtypes
EP1533618A1 (en) * 2003-11-04 2005-05-25 Ludwig-Maximilians-Universität München Method for distinguishing prognostically definable AML
WO2005043164A2 (en) * 2003-11-04 2005-05-12 Roche Diagnostics Gmbh Method for distinguishing cbf-positive aml subtypes from cbf-negative aml subtypes
WO2005045435A2 (en) * 2003-11-04 2005-05-19 Roche Diagnostics Gmbh METHOD FOR DISTINGUISHING T(11q23)/MLL-POSITIVE LEUKEMIAS FROM T(11q23)MLL NEGATIVE LEUKEMIAS
US20070128607A1 (en) * 2003-11-04 2007-06-07 Martin Dugas Method for distinguishing aml subtypes with different gene dosages
US20070105118A1 (en) * 2003-11-04 2007-05-10 Martin Dugas Method for distinguishing aml subtypes with recurring genetic aberrations
WO2005047881A2 (en) * 2003-11-05 2005-05-26 Exact Sciences Corporation Repetitive reversed-field affinity electrophoresis and uses therefor
JP2007512811A (en) * 2003-11-10 2007-05-24 インベスチゲン, インコーポレイテッド Methods for preparing nucleic acids for detection
EP1689879A4 (en) * 2003-11-12 2008-08-27 Geneohm Sciences Inc Nucleic acid hybridization methods
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
US8367324B2 (en) * 2003-11-17 2013-02-05 Canon Kabushiki Kaisha Method for judging change in probe-bearing substrate, probe-bearing substrate and detecting apparatus
KR100543705B1 (en) * 2003-11-20 2006-01-20 삼성전자주식회사 A microarray comprising a substrate formed with two dimensional grating and method for detecting a target molecule by using the same
US7713748B2 (en) 2003-11-21 2010-05-11 Kimberly-Clark Worldwide, Inc. Method of reducing the sensitivity of assay devices
US7943395B2 (en) 2003-11-21 2011-05-17 Kimberly-Clark Worldwide, Inc. Extension of the dynamic detection range of assay devices
US20050112703A1 (en) 2003-11-21 2005-05-26 Kimberly-Clark Worldwide, Inc. Membrane-based lateral flow assay devices that utilize phosphorescent detection
KR100580631B1 (en) * 2003-11-22 2006-05-16 삼성전자주식회사 A substrate having an oxide layer, method for detecting a target substance using the same and optical sensor containing the same
US7456968B2 (en) * 2003-11-24 2008-11-25 General Electric Company Sensor system and methods for improved quantitation of environmental parameters
US20050112587A1 (en) * 2003-11-25 2005-05-26 Sherrill James V. Analyzing biological probes
EP3427585A1 (en) 2003-11-26 2019-01-16 University of Massachusetts Sequence-specific inhibition of small rna function
EP1709198B1 (en) 2003-11-26 2013-08-14 AdvanDx, Inc. Peptide nucleic acid probes for analysis of certain staphylococcus species
EP1697534B1 (en) 2003-12-01 2010-06-02 Life Technologies Corporation Nucleic acid molecules containing recombination sites and methods of using the same
US7824857B2 (en) * 2003-12-02 2010-11-02 Musc Foundation For Research Development Methods and compositions for diagnosing epithelial cell cancer
KR100695123B1 (en) * 2003-12-03 2007-03-14 삼성전자주식회사 Polynucleotide microarray comprising 2 or more groups of probe polynucleotide immobilized on a substrate in accordance with Tm and method for detecting a target polynucleotide
JP2005173484A (en) * 2003-12-15 2005-06-30 Canon Inc Image forming apparatus and process cartridge
EP1694428A4 (en) * 2003-12-15 2010-10-06 Life Technologies Corp Automated oligomer synthesis
US20050136538A1 (en) * 2003-12-17 2005-06-23 Srikant Pathak Lithographic method for attaching biological cells to a solid substrate using a small molecule linker
KR100601936B1 (en) * 2003-12-17 2006-07-14 삼성전자주식회사 A patch for microarray reaction chamber having adhesive means support and two or more adhesion materials
EP1696920B8 (en) * 2003-12-19 2015-05-06 Plexxikon Inc. Compounds and methods for development of ret modulators
US7943089B2 (en) 2003-12-19 2011-05-17 Kimberly-Clark Worldwide, Inc. Laminated assay devices
US20070066641A1 (en) * 2003-12-19 2007-03-22 Prabha Ibrahim Compounds and methods for development of RET modulators
US20050164258A1 (en) * 2003-12-22 2005-07-28 Affymetrix, Inc. Process for high-yield synthesis of standard length and long-mer nucleic acid arrays
CA2550900A1 (en) 2003-12-23 2005-07-07 Mount Sinai Hospital Methods for detecting markers associated with endometrial disease or phase
EP1711591A4 (en) 2003-12-29 2010-04-28 Nugen Technologies Inc Methods for analysis of nucleic acid methylation status and methods for fragmentation, labeling and immobilization of nucleic acids
WO2005067649A2 (en) * 2004-01-08 2005-07-28 The Ohio State University Use of databases to create gene expression microarrays
KR100580642B1 (en) * 2004-01-12 2006-05-16 삼성전자주식회사 A method for immobilizing a biomolecule to a solid substrate at a high density by using a substrate having an activated carboxyl group at the surface thereof and microarray produced using the same
JP2007518422A (en) 2004-01-21 2007-07-12 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション Mutant sodium channel Naν1.7 and methods related thereto
US8017321B2 (en) * 2004-01-23 2011-09-13 The Regents Of The University Of Colorado, A Body Corporate Gefitinib sensitivity-related gene expression and products and methods related thereto
US20080113874A1 (en) * 2004-01-23 2008-05-15 The Regents Of The University Of Colorado Gefitinib sensitivity-related gene expression and products and methods related thereto
ATE368903T1 (en) * 2004-01-26 2007-08-15 Nimblegen Systems Inc COMPUTER SOFTWARE TO SUPPORT THE IDENTIFICATION OF SNPS USING MICROARRAYS
WO2005071058A2 (en) * 2004-01-27 2005-08-04 Compugen Ltd. Methods and systems for annotating biomolecular sequences
US20100216863A1 (en) * 2004-01-30 2010-08-26 Decode Genetics Ehf. Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
US8158362B2 (en) * 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
WO2005080604A2 (en) * 2004-02-12 2005-09-01 Compass Genetics, Llc Genetic analysis by sequence-specific sorting
US20050272059A1 (en) * 2004-02-12 2005-12-08 Xiaolian Gao Method for providing microarrays
JP4464158B2 (en) * 2004-02-13 2010-05-19 キヤノン株式会社 Biochemical reaction cartridge
KR100580644B1 (en) 2004-02-16 2006-05-16 삼성전자주식회사 A method for noncovalently immobilizing a biomolecule on a solid substrate and a microarray produced by the same
EP1564306B1 (en) 2004-02-17 2013-08-07 Affymetrix, Inc. Methods for fragmenting and labeling DNA
US20060228714A1 (en) * 2004-02-17 2006-10-12 Dana Farber Cancer Institute Nucleic acid representations utilizing type IIB restriction endonuclease cleavage products
WO2005080605A2 (en) 2004-02-19 2005-09-01 Helicos Biosciences Corporation Methods and kits for analyzing polynucleotide sequences
US7433123B2 (en) 2004-02-19 2008-10-07 Illumina, Inc. Optical identification element having non-waveguide photosensitive substrate with diffraction grating therein
US8581308B2 (en) 2004-02-19 2013-11-12 Rochester Institute Of Technology High temperature embedded charge devices and methods thereof
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
AU2005216949B2 (en) 2004-02-24 2011-09-22 The General Hospital Corporation Catalytic radiofluorination
US20050266432A1 (en) * 2004-02-26 2005-12-01 Illumina, Inc. Haplotype markers for diagnosing susceptibility to immunological conditions
WO2005084254A2 (en) * 2004-02-27 2005-09-15 Musc Foundation For Research Development Enhanced detection of rna using a panel of truncated gene-specific primers for reverse transcription
US20060046258A1 (en) * 2004-02-27 2006-03-02 Lapidus Stanley N Applications of single molecule sequencing
WO2005089110A2 (en) * 2004-02-27 2005-09-29 President And Fellows Of Harvard College Polynucleotide synthesis
US20100216153A1 (en) 2004-02-27 2010-08-26 Helicos Biosciences Corporation Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities
US20050209785A1 (en) * 2004-02-27 2005-09-22 Wells Martin D Systems and methods for disease diagnosis
GB0404578D0 (en) * 2004-03-01 2004-04-07 Spirogen Ltd Pyrrolobenzodiazepines
WO2005085848A1 (en) * 2004-03-04 2005-09-15 Ryoichi Imanaka Microarray and spotting apparatus
CA2559171A1 (en) 2004-03-12 2005-09-29 Biotrove, Inc. Nanoliter array loading
KR100590550B1 (en) * 2004-03-12 2006-06-19 삼성전자주식회사 A microarray having probe polynucleotide spots binding to a same target polynucleotide fragment maximally apart therebetween and a method of producing the same
US7425426B2 (en) 2004-03-15 2008-09-16 Cyntellect, Inc. Methods for purification of cells based on product secretion
CN1934447B (en) * 2004-03-17 2010-11-10 松下电器产业株式会社 Process for producing biochip
US20080254997A1 (en) * 2004-03-18 2008-10-16 Nissui Pharmaceutical Co., Ltd. Kit, Device and Method For Analyzing Biological Substance
CN1957256B (en) 2004-03-24 2013-01-02 三路影像公司 Methods and compositions for the detection of cervical disease
US20050269523A1 (en) * 2004-03-24 2005-12-08 Macaulay Calum E Light modulated microarray reader and methods relating thereto
US7265366B2 (en) * 2004-03-31 2007-09-04 Asml Netherlands B.V. Lithographic apparatus and device manufacturing method
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
WO2005100995A2 (en) * 2004-04-06 2005-10-27 Mount Sinai School Of Medicine Methods of determining allergen response using microarray imminoassay techinques
EP1737986A2 (en) * 2004-04-08 2007-01-03 Nimblegen Systems, Inc. Comparative genomic resequencing
KR100624420B1 (en) * 2004-04-10 2006-09-19 삼성전자주식회사 A microarray having microarray identification information stored in the form of a spot, method of producing the microarray and method of using the microarray
US20050226535A1 (en) * 2004-04-13 2005-10-13 Srinka Ghosh Method and system for rectilinearizing an image of a microarray having a non-rectilinear feature arrangement
CA2563168A1 (en) * 2004-04-14 2005-11-17 President And Fellows Of Harvard College Nucleic-acid programmable protein arrays
US20050239085A1 (en) * 2004-04-23 2005-10-27 Buzby Philip R Methods for nucleic acid sequence determination
WO2005113815A2 (en) * 2004-04-26 2005-12-01 Uab Research Foundation Polymorphisms in the fcgr2b promoter and uses thereof
US20070021918A1 (en) * 2004-04-26 2007-01-25 Georges Natsoulis Universal gene chip for high throughput chemogenomic analysis
US20050244984A1 (en) * 2004-04-28 2005-11-03 Parker Russell A Methods and compositions for calibrating chemical array readers
KR100580649B1 (en) 2004-04-30 2006-05-16 삼성전자주식회사 A polynucleotide probe having enhanced binding specificity a microarray having the probe immobilized thereon and a method for designing the probe
WO2005107412A2 (en) * 2004-04-30 2005-11-17 Rosetta Inpharmatics Llc Systems and methods for reconstruction gene networks in segregating populations
DE102004021904B4 (en) * 2004-05-04 2011-08-18 Carl Zeiss Microlmaging GmbH, 07745 Method and device for generating an analysis arrangement with discrete, separate measurement ranges for biological, biochemical or chemical analysis
US20050250108A1 (en) * 2004-05-04 2005-11-10 Jose Remacle Preparation method and use of micro-arrays supports for detection of multiple polynucleotide sequences with high sensitivity
JP2008503446A (en) 2004-05-06 2008-02-07 プレキシコン,インコーポレーテッド PDE4B inhibitor and use thereof
DE102004022263A1 (en) 2004-05-06 2005-12-15 Clondiag Chip Technologies Gmbh Apparatus and method for detecting molecular interactions
DE102005052713A1 (en) 2005-11-04 2007-05-16 Clondiag Chip Tech Gmbh Apparatus and method for detecting molecular interactions
US20050250147A1 (en) * 2004-05-10 2005-11-10 Macevicz Stephen C Digital profiling of polynucleotide populations
US20060003958A1 (en) * 2004-05-11 2006-01-05 Melville Mark W Novel polynucleotides related to oligonucleotide arrays to monitor gene expression
US8135595B2 (en) 2004-05-14 2012-03-13 H. Lee Moffitt Cancer Center And Research Institute, Inc. Computer systems and methods for providing health care
CA2567627C (en) * 2004-05-20 2014-09-30 Quest Diagnostics Investments Incorporated Single label comparative hybridization
EP1766412B1 (en) 2004-05-21 2009-04-01 The Institute for Systems Biology Compositions and methods for quantification of serum glycoproteins
US20050260609A1 (en) * 2004-05-24 2005-11-24 Lapidus Stanley N Methods and devices for sequencing nucleic acids
US7476734B2 (en) 2005-12-06 2009-01-13 Helicos Biosciences Corporation Nucleotide analogs
JP2008512084A (en) 2004-05-25 2008-04-24 ヘリコス バイオサイエンシーズ コーポレイション Methods and devices for nucleic acid sequencing
ES2537631T3 (en) * 2004-05-27 2015-06-10 The Regents Of The University Of Colorado Methods for predicting the clinical outcome for epidermal growth factor receptor inhibitors for cancer patients
US20090215192A1 (en) * 2004-05-27 2009-08-27 Stratos Biosystems, Llc Solid-phase affinity-based method for preparing and manipulating an analyte-containing solution
AU2005250432B2 (en) 2004-05-28 2011-09-15 Asuragen, Inc. Methods and compositions involving microRNA
US7338763B2 (en) * 2004-06-02 2008-03-04 Eppendorf Array Technologies S.A. Method and kit for the detection and/or quantification of homologous nucleotide sequences on arrays
US7302348B2 (en) 2004-06-02 2007-11-27 Agilent Technologies, Inc. Method and system for quantifying and removing spatial-intensity trends in microarray data
AU2005250056A1 (en) 2004-06-03 2005-12-15 Athlomics Pty Ltd Agents and methods for diagnosing stress
JP3952042B2 (en) * 2004-06-07 2007-08-01 ソニー株式会社 Hybridization detection unit including an electrode having a concave portion and a DNA chip including the detection unit
US8273579B2 (en) * 2004-06-08 2012-09-25 Bizpac (Australia) Pty. Ltd. Method and apparatus for inspecting biological samples
US20060035250A1 (en) * 2004-06-10 2006-02-16 Georges Natsoulis Necessary and sufficient reagent sets for chemogenomic analysis
CA2570872A1 (en) 2004-06-16 2006-01-26 Diversa Corporation Compositions and methods for enzymatic decolorization of chlorophyll
KR100634505B1 (en) * 2004-06-16 2006-10-16 삼성전자주식회사 A substrate for microarray and a microarray having a patterned thin layer and a method for producing the substrate for microarray and the microarray
WO2006009755A2 (en) * 2004-06-17 2006-01-26 Plexxikon, Inc. Azaindoles modulating c-kit activity and uses therefor
US7498342B2 (en) 2004-06-17 2009-03-03 Plexxikon, Inc. Compounds modulating c-kit activity
JP2008503222A (en) * 2004-06-18 2008-02-07 ニンブルゲン システムズ インコーポレイテッド Variable length probe selection
WO2006002191A1 (en) * 2004-06-21 2006-01-05 Nimblegen Systems, Inc. Probe optimization methods
US8034553B2 (en) 2004-06-24 2011-10-11 Kimberly-Clark Worldwide, Inc. Biomarkers for wound healing
US8536661B1 (en) 2004-06-25 2013-09-17 University Of Hawaii Biosensor chip sensor protection methods
US7521226B2 (en) 2004-06-30 2009-04-21 Kimberly-Clark Worldwide, Inc. One-step enzymatic and amine detection technique
US20060003335A1 (en) * 2004-06-30 2006-01-05 Crispino John D Methods for diagnosing acute megakaryoblastic leukemia
US20060004527A1 (en) * 2004-07-01 2006-01-05 Sampas Nicholas M Methods, systems and computer readable media for identifying dye-normalization probes
CA2571650A1 (en) 2004-07-09 2006-02-16 University Of Pittsburgh - Of The Commonwealth System Of Higher Educatio N Identification of makers in esophageal cancer, colon cancer, head and neck cancer and melanoma
US20060009038A1 (en) * 2004-07-12 2006-01-12 International Business Machines Corporation Processing for overcoming extreme topography
US20060014680A1 (en) * 2004-07-13 2006-01-19 Caiding Xu Peptides and compounds that bind to the IL-5 receptor
JP4756835B2 (en) * 2004-07-14 2011-08-24 キヤノン株式会社 Biochemical reaction cartridge
US7588892B2 (en) * 2004-07-19 2009-09-15 Entelos, Inc. Reagent sets and gene signatures for renal tubule injury
US20060024677A1 (en) 2004-07-20 2006-02-02 Morris David W Novel therapeutic targets in cancer
WO2006007664A1 (en) * 2004-07-22 2006-01-26 Genomics Research Partners Pty Ltd Agents and methods for diagnosing osteoarthritis
WO2006022628A1 (en) * 2004-07-22 2006-03-02 Sequenom, Inc. Methods for identifying risk of type ii diabetes and treatments thereof
CN101087890A (en) * 2004-07-26 2007-12-12 帕拉列勒生物科学公司 Simultaneous analysis of multiple genomes
US8563328B2 (en) * 2004-07-26 2013-10-22 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
BRPI0513826A2 (en) 2004-07-26 2010-06-22 Dow Global Technologies Inc process for improved protein expression through strain engineering
FR2873697B1 (en) * 2004-07-28 2006-10-27 Commissariat Energie Atomique PHOTOLABILE PROTECTIVE GROUPING COUPLING AGENTS AND THEIR USES, IN PARTICULAR FOR THE FUNCTIONALIZATION OF SOLID SUPPORTS
AU2005267756A1 (en) * 2004-07-30 2006-02-09 Rosetta Inpharmatics Llc Prognosis of breast cancer patients
US7848889B2 (en) 2004-08-02 2010-12-07 Bioarray Solutions, Ltd. Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
US7393903B2 (en) * 2004-08-04 2008-07-01 Guerry Grune Devices and methods for the rapid, reliable detection and determination of acrylamide concentration in food substances and prevention of acrylamide formation in the same
US20060105453A1 (en) 2004-09-09 2006-05-18 Brenan Colin J Coating process for microfluidic sample arrays
ZA200701614B (en) 2004-08-06 2008-10-29 Genentech Inc Assays and methods using biomarkers
EP1623996A1 (en) * 2004-08-06 2006-02-08 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Improved method of selecting a desired protein from a library
DK1774037T3 (en) 2004-08-06 2011-08-15 Genentech Inc Analyzes and approaches using biomarkers
US20060210542A1 (en) * 2004-08-16 2006-09-21 Yurkow Edward J Use of TPO mimetic compounds and pharmaceutical compositions in the treatment of anemia
WO2006023769A2 (en) * 2004-08-18 2006-03-02 Abbott Molecular, Inc. Determining data quality and/or segmental aneusomy using a computer system
US20090087848A1 (en) * 2004-08-18 2009-04-02 Abbott Molecular, Inc. Determining segmental aneusomy in large target arrays using a computer system
CN101043899B (en) * 2004-08-19 2011-03-30 比奥根艾迪克Ma公司 Refolding transforming growth factor beta family proteins
MX2007002029A (en) * 2004-08-19 2007-03-28 Biogen Idec Inc Neublastin variants.
US7598080B2 (en) 2004-08-20 2009-10-06 Carl Deirmengian Diagnostic assay for source of inflammation
KR100657896B1 (en) * 2004-08-20 2006-12-14 삼성전자주식회사 A method of storing substrate having immobilized reactive groups or probe molecules method of producing microarray using the UV film and a substrate having attached UV film
US20060046252A1 (en) * 2004-08-30 2006-03-02 Srinka Ghosh Method and system for developing probes for dye normalization of microarray signal-intensity data
US8484000B2 (en) * 2004-09-02 2013-07-09 Vialogy Llc Detecting events of interest using quantum resonance interferometry
US7884052B2 (en) * 2004-09-03 2011-02-08 Receptors Llc Combinatorial artificial receptors including tether building blocks on scaffolds
US7312035B2 (en) * 2004-09-03 2007-12-25 Affymetrix, Inc. Methods of genetic analysis of yeast
CA2583428A1 (en) * 2004-09-03 2006-03-09 Plexxikon, Inc. Bicyclic heteroaryl pde4b inhibitors
US7323308B2 (en) * 2004-09-03 2008-01-29 Affymetrix, Inc. Methods of genetic analysis of E. coli
US7645575B2 (en) 2004-09-08 2010-01-12 Xdx, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
EP1789792A2 (en) * 2004-09-11 2007-05-30 Receptors LLC Combinatorial artificial receptors including peptide building blocks
KR100682891B1 (en) * 2004-09-14 2007-02-15 삼성전자주식회사 Method for designing a probe set a microarray having a substrate immobilized thereon a probe designed by the method and a computer readable medium recorded thereon a program to execute the method
FI20041204A0 (en) 2004-09-16 2004-09-16 Riikka Lund Methods for the utilization of new target genes associated with immune-mediated diseases
US20060073506A1 (en) 2004-09-17 2006-04-06 Affymetrix, Inc. Methods for identifying biological samples
AU2005283422C1 (en) * 2004-09-17 2017-02-02 Eisai R & D Management Co., Ltd. Medicinal composition
US7406391B2 (en) * 2004-09-20 2008-07-29 Affymetrix, Inc. System, method, and computer product for detection instrument calibration
US7828954B2 (en) * 2004-09-21 2010-11-09 Gamida For Life B.V. Electrode based patterning of thin film self-assembled nanoparticles
US7314542B2 (en) * 2004-09-23 2008-01-01 Nanogen, Inc. Methods and materials for optimization of electronic transportation and hybridization reactions
FR2876116B1 (en) * 2004-10-01 2007-04-06 Biomerieux Sa METHOD FOR GENERATING TRANSCRIPTS
US20060073511A1 (en) 2004-10-05 2006-04-06 Affymetrix, Inc. Methods for amplifying and analyzing nucleic acids
CA2582137A1 (en) * 2004-10-05 2007-02-15 Wyeth Probe arrays for detecting multiple strains of different species
DK1809737T3 (en) 2004-10-07 2011-03-07 Argos Therapeutics Inc Compositions with mature dendrite cells and methods for growing them
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
US7571055B2 (en) * 2004-10-13 2009-08-04 Regents Of The University Of Minnesota Systemic lupus erythematosus
FR2876705B1 (en) * 2004-10-19 2008-12-12 Biomerieux Sa METHOD FOR THE DIAGNOSIS OF ASPIRIN INTOLERANCE
US7682782B2 (en) 2004-10-29 2010-03-23 Affymetrix, Inc. System, method, and product for multiple wavelength detection using single source excitation
CA2524964A1 (en) 2004-10-29 2006-04-29 Affymetrix, Inc. Automated method of manufacturing polymer arrays
US20060094024A1 (en) * 2004-11-01 2006-05-04 Pirrung Michael C Electrochemical arrays
US20090197249A1 (en) 2004-11-01 2009-08-06 George Mason University Compositions and methods for diagnosing colon disorders
JP3927978B2 (en) * 2004-11-02 2007-06-13 キヤノン株式会社 Biochemical reaction cartridge and biochemical processing system
NZ554895A (en) * 2004-11-03 2009-06-26 Almac Diagnostics Ltd Transcriptome microarray technology and methods of using the same
WO2006048262A2 (en) * 2004-11-04 2006-05-11 Roche Diagnostics Gmbh Classification of acute myeloid leukemia
DE102004056735A1 (en) 2004-11-09 2006-07-20 Clondiag Chip Technologies Gmbh Device for performing and analyzing microarray experiments
CN101142234A (en) * 2004-11-11 2008-03-12 阿费麦克斯公司 Novel peptides that bind to the erythropoietin receptor
ES2534304T3 (en) 2004-11-12 2015-04-21 Asuragen, Inc. Procedures and compositions involving miRNA and miRNA inhibitor molecules
US7785785B2 (en) 2004-11-12 2010-08-31 The Board Of Trustees Of The Leland Stanford Junior University Charge perturbation detection system for DNA and other molecules
US11105808B2 (en) 2004-11-12 2021-08-31 Health Discovery Corporation Methods for screening, predicting and monitoring prostate cancer
US20060275792A1 (en) * 2004-11-15 2006-12-07 Lee Jun E Enhancement of nucleic acid amplification using double-stranded DNA binding proteins
US20060105348A1 (en) * 2004-11-15 2006-05-18 Lee Jun E Compositions and methods for the detection and discrimination of nucleic acids
ATE459933T1 (en) 2004-11-16 2010-03-15 Illumina Inc METHOD AND APPARATUS FOR READING CODED MICROBALLS
US20060102471A1 (en) 2004-11-18 2006-05-18 Karl Maurer Electrode array device having an adsorbed porous reaction layer
ATE482288T1 (en) 2004-11-18 2010-10-15 Eppendorf Array Technologies REAL-TIME PCR OF TARGETS ON A MICROARRAY
US20060105355A1 (en) * 2004-11-18 2006-05-18 Karl Maurer Electrode array device having an adsorbed porous reaction layer having a linker moiety
EP1812714B1 (en) * 2004-11-19 2008-03-26 ebm-papst St. Georgen GmbH & Co. KG Arrangement with a ventilator and a pump
KR100695134B1 (en) * 2004-11-25 2007-03-14 삼성전자주식회사 Microarray using laminar flow and preparation method thereof
DE102004056980A1 (en) * 2004-11-25 2006-06-01 Clondiag Chip Technologies Gmbh Method for the site-specific synthesis of biopolymers on solid supports
US20060252057A1 (en) * 2004-11-30 2006-11-09 Mitch Raponi Lung cancer prognostics
US7647186B2 (en) * 2004-12-07 2010-01-12 Illumina, Inc. Oligonucleotide ordering system
JP4455306B2 (en) * 2004-12-13 2010-04-21 キヤノン株式会社 Biochemical treatment method
US20080119367A1 (en) * 2004-12-17 2008-05-22 Mayo Foundation For Medical Education And Research Prognosis of Renal Cell Carcinoma
WO2006069203A2 (en) 2004-12-22 2006-06-29 California Institute Of Technology Methods for proteomic profiling using non-natural amino acids
KR100763906B1 (en) * 2004-12-23 2007-10-05 삼성전자주식회사 9 9 A primer set capable of specifically amplifying a target sequence found in 9 bacterial species and probe oligonucleotide specifically hybridizable with each target sequence of the 9 bacterial species
US20060147943A1 (en) * 2004-12-30 2006-07-06 Lewis Mark A Substrates having pendant epoxide groups for binding biomolecules and methods of making and using thereof
CN101124339A (en) * 2004-12-30 2008-02-13 托德·M·豪泽 Compositions and methods for modulating gene expression using self-protected oligonucleotides
US7220549B2 (en) 2004-12-30 2007-05-22 Helicos Biosciences Corporation Stabilizing a nucleic acid for nucleic acid sequencing
US8338093B2 (en) * 2004-12-31 2012-12-25 Affymetrix, Inc. Primer array synthesis and validation
US7547775B2 (en) * 2004-12-31 2009-06-16 Affymetrix, Inc. Parallel preparation of high fidelity probes in an array format
EP1838752B1 (en) 2005-01-10 2017-10-04 The Regents of The University of California Cationic conjugated polymers suitable for strand-specific polynucleotide detection in homogeneous and solid state assays
US20060166224A1 (en) * 2005-01-24 2006-07-27 Norviel Vernon A Associations using genotypes and phenotypes
US20060183893A1 (en) * 2005-01-25 2006-08-17 North Don A Nucleic acids for apoptosis of cancer cells
CA2592562A1 (en) * 2005-01-25 2006-08-03 Sky Genetics, Inc. Nucleic acids for apoptosis of cancer cells
ATE491941T1 (en) * 2005-01-27 2011-01-15 Quest Diagnostics Invest Inc RAPID COMPARATIVE GENOME HYBRIDIZATION
US7482120B2 (en) 2005-01-28 2009-01-27 Helicos Biosciences Corporation Methods and compositions for improving fidelity in a nucleic acid synthesis reaction
FR2881437B1 (en) 2005-01-31 2010-11-19 Biomerieux Sa METHOD FOR THE DIAGNOSIS / PROGNOSIS OF A SEPTIC SYNDROME
US7476504B2 (en) * 2005-01-31 2009-01-13 Pacific Biosciences Of California, Inc. Use of reversible extension terminator in nucleic acid sequencing
US7663092B2 (en) * 2005-02-01 2010-02-16 Purdue Research Foundation Method and apparatus for phase contrast quadrature interferometric detection of an immunoassay
EP2239342A3 (en) 2005-02-01 2010-11-03 AB Advanced Genetic Analysis Corporation Reagents, methods and libraries for bead-based sequencing
EP2241637A1 (en) 2005-02-01 2010-10-20 AB Advanced Genetic Analysis Corporation Nucleic acid sequencing by performing successive cycles of duplex extension
US7910356B2 (en) * 2005-02-01 2011-03-22 Purdue Research Foundation Multiplexed biological analyzer planar array apparatus and methods
US20070023643A1 (en) * 2005-02-01 2007-02-01 Nolte David D Differentially encoded biological analyzer planar array apparatus and methods
US7402730B1 (en) 2005-02-03 2008-07-22 Lexicon Pharmaceuticals, Inc. Knockout animals manifesting hyperlipidemia
CA2600199A1 (en) * 2005-02-04 2006-08-10 Nimblegen Systems, Inc. Optimized probe selection method
US7393665B2 (en) 2005-02-10 2008-07-01 Population Genetics Technologies Ltd Methods and compositions for tagging and identifying polynucleotides
US7407757B2 (en) * 2005-02-10 2008-08-05 Population Genetics Technologies Genetic analysis by sequence-specific sorting
WO2006088445A2 (en) * 2005-02-11 2006-08-24 Southern Illinois University Metabolic primers for the detection of (per)chlorate-reducing bacteria and methods of use thereof
ATE526421T1 (en) 2005-02-14 2011-10-15 Univ Iowa Res Found METHODS AND REAGENTS FOR THE TREATMENT AND DIAGNOSIS OF AGE-RELATED MACULAR DEGENERATION
US20090124993A1 (en) 2005-02-17 2009-05-14 Burkly Linda C Treating neurological disorders
WO2006089045A2 (en) 2005-02-18 2006-08-24 Monogram Biosciences, Inc. Methods and compositions for determining hypersusceptibility of hiv-1 to non-nucleoside reverse transcriptase inhibitors
NZ560962A (en) * 2005-02-18 2011-12-22 Surface Logix Inc Methods of making pharmacokinetically improved compounds using sarcosine functional residues or groups and pharmaceutical compositions comprising said compounds
CA2601922C (en) * 2005-02-18 2020-11-24 Monogram Biosciences, Inc. Methods and compositions for determining anti-hiv drug susceptibility and replication capacity of hiv
MX2007010144A (en) * 2005-02-18 2008-02-15 Surface Logix Inc Pharmacokinetically improved compounds.
US8409808B2 (en) 2005-02-18 2013-04-02 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method for detecting risk of progression of low grade cervical dysplasia
US20090203547A1 (en) * 2005-02-18 2009-08-13 Albert Banes Gene and Cognate Protein Profiles and Methods to Determine Connective Tissue Markers in Normal and Pathologic Conditions
US7795503B2 (en) * 2005-02-22 2010-09-14 Ceres, Inc. Modulating plant alkaloids
JP2006242925A (en) 2005-03-07 2006-09-14 Seiko Epson Corp Electrode substrate, detector equipped with the substrate, kit including the detector, detection method using the kit
JP2006242926A (en) 2005-03-07 2006-09-14 Seiko Epson Corp Electrode substrate, detector equipped with the same, kit including detector, detection method using kit
KR101138864B1 (en) * 2005-03-08 2012-05-14 삼성전자주식회사 Method for designing primer and probe set, primer and probe set designed by the method, kit comprising the set, computer readable medium recorded thereon a program to execute the method, and method for identifying target sequence using the set
US20090038023A1 (en) 2005-03-10 2009-02-05 Verenium Corporation Lyase Enzymes, Nucleic Acids Encoding Them and Methods For Making and Using Them
AU2006223086A1 (en) * 2005-03-11 2006-09-21 The Regents Of The University Of Colorado Histone deacetylase inhibitors sensitize cancer cells to epidermal growth factor inhibitors
WO2006095259A2 (en) 2005-03-11 2006-09-14 Novartis Ag Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds
EP2604703B1 (en) 2005-03-14 2017-02-01 The Board of Trustees of the Leland Stanford Junior University Methods for evaluating graft survival in a solid organ transplant recipient
KR101393679B1 (en) 2005-03-15 2014-05-21 비피 코포레이션 노쓰 아메리카 인코포레이티드 Cellulases, nucleic acids encoding them and methods for making and using them
EP1856293A2 (en) * 2005-03-16 2007-11-21 Compass Genetics, Llc Methods and compositions for assay readouts on multiple analytical platforms
US20080241174A1 (en) * 2005-03-18 2008-10-02 The Board Of Trustees Of The Leland Stanford Junior University Production And Therapeutic Uses Of Th1-Like Regulatory T Cells
EP1863531A1 (en) 2005-03-19 2007-12-12 Medical Research Council Improvements in or relating to treatment and prevention of viral infections
US20070092886A1 (en) * 2005-03-22 2007-04-26 Raymond Tabibiazar Methods and compositions for diagnosis, monitoring and development of therapeutics for treatment of atherosclerotic disease
AU2006226861B2 (en) 2005-03-22 2012-08-16 Dana-Farber Cancer Institute, Inc. Treatment of protein degradation disorders
WO2006102547A2 (en) 2005-03-23 2006-09-28 Bio-Rad Laboratories, Inc. Method for purifying proteins
WO2006110314A2 (en) 2005-03-25 2006-10-19 Ambion, Inc. Methods and compositions for depleting abundant rna transcripts
US20070034513A1 (en) 2005-03-25 2007-02-15 Combimatrix Corporation Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array
ES2440953T3 (en) 2005-03-31 2014-01-31 The General Hospital Corporation Modulation of HGF / HGFR activity to treat lymphedema
US8309303B2 (en) 2005-04-01 2012-11-13 Qiagen Gmbh Reverse transcription and amplification of RNA with simultaneous degradation of DNA
MX2007012395A (en) * 2005-04-04 2008-04-14 Johnson & Johnson Laser microdissection and microarray analysis of breast tumors reveal estrogen receptor related genes and pathways.
US20060246576A1 (en) * 2005-04-06 2006-11-02 Affymetrix, Inc. Fluidic system and method for processing biological microarrays in personal instrumentation
US20090214536A1 (en) 2005-04-07 2009-08-27 Guoying Yu CACNA1E in Cancer Diagnosis, Detection and Treatment
EP1871911A2 (en) 2005-04-07 2008-01-02 Chiron Corporation Cancer-related genes (prlr)
US20070213293A1 (en) * 2005-04-08 2007-09-13 Nastech Pharmaceutical Company Inc. Rnai therapeutic for respiratory virus infection
AU2006235364A1 (en) 2005-04-08 2006-10-19 Marina Biotech, Inc. RNAi therapeutic for respiratory virus infection
US20100035244A1 (en) 2005-04-14 2010-02-11 The Trustees Of Boston University Diagnostic for lung disorders using class prediction
US9394167B2 (en) * 2005-04-15 2016-07-19 Customarray, Inc. Neutralization and containment of redox species produced by circumferential electrodes
US20090042736A1 (en) * 2005-04-18 2009-02-12 Johan Gerrit Bomer Biochip and process for the production of a biochip
US20060240443A1 (en) * 2005-04-20 2006-10-26 Combimatrix Corporation Microarray-based single nucleotide polymorphism, sequencing, and gene expression assay method
US7312376B2 (en) * 2005-04-20 2007-12-25 Ceres, Inc. Regulatory regions from Papaveraceae
US8351026B2 (en) 2005-04-22 2013-01-08 Affymetrix, Inc. Methods and devices for reading microarrays
WO2006114249A1 (en) * 2005-04-26 2006-11-02 Bayer Technology Services Gmbh Novel equipment and method for coating substrates for analyte detection by way of an affinity assay method
US20060286571A1 (en) 2005-04-28 2006-12-21 Prometheus Laboratories, Inc. Methods of predicting methotrexate efficacy and toxicity
US7452671B2 (en) * 2005-04-29 2008-11-18 Affymetrix, Inc. Methods for genotyping with selective adaptor ligation
US20060269948A1 (en) * 2005-05-16 2006-11-30 Halloran Philip F Tissue rejection
CA2608733A1 (en) * 2005-05-17 2007-02-01 Plexxikon, Inc. Pyrrol (2,3-b) pyridine derivatives protein kinase inhibitors
NZ563913A (en) 2005-05-18 2010-03-26 Decode Genetics Ehf Markers for prostate cancer in LD Block A on chromosome 8q24.21
PT1889065E (en) 2005-05-18 2013-09-27 Novartis Ag Methods for diagnosis and treatment of diseases having an autoimmune and/or inflammatory component
US7666596B2 (en) * 2005-05-23 2010-02-23 University Of Alberta Tissue rejection
US7968697B2 (en) * 2005-05-25 2011-06-28 Chrontech Pharma Ab Hepatitis C virus non-structural NS3/4A fusion gene
WO2006130477A2 (en) 2005-05-27 2006-12-07 Monogram Biosciences, Inc. Methods and compositions for determining resistance of hiv-1 to protease inhibitors
US8486629B2 (en) 2005-06-01 2013-07-16 Bioarray Solutions, Ltd. Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation
US7919461B2 (en) * 2005-06-03 2011-04-05 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US7550433B2 (en) 2005-06-03 2009-06-23 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US8324159B2 (en) * 2005-06-03 2012-12-04 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
WO2006133267A2 (en) 2005-06-06 2006-12-14 Monogram Biosciences, Inc. Methods and compositions for determining altered susceptibility of hiv-1 to anti-hiv drugs
US8053774B2 (en) 2005-06-06 2011-11-08 Intel Corporation Method and apparatus to fabricate polymer arrays on patterned wafers using electrochemical synthesis
US8940143B2 (en) * 2007-06-29 2015-01-27 Intel Corporation Gel-based bio chip for electrochemical synthesis and electrical detection of polymers
CN101262948B (en) * 2005-06-06 2011-07-06 决策生物标志股份有限公司 Assays based on liquid flow over arrays
US9506121B2 (en) 2005-06-06 2016-11-29 Monogram Biosciences, Inc. Methods for determining resistance or susceptibility to HIV entry inhibitors
EP1731620A1 (en) 2005-06-07 2006-12-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for the diagnosis of immune graft tolerance
WO2006133461A1 (en) * 2005-06-08 2006-12-14 Ceres Inc. Identification of terpenoid-biosynthesis related regulatory protein-regulatory region associations
JP4697944B2 (en) * 2005-06-10 2011-06-08 キヤノン株式会社 Method for producing probe-immobilized carrier that reduces non-specific adsorption
US9410889B2 (en) * 2005-06-10 2016-08-09 Applied Biosystem, Llc Method and system for multiplex genetic analysis
US7884260B2 (en) * 2005-06-14 2011-02-08 University Of Chicago Cell-based screen for agents useful for reducing neuronal demyelination or promoting neuronal remyelination
US8053627B2 (en) * 2005-06-14 2011-11-08 University Of Chicago Methods for treating demyelination disorders
US7368242B2 (en) * 2005-06-14 2008-05-06 Affymetrix, Inc. Method and kits for multiplex hybridization assays
US7423194B2 (en) * 2005-06-14 2008-09-09 University Of Chicago Animal models for demyelination disorders
US20090264299A1 (en) 2006-02-24 2009-10-22 Complete Genomics, Inc. High throughput genome sequencing on DNA arrays
CA2611671C (en) * 2005-06-15 2013-10-08 Callida Genomics, Inc. Single molecule arrays for genetic and chemical analysis
BRPI0612301A2 (en) * 2005-06-20 2009-01-27 Decode Genetics Ehf method for diagnosing a susceptibility to type ii diabetes in an individual, kit, and, method for assessing an individual for the likelihood of response to a tcf7l2 therapeutic agent
EP3088400A1 (en) * 2005-06-22 2016-11-02 Plexxikon Inc. Pyrrolo[2,3-b]pyridine derivatives as protein kinase inhibitors
US20060292559A1 (en) * 2005-06-23 2006-12-28 Beckman Coulter, Inc. Cell-based microarrays, and methods for their preparation and use
US20060292576A1 (en) * 2005-06-23 2006-12-28 Quest Diagnostics Investments Incorporated Non-in situ hybridization method for detecting chromosomal abnormalities
EP1736780A1 (en) 2005-06-24 2006-12-27 Eppendorf Array Technologies S.A. Method and means for detecting and/or quantifying hierarchical molecular change of a cell in response to an external stimulus
JP4789518B2 (en) * 2005-06-30 2011-10-12 キヤノン株式会社 Method for detecting target substance using probe-immobilized carrier with manufacturing conditions, and apparatus, kit and system therefor
US20080199872A1 (en) 2005-07-06 2008-08-21 Centre For Innovations Pty Ltd Method and Kit for Analyzing a Target Nucleic Acid Sequence
WO2007006091A1 (en) 2005-07-07 2007-01-18 Athlomics Pty Ltd Polynucleotide marker genes and their expression, for diagnosis of endotoxemia
US7722824B2 (en) 2005-08-02 2010-05-25 Wisconsin Alumni Research Foundation Synthesis of arrays of oligonucleotides and other chain molecules
CN1908189A (en) * 2005-08-02 2007-02-07 博奥生物有限公司 Method of external assistant identifying intestinal-type gastric cancer and differentiation degree thereof and special reagent case
EP1925676A4 (en) * 2005-08-02 2010-11-10 Eisai R&D Man Co Ltd Method for assay on the effect of vascularization inhibitor
US20090129980A1 (en) * 2005-08-04 2009-05-21 Helicos Biosciences Corporation Multi-Channel Flow Cells
US20080219890A1 (en) * 2005-08-04 2008-09-11 Helicos Biosciences Corporation Sample loading and recovery
US20070092890A1 (en) * 2005-08-05 2007-04-26 Genentech, Inc. Methods and compositions for detecting autoimmune disorders
US20070037169A1 (en) * 2005-08-09 2007-02-15 Combimatrix Corporation Selective Dehybridization using Electrochemically-Generated Reagent on an Electrode Microarray
WO2007021744A1 (en) * 2005-08-10 2007-02-22 Arena Pharmaceuticals, Inc. Methods for determining probability of an adverse or favorable reaction to a niacin receptor agonist
WO2007022157A2 (en) 2005-08-16 2007-02-22 Genentech, Inc. Apoptosis sensitivity to ap02l/trail by testing for 'galnac-t14 expression in cells/tissues
CN101356285A (en) * 2005-08-16 2009-01-28 梅洛根有限责任公司 Methods for identification of merle gene
US20070047388A1 (en) * 2005-08-25 2007-03-01 Rockwell Scientific Licensing, Llc Fluidic mixing structure, method for fabricating same, and mixing method
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
WO2007026864A1 (en) * 2005-09-01 2007-03-08 Eisai R & D Management Co., Ltd. Method for preparation of pharmaceutical composition having improved disintegradability
US7666584B2 (en) * 2005-09-01 2010-02-23 Philadelphia Health & Education Coporation Identification of a pin specific gene and protein (PIN-1) useful as a diagnostic treatment for prostate cancer
WO2007030759A2 (en) 2005-09-07 2007-03-15 Nugen Technologies, Inc. Improved nucleic acid amplification procedure
EP1762627A1 (en) 2005-09-09 2007-03-14 Qiagen GmbH Method for the activation of a nucleic acid for performing a polymerase reaction
JP2007078399A (en) * 2005-09-12 2007-03-29 Tokyo Institute Of Technology Solid support body, and dna chip
US7608395B2 (en) * 2005-09-15 2009-10-27 Baylor Research Institute Systemic lupus erythematosus diagnostic assay
WO2007035527A2 (en) 2005-09-15 2007-03-29 Duke University Non-fouling polymeric surface modification and signal amplification method for biomolecular detection
US7551294B2 (en) * 2005-09-16 2009-06-23 University Of Rochester System and method for brewster angle straddle interferometry
US20080050726A1 (en) 2005-09-19 2008-02-28 Yixin Wang Methods for diagnosing pancreatic cancer
US20070065877A1 (en) 2005-09-19 2007-03-22 Combimatrix Corporation Microarray having a base cleavable succinate linker
US20070231794A1 (en) 2005-09-21 2007-10-04 Combimatrix Corporation Process to detect binding events on an electrode microarray using enzymes
US8855955B2 (en) * 2005-09-29 2014-10-07 Custom Array, Inc. Process and apparatus for measuring binding events on a microarray of electrodes
US20100062137A1 (en) * 2005-09-30 2010-03-11 Steven Craig Bobzin Modulating plant tocopherol levels
US7763423B2 (en) * 2005-09-30 2010-07-27 Pacific Biosciences Of California, Inc. Substrates having low density reactive groups for monitoring enzyme activity
US7312079B1 (en) 2005-10-06 2007-12-25 Lexicon Pharmaceuticals, Inc. Variants of FAM3C
US7960104B2 (en) * 2005-10-07 2011-06-14 Callida Genomics, Inc. Self-assembled single molecule arrays and uses thereof
WO2007044245A2 (en) 2005-10-07 2007-04-19 Callida Genomics, Inc. Self-assembled single molecule arrays and uses thereof
EP1941057A4 (en) * 2005-10-07 2009-11-11 Baylor Res Inst Diagnosis of systemic onset juvenile idiopathic arthritis through blood leukocyte microarray analysis
WO2007047408A2 (en) * 2005-10-12 2007-04-26 Pathologica, Llc. Promac signature application
US20090178160A1 (en) * 2005-10-25 2009-07-09 Joon-Hyun Park Modulation of Triterpenoid Content in Plants
JP5430937B2 (en) 2005-10-27 2014-03-05 プレジデント アンド フェロウズ オブ ハーバード カレッジ Methods and compositions for labeling nucleic acids
US7842823B2 (en) * 2005-10-27 2010-11-30 The Regents Of The University Of California Fluorogenic probes for reactive oxygen species
EP2269724A1 (en) 2005-10-29 2011-01-05 Bayer Technology Services GmbH Method for determining one or more analytes in complex biological samples and use of same
US7749704B2 (en) 2005-11-01 2010-07-06 Mayo Foundation For Medical Education And Research Promoter polymorphisms of the BLyS gene and use in diagnostic methods
US20090291437A1 (en) * 2005-11-02 2009-11-26 O'brien Sean Methods for targeting quadruplex sequences
US20080311585A1 (en) * 2005-11-02 2008-12-18 Affymetrix, Inc. System and method for multiplex liquid handling
US8007267B2 (en) * 2005-11-02 2011-08-30 Affymetrix, Inc. System and method for making lab card by embossing
US20070099288A1 (en) * 2005-11-02 2007-05-03 Affymetrix, Inc. Microfluidic Methods, Devices, and Systems for Fluid Handling
US20080038714A1 (en) * 2005-11-02 2008-02-14 Affymetrix, Inc. Instrument to Pneumatically Control Lab Cards and Method Thereof
US8075852B2 (en) 2005-11-02 2011-12-13 Affymetrix, Inc. System and method for bubble removal
CA2627598C (en) 2005-11-07 2013-06-25 Eisai R & D Management Co., Ltd. Use of combination of anti-angiogenic substance and c-kit kinase inhibitor
EP1952147A2 (en) 2005-11-16 2008-08-06 Novartis AG Biomarkers for anti-nogo-a antibody treatment in spinal cord injury
US7576037B2 (en) * 2005-11-18 2009-08-18 Mei Technologies, Inc. Process and apparatus for combinatorial synthesis
US7889347B2 (en) * 2005-11-21 2011-02-15 Plexera Llc Surface plasmon resonance spectrometer with an actuator driven angle scanning mechanism
US7291471B2 (en) * 2005-11-21 2007-11-06 Agilent Technologies, Inc. Cleavable oligonucleotide arrays
US7329860B2 (en) * 2005-11-23 2008-02-12 Illumina, Inc. Confocal imaging methods and apparatus
US8076074B2 (en) 2005-11-29 2011-12-13 Quest Diagnostics Investments Incorporated Balanced translocation in comparative hybridization
US20070122842A1 (en) * 2005-11-30 2007-05-31 Rajasekaran John J Massively parallel synthesis of proteinaceous biomolecules
US7998717B2 (en) 2005-12-02 2011-08-16 Pacific Biosciences Of California, Inc. Mitigation of photodamage in analytical reactions
US7463358B2 (en) * 2005-12-06 2008-12-09 Lumera Corporation Highly stable surface plasmon resonance plates, microarrays, and methods
US7634363B2 (en) 2005-12-07 2009-12-15 Affymetrix, Inc. Methods for high throughput genotyping
KR20080080525A (en) 2005-12-08 2008-09-04 노파르티스 아게 Effects of inhibitors of fgfr3 on gene transcription
US7994098B2 (en) * 2005-12-09 2011-08-09 Wisconsin Alumni Research Foundation Light directed DNA synthesis using inverse capping for error reduction
US20090215055A1 (en) * 2005-12-13 2009-08-27 Erasmus University Medical Center Rotterdam Genetic Brain Tumor Markers
WO2007070560A2 (en) * 2005-12-13 2007-06-21 Nimblegen Systems, Inc. Method for identification and monitoring of epigenetic modifications
US8014957B2 (en) * 2005-12-15 2011-09-06 Fred Hutchinson Cancer Research Center Genes associated with progression and response in chronic myeloid leukemia and uses thereof
WO2007070642A2 (en) * 2005-12-15 2007-06-21 Helicos Biosciences Corporation Methods for increasing accuracy of nucleic acid sequencing
US20070161031A1 (en) * 2005-12-16 2007-07-12 The Board Of Trustees Of The Leland Stanford Junior University Functional arrays for high throughput characterization of gene expression regulatory elements
KR100738083B1 (en) * 2005-12-20 2007-07-12 삼성전자주식회사 A substrate used in a microarray and a method for preparing the same
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
ES2779992T3 (en) 2005-12-20 2020-08-21 Univ Duke Methods and compositions for delivering active agents with enhanced pharmacological properties
US11306351B2 (en) 2005-12-21 2022-04-19 Affymetrix, Inc. Methods for genotyping
WO2007075026A1 (en) * 2005-12-27 2007-07-05 Samsung Electronics Co., Ltd Primers, probes, microarray, and method for specific detection of nine respiratory disease-associated bacterial species
NZ569883A (en) 2005-12-28 2011-12-22 Translational Therapeutics Inc Use of triazole containing compounds for inhibiting 4E activity and proliferation of a cell
EP1979088A2 (en) * 2005-12-29 2008-10-15 Affymetrix, Inc. Use of acid scavengers for the synthesis of standard length and long-mer nucleic acid arrays
US20070154923A1 (en) * 2005-12-29 2007-07-05 Affymetrix, Inc. Method for Gridding and Quality Control of Polymer Arrays
US20070154946A1 (en) * 2005-12-29 2007-07-05 Rajasekaran John J Massively parallel synthesis of biopolymeric arrays
US20070198653A1 (en) * 2005-12-30 2007-08-23 Kurt Jarnagin Systems and methods for remote computer-based analysis of user-provided chemogenomic data
US20070255054A1 (en) * 2005-12-30 2007-11-01 Affymetrix, Inc. Oligonucleotide synthesis with intermittent and post synthetic oxidation
KR100829574B1 (en) * 2006-01-03 2008-05-14 삼성전자주식회사 Microarray substrate method of analyzing biomolecule using the microarray substrate and lab-on-a-chip including the microarray substrate
US7709227B2 (en) * 2006-01-04 2010-05-04 Phasebio Pharmaceuticals, Inc. Multimeric ELP fusion constructs
CA2636855C (en) 2006-01-11 2016-09-27 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
TWI507528B (en) * 2006-01-17 2015-11-11 Somalogic Inc Multiplexed analyses of test samples
US20070168197A1 (en) * 2006-01-18 2007-07-19 Nokia Corporation Audio coding
NZ569697A (en) 2006-01-20 2012-01-12 Women S & Children S Health Res Inst Method of treatment, prophylaxis and diagnosis of pathologies of the bone by the modulation of GPC3
US20090143238A1 (en) * 2006-01-23 2009-06-04 Junghuei Chen Oligonucleotide matrix and methods of use
US7537897B2 (en) * 2006-01-23 2009-05-26 Population Genetics Technologies, Ltd. Molecular counting
US20070172852A1 (en) * 2006-01-24 2007-07-26 Affymetrix, Inc. Non-destructive Quality Control Methods for Microarrays
US20070207487A1 (en) * 2006-01-25 2007-09-06 Emig Christopher J Photoelectrochemical synthesis of high density combinatorial polymer arrays
CA2635343C (en) 2006-01-27 2018-05-15 Athena Diagnostics, Inc. Methods of detecting mutations associated with ataxia-ocular apraxia 2 (aoa2)
US9445025B2 (en) 2006-01-27 2016-09-13 Affymetrix, Inc. System, method, and product for imaging probe arrays with small feature sizes
WO2007090076A2 (en) 2006-01-27 2007-08-09 Tripath Imaging, Inc. Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor
US8055098B2 (en) 2006-01-27 2011-11-08 Affymetrix, Inc. System, method, and product for imaging probe arrays with small feature sizes
WO2007092314A2 (en) 2006-02-02 2007-08-16 Verenium Corporation Esterases and related nucleic acids and methods
SI1986661T1 (en) 2006-02-08 2018-12-31 Genzyme Corporation Gene therapy for niemann-pick disease type a
NZ571087A (en) 2006-02-10 2012-04-27 Verenium Corp Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
ES2481413T3 (en) 2006-02-14 2014-07-30 The President And Fellows Of Harvard College Histone Deacetylase Inhibitors
EP3406621A1 (en) 2006-02-14 2018-11-28 BP Corporation North America Inc. Xylanases, nucleic acids encoding them and methods for making and using them
JP5441416B2 (en) 2006-02-14 2014-03-12 プレジデント アンド フェロウズ オブ ハーバード カレッジ Bifunctional histone deacetylase inhibitor
GB0602992D0 (en) * 2006-02-15 2006-03-29 Morvus Technology Ltd Methods, genes and proteins
JP5143026B2 (en) 2006-02-16 2013-02-13 ベンタナ・メデイカル・システムズ・インコーポレーテツド Reagents and methods for cancer prognosis and pathological staging.
US8460878B2 (en) 2006-02-21 2013-06-11 The Trustees Of Tufts College Methods and arrays for detecting cells and cellular components in small defined volumes
US11237171B2 (en) 2006-02-21 2022-02-01 Trustees Of Tufts College Methods and arrays for target analyte detection and determination of target analyte concentration in solution
US20070199090A1 (en) * 2006-02-22 2007-08-23 Nestor Apuya Modulating alkaloid biosynthesis
JP5180845B2 (en) 2006-02-24 2013-04-10 カリダ・ジェノミックス・インコーポレイテッド High-throughput genomic sequencing on DNA arrays
TWI501774B (en) * 2006-02-27 2015-10-01 Biogen Idec Inc Treatments for neurological disorders
US7815868B1 (en) 2006-02-28 2010-10-19 Fluidigm Corporation Microfluidic reaction apparatus for high throughput screening
WO2007100762A2 (en) 2006-02-28 2007-09-07 Montana State University Use of phenanthridium derivatives for distinguishing between intact and membrane-compromised cells using molecular nucleic acid-based techniques
ES2450065T3 (en) * 2006-03-01 2014-03-21 Biogen Idec Ma Inc. Compositions and methods for the administration of GDNF ligand family proteins
EP2322643B1 (en) 2006-03-07 2014-07-09 Cargill, Incorporated Aldolases, nucleic acids encoding them and methods for making and using them
ATE548450T1 (en) 2006-03-07 2012-03-15 Verenium Corp ALDOLASES, NUCLEIC ACIDS FOR ENCODING THEM AND METHODS FOR THEIR PRODUCTION AND USE
US7397546B2 (en) 2006-03-08 2008-07-08 Helicos Biosciences Corporation Systems and methods for reducing detected intensity non-uniformity in a laser beam
US20080309926A1 (en) * 2006-03-08 2008-12-18 Aaron Weber Systems and methods for reducing detected intensity non uniformity in a laser beam
US20090061454A1 (en) 2006-03-09 2009-03-05 Brody Jerome S Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
JP2009529878A (en) * 2006-03-13 2009-08-27 ベリデックス・エルエルシー Primary cell proliferation
US20100233350A1 (en) * 2006-03-15 2010-09-16 Boston Scientific Scimed, Inc. Drug delivery composition and methods of making same using nanofabrication
US7812206B2 (en) 2006-03-21 2010-10-12 Bp Corporation North America Inc. Apparatus and process for the separation of solids and liquids
US20080009552A1 (en) * 2006-03-23 2008-01-10 Craig Pennell Markers of pre-term labor
WO2007111937A1 (en) * 2006-03-23 2007-10-04 Applera Corporation Directed enrichment of genomic dna for high-throughput sequencing
EP2004221A2 (en) 2006-03-23 2008-12-24 Novartis Pharma AG Anti-tumor cell antigen antibody therapeutics
US20070224616A1 (en) * 2006-03-24 2007-09-27 Erdogan Gulari Method for forming molecular sequences on surfaces
US20080045471A1 (en) * 2006-03-27 2008-02-21 North Don A Nucleic Acids For Apoptosis Of Cancer Cells
US8975216B2 (en) * 2006-03-30 2015-03-10 Pacific Biosciences Of California Articles having localized molecules disposed thereon and methods of producing same
US20080050747A1 (en) * 2006-03-30 2008-02-28 Pacific Biosciences Of California, Inc. Articles having localized molecules disposed thereon and methods of producing and using same
US20070231805A1 (en) * 2006-03-31 2007-10-04 Baynes Brian M Nucleic acid assembly optimization using clamped mismatch binding proteins
US7914988B1 (en) 2006-03-31 2011-03-29 Illumina, Inc. Gene expression profiles to predict relapse of prostate cancer
US20080026386A1 (en) * 2006-03-31 2008-01-31 Behrens Timothy W Irf-5 haplotypes in systemic lupus erythematosus
US20070232556A1 (en) * 2006-03-31 2007-10-04 Montine Thomas J Methods and compositions for the treatment of neurological diseases and disorders
US7285388B1 (en) * 2006-04-07 2007-10-23 Merlogen, Llc Methods for identification of alport syndrome
WO2007117693A2 (en) * 2006-04-07 2007-10-18 Ceres, Inc. Regulatory protein-regulatory region associations related to alkaloid biosynthesis
US7830575B2 (en) 2006-04-10 2010-11-09 Illumina, Inc. Optical scanner with improved scan time
AU2007237909A1 (en) * 2006-04-19 2007-10-25 Applied Biosystems, Llc. Reagents, methods, and libraries for gel-free bead-based sequencing
TW200811111A (en) * 2006-04-20 2008-03-01 Glaxo Group Ltd Novel compounds
CA2650520A1 (en) * 2006-04-24 2008-01-31 Gloucester Pharmaceuticals Treatment of ras-expressing tumors
US20080057503A1 (en) 2006-04-24 2008-03-06 Genentech, Inc. Methods and compositions for detecting autoimmune disorders
CA2650730A1 (en) 2006-04-27 2007-11-08 Pikamab, Inc. Methods and compositions for antibody therapy
WO2007130434A2 (en) * 2006-05-02 2007-11-15 Applera Corporation Variable volume dispenser and method
US10522240B2 (en) 2006-05-03 2019-12-31 Population Bio, Inc. Evaluating genetic disorders
US7702468B2 (en) 2006-05-03 2010-04-20 Population Diagnostics, Inc. Evaluating genetic disorders
WO2007131103A2 (en) * 2006-05-03 2007-11-15 Quadraspec, Inc. Direct printing of patterned hydrophobic wells
EP2019674B1 (en) * 2006-05-03 2016-11-23 The President and Fellows of Harvard College Histone deacetylase and tubulin deacetylase inhibitors
EP2047910B1 (en) 2006-05-11 2012-01-11 Raindance Technologies, Inc. Microfluidic device and method
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
WO2007133740A1 (en) * 2006-05-15 2007-11-22 Generation Biotech, Llc Method for identification of novel physical linkage of genomic sequences
JP2007304043A (en) * 2006-05-15 2007-11-22 Canon Inc Method for manufacturing probe-fixing carrier
US20100216657A1 (en) * 2006-05-16 2010-08-26 Arcxis Biotechnologies, Inc. Pcr-free sample preparation and detection systems for high speed biologic analysis and identification
CN101443009A (en) * 2006-05-18 2009-05-27 卫材R&D管理有限公司 Antitumor agent for thyroid cancer
EP2024509A4 (en) 2006-05-22 2010-08-04 Clinical Genomics Pty Ltd Detection method
EP1862538A1 (en) * 2006-05-29 2007-12-05 IMBA-Institut für Molekulare Biotechnologie GmbH siRNA kinase and methods of use
AU2007268369A1 (en) * 2006-05-30 2007-12-06 Synergenz Bioscience Limited Methods and compositions for assessment of pulmonary function and disorders
EP3260556B1 (en) 2006-05-31 2019-07-31 Sequenom, Inc. Methods for the extraction of nucleic acid from a sample
EP2035541A4 (en) * 2006-05-31 2010-11-24 Univ Johns Hopkins Ablation based laser machining of biomolecule patterns on substrates
EP2035439A4 (en) 2006-06-05 2010-01-13 Cancer Care Ontario Assessment of risk for colorectal cancer
US11001881B2 (en) 2006-08-24 2021-05-11 California Institute Of Technology Methods for detecting analytes
JP2009540299A (en) * 2006-06-05 2009-11-19 カリフォルニア インスティテュート オブ テクノロジー Real-time microarray
US8957027B2 (en) * 2006-06-08 2015-02-17 Celgene Corporation Deacetylase inhibitor therapy
AU2007261114B2 (en) * 2006-06-12 2012-07-12 Pacific Biosciences Of California, Inc. Substrates for performing analytical reactions
WO2007147076A2 (en) 2006-06-14 2007-12-21 Living Microsystems, Inc. Methods for the diagnosis of fetal abnormalities
EP4108780A1 (en) 2006-06-14 2022-12-28 Verinata Health, Inc. Rare cell analysis using sample splitting and dna tags
KR100954322B1 (en) 2006-06-14 2010-04-21 주식회사 엘지생명과학 Gene familyLBFL313 associated with pancreatic cancer
EP2589668A1 (en) 2006-06-14 2013-05-08 Verinata Health, Inc Rare cell analysis using sample splitting and DNA tags
EP2029780A4 (en) * 2006-06-16 2010-03-31 Pacific Biosciences California Controlled initiation of primer extension
EP2057435A4 (en) * 2006-06-23 2011-04-20 Life Technologies Corp Systems and methods for cooling in biological analysis instruments
US8009889B2 (en) 2006-06-27 2011-08-30 Affymetrix, Inc. Feature intensity reconstruction of biological probe array
US8178316B2 (en) * 2006-06-29 2012-05-15 President And Fellows Of Harvard College Evaluating proteins
US20080004410A1 (en) * 2006-06-30 2008-01-03 Yu-Chin Lai Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same
EP2038429B1 (en) * 2006-06-30 2013-08-21 Nugen Technologies, Inc. Methods for fragmentation and labeling of nucleic acids
WO2008007468A1 (en) 2006-07-10 2008-01-17 Toto Ltd. Electrolyte-containing sheet for use in specific detection of analyte using photocurrent, and, employing the sheet, method of detection, sensor unit and measuring apparatus
NZ574046A (en) 2006-07-13 2012-09-28 Univ Iowa Res Found Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration
CA2657576C (en) 2006-07-14 2023-10-31 The Regents Of The University Of California Cancer biomarkers and methods of use thereof
EP2044420A2 (en) * 2006-07-17 2009-04-08 Max Wiki Analytical system comprising an arrangement for temporally variable spatial light modulation and detection method implemented thereby
US20080241951A1 (en) * 2006-07-20 2008-10-02 Visigen Biotechnologies, Inc. Method and apparatus for moving stage detection of single molecular events
WO2008009132A1 (en) * 2006-07-21 2008-01-24 The Governors Of The University Of Alberta Tissue rejection
KR100813262B1 (en) * 2006-07-25 2008-03-13 삼성전자주식회사 Method for producing a patterned spot microarray using photocatalyst and a microarray produced by the method
US20080026373A1 (en) * 2006-07-26 2008-01-31 Rodionova Natalia A Assays Based On Light Emission From Analyte Complexes Within A Cassette
WO2008013918A2 (en) * 2006-07-26 2008-01-31 Myelin Repair Foundation, Inc. Cell cycle regulation and differentiation
US7700756B2 (en) * 2006-07-27 2010-04-20 Southern Illinois University Metabolic primers for the detection of perchlorate-reducing bacteria and methods of use thereof
WO2008014485A2 (en) 2006-07-28 2008-01-31 California Institute Of Technology Multiplex q-pcr arrays
US11525156B2 (en) 2006-07-28 2022-12-13 California Institute Of Technology Multiplex Q-PCR arrays
EP2054711B1 (en) 2006-08-03 2020-11-25 National University of Singapore Process for producing microarrays
CA2669453C (en) 2006-08-04 2018-11-13 Verenium Corporation Glucanases, nucleic acids encoding them and methods for making and using them
EP2077912B1 (en) 2006-08-07 2019-03-27 The President and Fellows of Harvard College Fluorocarbon emulsion stabilizing surfactants
CA2660143A1 (en) 2006-08-07 2008-02-14 Nsure Holding B.V. Genomics-based quality diagnostics for fresh agricultural products
TWI316873B (en) * 2006-08-08 2009-11-11 Ind Tech Res Inst Apparatus of manufacturing biochip and manufacture method of biochip tip array
CA2660286A1 (en) 2006-08-09 2008-02-21 Homestead Clinical Corporation Organ-specific proteins and methods of their use
US7626185B2 (en) * 2006-08-11 2009-12-01 Battelle Memorial Institute Patterning compositions, masks, and methods
US7993832B2 (en) 2006-08-14 2011-08-09 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
EP2061322B1 (en) 2006-08-24 2015-07-01 Surface Logix, Inc. Pharmacokinetically improved compounds
US11560588B2 (en) 2006-08-24 2023-01-24 California Institute Of Technology Multiplex Q-PCR arrays
KR100755672B1 (en) * 2006-08-24 2007-09-05 삼성전자주식회사 Oligomer probe array having probe cell active formed in substrate and fabrication method thereof
EP2065372B1 (en) * 2006-08-28 2012-11-28 Eisai R&D Management Co., Ltd. Antitumor agent for undifferentiated gastric cancer
US20080131893A1 (en) * 2006-08-31 2008-06-05 Mayo Foundation For Medical Education And Research Predicting Parkinson's Disease
US8053191B2 (en) 2006-08-31 2011-11-08 Westend Asset Clearinghouse Company, Llc Iterative nucleic acid assembly using activation of vector-encoded traits
US7687103B2 (en) * 2006-08-31 2010-03-30 Gamida For Life B.V. Compositions and methods for preserving permeation layers for use on active electronic matrix devices
WO2008028160A2 (en) 2006-09-01 2008-03-06 Pacific Biosciences Of California, Inc. Substrates, systems and methods for analyzing materials
US7985542B2 (en) * 2006-09-07 2011-07-26 Institut Pasteur Genomic morse code
EP1900824A1 (en) * 2006-09-14 2008-03-19 Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts Gene expression signature for the prognosis, diagnosis and therapy of prostate cancer and uses thereof
US20100021885A1 (en) * 2006-09-18 2010-01-28 Mark Fielden Reagent sets and gene signatures for non-genotoxic hepatocarcinogenicity
WO2008036776A2 (en) 2006-09-19 2008-03-27 Asuragen, Inc. Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
JP5520605B2 (en) 2006-09-19 2014-06-11 アシュラジェン インコーポレイテッド MicroRNA differentially expressed in pancreatic diseases and uses thereof
GB0618514D0 (en) * 2006-09-20 2006-11-01 Univ Nottingham Trent Method of detecting interactions on a microarray using nuclear magnetic resonance
WO2008036863A2 (en) 2006-09-21 2008-03-27 Verenium Corporation Phospholipases, nucleic acids encoding them and methods for making and using them
EP2617728B1 (en) 2006-09-21 2016-03-09 BASF Enzymes LLC Phytases, nucleic acids encoding them and methods for making and using them
US8273539B2 (en) 2006-09-25 2012-09-25 Mayo Foundation For Medical Education And Research Extracellular and membrane-associated prostate cancer markers
KR100818275B1 (en) * 2006-09-26 2008-03-31 삼성전자주식회사 Primer set for amplifying target sequences of Norovirus probe set specifically hybridizable with the target sequences of Norovirus microarray having the immobilized probe set and method for detecting the presence of Norovirus using the probe set
WO2008060362A2 (en) 2006-09-27 2008-05-22 The Regents Of The University Of California Methods and compositions for the treatment of skin diseases and disorders
FR2906537A1 (en) 2006-09-28 2008-04-04 Biomerieux Sa METHOD FOR IN VITRO DIAGNOSIS OF BRONCHO-PULMONARY CANCER BY DETECTION OF ALTERNATIVE MAJORITY TRANSCRIPTS OF KLK8 GENE ENCODING KALLICREIN 8 AND USE THEREOF FOR THE PROGNOSIS OF SURVIVAL
KR100868760B1 (en) * 2006-09-28 2008-11-17 삼성전자주식회사 Primer set, probe set, method and kit for discriminating gram negative and positive bacteria
KR100868765B1 (en) * 2006-09-29 2008-11-17 삼성전자주식회사 A primer set for amplifying target sequences of bacterial species resistant to antibiotics, probe set specifically hybridizable with the target sequences of the bacterial species, a microarray having immobilized the probe set and a method for detecting the presence of one or more of the bacterial species
EP2067034B1 (en) 2006-09-29 2018-08-08 Translational Therapeutics, Inc. Eif4e regulon-based diagnostics
US20100240544A1 (en) * 2006-09-29 2010-09-23 Liu David J Aptamer biochip for multiplexed detection of biomolecules
US9096953B2 (en) * 2006-09-29 2015-08-04 Intel Corporation Method for high throughput, high volume manufacturing of biomolecule micro arrays
US20080079663A1 (en) * 2006-10-03 2008-04-03 Sharp Laboratories Of America, Inc. Micro-pixelated fluid-assay precursor structure
US8236571B2 (en) * 2006-10-06 2012-08-07 Sharp Laboratories Of America, Inc. Method of making micro-pixelated fluid-assay precursor structure
WO2008100344A2 (en) 2006-10-06 2008-08-21 Sirigen Inc. Fluorescent methods and materials for directed biomarker signal amplification
US8236245B2 (en) 2006-10-06 2012-08-07 Sharp Laboratories Of America, Inc. Micro-pixelated fluid-assay precursor structure
US8231831B2 (en) * 2006-10-06 2012-07-31 Sharp Laboratories Of America, Inc. Micro-pixelated fluid-assay structure
US8232108B2 (en) * 2006-10-06 2012-07-31 Sharp Laboratories Of America, Inc. Method of making micro-pixelated fluid-assay structure
US8236244B2 (en) * 2006-10-06 2012-08-07 Sharp Laboratories Of America, Inc. Micro-pixelated fluid-assay structure with on-board addressable, pixel-specific functionalization
US8232109B2 (en) * 2006-10-06 2012-07-31 Sharp Laboratories Of America, Inc. Micro-pixelated active-matrix fluid-assay performance
EP2084519B1 (en) 2006-10-10 2012-08-01 Los Alamos National Security, LLC X-ray fluorescence analysis method
US20080167532A1 (en) * 2006-10-13 2008-07-10 Mayo Foundation For Medical Education And Research Assessing cancer treatment responsiveness
US20080090236A1 (en) * 2006-10-13 2008-04-17 Yakhini Zohar H Methods and systems for identifying tumor progression in comparative genomic hybridization data
WO2008048120A2 (en) * 2006-10-17 2008-04-24 Synergenz Bioscience Limited Methods and compositions for assessment of pulmonary function and disorders
US9845494B2 (en) 2006-10-18 2017-12-19 Affymetrix, Inc. Enzymatic methods for genotyping on arrays
US20080108149A1 (en) * 2006-10-23 2008-05-08 Narayan Sundararajan Solid-phase mediated synthesis of molecular microarrays
US7910302B2 (en) 2006-10-27 2011-03-22 Complete Genomics, Inc. Efficient arrays of amplified polynucleotides
US8618248B2 (en) 2006-10-31 2013-12-31 President And Fellows Of Harvard College Phosphopeptide compositions and anti-phosphopeptide antibody compositions and methods of detecting phosphorylated peptides
EP2442107B1 (en) 2006-11-01 2014-03-12 Ventana Medical Systems, Inc. Haptens, hapten conjugates, compositions thereof and method for their preparation and use
JP2010508815A (en) 2006-11-02 2010-03-25 イエール・ユニバーシテイ Evaluation of oocyte receptivity
DE102006035392A1 (en) 2006-11-02 2008-10-16 Signature Diagnostics Ag Prognostic markers for the prediction of five-year progression-free survival of patients with colon carcinoma based on expression profiles of biological samples
DE102006035393A1 (en) 2006-11-02 2008-05-15 Signature Diagnostics Ag Prognostic markers for the classification of the three-year progression-free survival of patients with colon carcinoma based on expression profiles of biological samples
US8338109B2 (en) 2006-11-02 2012-12-25 Mayo Foundation For Medical Education And Research Predicting cancer outcome
DE102006035388A1 (en) * 2006-11-02 2008-05-15 Signature Diagnostics Ag Prognostic markers for the classification of colon carcinomas based on expression profiles of biological samples
NZ588574A (en) 2006-11-03 2012-07-27 Baylor Res Inst Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis
NZ551157A (en) * 2006-11-08 2008-06-30 Rebecca Lee Roberts Method of identifying individuals at risk of thiopurine drug resistance and intolerance - GMPS
WO2008140484A2 (en) 2006-11-09 2008-11-20 Xdx, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
US20080113915A1 (en) * 2006-11-09 2008-05-15 Duke University SAPAP3 knockout mouse and clinical modeling associated with the SAPAP3 gene
US20090105961A1 (en) * 2006-11-09 2009-04-23 Complete Genomics, Inc. Methods of nucleic acid identification in large-scale sequencing
US20090075343A1 (en) 2006-11-09 2009-03-19 Complete Genomics, Inc. Selection of dna adaptor orientation by nicking
US20110294782A1 (en) 2006-11-10 2011-12-01 Massachusetts Institute Of Technology Small molecule pak inhibitors
US8293481B2 (en) * 2006-11-10 2012-10-23 Mayo Foundation For Medical Education And Research Biomarkers for chronic vascular dysfunction
WO2008058394A1 (en) 2006-11-15 2008-05-22 The University Of British Columbia Polymorphisms predictive of anthracycline-induced cardiotoxicity
CA2669135A1 (en) * 2006-11-15 2008-05-22 The University Of British Columbia Polymorphisms predictive of platinum-coordinating complex-induced ototoxicity
US20080242560A1 (en) * 2006-11-21 2008-10-02 Gunderson Kevin L Methods for generating amplified nucleic acid arrays
US7813013B2 (en) * 2006-11-21 2010-10-12 Illumina, Inc. Hexagonal site line scanning method and system
US7791013B2 (en) * 2006-11-21 2010-09-07 Illumina, Inc. Biological microarray line scanning method and system
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
US8293684B2 (en) * 2006-11-29 2012-10-23 Exiqon Locked nucleic acid reagents for labelling nucleic acids
US9114398B2 (en) 2006-11-29 2015-08-25 Canon U.S. Life Sciences, Inc. Device and method for digital multiplex PCR assays
KR20090087486A (en) * 2006-11-30 2009-08-17 디코드 제네틱스 이에이치에프 Genetic susceptibility variants of type 2 diabetes mellitus
US7522282B2 (en) * 2006-11-30 2009-04-21 Purdue Research Foundation Molecular interferometric imaging process and apparatus
US20100291569A1 (en) * 2006-11-30 2010-11-18 Abbott Laboratories Assay for prediction of response to met antagonists
EP2099935B1 (en) * 2006-11-30 2014-02-26 The Regents Of The University Of California Array for detecting microbes
US7807359B2 (en) * 2006-12-01 2010-10-05 Quest Diagnostics Investments Incorporated Methods of detecting TPMT mutations
US7902345B2 (en) 2006-12-05 2011-03-08 Sequenom, Inc. Detection and quantification of biomolecules using mass spectrometry
US7989396B2 (en) * 2006-12-05 2011-08-02 The Board Of Trustees Of The Leland Stanford Junior University Biomolecule immobilization on biosensors
WO2008068780A2 (en) * 2006-12-05 2008-06-12 Decode Genetics Ehf. Genetic markers for risk management of cardiac arrhythmia
KR101532797B1 (en) 2006-12-06 2015-07-01 메디뮨 엘엘씨 Interferon alpha-induced pharmacodynamic markers
DK2104737T3 (en) 2006-12-08 2013-05-27 Asuragen Inc Functions and Purposes of Easy-7 Micro-RNAs
US8349167B2 (en) 2006-12-14 2013-01-08 Life Technologies Corporation Methods and apparatus for detecting molecular interactions using FET arrays
US8262900B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
EP2677309B9 (en) 2006-12-14 2014-11-19 Life Technologies Corporation Methods for sequencing a nucleic acid using large scale FET arrays, configured to measure a limited pH range
US11339430B2 (en) 2007-07-10 2022-05-24 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
CA2673092A1 (en) * 2006-12-19 2008-06-26 Synergenz Bioscience Limited Methods and compositions for the assessment of cardiovascular function and disorders
US20080182328A1 (en) * 2006-12-19 2008-07-31 The Burnham Institute Mammalian extraembryonic endoderm cells and methods of isolation
US7622295B2 (en) * 2006-12-19 2009-11-24 Edelmira Cabezas Molecular microarrays and helical peptides
CA2672951A1 (en) 2006-12-20 2008-07-03 Bayer Healthcare Llc Hydroxy methyl phenyl pyrazolyl urea compound useful in the treatment of cancer
US20080153135A1 (en) * 2006-12-20 2008-06-26 Liu Timothy Z Methods and apparatus for conducting amplification reactions on high density hydrophilic patterned microplates
US7932034B2 (en) * 2006-12-20 2011-04-26 The Board Of Trustees Of The Leland Stanford Junior University Heat and pH measurement for sequencing of DNA
KR100834745B1 (en) * 2006-12-20 2008-06-09 삼성전자주식회사 Oligomer probe array chip based on analysis-friendly layout, mask being used in fabrication thereof, and hybridization analysis method thereof
MX2009006688A (en) 2006-12-21 2009-06-30 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor.
PE20121126A1 (en) * 2006-12-21 2012-08-24 Plexxikon Inc PIRROLO [2,3-B] PYRIDINES COMPOUNDS AS KINASE MODULATORS
ES2620288T3 (en) 2006-12-21 2017-06-28 Basf Enzymes Llc Amylases and glucoamylases, nucleic acids that encode them and methods to form and use them
WO2008079909A1 (en) * 2006-12-21 2008-07-03 Plexxikon, Inc. Pyrrolo [2,3-b] pyridines as kinase modulators
US20080153134A1 (en) * 2006-12-22 2008-06-26 Willy Wiyatno Methods and apparatus for generating hydrophilic patterning of high density microplates using an amphiphilic polymer
US7923237B2 (en) 2006-12-28 2011-04-12 Intel Corporation Method and apparatus for combined electrochemical synthesis and detection of analytes
US8614086B2 (en) * 2006-12-28 2013-12-24 Intel Corporation Quality control methods for the manufacture of polymer arrays
US20100248975A1 (en) * 2006-12-29 2010-09-30 Gunjan Tiwari Fluorogenic peptide substrate arrays for highly multiplexed, real-time monitoring of kinase activities
US20080161202A1 (en) * 2006-12-29 2008-07-03 Edelmira Cabezas Novel strategy for selective regulation of background surface property in microarray fabrication and method to eliminated self quenching in micro arrays
US8930178B2 (en) 2007-01-04 2015-01-06 Children's Hospital Medical Center Processing text with domain-specific spreading activation methods
EP2118651A4 (en) * 2007-01-05 2012-11-14 Integrated Dna Tech Inc Method for estimating melting temperature of a nucleic acid in buffers containing divalent ions
KR101443214B1 (en) * 2007-01-09 2014-09-24 삼성전자주식회사 A composition, kit and microarray for diagnosing the risk of lung cancer recurrence in a patient after lung cancer treatment or a lung cancer patient
DK2121977T3 (en) * 2007-01-11 2017-09-18 Erasmus Univ Medical Center Capture (4C) OF CHROMOSOMES WITH CIRCULAR CONFORMATION
US7855054B2 (en) * 2007-01-16 2010-12-21 Somalogic, Inc. Multiplexed analyses of test samples
US20110136099A1 (en) * 2007-01-16 2011-06-09 Somalogic, Inc. Multiplexed Analyses of Test Samples
US7659968B2 (en) * 2007-01-19 2010-02-09 Purdue Research Foundation System with extended range of molecular sensing through integrated multi-modal data acquisition
US20080175757A1 (en) * 2007-01-19 2008-07-24 Andrew Powell Microarray device with elastomeric well structure
WO2008092041A2 (en) 2007-01-24 2008-07-31 Carnegie Mellon University Optical biosensors
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
US9164037B2 (en) * 2007-01-26 2015-10-20 Palo Alto Research Center Incorporated Method and system for evaluation of signals received from spatially modulated excitation and emission to accurately determine particle positions and distances
US8821799B2 (en) 2007-01-26 2014-09-02 Palo Alto Research Center Incorporated Method and system implementing spatially modulated excitation or emission for particle characterization with enhanced sensitivity
WO2008093855A1 (en) * 2007-01-29 2008-08-07 Eisai R & D Management Co., Ltd. Composition for treatment of undifferentiated-type of gastric cancer
BRPI0807132A2 (en) 2007-01-30 2018-12-04 Syngenta Participations Ag enzymes for the treatment of lignocellulosics, nucleic acids encoding them, and methods and use thereof
CA2677000A1 (en) 2007-01-30 2008-08-07 Pharmacyclics, Inc. Methods for determining cancer resistance to histone deacetylase inhibitors
US11035823B2 (en) 2009-03-17 2021-06-15 Qiagen Sciences, Llc Methods and devices for sequencing nucleic acids in smaller batches
US11940413B2 (en) 2007-02-05 2024-03-26 IsoPlexis Corporation Methods and devices for sequencing nucleic acids in smaller batches
US8481259B2 (en) 2007-02-05 2013-07-09 Intelligent Bio-Systems, Inc. Methods and devices for sequencing nucleic acids in smaller batches
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
NZ579401A (en) 2007-02-07 2012-03-30 Decode Genetics Ehf Genetic variants contributing to risk of prostate cancer
KR100827449B1 (en) * 2007-02-07 2008-05-07 삼성전자주식회사 Photolabile compound, oligomer probe array and substrate for oligomer probe array with the same and the method of fabricating the same
WO2008098142A2 (en) 2007-02-08 2008-08-14 Sequenom, Inc. Nucleic acid-based tests for rhd typing, gender determination and nucleic acid quantification
SG178811A1 (en) * 2007-02-21 2012-03-29 Decode Genetics Ehf Genetic susceptibility variants associated with cardiovascular disease
EP1961825A1 (en) 2007-02-26 2008-08-27 INSERM (Institut National de la Santé et de la Recherche Medicale) Method for predicting the occurrence of metastasis in breast cancer patients
US9581595B2 (en) 2007-02-26 2017-02-28 Laboratory Corporation Of America Holdings Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy
CA2679954A1 (en) 2007-03-05 2008-09-12 Cancer Care Ontario Assessment of risk for colorectal cancer
US20080220537A1 (en) * 2007-03-07 2008-09-11 Pacific Biosciences Of California, Inc. Substrates and methods for selective immobilization of active molecules
WO2008112127A2 (en) * 2007-03-08 2008-09-18 Switchgear Genomics Functional arrays for high throughput characterization of regulatory elements in untranslated regions of genes
US20080228699A1 (en) 2007-03-16 2008-09-18 Expanse Networks, Inc. Creation of Attribute Combination Databases
US20080234143A1 (en) * 2007-03-23 2008-09-25 Pacific Biosciences Of California, Inc. Mechanical methods for producing substrates having selectively immobilized molecules
WO2008117314A2 (en) * 2007-03-26 2008-10-02 Decode Genetics Ehf Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
WO2008118988A1 (en) 2007-03-26 2008-10-02 Sequenom, Inc. Restriction endonuclease enhanced polymorphic sequence detection
CA2681722A1 (en) * 2007-03-26 2008-10-02 Purdue Research Foundation Method and apparatus for conjugate quadrature interferometric detection of an immunoassay
US20080243865A1 (en) * 2007-03-28 2008-10-02 Oracle International Corporation Maintaining global state of distributed transaction managed by an external transaction manager for clustered database systems
US20080241831A1 (en) * 2007-03-28 2008-10-02 Jian-Bing Fan Methods for detecting small RNA species
US7572990B2 (en) * 2007-03-30 2009-08-11 Intermec Ip Corp. Keypad overlay membrane
EP2137535B1 (en) * 2007-04-13 2015-06-03 Dana-Farber Cancer Institute, Inc. Receptor tyrosine kinase profiling
CA2683559C (en) 2007-04-13 2019-09-24 Dana Farber Cancer Institute, Inc. Methods for treating cancer resistant to erbb therapeutics
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
WO2008128333A1 (en) * 2007-04-19 2008-10-30 The Governors Of The University Of Alberta A method to distinguish antibody-mediated tissue rejection from t cell-mediated tissue rejection
US20080268440A1 (en) * 2007-04-26 2008-10-30 Liu Timothy Z Biomolecule immobilization on surface via hydrophobic interactions
WO2008134571A1 (en) 2007-04-27 2008-11-06 University Of California Plant co2 sensors, nucleic acids encoding them, and methods for making and using them
US9580719B2 (en) * 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
CN101688213A (en) 2007-04-27 2010-03-31 陶氏环球技术公司 Be used for rapidly screening microbial hosts to identify some method at the bacterial strain of output that has improvement aspect the expressing heterologous protein and/or quality
EP2142659A4 (en) 2007-04-30 2010-06-09 Univ Ohio State Res Found Methods for differentiating pancreatic cancer from normal pancreatic function and/or chronic pancreatitis
EP2155907B1 (en) 2007-04-30 2015-05-27 Decode Genetics EHF Genetic variants useful for risk assessment of coronary artery disease and myocardial infarction
US20080274458A1 (en) * 2007-05-01 2008-11-06 Latham Gary J Nucleic acid quantitation methods
CN101688245B (en) 2007-05-01 2013-09-25 加利福尼亚大学董事会 Methods for diagnosing ischemia
WO2008137586A1 (en) * 2007-05-01 2008-11-13 University Of Miami Transcriptomic biomarkers for individual risk assessment in new onset heart failure
TWI445544B (en) * 2007-05-01 2014-07-21 Biogen Idec Inc Compositions and methods for increasing vascularization
EP2068924A4 (en) 2007-05-03 2011-07-20 Medimmune Llc Interferon alpha-induced pharmacodynamic markers
US20080286881A1 (en) * 2007-05-14 2008-11-20 Apel William A Compositions and methods for combining report antibodies
US8200440B2 (en) 2007-05-18 2012-06-12 Affymetrix, Inc. System, method, and computer software product for genotype determination using probe array data
CA2687787A1 (en) * 2007-05-21 2008-12-18 Dana Farber Cancer Institute, Inc. Compositions and methods for cancer gene discovery
US20080293589A1 (en) * 2007-05-24 2008-11-27 Affymetrix, Inc. Multiplex locus specific amplification
EP2535425A1 (en) 2007-05-25 2012-12-19 Decode Genetics EHF. Variantes génétiques sur les chr 10q26 utilisées comme marqueurs dans l'évaluation, le diagnostic, le pronostic et le traitement d'un risque de cancer du sein
US20100203051A1 (en) 2007-05-31 2010-08-12 The University Of Queensland Diagnostic markers for ankylosing spondylitis and uses thereof
US8351674B2 (en) * 2007-05-31 2013-01-08 Battelle Energy Alliance, Llc Image portion identification methods, image parsing methods, image parsing systems, and articles of manufacture
US20100093554A1 (en) * 2007-06-01 2010-04-15 Keting Chu Methods for identifying biomarkers, autoantibody signatures, and stratifying subject groups using peptide arrays
PE20090321A1 (en) 2007-06-04 2009-04-20 Genentech Inc ANTI-NOTCH1 NRR ANTIBODIES, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITION
EA200901494A1 (en) 2007-06-06 2010-06-30 Домантис Лимитед METHODS OF SELECTION OF PROTEASO-RESISTANT POLYPEPTIDES
BRPI0812461A2 (en) 2007-06-08 2017-06-13 Biogen Idec Inc method of predicting an individual's response to therapy, method of treating an immune disorder, composition and kit
US8097422B2 (en) 2007-06-20 2012-01-17 Salk Institute For Biological Studies Kir channel modulators
DE102007031526B4 (en) 2007-07-06 2010-07-08 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Use of an anode in a fuel cell for the oxidation of ethanol and / or at least one C3 to C10-containing alcohol
GB0713183D0 (en) * 2007-07-06 2007-08-15 King S College London Method
WO2009009662A1 (en) * 2007-07-10 2009-01-15 University Of South Florida Method of predicting non-response to first line chemotherapy
US20100190659A1 (en) 2007-07-12 2010-07-29 The Brigham And Women's Hospital, Inc. Compositions and Methods for Diagnosing and Assessing Inflammatory Myopathies
NZ582772A (en) 2007-07-17 2012-06-29 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
EP2190481B1 (en) 2007-07-17 2014-12-24 The General Hospital Corporation Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof
KR20090012582A (en) * 2007-07-30 2009-02-04 삼성전자주식회사 Apparatus for synthesizing polymer on a substrate and method of synthesizing polymer
US7507539B2 (en) * 2007-07-30 2009-03-24 Quest Diagnostics Investments Incorporated Substractive single label comparative hybridization
US8679485B2 (en) 2007-08-02 2014-03-25 Gilead Biologics, Inc. Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis
US20110135648A1 (en) * 2007-08-08 2011-06-09 Biogen Idec Ma Inc. Anti-neublastin antibodies and uses thereof
US8067164B2 (en) * 2007-08-12 2011-11-29 Integrated Dna Technologies, Inc. Microarray system with improved sequence specificity
WO2009023733A1 (en) * 2007-08-13 2009-02-19 Trustees Of Tufts College Methods and microarrays for detecting enteric viruses
JP2010535529A (en) * 2007-08-13 2010-11-25 アルマック ダイアグノスティックス リミテッド 3'-based sequencing method for microarray manufacturing
CN101778954A (en) 2007-08-14 2010-07-14 霍夫曼-拉罗奇有限公司 Predictive markers for egfr inhibitor treatment
SI2179056T1 (en) 2007-08-14 2012-12-31 F. Hoffmann-La Roche Ag Egfr inhibitor treatment marker
MX2010001582A (en) 2007-08-14 2010-06-02 Hoffmann La Roche Predictive markers for egfr inhibitors treatment.
MX2010001583A (en) 2007-08-14 2010-03-15 Hoffmann La Roche Predictive marker for egfr inhibitor treatment.
EP2185195A2 (en) * 2007-08-16 2010-05-19 Tripep Ab Immunogen platform
US20110166028A1 (en) * 2007-08-28 2011-07-07 Donald Bergstrom Methods for predicting treatment response based on the expression profiles of biomarker genes in notch mediated cancers
EP2195452B1 (en) 2007-08-29 2012-03-14 Sequenom, Inc. Methods and compositions for universal size-specific polymerase chain reaction
US20090060786A1 (en) * 2007-08-29 2009-03-05 Gibum Kim Microfluidic apparatus for wide area microarrays
ES2556627T3 (en) 2007-08-30 2016-01-19 Trustees Of Tufts College Methods to determine the concentration of an analyte in solution
US9388457B2 (en) 2007-09-14 2016-07-12 Affymetrix, Inc. Locus specific amplification using array probes
WO2009039122A2 (en) 2007-09-17 2009-03-26 Sequenom, Inc. Integrated robotic sample transfer device
JP5723154B2 (en) 2007-09-19 2015-05-27 アプライド バイオシステムズ リミテッド ライアビリティー カンパニー SiRNA sequence-independent modification format for reducing the influence of off-target phenotype in RNAi and its stabilized form
EP2212434A1 (en) * 2007-10-01 2010-08-04 Applied Biosystems Inc. Chase ligation sequencing
MX2010003600A (en) 2007-10-03 2010-12-14 Verenium Corp Xylanases, nucleic acids encoding them and methods for making and using them.
US20090139311A1 (en) 2007-10-05 2009-06-04 Applied Biosystems Inc. Biological Analysis Systems, Devices, and Methods
WO2009047809A2 (en) * 2007-10-12 2009-04-16 Decode Genetics Ehf Sequence variants for inferring human pigmentation patterns
ATE545033T1 (en) * 2007-10-15 2012-02-15 King S College London DIAGNOSTIC METHODS FOR HIV INFECTION
US8951731B2 (en) * 2007-10-15 2015-02-10 Complete Genomics, Inc. Sequence analysis using decorated nucleic acids
ES2684219T3 (en) 2007-10-23 2018-10-01 Clinical Genomics Pty Ltd A method for the diagnosis of neoplasms - II
EP2053132A1 (en) * 2007-10-23 2009-04-29 Roche Diagnostics GmbH Enrichment and sequence analysis of geomic regions
US20100292094A1 (en) 2007-10-23 2010-11-18 Clinical Genomics Pty. Ltd. Method of diagnosing neoplasms
JP2011502162A (en) * 2007-10-29 2011-01-20 ザ ユニバーシティー オブ カリフォルニア Osteoarthritis gene therapy
US7897344B2 (en) * 2007-11-06 2011-03-01 Complete Genomics, Inc. Methods and oligonucleotide designs for insertion of multiple adaptors into library constructs
US20090263872A1 (en) * 2008-01-23 2009-10-22 Complete Genomics Inc. Methods and compositions for preventing bias in amplification and sequencing reactions
US8415099B2 (en) * 2007-11-05 2013-04-09 Complete Genomics, Inc. Efficient base determination in sequencing reactions
US8518640B2 (en) * 2007-10-29 2013-08-27 Complete Genomics, Inc. Nucleic acid sequencing and process
CN105349647B (en) 2007-10-30 2020-08-28 完整基因有限公司 Methods for high throughput sequencing of nucleic acids
JP4400668B2 (en) 2007-11-01 2010-01-20 株式会社豊田中央研究所 Method for producing solid-phase body on which minute object is immobilized and use thereof
WO2009061840A1 (en) * 2007-11-05 2009-05-14 Complete Genomics, Inc. Methods and oligonucleotide designs for insertion of multiple adaptors employing selective methylation
US8906700B2 (en) 2007-11-06 2014-12-09 Ambergen, Inc. Methods and compositions for phototransfer
BRPI0820707A2 (en) 2007-11-07 2015-06-16 Genentech Inc Methods and composition for assessing B cell lymphoma responsiveness for anti-cd40 antibody treatment
CA2704000C (en) * 2007-11-09 2016-12-13 Eisai R&D Management Co., Ltd. Combination of anti-angiogenic substance and anti-tumor platinum complex
WO2009067657A2 (en) * 2007-11-21 2009-05-28 Arizona Board Of Regents, Acting For And On Behalf Of Arizona State University Methods of identifying molecular function
US8093063B2 (en) * 2007-11-29 2012-01-10 Quest Diagnostics Investments Incorporated Assay for detecting genetic abnormalities in genomic nucleic acids
US20090142759A1 (en) * 2007-11-29 2009-06-04 Erik Larsson qPCR array with IN SITU primer synthesis
WO2009073629A2 (en) * 2007-11-29 2009-06-11 Complete Genomics, Inc. Efficient shotgun sequencing methods
WO2009073511A2 (en) * 2007-11-30 2009-06-11 Mayo Foundation For Medical Education And Research Polymorphisms of the blys gene and use in diagnostic methods
US8697360B2 (en) 2007-11-30 2014-04-15 Decode Genetics Ehf. Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
US8592150B2 (en) 2007-12-05 2013-11-26 Complete Genomics, Inc. Methods and compositions for long fragment read sequencing
EP2565279B1 (en) 2007-12-05 2014-12-03 Complete Genomics, Inc. Efficient base determination in sequencing reactions
US8716437B2 (en) * 2007-12-07 2014-05-06 Steven A. Goldstein Identification of toxin ligands
US8004669B1 (en) 2007-12-18 2011-08-23 Plexera Llc SPR apparatus with a high performance fluid delivery system
CA2709217C (en) * 2007-12-19 2021-01-05 Singulex, Inc. Scanning analyzer for single molecule detection and methods of use
US20110003708A1 (en) * 2007-12-27 2011-01-06 Compugen Ltd. Biomarkers for the prediction of renal injury
AU2009204346A1 (en) 2008-01-02 2009-07-16 Suregene Llc Genetic markers of mental illness
CN101965397B (en) 2008-01-03 2016-09-28 巴斯夫酶有限责任公司 Transferring enzyme and oxidoreductase, the nucleic acid encoding them and its methods for making and using same
AU2009205920A1 (en) 2008-01-17 2009-07-23 Suregene Llc Genetic markers of mental illness
CA2712773A1 (en) * 2008-01-22 2009-07-30 Veridex, Llc Molecular staging of stage ii and iii colon cancer and prognosis
WO2009128730A1 (en) 2008-01-25 2009-10-22 Patrick Gladding Methods and compositions for the assessment of drug response
WO2009097368A2 (en) 2008-01-28 2009-08-06 Complete Genomics, Inc. Methods and compositions for efficient base calling in sequencing reactions
US8658379B2 (en) 2008-01-29 2014-02-25 University of Pittsburgh—of the Commonwealth System of Higher Education Follistatin-like protein-1 as a biomarker for sepsis
WO2009097424A1 (en) * 2008-01-29 2009-08-06 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Fstl-1 as a biomarker of inflammation
US7763856B2 (en) * 2008-01-31 2010-07-27 Palo Alto Research Center Incorporated Producing time variation in emanating light
US7894068B2 (en) * 2008-02-04 2011-02-22 Palo Alto Research Center Incorporated Producing filters with combined transmission and/or reflection functions
US8153950B2 (en) * 2008-12-18 2012-04-10 Palo Alto Research Center Incorporated Obtaining sensing results and/or data in response to object detection
US7701580B2 (en) * 2008-02-01 2010-04-20 Palo Alto Research Center Incorporated Transmitting/reflecting emanating light with time variation
US8263955B2 (en) * 2008-12-18 2012-09-11 Palo Alto Research Center Incorporated Causing relative motion
AU2009208607B2 (en) * 2008-01-31 2013-08-01 Compugen Ltd. Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
US8629981B2 (en) 2008-02-01 2014-01-14 Palo Alto Research Center Incorporated Analyzers with time variation based on color-coded spatial modulation
US8373860B2 (en) * 2008-02-01 2013-02-12 Palo Alto Research Center Incorporated Transmitting/reflecting emanating light with time variation
CA2618163A1 (en) 2008-02-07 2009-08-07 K. W. Michael Siu Head and neck cancer biomarkers
EP2245197B1 (en) * 2008-02-07 2016-10-12 Whitespace Enterprise Corporation Improvements in and relating to analysis
US20090203531A1 (en) * 2008-02-12 2009-08-13 Nurith Kurn Method for Archiving and Clonal Expansion
US8105777B1 (en) 2008-02-13 2012-01-31 Nederlands Kanker Instituut Methods for diagnosis and/or prognosis of colon cancer
AU2009213689B2 (en) 2008-02-14 2014-11-20 Decode Genetics Ehf. Susceptibility variants for lung cancer
US20090233809A1 (en) * 2008-03-04 2009-09-17 Affymetrix, Inc. Resequencing methods for identification of sequence variants
US9012370B2 (en) * 2008-03-11 2015-04-21 National Cancer Center Method for measuring chromosome, gene or specific nucleotide sequence copy numbers using SNP array
WO2009114543A2 (en) 2008-03-11 2009-09-17 Sequenom, Inc. Nucleic acid-based tests for prenatal gender determination
US9074244B2 (en) 2008-03-11 2015-07-07 Affymetrix, Inc. Array-based translocation and rearrangement assays
US7932036B1 (en) 2008-03-12 2011-04-26 Veridex, Llc Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase
US20110071049A1 (en) 2008-03-12 2011-03-24 Nathaniel Heintz Methods and compositions for translational profiling and molecular phenotyping
US9017973B2 (en) 2008-03-19 2015-04-28 Intelligent Biosystems, Inc. Methods and compositions for incorporating nucleotides
US8883999B2 (en) * 2008-03-19 2014-11-11 Intelligent Bio Systems, Inc. Methods and solutions for inhibiting undesired cleaving of labels
US10745740B2 (en) 2008-03-19 2020-08-18 Qiagen Sciences, Llc Sample preparation
WO2009117698A2 (en) 2008-03-21 2009-09-24 Nugen Technologies, Inc. Methods of rna amplification in the presence of dna
CA2718137A1 (en) 2008-03-26 2009-10-01 Sequenom, Inc. Restriction endonuclease enhanced polymorphic sequence detection
US8796184B2 (en) 2008-03-28 2014-08-05 Sentilus, Inc. Detection assay devices and methods of making and using the same
EP2107125A1 (en) 2008-03-31 2009-10-07 Eppendorf Array Technologies SA (EAT) Real-time PCR of targets on a micro-array
US20090246788A1 (en) 2008-04-01 2009-10-01 Roche Nimblegen, Inc. Methods and Assays for Capture of Nucleic Acids
EP2274450A2 (en) 2008-04-01 2011-01-19 Decode Genetics EHF Susceptibility variants for peripheral arterial disease and abdominal aortic aneurysm
US20090270273A1 (en) * 2008-04-21 2009-10-29 Complete Genomics, Inc. Array structures for nucleic acid detection
WO2009130588A2 (en) 2008-04-22 2009-10-29 Tripep Ab Immunogen platform
US20090269746A1 (en) * 2008-04-25 2009-10-29 Gil Atzmon Microsequencer-whole genome sequencer
WO2009137369A1 (en) * 2008-05-03 2009-11-12 Tufts Medical Center, Inc. Neonatal salivary genomics
US8039817B2 (en) 2008-05-05 2011-10-18 Illumina, Inc. Compensator for multiple surface imaging
JP2009268665A (en) * 2008-05-07 2009-11-19 Canon Inc Inhalation device
EP2294214A2 (en) * 2008-05-07 2011-03-16 Illumina, Inc. Compositions and methods for providing substances to and from an array
EP2285960B1 (en) 2008-05-08 2015-07-08 Asuragen, INC. Compositions and methods related to mir-184 modulation of neovascularization or angiogenesis
JP2010043063A (en) 2008-05-09 2010-02-25 Agency For Science Technology & Research Diagnosis and treatment of kawasaki disease
EP2297347B1 (en) 2008-05-14 2017-03-08 Millennium Pharmaceuticals, Inc. Methods and kits for monitoring the effects of immunomodulators on adaptive immunity
KR100956447B1 (en) * 2008-05-16 2010-05-06 한국전자통신연구원 A method for fabricating patterned biosensor substrate and a biosensor using the same
EP2806054A1 (en) 2008-05-28 2014-11-26 Genomedx Biosciences Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
US20090298082A1 (en) * 2008-05-30 2009-12-03 Klee George G Biomarker panels for predicting prostate cancer outcomes
WO2009143624A1 (en) 2008-05-30 2009-12-03 The University Of British Columbia Methods of diagnosing rejection of a kidney allograft using genomic or proteomic expression profiling
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
JP2011525106A (en) * 2008-06-04 2011-09-15 ジ・アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・ザ・ユニバーシティ・オブ・アリゾナ Markers for diffuse B large cell lymphoma and methods of use thereof
EP2294420B8 (en) * 2008-06-06 2015-10-21 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Survival predictor for diffuse large B cell lymphoma
WO2009152102A2 (en) * 2008-06-10 2009-12-17 The Regents Of The University Of California Pro-fluorescent probes
CN102203282B (en) 2008-06-25 2014-04-30 生命技术公司 Methods and apparatus for measuring analytes using large scale FET arrays
JP2011526303A (en) 2008-06-27 2011-10-06 デューク ユニバーシティ A therapeutic agent containing an elastin-like peptide
US20110111419A1 (en) * 2008-07-04 2011-05-12 deCODE Geneties ehf. Copy Number Variations Predictive of Risk of Schizophrenia
US8951735B2 (en) 2008-07-07 2015-02-10 Decode Genetics Ehf. Genetic variants for breast cancer risk assessment
WO2010004695A1 (en) 2008-07-09 2010-01-14 パナソニック株式会社 Sequencer
WO2010009365A1 (en) 2008-07-18 2010-01-21 Raindance Technologies, Inc. Droplet libraries
CA2731730C (en) * 2008-07-23 2017-06-13 President And Fellows Of Harvard College Deacetylase inhibitors and uses thereof
US9182406B2 (en) * 2008-08-04 2015-11-10 Biodesy, Inc. Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability
JP2011530306A (en) * 2008-08-12 2011-12-22 ディコーデ ジェネテクス イーエイチエフ Genetic variation useful for risk assessment of thyroid cancer
US8530716B2 (en) * 2008-08-14 2013-09-10 Bp Corporation North America Inc. Melt-crystallization separation and purification process
EP2329037B1 (en) * 2008-08-15 2015-01-28 Decode Genetics EHF Genetic variants predictive of cancer risk
EP2631301B1 (en) 2008-08-18 2017-10-11 The Board of Trustees of the Leland Stanford Junior University Methods for determining a graft tolerant phenotype in a subject
WO2010025310A2 (en) 2008-08-27 2010-03-04 Westend Asset Clearinghouse Company, Llc Methods and devices for high fidelity polynucleotide synthesis
KR20100025328A (en) * 2008-08-27 2010-03-09 삼성전자주식회사 Method of producing microarray having immoblized double strand nucleic acids comprising double strand region and terminal single strand region
EP2329259B1 (en) 2008-08-29 2016-04-20 Janssen Biotech, Inc. Markers and methods for assessing and treating ulcerative colitis and related disorders using a 20 gene panel
US8153391B2 (en) 2008-08-29 2012-04-10 Bunge Oils, Inc. Hydrolases, nucleic acids encoding them and methods for making and using them
US8198062B2 (en) 2008-08-29 2012-06-12 Dsm Ip Assets B.V. Hydrolases, nucleic acids encoding them and methods for making and using them
US8357503B2 (en) 2008-08-29 2013-01-22 Bunge Oils, Inc. Hydrolases, nucleic acids encoding them and methods for making and using them
EP2331934B1 (en) 2008-09-16 2020-01-01 Pacific Biosciences of California, Inc. Analytic device including a zero mode waveguide substrate
US8962247B2 (en) 2008-09-16 2015-02-24 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
US8476013B2 (en) * 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US20100075862A1 (en) * 2008-09-23 2010-03-25 Quanterix Corporation High sensitivity determination of the concentration of analyte molecules or particles in a fluid sample
US20100075439A1 (en) * 2008-09-23 2010-03-25 Quanterix Corporation Ultra-sensitive detection of molecules by capture-and-release using reducing agents followed by quantification
US8222047B2 (en) * 2008-09-23 2012-07-17 Quanterix Corporation Ultra-sensitive detection of molecules on single molecule arrays
WO2010036969A2 (en) 2008-09-25 2010-04-01 Suregene Llc Genetic markers for assessing risk of developing schizophrenia
US20100087325A1 (en) * 2008-10-07 2010-04-08 Illumina, Inc. Biological sample temperature control system and method
US20100137143A1 (en) 2008-10-22 2010-06-03 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
US20100301398A1 (en) 2009-05-29 2010-12-02 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
EP2340314B8 (en) 2008-10-22 2015-02-18 Illumina, Inc. Preservation of information related to genomic dna methylation
CN102308004A (en) 2008-10-30 2012-01-04 卡里斯生命科学卢森堡控股有限责任公司 Methods for assessing RNA patterns
JP5502413B2 (en) * 2008-10-31 2014-05-28 シスメックス株式会社 Test chip, test substance detection device, and test substance specific detection method
US7897356B2 (en) 2008-11-12 2011-03-01 Caris Life Sciences Methods and systems of using exosomes for determining phenotypes
US8498822B2 (en) * 2008-10-31 2013-07-30 Abbvie Inc. Genomic classification of colorectal cancer based on patterns of gene copy number alterations
MX2011004589A (en) * 2008-10-31 2011-05-25 Abbott Lab Methods for assembling panels of cancer cell lines for use in testing the efficacy of one or more pharmaceutical compositions.
MX2011004588A (en) * 2008-10-31 2011-08-03 Abbott Lab Genomic classification of non-small cell lung carcinoma based on patterns of gene copy number alterations.
CN102203789B (en) * 2008-10-31 2015-06-03 Abbvie公司 Genomic classification of malignant melanoma based on patterns of gene copy number alterations
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
EP2352998A4 (en) 2008-11-07 2011-09-21 Centocor Ortho Biotech Inc Markers and methods for assessing and treating lupus patients susceptible to photoprovocation
GB0820822D0 (en) 2008-11-13 2008-12-24 Inst Catala D Oncologia Novel product and processes
EP2356446A4 (en) 2008-11-14 2014-03-19 Brigham & Womens Hospital Therapeutic and diagnostic methods relating to cancer stem cells
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
AU2009324037B2 (en) 2008-12-05 2015-07-30 Glaxo Group Limited Methods for selecting protease resistant polypeptides
WO2010068702A2 (en) * 2008-12-10 2010-06-17 Illumina, Inc. Methods and compositions for hybridizing nucleic acids
US8039794B2 (en) * 2008-12-16 2011-10-18 Quest Diagnostics Investments Incorporated Mass spectrometry assay for thiopurine-S-methyl transferase activity and products generated thereby
US8374818B2 (en) * 2008-12-19 2013-02-12 Affymetrix, Inc. System, method and apparatus for calibrating inspection tools
US20100161607A1 (en) * 2008-12-22 2010-06-24 Jasjit Singh System and method for analyzing genome data
WO2010075249A2 (en) 2008-12-22 2010-07-01 Genentech, Inc. A method for treating rheumatoid arthritis with b-cell antagonists
SG172355A1 (en) 2008-12-23 2011-07-28 Genentech Inc Methods and compositions for diagnostic use in cancer patients
US8108406B2 (en) 2008-12-30 2012-01-31 Expanse Networks, Inc. Pangenetic web user behavior prediction system
EP3276526A1 (en) 2008-12-31 2018-01-31 23Andme, Inc. Finding relatives in a database
US8715732B2 (en) * 2009-01-05 2014-05-06 Cornell University Nucleic acid hydrogel via rolling circle amplification
CN102341505A (en) * 2009-01-09 2012-02-01 英特拉克森公司 Genetic analysis of cells
KR20110108390A (en) 2009-01-12 2011-10-05 신텔렉트 인코포레이티드 Laser mediated sectioning and transfer of cell colonies
EP2387627B1 (en) 2009-01-15 2016-03-30 Adaptive Biotechnologies Corporation Adaptive immunity profiling and methods for generation of monoclonal antibodies
TW202241853A (en) 2009-01-16 2022-11-01 美商艾克塞里克斯公司 Pharmaceutical composition comprising malate salt of n-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide and use thereof
KR20110119702A (en) 2009-01-22 2011-11-02 모멘타 파머슈티컬스 인코포레이티드 Galactose-alpha-1,3-galactose-containing n-glycans in glycoprotein products derived from cho cells
KR20100086827A (en) * 2009-01-23 2010-08-02 삼성전자주식회사 Method of analyzing probe nucleic acid, microarray and kit for same and method of determining yield for probe synthesis
US8940501B2 (en) 2009-01-30 2015-01-27 Whitehead Institute For Biomedical Research Methods for ligation and uses thereof
US20100221726A1 (en) * 2009-02-09 2010-09-02 Frederic Zenhausern Relating to devices
JP2012517238A (en) 2009-02-11 2012-08-02 カリス エムピーアイ インコーポレイテッド Molecular profiling of tumors
US20100331204A1 (en) 2009-02-13 2010-12-30 Jeff Jeddeloh Methods and systems for enrichment of target genomic sequences
WO2010096658A1 (en) 2009-02-19 2010-08-26 The Cleveland Clinic Foundation Corin as a marker for heart failure
US9074258B2 (en) 2009-03-04 2015-07-07 Genomedx Biosciences Inc. Compositions and methods for classifying thyroid nodule disease
MX338098B (en) * 2009-03-09 2016-04-01 Bioatla Llc Mirac proteins.
JP5342421B2 (en) * 2009-03-11 2013-11-13 信越化学工業株式会社 Method for producing molecular immobilization substrate
WO2010107825A2 (en) 2009-03-16 2010-09-23 Pangu Biopharma Limited Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
WO2010107088A1 (en) 2009-03-18 2010-09-23 Toto株式会社 Measurement device used for specifically detecting substance to be examined using photocurrent, sensor unit used for same, and method for specifically detecting substance to be examined using photocurrent
WO2010107946A2 (en) * 2009-03-18 2010-09-23 Sequenom, Inc. Use of thermostable endonucleases for generating reporter molecules
WO2010111231A1 (en) 2009-03-23 2010-09-30 Raindance Technologies, Inc. Manipulation of microfluidic droplets
US20110014612A1 (en) 2009-03-27 2011-01-20 Life Technologies Corporation Polymerase compositions & methods
WO2010113088A1 (en) * 2009-03-31 2010-10-07 Centre Hospitalier Universitaire Vaudois Methylation ligation-dependent macroarray (mlm)
CA2757289A1 (en) 2009-03-31 2010-10-21 Atyr Pharma, Inc. Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities
EA031116B1 (en) * 2009-04-03 2018-11-30 Ф. Хоффманн-Ля Рош Аг PROPANE-1-SULFONIC ACID {3-[5-(4-CHLORO-PHENYL)-1H-PYRROLO[2,3-b]PYRIDINE-3-CARBONYL]-2,4-DIFLUORO-PHENYL}AMIDE CRYSTALLINE POLYMORPH FORMS
US8795963B2 (en) 2009-04-03 2014-08-05 Decode Genetics Ehf. Genetic markers for risk management of atrial fibrillation and stroke
WO2010115016A2 (en) 2009-04-03 2010-10-07 Sequenom, Inc. Nucleic acid preparation compositions and methods
WO2010118243A2 (en) 2009-04-08 2010-10-14 Genentech, Inc. Use of il-27 antagonists to treat lupus
WO2010118264A2 (en) 2009-04-09 2010-10-14 California Institute Of Technology Multiplexed sites for polymer synthesis
AU2010236168B2 (en) 2009-04-18 2015-08-13 Genentech, Inc. Methods for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies
US20100330569A1 (en) 2009-04-23 2010-12-30 Intelligent Bio-Systems, Inc. Hydroxymethyl Linkers For Labeling Nucleotides
US8741581B2 (en) 2009-04-27 2014-06-03 Technion Research And Development Foundation Ltd. Markers for cancer detection
CA2753916C (en) 2009-04-29 2020-08-25 Genomedx Biosciences Inc. Systems and methods for expression-based classification of thyroid tissue
JP6078339B2 (en) 2009-05-07 2017-02-08 ベラサイト インコーポレイテッド Methods and compositions for diagnosis of thyroid status
EP2451975A4 (en) * 2009-05-08 2013-08-14 Decode Genetics Ehf Genetic variants contributing to risk of prostate cancer
US20110003301A1 (en) * 2009-05-08 2011-01-06 Life Technologies Corporation Methods for detecting genetic variations in dna samples
EP2253715A1 (en) 2009-05-14 2010-11-24 RWTH Aachen New targets for cancer therapy and/or diagnosis
ES2608690T3 (en) 2009-05-21 2017-04-12 Basf Enzymes Llc Phytases, nucleic acids that encode them and methods for their production and use
US9767342B2 (en) 2009-05-22 2017-09-19 Affymetrix, Inc. Methods and devices for reading microarrays
US20100298171A1 (en) * 2009-05-22 2010-11-25 Affymetrix, Inc. Apparatus for polymer synthesis
US8776573B2 (en) 2009-05-29 2014-07-15 Life Technologies Corporation Methods and apparatus for measuring analytes
US8673627B2 (en) 2009-05-29 2014-03-18 Life Technologies Corporation Apparatus and methods for performing electrochemical reactions
EP2435580A2 (en) 2009-05-29 2012-04-04 The Regents of the University of California B cell signature associated with tolerance in transplant recipients
US20120261274A1 (en) 2009-05-29 2012-10-18 Life Technologies Corporation Methods and apparatus for measuring analytes
CA2764158A1 (en) 2009-06-01 2010-12-09 Halo-Bio Rnai Therapeutics, Inc. Polynucleotides for multivalent rna interference, compositions and methods of use thereof
WO2010141546A1 (en) 2009-06-02 2010-12-09 University Of Miami Diagnostic transcriptomic biomakers in inflammatory cardiomyopathies
US20100311144A1 (en) 2009-06-05 2010-12-09 Life Technologies Corporation Mutant dna polymerases
CA2765427A1 (en) 2009-06-15 2010-12-23 Complete Genomics, Inc. Methods and compositions for long fragment read sequencing
US9524369B2 (en) 2009-06-15 2016-12-20 Complete Genomics, Inc. Processing and analysis of complex nucleic acid sequence data
EP2443459B1 (en) 2009-06-19 2018-12-26 The Arizona Board of Regents, A Body Corporate Of the State of Arizona acting for and on behalf Of Arizona State University Compound arrays for sample profiling
JP5359600B2 (en) * 2009-06-24 2013-12-04 Jsr株式会社 Acid transfer resin composition and biochip manufacturing method
WO2010151807A1 (en) 2009-06-26 2010-12-29 Sirigen, Inc. Signal amplified biological detection with conjugated polymers
AU2010269841A1 (en) 2009-07-10 2012-02-23 Decode Genetics Ehf Genetic markers associated with risk of diabetes mellitus
WO2011006169A1 (en) 2009-07-10 2011-01-13 Portola Pharmaceuticals, Inc. Methods for diagnosis and treatment of thrombotic disorders mediated by cyp2c19*2
KR20120106935A (en) 2009-07-13 2012-09-27 제넨테크, 인크. Diagnostic methods and compositions for treatment of cancer
US8501406B1 (en) 2009-07-14 2013-08-06 Pacific Biosciences Of California, Inc. Selectively functionalized arrays
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
UA108618C2 (en) 2009-08-07 2015-05-25 APPLICATION OF C-MET-MODULATORS IN COMBINATION WITH THEMOSOLOMID AND / OR RADIATION THERAPY FOR CANCER TREATMENT
US8716344B2 (en) 2009-08-11 2014-05-06 President And Fellows Of Harvard College Class- and isoform-specific HDAC inhibitors and uses thereof
RU2589255C2 (en) * 2009-08-14 2016-07-10 Фейзбайо Фармасьютикалз, Инк. Modified vasoactive intestinal peptides
US20110117083A1 (en) 2009-08-14 2011-05-19 Genentech, Inc. Biological markers for monitoring patient response to vegf antagonists
US9771618B2 (en) * 2009-08-19 2017-09-26 Bioarray Genetics, Inc. Methods for treating breast cancer
JP5951487B2 (en) 2009-08-22 2016-07-13 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー Imaging and evaluation of embryos, oocytes, and stem cells
US20110059453A1 (en) * 2009-08-23 2011-03-10 Affymetrix, Inc. Poly(A) Tail Length Measurement by PCR
WO2011026136A1 (en) 2009-08-31 2011-03-03 Life Technologies Corporation Low-volume sequencing system and method of use
US10174368B2 (en) 2009-09-10 2019-01-08 Centrillion Technology Holdings Corporation Methods and systems for sequencing long nucleic acids
WO2011032040A1 (en) 2009-09-10 2011-03-17 Centrillion Technology Holding Corporation Methods of targeted sequencing
US8815779B2 (en) * 2009-09-16 2014-08-26 SwitchGear Genomics, Inc. Transcription biomarkers of biological responses and methods
US9410965B2 (en) * 2009-09-17 2016-08-09 Battelle Energy Alliance, Llc Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual
ES2530732T3 (en) 2009-09-17 2015-03-05 Hoffmann La Roche Diagnostic procedures for lung cancer
US8969009B2 (en) * 2009-09-17 2015-03-03 Vicki S. Thompson Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual
CA2774116A1 (en) 2009-09-25 2011-03-31 Signature Genomics Laboratories Llc Multiplex (+/-) stranded arrays and assays for detecting chromosomal abnormalities associated with cancer and other diseases
TWI384554B (en) * 2009-10-02 2013-02-01 Univ Southern Taiwan Tech Cell particle control biochip with three layers of electrodes and microcavity arrays and manufacture method for the same
WO2011042564A1 (en) 2009-10-09 2011-04-14 Universite De Strasbourg Labelled silica-based nanomaterial with enhanced properties and uses thereof
UA109884C2 (en) 2009-10-16 2015-10-26 A POLYPEPTIDE THAT HAS THE ACTIVITY OF THE PHOSPHATIDYLINOSYTOL-SPECIFIC PHOSPHOLIPASE C, NUCLEIC ACID, AND METHOD OF METHOD
HUE026447T2 (en) 2009-10-16 2016-05-30 Novartis Ag Biomarkers of tumor pharmacodynamic response
UA111708C2 (en) 2009-10-16 2016-06-10 Бандж Ойлз, Інк. METHOD OF OIL REFINING
WO2011048499A1 (en) 2009-10-19 2011-04-28 Stichting Het Nederlands Kanker Instituut Predicting response to anti-cancer therapy via array comparative genomic hybridization
EP2491141A2 (en) 2009-10-19 2012-08-29 Stichting Het Nederlands Kanker Instituut Differentiation between brca2-associated tumours and sporadic tumours via array comparative genomic hybridization
US20120322677A1 (en) 2009-10-19 2012-12-20 Stichting Het Nederlands Kanker Instituut Predicting benefit of anti-cancer therapy via array comparative genomic hybridization
US9644240B2 (en) 2009-10-22 2017-05-09 Leiden University Disease susceptibility
EP2314714A1 (en) 2009-10-22 2011-04-27 Universiteit Leiden Disease susceptibility
WO2011056505A1 (en) 2009-10-26 2011-05-12 Abbott Laboratories Detection of chromosomal abnormalities associated with prognosis of non small cell lung cancer
EP2494077A4 (en) 2009-10-27 2013-08-21 Caris Mpi Inc Molecular profiling for personalized medicine
WO2011050981A2 (en) 2009-10-30 2011-05-05 Roche Diagnostics Gmbh Method for detecting balanced chromosomal aberrations in a genome
WO2011056872A2 (en) 2009-11-03 2011-05-12 Gen9, Inc. Methods and microfluidic devices for the manipulation of droplets in high fidelity polynucleotide assembly
US7972793B2 (en) 2009-11-04 2011-07-05 Suregene, Llc Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
EP2496944A2 (en) 2009-11-05 2012-09-12 Novartis AG Biomarkers predictive of progression of fibrosis
MX2012005284A (en) 2009-11-06 2012-06-28 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor.
JP2013510574A (en) 2009-11-11 2013-03-28 モメンタ ファーマシューティカルズ インコーポレイテッド Glycosyltransferases from Chinese hamsters and related methods
CA2812929C (en) * 2009-11-12 2015-02-03 Texas Tech University Compositions and methods for treating hyperproliferative disorders
WO2011062962A2 (en) 2009-11-17 2011-05-26 The Trustees Of The University Of Pennsylvania Smndelta7 degron: novel compositions and methods of use
US8961989B2 (en) 2009-11-20 2015-02-24 Oregon Health & Science University Methods for producing an immune response to tuberculosis
AU2010321533A1 (en) * 2009-11-23 2012-05-31 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutic delivery
WO2011066185A1 (en) 2009-11-25 2011-06-03 Gen9, Inc. Microfluidic devices and methods for gene synthesis
WO2011066186A1 (en) 2009-11-25 2011-06-03 Gen9, Inc. Methods and apparatuses for chip-based dna error reduction
AU2010324594B2 (en) 2009-11-30 2016-09-15 Caris Life Sciences Switzerland Holdings Gmbh Methods and systems for isolating, storing, and analyzing vesicles
WO2011068829A1 (en) 2009-12-02 2011-06-09 The Board Of Trustees Of The Leland Stanford Junior University Biomarkers for determining an allograft tolerant phenotype
US8501122B2 (en) 2009-12-08 2013-08-06 Affymetrix, Inc. Manufacturing and processing polymer arrays
US10446272B2 (en) 2009-12-09 2019-10-15 Veracyte, Inc. Methods and compositions for classification of samples
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
US9315857B2 (en) 2009-12-15 2016-04-19 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse label-tags
US20110143966A1 (en) * 2009-12-15 2011-06-16 Affymetrix, Inc. Surface Modifications and Methods for their Synthesis and Use
GB0922085D0 (en) 2009-12-17 2010-02-03 Cambridge Entpr Ltd Cancer diagnosis and treatment
DE102009059112A1 (en) 2009-12-18 2011-06-22 Biotype Diagnostic GmbH, 01109 A device for determining molecular interactions, and a film for producing such
DK2516680T3 (en) 2009-12-22 2016-05-02 Sequenom Inc Method and kits to identify aneuploidy
GB0922377D0 (en) 2009-12-22 2010-02-03 Arab Gulf University The Mutant LDL receptor
FR2954349A1 (en) 2009-12-22 2011-06-24 Agronomique Inst Nat Rech SULFATASE SELECTIVELY MODIFYING GLYCOSAMINOGLYCANS
EP2517025B1 (en) 2009-12-23 2019-11-27 Bio-Rad Laboratories, Inc. Methods for reducing the exchange of molecules between droplets
ES2585350T3 (en) 2009-12-23 2016-10-05 F. Hoffmann-La Roche Ag Anti Bv8 antibodies and uses thereof
WO2011079280A2 (en) 2009-12-23 2011-06-30 Hill's Pet Nutrition, Inc. Compositions and methods for diagnosing and treating kidney disorders in a canine
WO2011082106A1 (en) 2009-12-29 2011-07-07 Hill's Pet Nutrition, Inc. Compositions including ginger for the amelioration or prevention of inflammatory conditions
SG182303A1 (en) 2009-12-31 2012-08-30 Ventana Med Syst Inc Methods for producing uniquely specific nucleic acid probes
WO2011085075A2 (en) 2010-01-07 2011-07-14 Gen9, Inc. Assembly of high fidelity polynucleotides
WO2011088226A2 (en) 2010-01-13 2011-07-21 Caris Life Sciences Luxembourg Holdings Detection of gastrointestinal disorders
US8575303B2 (en) 2010-01-19 2013-11-05 Sirigen Group Limited Reagents for directed biomarker signal amplification
US9927434B2 (en) 2010-01-20 2018-03-27 Customarray, Inc. Multiplex microarray of serially deposited biomolecules on a microarray
EP2529033B1 (en) 2010-01-26 2017-05-24 National Jewish Health Methods for risk prediction, diagnosis, prognosis of pulmonary disorders
US20130071408A1 (en) 2010-02-01 2013-03-21 Atul J. Butte Methods for Diagnosis and Treatment of Non-Insulin Dependent Diabetes Mellitus
WO2011093939A1 (en) 2010-02-01 2011-08-04 Illumina, Inc. Focusing methods and optical systems and assemblies using the same
CN102770767A (en) 2010-02-10 2012-11-07 诺瓦提斯公司 Methods and compounds for muscle growth
EP2534267B1 (en) 2010-02-12 2018-04-11 Raindance Technologies, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US8415171B2 (en) * 2010-03-01 2013-04-09 Quanterix Corporation Methods and systems for extending dynamic range in assays for the detection of molecules or particles
US9678068B2 (en) * 2010-03-01 2017-06-13 Quanterix Corporation Ultra-sensitive detection of molecules using dual detection methods
ES2544635T3 (en) 2010-03-01 2015-09-02 Quanterix Corporation Methods to extend the dynamic range in assays for the detection of molecules or particles
US8236574B2 (en) 2010-03-01 2012-08-07 Quanterix Corporation Ultra-sensitive detection of molecules or particles using beads or other capture objects
CN103237901B (en) 2010-03-01 2016-08-03 卡里斯生命科学瑞士控股有限责任公司 For treating the biomarker of diagnosis
US8716467B2 (en) 2010-03-03 2014-05-06 Gen9, Inc. Methods and devices for nucleic acid synthesis
ES2631458T3 (en) 2010-03-04 2017-08-31 Interna Technologies B.V. MRNA molecule defined by its source and its therapeutic uses in cancer associated with EMT
WO2011112465A1 (en) 2010-03-06 2011-09-15 Illumina, Inc. Systems, methods, and apparatuses for detecting optical signals from a sample
EP2369325A1 (en) 2010-03-12 2011-09-28 Eppendorf Ag Array analysis for online detection
CA2794255C (en) 2010-03-25 2020-01-14 Minnie M. Sarwal Protein and gene biomarkers for rejection of organ transplants
EP2558622A4 (en) 2010-04-06 2013-07-24 Univ George Washington Compositions and methods for identifying autism spectrum disorders
BR112012025593A2 (en) 2010-04-06 2019-06-25 Caris Life Sciences Luxembourg Holdings circulating biomarkers for disease
NZ720529A (en) 2010-04-16 2017-01-27 Zeus Scientific Inc Methods for measuring enzyme activity useful in determining cell viability in non-purified samples
WO2011128096A1 (en) 2010-04-16 2011-10-20 Roche Diagnostics Gmbh Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
CN103079567A (en) 2010-04-17 2013-05-01 拜尔健康护理有限责任公司 Synthetic metabolites of fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention diseases and conditions
BR112012026870A2 (en) 2010-04-19 2017-01-10 Procter & Gamble Genetic signatures and gene chips associated with electrically conducted rfsudio frequency administration to the skin and related methods and treatments
WO2011133539A2 (en) 2010-04-19 2011-10-27 The Procter & Gamble Company Combined energy and topical composition application for regulating the condition of mammalian skin
EP2563380B1 (en) 2010-04-26 2018-05-30 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
AU2011248614B2 (en) 2010-04-27 2017-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases
US20120003639A1 (en) 2010-04-27 2012-01-05 Prelude, Inc. Cancer biomarkers and methods of use thereof
US8993723B2 (en) 2010-04-28 2015-03-31 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-tRNA synthetases
WO2011135459A2 (en) 2010-04-29 2011-11-03 Medical Prognosis Institute A/S Methods and devices for predicting treatment efficacy
CA2797374C (en) 2010-04-29 2021-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
EP2563383B1 (en) 2010-04-29 2017-03-01 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
WO2011139986A2 (en) 2010-05-03 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
CN103140233B (en) 2010-05-03 2017-04-05 Atyr 医药公司 Treatment, diagnosis and the discovery of antibody compositions related to the protein fragments of methionyl-tRNA synthetase
ES2623805T3 (en) 2010-05-03 2017-07-12 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic and antibody compositions related to phenylalanyl-alpha-tRNA synthetase protein fragments
JP6008844B2 (en) 2010-05-04 2016-10-19 エータイアー ファーマ, インコーポレイテッド Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of the p38 MULTI-tRNA synthetase complex
CA2798190A1 (en) 2010-05-10 2011-11-17 Abbott Laboratories Detection of chromosomal abnormalities associated with endometrial cancer
WO2011143556A1 (en) 2010-05-13 2011-11-17 Gen9, Inc. Methods for nucleotide sequencing and high fidelity polynucleotide synthesis
AU2011252990B2 (en) 2010-05-14 2017-04-20 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
EP2571421B1 (en) 2010-05-17 2017-08-02 Sentilus Holdco, LLC Detection devices and related methods of use
CA2799480C (en) 2010-05-17 2020-12-15 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases
EP2388336A1 (en) 2010-05-19 2011-11-23 Signature Diagnostics AG Method and kits for diagnosing colorectal cancer
WO2011146725A1 (en) 2010-05-19 2011-11-24 Bayer Healthcare Llc Biomarkers for a multikinase inhibitor
EP2575856B1 (en) 2010-05-27 2017-08-16 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
US9187777B2 (en) 2010-05-28 2015-11-17 Gen9, Inc. Methods and devices for in situ nucleic acid synthesis
WO2011153277A2 (en) 2010-06-01 2011-12-08 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
WO2011153224A2 (en) 2010-06-02 2011-12-08 Genentech, Inc. Diagnostic methods and compositions for treatment of cancer
CA3007787C (en) 2010-06-03 2020-03-10 Pharmacyclics Llc The use of inhibitors of bruton's tyrosine kinase (btk)
US9228240B2 (en) 2010-06-03 2016-01-05 California Institute Of Technology Methods for detecting and quantifying viable bacterial endo-spores
EP2576815B1 (en) 2010-06-04 2018-02-14 Biomérieux Method for the prognosis of colorectal cancer
CA2801468C (en) 2010-06-04 2018-09-04 Chronix Biomedical Prostate cancer associated circulating nucleic acid biomarkers
US20120009177A1 (en) 2010-06-07 2012-01-12 Roche Molecular Systems, Inc. Gene expression markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
AU2011268211B2 (en) 2010-06-16 2015-07-16 Dynavax Technologies Corporation Methods of treatment using TLR7 and/or TLR9 inhibitors
WO2011159942A1 (en) 2010-06-18 2011-12-22 Illumina, Inc. Conformational probes and methods for sequencing nucleic acids
ES2573515T3 (en) 2010-06-25 2016-06-08 Eisai R&D Management Co., Ltd. Anti-tumor agent that uses compounds with combined kinase inhibitory effect
WO2012003380A2 (en) 2010-06-30 2012-01-05 Life Technologies Corporation Array column integrator
CN103154718B (en) 2010-06-30 2015-09-23 生命科技公司 The electric charge accumulation circuit of sensing ion and method
TWI539172B (en) 2010-06-30 2016-06-21 生命技術公司 Methods and apparatus for testing isfet arrays
US11307166B2 (en) 2010-07-01 2022-04-19 Life Technologies Corporation Column ADC
TWI527245B (en) 2010-07-03 2016-03-21 生命技術公司 Chemically sensitive sensor with lightly doped drains
EP2591106A1 (en) 2010-07-06 2013-05-15 InteRNA Technologies B.V. Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
WO2012021247A2 (en) 2010-07-12 2012-02-16 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
AU2011279303B2 (en) 2010-07-12 2015-07-16 Celgene Corporation Romidepsin solid forms and uses thereof
US9663834B2 (en) 2010-07-16 2017-05-30 Tocagen Inc. Retrovirus detection
DK2601609T3 (en) 2010-08-02 2017-06-06 Population Bio Inc COMPOSITIONS AND METHODS FOR DISCOVERING MUTATIONS CAUSING GENETIC DISORDERS
WO2012019099A2 (en) 2010-08-05 2012-02-09 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Follistatin-like-protein-1 as a biomarker for inflammatory disorders
US20140342940A1 (en) 2011-01-25 2014-11-20 Ariosa Diagnostics, Inc. Detection of Target Nucleic Acids using Hybridization
US10167508B2 (en) 2010-08-06 2019-01-01 Ariosa Diagnostics, Inc. Detection of genetic abnormalities
US20120034603A1 (en) 2010-08-06 2012-02-09 Tandem Diagnostics, Inc. Ligation-based detection of genetic variants
US8700338B2 (en) 2011-01-25 2014-04-15 Ariosa Diagnosis, Inc. Risk calculation for evaluation of fetal aneuploidy
US11203786B2 (en) 2010-08-06 2021-12-21 Ariosa Diagnostics, Inc. Detection of target nucleic acids using hybridization
US20130040375A1 (en) 2011-08-08 2013-02-14 Tandem Diagnotics, Inc. Assay systems for genetic analysis
US11031095B2 (en) 2010-08-06 2021-06-08 Ariosa Diagnostics, Inc. Assay systems for determination of fetal copy number variation
US20130261003A1 (en) 2010-08-06 2013-10-03 Ariosa Diagnostics, In. Ligation-based detection of genetic variants
US10533223B2 (en) 2010-08-06 2020-01-14 Ariosa Diagnostics, Inc. Detection of target nucleic acids using hybridization
WO2012021733A2 (en) 2010-08-12 2012-02-16 Pacific Biosciences Of California, Inc. Photodamage mitigation compounds and systems
US9040464B2 (en) 2010-08-16 2015-05-26 Mount Sinai Hosptial Markers of the male urogenital tract
DK2609216T3 (en) 2010-08-24 2016-09-12 Dana Farber Cancer Inst Inc Methods to predict anti-cancer response
AU2011293294B2 (en) 2010-08-25 2016-03-24 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Tyrosyl-tRNA synthetases
US8859502B2 (en) 2010-09-13 2014-10-14 Celgene Corporation Therapy for MLL-rearranged leukemia
BR112013005929B1 (en) 2010-09-13 2021-02-09 Clinical Genomics Pty. Ltd. methods of screening for onset or predisposition to onset of large intestine neoplasm or monitoring of neoplasm progress in an individual
EP2617061B1 (en) 2010-09-15 2021-06-30 Life Technologies Corporation Methods and apparatus for measuring analytes
JP2013537045A (en) 2010-09-15 2013-09-30 アルマック ダイアグノスティックス リミテッド Molecular diagnostic tests for cancer
US20130296183A1 (en) 2010-09-17 2013-11-07 President And Fellows Of Harvard College Functional genomics assay for characterizing pluripotent stem cell utility and safety
EP2619326A2 (en) 2010-09-20 2013-07-31 Stichting Het Nederlands Kanker Instituut Methods for predicting response to anti-cancer therapy in cancer patients
ES2595433T3 (en) 2010-09-21 2016-12-30 Population Genetics Technologies Ltd. Increased confidence in allele identifications with molecular count
US8796036B2 (en) 2010-09-24 2014-08-05 Life Technologies Corporation Method and system for delta double sampling
US9110079B2 (en) 2010-09-29 2015-08-18 Biomerieux Method and kit for establishing an in vitro prognosis on a patient exhibiting SIRS
US8759038B2 (en) 2010-09-29 2014-06-24 Illumina Cambridge Limited Compositions and methods for sequencing nucleic acids
WO2012045012A2 (en) 2010-09-30 2012-04-05 Raindance Technologies, Inc. Sandwich assays in droplets
CA2811789A1 (en) 2010-10-06 2012-04-12 Bp Corporation North America Inc. Variant cbh i polypeptides with reduced product inhibition
US9279770B2 (en) 2010-10-15 2016-03-08 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Mid-infrared imaging of microarrays
US20120095029A1 (en) 2010-10-15 2012-04-19 Hoffmann-La Roche Inc. Ipp complex as marker for erlotinib treatment
WO2012055929A1 (en) 2010-10-26 2012-05-03 Illumina, Inc. Sequencing methods
WO2012058532A2 (en) 2010-10-28 2012-05-03 Yale University Methods and compositions for assessing and treating cancer
GB201018312D0 (en) 2010-10-29 2010-12-15 Vib Vzw Metagene expression signature for prognosis of breast cancer patients
CA2817697C (en) 2010-11-12 2021-11-16 Gen9, Inc. Methods and devices for nucleic acids synthesis
EP4039363A1 (en) 2010-11-12 2022-08-10 Gen9, Inc. Protein arrays and methods of using and making the same
EP2640403A4 (en) 2010-11-15 2014-04-23 Jua-Nan Lee Generation of neural stem cells from human trophoblast stem cells
EP2772550B1 (en) 2010-11-17 2017-03-29 Interpace Diagnostics, LLC Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms
WO2012069511A1 (en) 2010-11-24 2012-05-31 F. Hoffmann-La Roche Ag Methods for detecting low grade inflammation
DK2643470T3 (en) 2010-11-24 2016-05-17 Univ Yale Preparations and methods for treating ischemic injury with D-DT
JP5754685B2 (en) * 2010-12-02 2015-07-29 国立研究開発法人農業・食品産業技術総合研究機構 How to synthesize a build-up combinatorial library on a substrate
US20140017797A1 (en) 2010-12-13 2014-01-16 De Staadt der Nederlanden, vert doorde minister van VWS Protein affinity tag and uses thereof
KR20120066924A (en) 2010-12-15 2012-06-25 제일모직주식회사 Ortho-nitrobenzyl ester compound and positive type photosensitive resin composition including the same
WO2012083240A2 (en) 2010-12-16 2012-06-21 Dana-Farber Cancer Institute, Inc. Oligonucleotide array for tissue typing
JP2012131718A (en) 2010-12-20 2012-07-12 Samsung Electronics Co Ltd Method for synthesizing compound, microarray, composition for acid transfer, and composition for fabricating biochip
WO2012090073A2 (en) 2010-12-30 2012-07-05 The Netherlands Cancer Institute Methods and compositions for predicting chemotherapy sensitivity
US8951781B2 (en) 2011-01-10 2015-02-10 Illumina, Inc. Systems, methods, and apparatuses to image a sample for biological or chemical analysis
EP2474617A1 (en) 2011-01-11 2012-07-11 InteRNA Technologies BV Mir for treating neo-angiogenesis
WO2012095872A1 (en) 2011-01-13 2012-07-19 Decode Genetics Ehf Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment
US20120190020A1 (en) 2011-01-25 2012-07-26 Aria Diagnostics, Inc. Detection of genetic abnormalities
US9994897B2 (en) 2013-03-08 2018-06-12 Ariosa Diagnostics, Inc. Non-invasive fetal sex determination
US10131947B2 (en) 2011-01-25 2018-11-20 Ariosa Diagnostics, Inc. Noninvasive detection of fetal aneuploidy in egg donor pregnancies
US8756020B2 (en) 2011-01-25 2014-06-17 Ariosa Diagnostics, Inc. Enhanced risk probabilities using biomolecule estimations
US11270781B2 (en) 2011-01-25 2022-03-08 Ariosa Diagnostics, Inc. Statistical analysis for non-invasive sex chromosome aneuploidy determination
US9952237B2 (en) 2011-01-28 2018-04-24 Quanterix Corporation Systems, devices, and methods for ultra-sensitive detection of molecules or particles
PT2672967T (en) 2011-02-07 2018-12-07 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
US9335289B2 (en) 2011-02-07 2016-05-10 The Governing Council Of The University Of Toronto Bioprobes and methods of use thereof
JP6020164B2 (en) 2011-02-10 2016-11-02 三菱レイヨン株式会社 Nucleic acid detection method
EP2673614B1 (en) 2011-02-11 2018-08-01 Raindance Technologies, Inc. Method for forming mixed droplets
EP2675819B1 (en) 2011-02-18 2020-04-08 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
TWI558702B (en) 2011-02-21 2016-11-21 普雷辛肯公司 Solid forms of a pharmaceutically active substance
ES2657927T3 (en) 2011-02-23 2018-03-07 The Board Of Trustees Of The Leland Stanford Junior University Aneuploidy detection methods in human embryos
CN103384832B (en) 2011-02-24 2016-06-29 希尔氏宠物营养品公司 For diagnosing and treat compositions and the method for renal dysfunction in felid
US20120219950A1 (en) 2011-02-28 2012-08-30 Arnold Oliphant Assay systems for detection of aneuploidy and sex determination
EP2681566A2 (en) 2011-02-28 2014-01-08 University of Iowa Research Foundation Anti-müllerian hormone changes in pregnancy and prediction ofadverse pregnancy outcomes and gender
PE20180776A1 (en) 2011-03-02 2018-05-07 Berg Llc CELL-BASED INTERROGATORY TESTS AND THE USE OF THEM
ES2551922T3 (en) 2011-03-07 2015-11-24 Accelerate Diagnostics, Inc. Rapid cell purification systems
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
SG193489A1 (en) 2011-03-18 2013-10-30 Eisai R&D Man Co Ltd Methods and compositions for predicting response to eribulin
CA2831136A1 (en) 2011-03-21 2012-09-27 Biodesy, Llc Classification of kinase inhibitors using nonlinear optical techniques
EP2689028B1 (en) 2011-03-23 2017-08-30 Pacific Biosciences Of California, Inc. Isolation of polymerase-nucleic acid complexes and loading onto substrates
WO2012129758A1 (en) 2011-03-25 2012-10-04 Biomerieux Method and kit for determining in vitro probability for individual to suffer from colorectal cancer
EP2691538A1 (en) 2011-03-28 2014-02-05 Novartis AG Markers associated with cyclin-dependent kinase inhibitors
WO2012134813A1 (en) 2011-03-31 2012-10-04 St. Jude Children's Research Hospital Methods and compositions for identifying minimal residual disease in acute lymphoblastic leukemia
US20120252682A1 (en) 2011-04-01 2012-10-04 Maples Corporate Services Limited Methods and systems for sequencing nucleic acids
EP2694678A2 (en) 2011-04-04 2014-02-12 Netherland Cancer Institute Methods and compositions for predicting resistance to anticancer treatment
WO2012138783A2 (en) 2011-04-04 2012-10-11 Netherlands Cancer Institute Methods and compositions for predicting resistance to anticancer treatment
EP3150750B1 (en) 2011-04-08 2018-12-26 Prognosys Biosciences, Inc. Peptide constructs and assay systems
EP2694554A1 (en) 2011-04-08 2014-02-12 Gilead Biologics, Inc. Methods and compositions for normalization of tumor vasculature by inhibition of loxl2
US20140302532A1 (en) 2011-04-12 2014-10-09 Quanterix Corporation Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury
RU2580609C2 (en) 2011-04-18 2016-04-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Anticancer therapeutic agent
US20140106354A1 (en) 2011-04-18 2014-04-17 Garvan Institute Of Medical Research Method of Diagnosing Cancer
WO2012149339A2 (en) 2011-04-29 2012-11-01 Sequenom, Inc. Quantification of a minority nucleic acid species
EP2527459A1 (en) 2011-05-02 2012-11-28 Rheinische Friedrich-Wilhelms-Universität Bonn Blood-based gene detection of non-small cell lung cancer
EP2520661A1 (en) 2011-05-02 2012-11-07 Rheinische Friedrich-Wilhelms-Universität Bonn Blood-based gene expression signatures in lung cancer
AU2012251027B2 (en) 2011-05-04 2015-03-26 Htg Molecular Diagnostics, Inc. Quantitative nuclease protection Assay (qNPA) and sequencing (qNPS) improvements
CA2836474A1 (en) 2011-05-17 2012-11-22 Plexxikon Inc. Kinase modulation and indications therefor
WO2012156515A1 (en) 2011-05-18 2012-11-22 Rheinische Friedrich-Wilhelms-Universität Bonn Molecular analysis of acute myeloid leukemia
EP2524967A1 (en) 2011-05-19 2012-11-21 Signature Diagnostics AG Methods and kits for diagnosing colorectal cancer
CA2835942C (en) 2011-05-19 2019-01-22 Sequenom, Inc. Products and processes for multiplex nucleic acid identification
EP2524968A1 (en) 2011-05-19 2012-11-21 Signature Diagnostics AG Methods and kits for diagnosing colorectal cancer
CA2836836A1 (en) 2011-06-01 2012-12-06 Medical Prognosis Institute A/S Methods and devices for prognosis of cancer relapse
US10260097B2 (en) 2011-06-02 2019-04-16 Almac Diagnostics Limited Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
AU2012262961A1 (en) 2011-06-02 2013-11-28 Novartis Ag Biomarkers for hedgehog inhibitor therapy
DE202012013668U1 (en) 2011-06-02 2019-04-18 Raindance Technologies, Inc. enzyme quantification
ES2841809T3 (en) 2011-06-03 2021-07-09 Eisai R&D Man Co Ltd Biomarkers to predict and evaluate the degree of response of subjects with thyroid and kidney cancer to lenvatinib compounds
CA2873553C (en) 2011-06-06 2020-01-28 Phasebio Pharmaceuticals, Inc. Use of modified vasoactive intestinal peptides in the treatment of hypertension
WO2012170936A2 (en) 2011-06-09 2012-12-13 Illumina, Inc. Patterned flow-cells useful for nucleic acid analysis
BR112013032354A2 (en) 2011-06-15 2017-01-03 Hills Pet Nutrition Inc COMPOSITIONS AND METHODS FOR DIAGNOSIS AND MONITORING HYPERTHYROIDISM IN A FELINE
LT2721154T (en) 2011-06-15 2019-04-25 Gen9, Inc. Methods for preparative in vitro cloning
US9752176B2 (en) 2011-06-15 2017-09-05 Ginkgo Bioworks, Inc. Methods for preparative in vitro cloning
EP2721176A2 (en) 2011-06-17 2014-04-23 Dana-Farber Cancer Institute, Inc. Signatures for predicting the survivability of myelodysplastic syndrome subjects
JP6117194B2 (en) 2011-06-17 2017-04-19 ミリアド・ジェネティックス・インコーポレイテッド Methods and materials for assessing allelic imbalance
EP2723901B1 (en) 2011-06-22 2018-08-08 Yale University Compositions and methods of diagnosing diseases and disorders associated with cell death
US20140235474A1 (en) 2011-06-24 2014-08-21 Sequenom, Inc. Methods and processes for non invasive assessment of a genetic variation
WO2013009705A2 (en) 2011-07-09 2013-01-17 The Trustees Of Columbia University In The City Of New York Biomarkers, methods, and compositions for inhibiting a multi-cancer mesenchymal transition mechanism
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
KR101545826B1 (en) 2011-07-25 2015-08-19 씨에스아이알 Array printing
US8723140B2 (en) 2011-08-09 2014-05-13 Palo Alto Research Center Incorporated Particle analyzer with spatial modulation and long lifetime bioprobes
US9029800B2 (en) 2011-08-09 2015-05-12 Palo Alto Research Center Incorporated Compact analyzer with spatial modulation and multiple intensity modulated excitation sources
EP3954770A1 (en) 2011-08-26 2022-02-16 Gen9, Inc. Compositions and methods for high fidelity assembly of nucleic acids
WO2013033073A1 (en) 2011-08-31 2013-03-07 Ventana Medical Systems, Inc. Expression of ets related gene (erg) and phosphatase and tensin homolog (pten) correlates with prostate cancer capsular penetration
US8712697B2 (en) 2011-09-07 2014-04-29 Ariosa Diagnostics, Inc. Determination of copy number variations using binomial probability calculations
EP2763540A4 (en) 2011-09-09 2015-04-22 Univ Yale Compositions and methods for assessing and treating inflammatory diseases and disorders
US9644241B2 (en) 2011-09-13 2017-05-09 Interpace Diagnostics, Llc Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease
CA2849306C (en) 2011-09-22 2020-10-27 Medvet Science Pty. Ltd. Use of 14-3-3.zeta. expression for diagnosis of schizophrenia
JP2013083639A (en) 2011-09-26 2013-05-09 Toto Ltd Method for specifically detecting test substance
SG10201602144PA (en) 2011-10-03 2016-04-28 Celmatix Inc Methods and devices for assessing risk to a putative offspring of developing a condition
WO2013052907A2 (en) 2011-10-06 2013-04-11 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10424394B2 (en) 2011-10-06 2019-09-24 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9984198B2 (en) 2011-10-06 2018-05-29 Sequenom, Inc. Reducing sequence read count error in assessment of complex genetic variations
US9367663B2 (en) 2011-10-06 2016-06-14 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9566560B2 (en) 2011-10-06 2017-02-14 Illumina, Inc. Array domains having rotated patterns
US10196681B2 (en) 2011-10-06 2019-02-05 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US20130090329A1 (en) 2011-10-07 2013-04-11 Suregene, Llc Methods and Compositions for the Treatment of Psychotic Disorders Through the Identification of the Olanzapine Poor Response Predictor Genetic Signature
EP2766483B1 (en) 2011-10-10 2022-03-23 The Hospital For Sick Children Methods and compositions for screening and treating developmental disorders
EP2766498B1 (en) 2011-10-14 2019-06-19 President and Fellows of Harvard College Sequencing by structure assembly
US9347900B2 (en) 2011-10-14 2016-05-24 Pacific Biosciences Of California, Inc. Real-time redox sequencing
CA2852949A1 (en) 2011-10-19 2013-04-25 Nugen Technologies, Inc. Compositions and methods for directional nucleic acid amplification and sequencing
EP2768985B1 (en) 2011-10-21 2019-03-20 Chronix Biomedical Colorectal cancer associated circulating nucleic acid biomarkers
US20130157884A1 (en) 2011-10-26 2013-06-20 Asuragen, Inc. Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts
EP2771487A1 (en) 2011-10-27 2014-09-03 Asuragen, INC. Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors
JP6238900B2 (en) 2011-10-28 2017-11-29 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Biomarkers of response to NAE inhibitors
CA3003082C (en) 2011-10-28 2020-12-15 Illumina, Inc. Microarray fabrication system and method
US10837879B2 (en) 2011-11-02 2020-11-17 Complete Genomics, Inc. Treatment for stabilizing nucleic acid arrays
US10100092B2 (en) 2011-11-03 2018-10-16 Vca, Inc. Compositions and methods to detect various infectious organisms
EP2773779B1 (en) 2011-11-04 2020-10-14 Population Bio, Inc. Methods and compositions for diagnosing, prognosing, and treating neurological conditions
US9212381B2 (en) 2011-11-10 2015-12-15 President And Fellows Of Harvard College Methods and compositions for labeling polypeptides
EP2776586B1 (en) 2011-11-11 2018-03-07 Millennium Pharmaceuticals, Inc. Biomarkers of response to proteasome inhibitors
EP2776043B1 (en) 2011-11-11 2018-02-21 Millennium Pharmaceuticals, Inc. Biomarkers of response to proteasome inhibitors
SG11201402392QA (en) 2011-11-18 2014-06-27 Alnylam Pharmaceuticals Inc Rnai agents, compositions and methods of use thereof for treating transthyretin (ttr) associated diseases
AU2012340192B2 (en) 2011-11-18 2016-04-07 Memorial Sloan-Kettering Cancer Center 2-hydroxyglutarate as a biomarker for chronic hypoxia
US10437858B2 (en) 2011-11-23 2019-10-08 23Andme, Inc. Database and data processing system for use with a network-based personal genetics services platform
US9958386B2 (en) * 2011-11-30 2018-05-01 Sony Corporation Chemical sensor, chemical sensor module, chemical substance detection apparatus, and chemical substance detection method
US20140017174A1 (en) 2011-11-30 2014-01-16 Raja Atreya Methods and compositions for determining responsiveness to treatment with a tnf-alpha inhibitor
EP3483288B1 (en) 2011-11-30 2022-03-16 Children's Hospital Medical Center Personalized pain management and anesthesia: preemptive risk identification
US9970984B2 (en) 2011-12-01 2018-05-15 Life Technologies Corporation Method and apparatus for identifying defects in a chemical sensor array
US8748097B1 (en) 2011-12-02 2014-06-10 President And Fellows Of Harvard College Identification of agents for treating calcium disorders and uses thereof
WO2013087789A1 (en) 2011-12-13 2013-06-20 Glykos Finland Ltd. Antibody isoform arrays and methods thereof
US10513737B2 (en) 2011-12-13 2019-12-24 Decipher Biosciences, Inc. Cancer diagnostics using non-coding transcripts
WO2013095935A1 (en) 2011-12-19 2013-06-27 Hill's Pet Nutrition, Inc. Compositions and methods for diagnosing and treating hyperthyroidism in companion animals
US9366669B2 (en) 2011-12-20 2016-06-14 Siemens Healthcare Diagnostics Inc. Coated substrates for high energy capture phase binding and methods of production and use thereof
CN107267598B (en) 2011-12-21 2022-03-25 美瑞德生物工程公司 Methods and materials for assessing loss of heterozygosity
WO2013096819A2 (en) 2011-12-22 2013-06-27 Ibis Biosciences, Inc. Macromolecule positioning by electrical potential
US9823246B2 (en) 2011-12-28 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Fluorescence enhancing plasmonic nanoscopic gold films and assays based thereon
US9803231B2 (en) 2011-12-29 2017-10-31 Ibis Biosciences, Inc. Macromolecule delivery to nanowells
US9316647B2 (en) 2011-12-30 2016-04-19 Somalogic, Inc. Aptamers and diagnostic methods for detecting the EGF receptor
WO2013101771A2 (en) 2011-12-30 2013-07-04 Genentech, Inc. Compositions and method for treating autoimmune diseases
BR112014017320A2 (en) 2012-01-13 2018-05-29 Genentech Inc method for determining whether a patient is prone to respond to treatment with a vegf antagonist, method for optimizing the therapeutic efficacy of a vegf antagonist, method for selecting a therapy, method for identifying a biomarker, and method for diagnosing an angiogenic disorder
US8821798B2 (en) 2012-01-19 2014-09-02 Life Technologies Corporation Titanium nitride as sensing layer for microwell structure
US8747748B2 (en) 2012-01-19 2014-06-10 Life Technologies Corporation Chemical sensor with conductive cup-shaped sensor surface
EP4148739A1 (en) 2012-01-20 2023-03-15 Sequenom, Inc. Diagnostic processes that factor experimental conditions
EP2807271B1 (en) 2012-01-24 2018-08-22 CD Diagnostics, Inc. System for detecting infection in synovial fluid
EP3578697B1 (en) 2012-01-26 2024-03-06 Tecan Genomics, Inc. Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
US9135497B2 (en) 2012-01-27 2015-09-15 National Instruments Corporation Identifying randomly distributed microparticles in images to sequence a polynucleotide
CA3191015A1 (en) 2012-02-07 2013-08-15 Vibrant Holdings, Llc Substrates, peptide arrays, and methods
CA2863887C (en) 2012-02-09 2023-01-03 Population Diagnostics, Inc. Methods of screening low frequency gdna variation biomarkers for pervasive developmental disorder (pdd) or pervasive developmental disorder - not otherwise specified (pdd_nos)
EP2814514B1 (en) 2012-02-16 2017-09-13 Atyr Pharma, Inc. Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
US10202628B2 (en) 2012-02-17 2019-02-12 President And Fellows Of Harvard College Assembly of nucleic acid sequences in emulsions
GB2501611B (en) 2012-02-21 2015-03-04 Cytonics Corp Alpha-2-macroglobulin compositions and therapeutic uses
SG11201404285VA (en) 2012-02-22 2014-10-30 Univ Pennsylvania Compositions and methods for generating a persisting population of t cells useful for the treatment of cancer
CA3080441A1 (en) 2012-02-23 2013-09-06 The Children's Hospital Corporation Methods for predicting anti-cancer response
WO2013124740A2 (en) 2012-02-23 2013-08-29 Stichting Vu-Vumc BRCA DEFICIENCY PROTEIN AND mRNA SIGNATURES USEFUL IN IDENTIFICATION OF PATIENTS WITH BRCA-DEFICIENT TUMORS AND PREDICTING BENEFIT OF ANTI-CANCER THERAPY IN CANCER PATIENTS
ES2776673T3 (en) 2012-02-27 2020-07-31 Univ North Carolina Chapel Hill Methods and uses for molecular tags
SG11201405274WA (en) 2012-02-27 2014-10-30 Cellular Res Inc Compositions and kits for molecular counting
US9670529B2 (en) 2012-02-28 2017-06-06 Population Genetics Technologies Ltd. Method for attaching a counter sequence to a nucleic acid sample
US9605313B2 (en) 2012-03-02 2017-03-28 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
ES2662128T3 (en) 2012-03-05 2018-04-05 Adaptive Biotechnologies Corporation Determination of paired immune receptor chains from the frequency of matching subunits
US9150853B2 (en) 2012-03-21 2015-10-06 Gen9, Inc. Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis
WO2013144202A1 (en) 2012-03-29 2013-10-03 Roche Diagnostics Gmbh Biomarkers for discriminating healthy and/or non-malignant neoplastic colorectal cells from colorectal cancer cells
RU2666627C2 (en) 2012-03-30 2018-09-11 Дженентек, Инк. Methods of diagnosis and composition for cancer treatment
EP2834366A4 (en) 2012-04-02 2016-04-27 Berg Llc Interrogatory cell-based assays and uses thereof
US20140018253A1 (en) 2012-04-05 2014-01-16 Oregon Health And Science University Gene expression panel for breast cancer prognosis
EP2841601B1 (en) 2012-04-24 2019-03-06 Gen9, Inc. Methods for sorting nucleic acids and multiplexed preparative in vitro cloning
MA37475A1 (en) 2012-05-04 2016-05-31 Novartis Ag Biomarkers for iap inhibitor therapy
ES2582554T3 (en) 2012-05-08 2016-09-13 Adaptive Biotechnologies Corporation Compositions and method for measuring and calibrating amplification bias in multiplexed PCR reactions
WO2013167387A1 (en) 2012-05-10 2013-11-14 Ventana Medical Systems, Inc. Uniquely specific probes for pten, pik3ca, met, top2a, and mdm2
ES2749514T3 (en) 2012-05-11 2020-03-20 Clinical Genomics Pty Ltd Colorectal Cancer Diagnostic Genetic Markers Panel
EP2850212B1 (en) 2012-05-18 2020-01-01 Clinical Genomics Pty. Ltd. A method of screening for colorectal cancer
US10458915B2 (en) 2012-05-18 2019-10-29 Pacific Biosciences Of California, Inc. Heteroarylcyanine dyes
EP2852671B1 (en) 2012-05-21 2018-08-22 The Regents of the University of California Generation of human ips cells by a synthetic self- replicative rna
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10289800B2 (en) 2012-05-21 2019-05-14 Ariosa Diagnostics, Inc. Processes for calculating phased fetal genomic sequences
US8786331B2 (en) 2012-05-29 2014-07-22 Life Technologies Corporation System for reducing noise in a chemical sensor array
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
US9914967B2 (en) 2012-06-05 2018-03-13 President And Fellows Of Harvard College Spatial sequencing of nucleic acids using DNA origami probes
US11091808B2 (en) 2012-06-07 2021-08-17 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (BRCA1/2) in human tumors
EP3339861B8 (en) 2012-06-15 2023-11-01 Genesis Theranostix Korlatolt Felelossegu Tarsasag Biomarker test for prediction or early detection of preeclampsia
EP3182126A3 (en) 2012-06-15 2017-08-02 Wayne State University Biomarker test for prediction or early detection of preeclampsia and/or hellp syndrome
US9957549B2 (en) 2012-06-18 2018-05-01 Nugen Technologies, Inc. Compositions and methods for negative selection of non-desired nucleic acid sequences
US10497461B2 (en) 2012-06-22 2019-12-03 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
JP6509727B2 (en) 2012-06-25 2019-05-15 ギンゴー バイオワークス, インコーポレイテッド Methods for nucleic acid assembly and high-throughput sequencing
EP2870263A1 (en) 2012-07-03 2015-05-13 InteRNA Technologies B.V. Diagnostic portfolio and its uses
US20150011396A1 (en) 2012-07-09 2015-01-08 Benjamin G. Schroeder Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
EP3309263B1 (en) 2012-07-09 2019-12-25 Novartis AG Biomarkers associated with cdk inhibitors
WO2014009245A2 (en) 2012-07-09 2014-01-16 Qithera Gmbh Novel drug target indentification methods
WO2014011928A1 (en) 2012-07-13 2014-01-16 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
CA2878280A1 (en) 2012-07-19 2014-01-23 Ariosa Diagnostics, Inc. Multiplexed sequential ligation-based detection of genetic variants
CN108875312A (en) 2012-07-19 2018-11-23 哈佛大学校长及研究员协会 Utilize the method for nucleic acid storage information
WO2014015217A1 (en) 2012-07-19 2014-01-23 Vertex Pharmaceuticals Incorporated Biomarkers for hcv infected patients
WO2014012147A1 (en) 2012-07-20 2014-01-23 Latrobe University Method of diagnosis and treatment
EP2877494B1 (en) 2012-07-23 2020-07-15 La Jolla Institute for Allergy and Immunology Ptprs and proteoglycans in autoimmune disease
WO2014018567A1 (en) 2012-07-24 2014-01-30 Pharmacyclics, Inc. Mutations associated with resistance to inhibitors of bruton's tyrosine kinase (btk)
BR112015001521A2 (en) 2012-07-27 2017-11-07 Novartis Ag prediction of treatment response for jak / stat inhibitor
EP2880447B1 (en) 2012-07-31 2019-05-15 Novartis AG Markers associated with sensitivity to inhibitors of human double minute 2 (mdm2)
US11035005B2 (en) 2012-08-16 2021-06-15 Decipher Biosciences, Inc. Cancer diagnostics using biomarkers
CA2881823C (en) 2012-08-20 2019-06-11 Illumina, Inc. Method and system for fluorescence lifetime based sequencing
US11913065B2 (en) 2012-09-04 2024-02-27 Guardent Health, Inc. Systems and methods to detect rare mutations and copy number variation
KR102393608B1 (en) 2012-09-04 2022-05-03 가던트 헬쓰, 인크. Systems and methods to detect rare mutations and copy number variation
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US10876152B2 (en) 2012-09-04 2020-12-29 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
AU2013202506B2 (en) 2012-09-07 2015-06-18 Celgene Corporation Resistance biomarkers for hdac inhibitors
WO2014043519A1 (en) 2012-09-14 2014-03-20 Population Diagnostics Inc. Methods and compositions for diagnosing, prognosing, and treating neurological conditions
WO2014048942A1 (en) 2012-09-25 2014-04-03 Ventana Medical Systems, Inc. Probes for pten, pik3ca, met, and top2a, and method for using the probes
WO2014052855A1 (en) 2012-09-27 2014-04-03 Population Diagnostics, Inc. Methods and compositions for screening and treating developmental disorders
US10006909B2 (en) 2012-09-28 2018-06-26 Vibrant Holdings, Llc Methods, systems, and arrays for biomolecular analysis
CA3178433A1 (en) 2012-09-28 2014-04-03 Vibrant Holdings, Llc Methods, systems, and arrays for biomolecular analysis
JP6486826B2 (en) 2012-10-01 2019-03-20 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Biomarkers and methods for predicting response to inhibitors and uses thereof
US20140094432A1 (en) 2012-10-02 2014-04-03 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
US10482994B2 (en) 2012-10-04 2019-11-19 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US20140100124A1 (en) 2012-10-04 2014-04-10 Asuragen, Inc. Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions
US9177098B2 (en) 2012-10-17 2015-11-03 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
US10162800B2 (en) 2012-10-17 2018-12-25 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
US9476089B2 (en) 2012-10-18 2016-10-25 President And Fellows Of Harvard College Methods of making oligonucleotide probes
US20150354006A1 (en) 2012-10-19 2015-12-10 Novartis Ag Markers for acute lymphoblastic leukemia
EP2722105A1 (en) 2012-10-22 2014-04-23 Universität Wien Method of in situ synthesizing microarrays
CN104769410B (en) 2012-11-06 2018-07-27 拜奥-多特公司 The controlled printing of cell sample for karyotyping
WO2014074942A1 (en) 2012-11-08 2014-05-15 Illumina, Inc. Risk variants of alzheimer's disease
US10286376B2 (en) 2012-11-14 2019-05-14 Vibrant Holdings, Llc Substrates, systems, and methods for array synthesis and biomolecular analysis
CA2891651C (en) 2012-11-14 2019-01-22 Vibrant Holdings, Llc Substrates, systems, and methods for array synthesis and biomolecular analysis
AU2013202507B9 (en) 2012-11-14 2015-08-13 Celgene Corporation Inhibition of drug resistant cancer cells
WO2014078652A1 (en) 2012-11-16 2014-05-22 Zs Genetics, Inc. Heavy atom labeled nucleosides, nucleotides, and nucleic acid polymers, and uses thereof
GB201220924D0 (en) 2012-11-21 2013-01-02 Cancer Res Inst Royal Materials and methods for determining susceptibility or predisposition to cancer
WO2014085434A1 (en) 2012-11-27 2014-06-05 Pontificia Universidad Catolica De Chile Compositions and methods for diagnosing thyroid tumors
BR112015012295A8 (en) 2012-11-28 2023-03-14 Merck Sharp & Dohme USE OF A WEE1 INHIBITOR, E, KIT TO IDENTIFY A PATIENT WITH CANCER
CA3137404A1 (en) 2012-11-30 2014-06-05 Accelerated Biosciences Corp. Pancreatic progenitor cells expressing betatrophin and insulin
SG11201504023SA (en) 2012-12-03 2015-06-29 Almac Diagnostics Ltd Molecular diagnostic test for cancer
JP6574383B2 (en) 2012-12-05 2019-09-11 アルナイラム ファーマシューティカルズ, インコーポレイテッドAlnylam Pharmaceuticals, Inc. PCSK9 iRNA composition and method of use thereof
EP2848690B1 (en) 2012-12-12 2020-08-19 The Broad Institute, Inc. Crispr-cas component systems, methods and compositions for sequence manipulation
ES2701749T3 (en) 2012-12-12 2019-02-25 Broad Inst Inc Methods, models, systems and apparatus to identify target sequences for Cas enzymes or CRISPR-Cas systems for target sequences and transmit results thereof
SG10201801969TA (en) 2012-12-12 2018-04-27 Broad Inst Inc Engineering and Optimization of Improved Systems, Methods and Enzyme Compositions for Sequence Manipulation
EP2931899A1 (en) 2012-12-12 2015-10-21 The Broad Institute, Inc. Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
ES2883590T3 (en) 2012-12-12 2021-12-09 Broad Inst Inc Supply, modification and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications
US8993233B2 (en) 2012-12-12 2015-03-31 The Broad Institute Inc. Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains
US9836577B2 (en) 2012-12-14 2017-12-05 Celmatix, Inc. Methods and devices for assessing risk of female infertility
AU2013364953A1 (en) 2012-12-21 2015-04-30 Eisai R&D Management Co., Ltd. Amorphous form of quinoline derivative, and method for producing same
WO2014100626A1 (en) 2012-12-21 2014-06-26 Hutman Diagnostics AG Microarrays
US9080968B2 (en) 2013-01-04 2015-07-14 Life Technologies Corporation Methods and systems for point of use removal of sacrificial material
US9841398B2 (en) 2013-01-08 2017-12-12 Life Technologies Corporation Methods for manufacturing well structures for low-noise chemical sensors
US9932626B2 (en) 2013-01-15 2018-04-03 Quanterix Corporation Detection of DNA or RNA using single molecule arrays and other techniques
EP2946345B1 (en) 2013-01-17 2024-04-03 Personalis, Inc. Methods and systems for genetic analysis
US20140206841A1 (en) * 2013-01-18 2014-07-24 Protein Technologies, Inc. Peptide Synthesis Apparatus and Methods Using Infrared Energy
US20140205613A1 (en) 2013-01-21 2014-07-24 Abbvie Inc. Anti-tnf and anti-il 17 combination therapy biomarkers for inflammatory disease
US20130309666A1 (en) 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US8962366B2 (en) 2013-01-28 2015-02-24 Life Technologies Corporation Self-aligned well structures for low-noise chemical sensors
US9896728B2 (en) 2013-01-29 2018-02-20 Arcticrx Ltd. Method for determining a therapeutic approach for the treatment of age-related macular degeneration (AMD)
US9411930B2 (en) 2013-02-01 2016-08-09 The Regents Of The University Of California Methods for genome assembly and haplotype phasing
CN108624668B (en) 2013-02-01 2022-12-02 加利福尼亚大学董事会 Methods for genome assembly and haplotype phasing
US10568975B2 (en) 2013-02-05 2020-02-25 The Johns Hopkins University Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
JP2016514091A (en) 2013-02-08 2016-05-19 ミスフォールディング ダイアグノスティクス, インコーポレイテッド Transthyretin antibodies and uses thereof
CN105143467B (en) 2013-02-14 2019-08-27 科罗拉多大学董事会,法人团体 Method for predicting the risk of interstitial pneumonia
EP2956771B1 (en) 2013-02-15 2020-04-08 Vibrant Holdings, LLC Methods and compositions for amplified electrochemiluminescence detection
RU2015140573A (en) 2013-02-25 2017-03-30 Дженентек, Инк. METHODS AND COMPOSITIONS FOR DETECTION AND TREATMENT OF DRUG-RESISTANT MUTANT RESISTANT TO MEDICINES
US9512422B2 (en) 2013-02-26 2016-12-06 Illumina, Inc. Gel patterned surfaces
DK2962100T3 (en) 2013-02-28 2021-11-01 Caprion Proteomics Inc TUBERCULOSEBIOMARKEARS AND USES THEREOF
US9267171B2 (en) 2013-02-28 2016-02-23 New York University DNA photolithography with cinnamate crosslinkers
WO2014164594A1 (en) 2013-03-11 2014-10-09 Meso Scale Technologies, Llc. Improved methods for conducting multiplexed assays
TWI582239B (en) 2013-03-11 2017-05-11 諾華公司 Markers associated with wnt inhibitors
EP3597774A1 (en) 2013-03-13 2020-01-22 Sequenom, Inc. Primers for dna methylation analysis
US8963216B2 (en) 2013-03-13 2015-02-24 Life Technologies Corporation Chemical sensor with sidewall spacer sensor surface
US8841217B1 (en) 2013-03-13 2014-09-23 Life Technologies Corporation Chemical sensor with protruded sensor surface
WO2014159242A1 (en) 2013-03-14 2014-10-02 Novartis Ag Notch 3 mutants and uses thereof
WO2014160080A1 (en) 2013-03-14 2014-10-02 Children's Medical Center Corporation Cancer diagnosis, treatment selection and treatment
KR20230162998A (en) 2013-03-14 2023-11-29 알닐람 파마슈티칼스 인코포레이티드 Complement component c5 irna compositions and methods of use thereof
US9146248B2 (en) 2013-03-14 2015-09-29 Intelligent Bio-Systems, Inc. Apparatus and methods for purging flow cells in nucleic acid sequencing instruments
EP2970479B1 (en) 2013-03-14 2019-04-24 Novartis AG Antibodies against notch 3
US20140274749A1 (en) 2013-03-15 2014-09-18 Affymetrix, Inc. Systems and Methods for SNP Characterization and Identifying off Target Variants
US9116117B2 (en) 2013-03-15 2015-08-25 Life Technologies Corporation Chemical sensor with sidewall sensor surface
EP3404116B1 (en) 2013-03-15 2022-10-19 The University of Chicago Methods and compositions related to t-cell activity
US9758835B2 (en) 2013-03-15 2017-09-12 Baylor Research Institute Ulcerative colitis (UC)-associated colorectal neoplasia markers
US9591268B2 (en) 2013-03-15 2017-03-07 Qiagen Waltham, Inc. Flow cell alignment methods and systems
CA2907377A1 (en) 2013-03-15 2014-09-18 Baylor Research Institute Tissue and blood-based mirna biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer
US10535420B2 (en) 2013-03-15 2020-01-14 Affymetrix, Inc. Systems and methods for probe design to detect the presence of simple and complex indels
US9835585B2 (en) 2013-03-15 2017-12-05 Life Technologies Corporation Chemical sensor with protruded sensor surface
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
CN105264366B (en) 2013-03-15 2019-04-16 生命科技公司 Chemical sensor with consistent sensor surface area
GB2525568B (en) 2013-03-15 2020-10-14 Abvitro Llc Single cell barcoding for antibody discovery
EP2971130A4 (en) 2013-03-15 2016-10-05 Nugen Technologies Inc Sequential sequencing
EP2972279B1 (en) 2013-03-15 2021-10-06 Life Technologies Corporation Chemical sensors with consistent sensor surface areas
US10006919B2 (en) 2013-03-15 2018-06-26 Arizona Board Of Regents On Behalf Of Arizona State University Peptide array quality control
CN105051525B (en) 2013-03-15 2019-07-26 生命科技公司 Chemical device with thin conducting element
US9970932B2 (en) 2013-03-15 2018-05-15 Arizona Board Of Regents On Behalf Of Arizona State University Non-covalent patterned chemical features and use thereof in MALDI-based quality control
EP3633048B1 (en) 2013-03-27 2022-10-12 Alan Handyside Assessment of risk of aneuploidy
EP4187543A1 (en) 2013-04-03 2023-05-31 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
WO2014169928A1 (en) * 2013-04-17 2014-10-23 Karlsruher Institut für Technologie Method for combinatorial particle manipulation for producing high-density molecular arrays, particularly peptide arrays, and molecular arrays which can be obtained therefrom
WO2014176047A1 (en) 2013-04-25 2014-10-30 Novartis Ag Markers for ezh2 inhibitors
MX2015015115A (en) 2013-05-01 2016-06-07 Five Prime Therapeutics Inc Methods of treating cancer.
EP2994544B1 (en) 2013-05-06 2019-10-02 Pacific Biosciences Of California, Inc. Real-time electronic sequencing
US20140336063A1 (en) 2013-05-09 2014-11-13 Life Technologies Corporation Windowed Sequencing
US10517861B2 (en) 2013-05-14 2019-12-31 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
WO2014187308A2 (en) 2013-05-21 2014-11-27 生物梅里埃股份公司 Colorectal cancer prognosis agent kit
HUE038146T2 (en) 2013-05-22 2018-09-28 Alnylam Pharmaceuticals Inc Serpina1 irna compositions and methods of use thereof
KR102365809B1 (en) 2013-05-22 2022-02-23 알닐람 파마슈티칼스 인코포레이티드 Tmprss6 compositions and methods of use thereof
WO2014190147A2 (en) 2013-05-23 2014-11-27 Five Prime Therapeutics, Inc. Methods of treating cancer
CN112575075A (en) 2013-05-24 2021-03-30 塞昆纳姆股份有限公司 Methods and processes for non-invasive assessment of genetic variation
WO2014195032A1 (en) 2013-06-07 2014-12-11 Medical Prognosis Institute A/S Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients
US10458942B2 (en) 2013-06-10 2019-10-29 Life Technologies Corporation Chemical sensor array having multiple sensors per well
JP6697380B2 (en) 2013-06-10 2020-05-20 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Early developmental genomic assay to characterize the utility and safety of pluripotent stem cells
EP3663414B1 (en) 2013-06-13 2023-11-22 Roche Diagnostics GmbH Statistical analysis for non-invasive y chromosome aneuploidy determination
CN105308073B (en) 2013-06-14 2019-08-13 加利福尼亚太平洋生物科学股份有限公司 Double biotinylation tags
US10544449B2 (en) 2013-06-14 2020-01-28 Pacific Biosciences Of California, Inc. Bis-biotinylation tags
EP3011034B1 (en) 2013-06-17 2019-08-07 The Broad Institute, Inc. Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using viral components
CA2915837A1 (en) 2013-06-17 2014-12-24 The Broad Institute, Inc. Optimized crispr-cas double nickase systems, methods and compositions for sequence manipulation
EP3011032B1 (en) 2013-06-17 2019-10-16 The Broad Institute, Inc. Delivery, engineering and optimization of systems, methods and compositions for targeting and modeling diseases and disorders of post mitotic cells
BR112015031608A2 (en) 2013-06-17 2017-08-22 Massachusetts Inst Technology APPLICATION AND USE OF CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR LIVER TARGETING AND THERAPY
DK3011029T3 (en) 2013-06-17 2020-03-16 Broad Inst Inc ADMINISTRATION, MODIFICATION AND OPTIMIZATION OF TANDEM GUIDE SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION
US10622094B2 (en) 2013-06-21 2020-04-14 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9069358B2 (en) 2013-06-24 2015-06-30 Biolytic Lab Performance, Inc. System for controlling and optimizing reactions in solid phase synthesis of small molecules
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
US9404922B2 (en) 2013-07-15 2016-08-02 The Rockefeller University Recombinant phages and proteins
TWI805996B (en) 2013-08-05 2023-06-21 美商扭轉生物科技有限公司 De novo synthesized gene libraries
JP6463359B2 (en) 2013-08-12 2019-01-30 ジェネンテック, インコーポレイテッド Compositions and methods for treating complement related conditions
GB201314721D0 (en) * 2013-08-16 2013-10-02 Almagen Ltd A method of selectively masking one or more sites on a surface and a method of synthesising an array of molecules
US9683937B2 (en) * 2013-08-23 2017-06-20 Semiconductor Components Industries, Llc Imaging devices for molecule detection
EP3038635A4 (en) 2013-08-28 2017-04-05 Cytonics Corporation Systems, compositions, and methods for transplantation and treating conditions
SG10201806890VA (en) 2013-08-28 2018-09-27 Cellular Res Inc Massively parallel single cell analysis
WO2015031604A1 (en) 2013-08-28 2015-03-05 Crown Bioscience, Inc. Gene expression signatures predictive of subject response to a multi-kinase inhibitor and methods of using the same
US10456470B2 (en) 2013-08-30 2019-10-29 Genentech, Inc. Diagnostic methods and compositions for treatment of glioblastoma
EP3039161B1 (en) 2013-08-30 2021-10-06 Personalis, Inc. Methods and systems for genomic analysis
JP6683615B2 (en) 2013-09-19 2020-04-22 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー Methods and compositions for producing hepatocyte-like cells
TW201610151A (en) 2013-09-23 2016-03-16 阿尼拉製藥公司 Methods for treating or preventing transthyretin (TTR) associated diseases
CN112592975A (en) 2013-09-23 2021-04-02 芝加哥大学 Methods and compositions relating to DNA damaging agents for cancer treatment
US9352315B2 (en) 2013-09-27 2016-05-31 Taiwan Semiconductor Manufacturing Company, Ltd. Method to produce chemical pattern in micro-fluidic structure
KR102392423B1 (en) 2013-10-02 2022-05-02 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 Wnt compositions and methods for purification
WO2015051275A1 (en) 2013-10-03 2015-04-09 Personalis, Inc. Methods for analyzing genotypes
SG11201602540XA (en) 2013-10-03 2016-04-28 Oklahoma Med Res Found Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
WO2015051163A2 (en) 2013-10-04 2015-04-09 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9582877B2 (en) 2013-10-07 2017-02-28 Cellular Research, Inc. Methods and systems for digitally counting features on arrays
CN105874082B (en) 2013-10-07 2020-06-02 塞昆纳姆股份有限公司 Methods and processes for non-invasive assessment of chromosomal changes
EP3058091B1 (en) 2013-10-18 2020-03-25 The Broad Institute, Inc. Spatial and cellular mapping of biomolecules in situ by high-throughput sequencing
EP3060685B1 (en) 2013-10-23 2019-05-01 F. Hoffmann-La Roche AG Method of predicting the response of an asthma patient to therapy
EP3066218B1 (en) 2013-11-05 2018-12-26 HTG Molecular Diagnostics, Inc. Methods for detecting nucleic acids
WO2015069790A1 (en) 2013-11-06 2015-05-14 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method for subtyping lymphoma types by means expression profiling
DK3511422T3 (en) 2013-11-12 2023-02-06 Population Bio Inc METHODS AND COMPOSITIONS FOR DIAGNOSING, PROGNOSIS AND TREATMENT OF ENDOMETRIOSIS
CN105849264B (en) 2013-11-13 2019-09-27 纽亘技术公司 For identifying the composition and method that repeat sequencing reading
US11149316B2 (en) 2013-12-09 2021-10-19 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (BRCA1/2) in human tumors
AU2014362262B2 (en) 2013-12-12 2021-05-13 Alnylam Pharmaceuticals, Inc. Complement component iRNA compositions and methods of use thereof
BR112016013213A2 (en) 2013-12-12 2017-12-05 Massachusetts Inst Technology administration, use and therapeutic applications of crisper systems and compositions for targeting disorders and diseases using particle delivery components
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
EP3084003A4 (en) 2013-12-17 2017-07-19 Merck Sharp & Dohme Corp. Ifn-gamma gene signature biomarkers of tumor response to pd-1 antagonists
ES2837437T3 (en) 2013-12-20 2021-06-30 Univ Lausanne Diagnostic, prognostic and therapeutic uses of long non-coding RNAs for heart disease and regenerative medicine
NZ630311A (en) 2013-12-27 2016-03-31 Celgene Corp Romidepsin formulations and uses thereof
CN106062214B (en) 2013-12-28 2020-06-09 夸登特健康公司 Methods and systems for detecting genetic variations
WO2015103367A1 (en) 2013-12-31 2015-07-09 Raindance Technologies, Inc. System and method for detection of rna species
US20150259743A1 (en) 2013-12-31 2015-09-17 Roche Nimblegen, Inc. Methods of assessing epigenetic regulation of genome function via dna methylation status and systems and kits therefor
WO2015109234A1 (en) 2014-01-16 2015-07-23 Illumina, Inc. Gene expression panel for prognosis of prostate cancer recurrence
WO2015116627A1 (en) 2014-01-29 2015-08-06 Arizona Board Of Regents On Behalf Of Arizona State University Microreactor array platform
WO2015120130A1 (en) 2014-02-07 2015-08-13 Novartis Ag Impact of genetic factors on disease progression and response to anti-c5 antibody in geographic atrophy
GB201409479D0 (en) 2014-05-28 2014-07-09 Almac Diagnostics Ltd Molecular diagnostic test for cancer
BR112016018205A8 (en) 2014-02-08 2018-04-17 Genentech Inc methods of treating alzheimer's disease, patient selection, patient identification, prediction, therapeutic efficacy optimization, kit, agent use and in vitro agent use
NZ724210A (en) 2014-02-21 2017-10-27 Vibrant Holdings Llc Selective photo activation of amino acids for single step peptide coupling
WO2015127242A1 (en) 2014-02-21 2015-08-27 President And Fellows Of Harvard College De novo design of allosteric proteins
CA2940422A1 (en) 2014-02-24 2015-08-27 Children's Hospital Medical Center Methods and compositions for personalized pain management
US9745614B2 (en) 2014-02-28 2017-08-29 Nugen Technologies, Inc. Reduced representation bisulfite sequencing with diversity adaptors
CA2941612A1 (en) 2014-03-05 2015-09-11 Adaptive Biotechnologies Corporation Methods using randomer-containing synthetic molecules
EP3117011B1 (en) 2014-03-13 2020-05-06 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
JP2017509336A (en) 2014-03-20 2017-04-06 ファーマサイクリックス エルエルシー Mutations associated with phospholipase C gamma 2 and resistance
WO2015148919A2 (en) 2014-03-27 2015-10-01 Yale University Circulating micrornas as biomarkers for endometriosis
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
ES2777529T3 (en) 2014-04-17 2020-08-05 Adaptive Biotechnologies Corp Quantification of adaptive immune cell genomes in a complex mixture of cells
EP3139949B1 (en) 2014-05-08 2020-07-29 Phasebio Pharmaceuticals, Inc. Compositions comprising a vip-elp fusion protein for use in treating cystic fibrosis
MX2016014824A (en) 2014-05-13 2017-03-23 Bioatla Llc Conditionally active biological proteins.
EP3149209B1 (en) 2014-05-30 2021-02-17 Genecentric Therapeutics, Inc. Methods for typing of lung cancer
WO2015191783A2 (en) 2014-06-10 2015-12-17 Abbvie Inc. Biomarkers for inflammatory disease and methods of using same
WO2015189390A1 (en) 2014-06-13 2015-12-17 Q-Linea Ab Method for detecting and characterising a microorganism
EP3169801A1 (en) 2014-07-14 2017-05-24 F. Hoffmann-La Roche AG Diagnostic methods and compositions for treatment of glioblastoma
CA2954764A1 (en) 2014-07-15 2016-01-21 Ontario Institute For Cancer Research Methods and devices for predicting anthracycline treatment efficacy
WO2016011377A1 (en) 2014-07-17 2016-01-21 Celmatix Inc. Methods and systems for assessing infertility and related pathologies
EP3760739A1 (en) 2014-07-30 2021-01-06 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
AU2015296029B2 (en) 2014-08-01 2022-01-27 Dovetail Genomics, Llc Tagging nucleic acids for sequence assembly
EP3177738B1 (en) 2014-08-08 2019-10-09 Children's Hospital Medical Center Diagnostic method for distinguishing forms of esophageal eosinophilia
EP3194623B1 (en) 2014-08-12 2022-01-05 Wayne State University Systems and methods to detect stem cell stress and uses thereof
US10093967B2 (en) 2014-08-12 2018-10-09 The Regents Of The University Of Michigan Detection of nucleic acids
AU2015301390B2 (en) 2014-08-15 2021-08-26 Myriad Genetics, Inc. Methods and materials for assessing homologous recombination deficiency
ES2780904T3 (en) 2014-08-17 2020-08-27 Broad Inst Inc Genomic editing using Cas9 nickases
EP3453396A1 (en) 2014-08-28 2019-03-13 Yale University Compositions and methods for treating an inflammatory disease or disorder
US11111288B2 (en) 2014-08-28 2021-09-07 Bioatla, Inc. Conditionally active chimeric antigen receptors for modified t-cells
HRP20221047T1 (en) 2014-08-28 2022-11-11 Eisai R&D Management Co., Ltd. High-purity quinoline derivative and method for manufacturing same
CN107074975A (en) 2014-08-28 2017-08-18 生物蛋白有限公司 Condition active chimeric antigen receptor for the T cell of modification
EP3189152A4 (en) 2014-09-03 2018-04-04 BioAtla LLC Discovering and producing conditionally active biologic proteins in the same eukaryotic cell production hosts
WO2016036403A1 (en) 2014-09-05 2016-03-10 Population Diagnostics Inc. Methods and compositions for inhibiting and treating neurological conditions
US20180010132A1 (en) 2014-09-11 2018-01-11 Novartis Ag Inhibition of prmt5 to treat mtap-deficiency-related diseases
WO2016040589A1 (en) 2014-09-12 2016-03-17 Alnylam Pharmaceuticals, Inc. Polynucleotide agents targeting complement component c5 and methods of use thereof
EP3194624B1 (en) 2014-09-15 2022-02-16 Garvan Institute of Medical Research Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor
AU2015318011B2 (en) 2014-09-15 2020-07-23 Abvitro Llc High-throughput nucleotide library sequencing
FI3198035T3 (en) 2014-09-26 2023-01-31 Methods for predicting drug responsiveness
WO2016054483A1 (en) 2014-10-03 2016-04-07 Novartis Ag Use of ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitors
JOP20200115A1 (en) 2014-10-10 2017-06-16 Alnylam Pharmaceuticals Inc Compositions And Methods For Inhibition Of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) Gene Expression
WO2016061487A1 (en) 2014-10-17 2016-04-21 Alnylam Pharmaceuticals, Inc. Polynucleotide agents targeting aminolevulinic acid synthase-1 (alas1) and uses thereof
US10392663B2 (en) 2014-10-29 2019-08-27 Adaptive Biotechnologies Corp. Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from a large number of samples
EP4026913A1 (en) 2014-10-30 2022-07-13 Personalis, Inc. Methods for using mosaicism in nucleic acids sampled distal to their origin
WO2016069694A2 (en) 2014-10-30 2016-05-06 Alnylam Pharmaceuticals, Inc. Polynucleotide agents targeting serpinc1 (at3) and methods of use thereof
CN107110851B (en) 2014-11-05 2019-10-22 纳迈达斯生物科技中心 For enhancing the metal composite of imaging
EP3770274A1 (en) 2014-11-05 2021-01-27 Veracyte, Inc. Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
JP7231326B2 (en) 2014-11-10 2023-03-01 ジェネンテック, インコーポレイテッド Therapeutic and diagnostic methods for IL-33-mediated disorders
US10030268B2 (en) 2014-11-11 2018-07-24 Abbott Molecular Inc. Hybridization probes and methods
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
GB2548059B (en) 2014-11-26 2020-09-02 Accelerated Biosciences Corp Induced hepatocytes and uses thereof
EP3227446A1 (en) 2014-12-01 2017-10-11 Novartis AG Compositions and methods for diagnosis and treatment of prostate cancer
CN107427515B (en) 2014-12-03 2021-11-16 奥克兰联合服务有限公司 Kinase inhibitor prodrugs for the treatment of cancer
EP3227687A4 (en) 2014-12-05 2018-10-24 Prelude, Inc. Dcis recurrence and invasive breast cancer
EP4242329A3 (en) 2014-12-08 2023-10-25 Berg LLC Use of markers including filamin a in the diagnosis and treatment of prostate cancer
AU2015360736A1 (en) 2014-12-09 2017-06-01 Merck Sharp & Dohme Corp. System and methods for deriving gene signature biomarkers of response to PD-1 antagonists
WO2016094874A1 (en) 2014-12-12 2016-06-16 The Broad Institute Inc. Escorted and functionalized guides for crispr-cas systems
WO2016094872A1 (en) 2014-12-12 2016-06-16 The Broad Institute Inc. Dead guides for crispr transcription factors
WO2016094867A1 (en) 2014-12-12 2016-06-16 The Broad Institute Inc. Protected guide rnas (pgrnas)
US10077472B2 (en) 2014-12-18 2018-09-18 Life Technologies Corporation High data rate integrated circuit with power management
CN111505087A (en) 2014-12-18 2020-08-07 生命科技公司 Method and apparatus for measuring analytes using large scale FET arrays
US10605767B2 (en) 2014-12-18 2020-03-31 Life Technologies Corporation High data rate integrated circuit with transmitter configuration
EP3237906B8 (en) 2014-12-23 2020-10-28 Bluelight Therapeutics, Inc. Attachment of proteins to interfaces for use in nonlinear optical detection
WO2016106244A1 (en) 2014-12-24 2016-06-30 The Broad Institute Inc. Crispr having or associated with destabilization domains
RU2739942C2 (en) 2014-12-24 2020-12-30 Дженентек, Инк. Therapeutic, diagnostic and prognostic methods for bladder cancer
US10302972B2 (en) 2015-01-23 2019-05-28 Pacific Biosciences Of California, Inc. Waveguide transmission
US10485757B2 (en) 2015-01-27 2019-11-26 The Johns Hopkins University Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces
EP3250588A1 (en) 2015-01-29 2017-12-06 Board of Trustees of Michigan State University Cryptic polypeptides and uses thereof
CA2975855A1 (en) 2015-02-04 2016-08-11 Twist Bioscience Corporation Compositions and methods for synthetic gene assembly
CA2975852A1 (en) 2015-02-04 2016-08-11 Twist Bioscience Corporation Methods and devices for de novo oligonucleic acid assembly
AU2016219513B2 (en) 2015-02-09 2021-09-30 Immunoforge Co., Ltd. Methods and compositions for treating muscle disease and disorders
US10801065B2 (en) 2015-02-10 2020-10-13 Dana-Farber Cancer Institute, Inc. Methods of determining levels of exposure to radiation and uses thereof
WO2016130806A2 (en) 2015-02-13 2016-08-18 Alnylam Pharmaceuticals, Inc. Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof
WO2016130923A1 (en) 2015-02-13 2016-08-18 Quanterix Corporation Immunoassays for diffrential detection of clostridium difficile
SG11201706730XA (en) 2015-02-17 2017-09-28 Dovetail Genomics Llc Nucleic acid sequence assembly
ES2824700T3 (en) 2015-02-19 2021-05-13 Becton Dickinson Co High-throughput single-cell analysis combining proteomic and genomic information
ES2965764T3 (en) 2015-02-24 2024-04-16 Hope City Chemically Encoded Spatially Addressed Library Screening Platforms
ES2858306T3 (en) 2015-02-24 2021-09-30 Adaptive Biotechnologies Corp Method for determining HLA status by sequencing the immune repertoire
MX2017010795A (en) 2015-02-24 2018-04-11 Bioatla Llc Conditionally active biological proteins.
FI3263106T3 (en) 2015-02-25 2024-01-03 Eisai R&D Man Co Ltd Method for suppressing bitterness of quinoline derivative
US9727810B2 (en) 2015-02-27 2017-08-08 Cellular Research, Inc. Spatially addressable molecular barcoding
CA2978226A1 (en) 2015-03-04 2016-09-09 Merck Sharpe & Dohme Corp. Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
WO2016145434A1 (en) 2015-03-12 2016-09-15 Vibrant Holdings, Llc Polypeptide arrays and methods of attaching polypeptides to an array
US9708647B2 (en) 2015-03-23 2017-07-18 Insilixa, Inc. Multiplexed analysis of nucleic acid hybridization thermodynamics using integrated arrays
WO2016154193A1 (en) 2015-03-24 2016-09-29 Illumina, Inc. Methods, carrier assemblies, and systems for imaging samples for biological or chemical analysis
GB2554572B (en) 2015-03-26 2021-06-23 Dovetail Genomics Llc Physical linkage preservation in DNA storage
KR20170132856A (en) 2015-03-30 2017-12-04 액셀러레이트 다이어그노스틱스, 아이엔씨. Instruments and systems for rapid microbiological identification and antimicrobial susceptibility testing
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
EP3277843A2 (en) 2015-03-30 2018-02-07 Cellular Research, Inc. Methods and compositions for combinatorial barcoding
WO2016161273A1 (en) 2015-04-01 2016-10-06 Adaptive Biotechnologies Corp. Method of identifying human compatible t cell receptors specific for an antigenic target
US10160755B2 (en) 2015-04-08 2018-12-25 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
ES2844799T3 (en) 2015-04-17 2021-07-22 Merck Sharp & Dohme Blood biomarkers of tumor sensitivity to PD-1 antagonists
AU2016251501A1 (en) 2015-04-20 2017-10-19 F. Hoffmann-La Roche Ag Specific peptide binders to proteins identified via systemic discovery, maturation and extension process
US9981239B2 (en) 2015-04-21 2018-05-29 Twist Bioscience Corporation Devices and methods for oligonucleic acid library synthesis
CN107580632B (en) 2015-04-23 2021-12-28 贝克顿迪金森公司 Methods and compositions for whole transcriptome amplification
CA2983224A1 (en) 2015-04-24 2016-10-27 Agena Bioscience, Inc. Multiplexed method for the identification and quantitation of minor alleles and polymorphisms
GB201507026D0 (en) 2015-04-24 2015-06-10 Linea Ab Q Medical sample transportation container
US10640817B2 (en) 2015-04-24 2020-05-05 Agena Bioscience, Inc. Multiplex methods for detection and quantification of minor variants
EP3289106A4 (en) 2015-05-01 2019-03-20 Griffith University Diagnostic methods
EP3289107A4 (en) 2015-05-01 2018-09-12 The University of British Columbia Biomarkers for the detection of acute rejection in heart transplantation
US10900975B2 (en) 2015-05-12 2021-01-26 Arizona Board Of Regents On Behalf Of Arizona State University Systems and methods of epitope binning and antibody profiling
WO2016196065A1 (en) 2015-05-29 2016-12-08 Genentech, Inc. Methods and compositions for assessing responsiveness of cancers to bet inhibitors
BR112017025587B1 (en) 2015-05-29 2022-09-27 Illumina, Inc SAMPLE CARRIER AND ASSAY SYSTEM TO CONDUCT DESIGNATED REACTIONS
WO2016196229A1 (en) 2015-06-01 2016-12-08 Cellular Research, Inc. Methods for rna quantification
EP3307316A1 (en) 2015-06-12 2018-04-18 Alnylam Pharmaceuticals, Inc. Complement component c5 irna compositions and methods of use thereof
CA2988707C (en) 2015-06-16 2023-10-10 Eisai R&D Management Co., Ltd. Combination of cbp/catenin inhibitor and immune checkpoint inhibitor for treating cancer
WO2016205323A1 (en) 2015-06-18 2016-12-22 Alnylam Pharmaceuticals, Inc. Polynucleotde agents targeting hydroxyacid oxidase (glycolate oxidase, hao1) and methods of use thereof
WO2016205749A1 (en) 2015-06-18 2016-12-22 The Broad Institute Inc. Novel crispr enzymes and systems
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
EP3666895A1 (en) 2015-06-18 2020-06-17 The Broad Institute, Inc. Novel crispr enzymes and systems
WO2017011286A1 (en) 2015-07-10 2017-01-19 Alnylam Pharmaceuticals, Inc. Insulin-like growth factor binding protein, acid labile subunit (igfals) and insulin-like growth factor 1 (igf-1) irna compositions and methods of use thereof
ES2865259T3 (en) 2015-07-20 2021-10-15 Sentilus Holdco LLC Chips, detectors and methods to make and use them
GB201512869D0 (en) 2015-07-21 2015-09-02 Almac Diagnostics Ltd Gene signature for minute therapies
KR101844048B1 (en) 2015-07-22 2018-03-30 주식회사 스몰머신즈 Molecule immobilization patterns and method for forming the same
WO2017019804A2 (en) 2015-07-28 2017-02-02 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
JP6923509B2 (en) 2015-07-28 2021-08-18 オトノミ—,インク. Treatment with truncated TRKB and TRKC antagonists
EP3124619B1 (en) 2015-07-31 2019-03-06 Menicon Co., Ltd Reagents, method and kit for across and within dog breed glaucoma diagnosis
CN108136051A (en) 2015-08-04 2018-06-08 Cd诊断股份有限公司 The method for detecting bad local organization reaction (ALTR) necrosis
WO2017024017A1 (en) 2015-08-06 2017-02-09 Pacific Biosciences Of California, Inc. Systems and methods for selectively addressing sparsely arranged electronic measurement devices
EP3130681B1 (en) 2015-08-13 2019-11-13 Centrillion Technology Holdings Corporation Methods for synchronizing nucleic acid molecules
EP3130682B1 (en) * 2015-08-13 2020-03-18 Centrillion Technology Holdings Corporation Methods for generating polymer arrays
EP3338096B1 (en) 2015-08-24 2024-03-06 Illumina, Inc. In-line pressure accumulator and flow-control system for biological or chemical assays
CA2995995A1 (en) 2015-08-24 2017-03-02 Halo-Bio Rnai Therapeutics, Inc. Polynucleotide nanoparticles for the modulation of gene expression and uses thereof
SG10202007937SA (en) 2015-09-02 2020-09-29 Alnylam Pharmaceuticals Inc PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US9499861B1 (en) 2015-09-10 2016-11-22 Insilixa, Inc. Methods and systems for multiplex quantitative nucleic acid amplification
WO2017044574A1 (en) 2015-09-11 2017-03-16 Cellular Research, Inc. Methods and compositions for nucleic acid library normalization
EP3141613A1 (en) 2015-09-11 2017-03-15 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO Detection of quality of surface water
US10758886B2 (en) 2015-09-14 2020-09-01 Arizona Board Of Regents On Behalf Of Arizona State University Conditioned surfaces for in situ molecular array synthesis
US10844373B2 (en) 2015-09-18 2020-11-24 Twist Bioscience Corporation Oligonucleic acid variant libraries and synthesis thereof
KR20180058772A (en) 2015-09-22 2018-06-01 트위스트 바이오사이언스 코포레이션 Flexible substrate for nucleic acid synthesis
US11156611B2 (en) 2015-09-24 2021-10-26 Abvitro Llc Single cell characterization using affinity-oligonucleotide conjugates and vessel barcoded polynucleotides
WO2018057051A1 (en) 2016-09-24 2018-03-29 Abvitro Llc Affinity-oligonucleotide conjugates and uses thereof
EP3353550A1 (en) 2015-09-25 2018-08-01 AbVitro LLC High throughput process for t cell receptor target identification of natively-paired t cell receptor sequences
WO2017050874A1 (en) 2015-09-25 2017-03-30 F. Hoffmann-La Roche Ag Process for producing thioesters employing a sortase a
CN108026560A (en) 2015-09-25 2018-05-11 豪夫迈·罗氏有限公司 Reacted in eutectic solvent using the acid amides that turns of sorting enzyme
JP6998862B2 (en) 2015-09-25 2022-02-04 エフ.ホフマン-ラ ロシュ アーゲー Soluble sortase A
JP6836586B2 (en) 2015-09-29 2021-03-03 エイチティージー モレキュラー ダイアグノスティクス, インコーポレイテッド Methods for Subtyping Diffuse Large B-Cell Lymphoma (DLBCL)
CN108513586A (en) 2015-09-30 2018-09-07 因姆内克斯普雷斯私人有限公司 Pathogenic organisms marker and application thereof
JP2018532404A (en) 2015-10-14 2018-11-08 ライフ テクノロジーズ コーポレーション Ribonucleoprotein transfection agent
EP3362580B1 (en) 2015-10-18 2021-02-17 Affymetrix, Inc. Multiallelic genotyping of single nucleotide polymorphisms and indels
AU2016341198B2 (en) 2015-10-19 2023-03-09 Dovetail Genomics, Llc Methods for genome assembly, haplotype phasing, and target independent nucleic acid detection
CN108350505A (en) 2015-10-22 2018-07-31 震动疗法股份有限公司 Genetic marker for measuring ICOS expression
WO2017070605A1 (en) 2015-10-22 2017-04-27 The Broad Institute Inc. Type vi-b crispr enzymes and systems
WO2017075294A1 (en) 2015-10-28 2017-05-04 The Board Institute Inc. Assays for massively combinatorial perturbation profiling and cellular circuit reconstruction
US10427126B2 (en) 2015-10-28 2019-10-01 Roche Sequencing Solutions, Inc. System and method for longitudinal analysis of peptide synthesis
WO2017087416A1 (en) 2015-11-16 2017-05-26 Revere Biosensors, Llc Systems and methods for identifying and distinguishing genetic samples
US10731211B2 (en) 2015-11-18 2020-08-04 Pacific Biosciences Of California, Inc. Methods and compositions for loading of polymerase complexes
US20170152543A1 (en) 2015-11-30 2017-06-01 Roche Sequencing Solutions, Inc. System and method for identification of protease substrates
US9895673B2 (en) 2015-12-01 2018-02-20 Twist Bioscience Corporation Functionalized surfaces and preparation thereof
JP6862468B2 (en) 2015-12-07 2021-04-21 プレキシコン インコーポレーテッドPlexxikon Inc. Compounds and methods for kinase regulation and instructions for them
EP3387154A4 (en) 2015-12-09 2019-05-15 Intuitive Biosciences, Inc. Automated silver enhancement system
WO2017106768A1 (en) 2015-12-17 2017-06-22 Guardant Health, Inc. Methods to determine tumor gene copy number by analysis of cell-free dna
US20190233814A1 (en) 2015-12-18 2019-08-01 The Broad Institute, Inc. Novel crispr enzymes and systems
US20200371099A1 (en) 2015-12-24 2020-11-26 Immunexpress Pty Ltd Triage biomarkers and uses therefor
WO2017123401A1 (en) 2016-01-13 2017-07-20 Children's Hospital Medical Center Compositions and methods for treating allergic inflammatory conditions
US10519442B2 (en) 2016-02-11 2019-12-31 City Of Hope Twist signaling inhibitor compositions and methods of using the same
US10184939B2 (en) 2016-02-12 2019-01-22 Roche Sequencing Solutions, Inc. Detection of neoantigens using peptide arrays
KR20180116377A (en) 2016-02-23 2018-10-24 더브테일 제노믹스 엘엘씨 Generation and Hexagonal Paging of a Paged Read Set for Genome Assemblies
WO2017155858A1 (en) 2016-03-07 2017-09-14 Insilixa, Inc. Nucleic acid sequence identification using solid-phase cyclic single base extension
US10458995B2 (en) 2016-03-25 2019-10-29 Muralidhar Reddy Moola Combinatorial synthesis and biomarker development
WO2017167712A1 (en) 2016-03-30 2017-10-05 F. Hoffmann-La Roche Ag Improved sortase
WO2017173247A1 (en) 2016-03-31 2017-10-05 City Of Hope Aptamer compositions and the use thereof
US20190113522A1 (en) * 2016-04-01 2019-04-18 Healthtell Inc. Array-based peptide libraries for therapeutic antibody characterization
JP7049683B2 (en) 2016-04-04 2022-04-07 シノピア バイオサイエンシーズ,インク. Treatment of extrapyramidal syndrome with trapidil
SG10202010311SA (en) 2016-04-19 2020-11-27 Broad Inst Inc Novel Crispr Enzymes and Systems
MA45295A (en) 2016-04-19 2019-02-27 Alnylam Pharmaceuticals Inc HIGH DENSITY LIPOPROTEIN BINDING PROTEIN (HDLBP / VIGILINE) RNA COMPOSITION AND METHODS FOR USING THEM
EP3445856A1 (en) 2016-04-19 2019-02-27 The Broad Institute Inc. Novel crispr enzymes and systems
US11286478B2 (en) 2016-04-19 2022-03-29 The Broad Institute, Inc. Cpf1 complexes with reduced indel activity
US20190128895A1 (en) 2016-04-20 2019-05-02 Ldx Prognostics Limited Co. Methods and compositions for prognosing preterm birth
WO2017184861A1 (en) 2016-04-20 2017-10-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Evaluation of mantle cell lymphoma and methods related thereto
GB2554767A (en) 2016-04-21 2018-04-11 Q Linea Ab Detecting and characterising a microorganism
US10822643B2 (en) 2016-05-02 2020-11-03 Cellular Research, Inc. Accurate molecular barcoding
IL262404B2 (en) 2016-05-13 2024-04-01 Bioatla Llc Anti-ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof
IL262946B2 (en) 2016-05-13 2023-03-01 Dovetail Genomics Llc Recovering long-range linkage information from preserved samples
JP7241352B2 (en) 2016-05-17 2023-03-17 ジーンセントリック セラピューティクス, インコーポレイテッド Methods for subtyping lung squamous cell carcinoma
CN116987790A (en) 2016-05-17 2023-11-03 基因中心治疗公司 Methods for typing lung adenocarcinoma subtypes
JP6691617B2 (en) 2016-05-17 2020-04-28 エルディエックス・プログノスティクス・リミテッド・カンパニーLdx Prognostics Limited Co. Methods and compositions for providing an assessment of preeclampsia
US10301677B2 (en) 2016-05-25 2019-05-28 Cellular Research, Inc. Normalization of nucleic acid libraries
CN109074430B (en) 2016-05-26 2022-03-29 贝克顿迪金森公司 Molecular marker counting adjustment method
WO2017205823A1 (en) 2016-05-27 2017-11-30 Personalis, Inc. Personalized genetic testing
US11299783B2 (en) 2016-05-27 2022-04-12 Personalis, Inc. Methods and systems for genetic analysis
US10202641B2 (en) 2016-05-31 2019-02-12 Cellular Research, Inc. Error correction in amplification of samples
US10640763B2 (en) 2016-05-31 2020-05-05 Cellular Research, Inc. Molecular indexing of internal sequences
WO2017214068A1 (en) 2016-06-05 2017-12-14 Berg Llc Systems and methods for patient stratification and identification of potential biomarkers
JP2019518028A (en) 2016-06-10 2019-06-27 アルナイラム ファーマシューティカルズ, インコーポレイテッドAlnylam Pharmaceuticals, Inc. Complement component C5i RNA composition and its use for treating paroxysmal nocturnal hemoglobinuria (PNH)
WO2017222834A1 (en) 2016-06-10 2017-12-28 City Of Hope Compositions and methods for mitochondrial genome editing
KR20230156150A (en) 2016-06-17 2023-11-13 더 브로드 인스티튜트, 인코퍼레이티드 Type vi crispr orthologs and systems
EP3472354A4 (en) 2016-06-17 2020-01-01 California Institute of Technology Nucleic acid reactions and related methods and compositions
EP3472181A4 (en) 2016-06-20 2020-05-13 Healthtell Inc. Methods for diagnosis and treatment of autoimmune diseases
EP3472201A4 (en) 2016-06-20 2020-05-13 Healthtell Inc. Methods for differential diagnosis of autoimmune diseases
CA3028370A1 (en) 2016-06-29 2018-01-04 Mitsubishi Chemical Corporation Composition for preventing drying of gel, gel composite and dna chip containing said composite, and method for producing said composition, composite, and chip
US20210222164A1 (en) 2016-06-29 2021-07-22 The Broad Institute, Inc. Crispr-cas systems having destabilization domain
EP3485032B1 (en) 2016-07-12 2021-02-17 Life Technologies Corporation Compositions and methods for detecting nucleic acid regions
WO2018013883A1 (en) 2016-07-14 2018-01-18 Caprion Proteomics Inc. Biomarkers of latent tuberculosis infection
WO2018022890A1 (en) 2016-07-27 2018-02-01 Sequenom, Inc. Genetic copy number alteration classifications
CA3032827A1 (en) 2016-08-04 2018-02-08 Baylor Research Institute Methods for diagnosing and treating esophageal cancer
EP3497446B1 (en) 2016-08-15 2021-04-28 F. Hoffmann-La Roche AG Method and composition for detection of peptide cyclization using protein tags
CA3034769A1 (en) 2016-08-22 2018-03-01 Twist Bioscience Corporation De novo synthesized nucleic acid libraries
AU2017315425B2 (en) 2016-08-24 2023-11-09 The Regents Of The University Of Michigan Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
WO2018053228A1 (en) 2016-09-15 2018-03-22 The Regents Of The University Of California Biomarkers for bipolar disorder and schizophrenia
US10417457B2 (en) 2016-09-21 2019-09-17 Twist Bioscience Corporation Nucleic acid based data storage
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
TW201815766A (en) 2016-09-22 2018-05-01 美商普雷辛肯公司 Compounds and methods for IDO and TDO modulation, and indications therefor
WO2018058073A2 (en) 2016-09-26 2018-03-29 Cellular Research, Inc. Measurement of protein expression using reagents with barcoded oligonucleotide sequences
WO2018064116A1 (en) 2016-09-28 2018-04-05 Illumina, Inc. Methods and systems for data compression
JP2020510608A (en) 2016-11-02 2020-04-09 デビオファーム インターナショナル, エス. アー. Method for improving anti-CD37 immunoconjugate therapy
KR20190077061A (en) 2016-11-08 2019-07-02 셀룰러 리서치, 인크. Cell labeling method
EP3539035B1 (en) 2016-11-08 2024-04-17 Becton, Dickinson and Company Methods for expression profile classification
KR20190082275A (en) 2016-11-09 2019-07-09 헬스텔 인크. Coatings with adjustable amine density
EP3538893A4 (en) 2016-11-11 2020-09-23 Healthtell Inc. Methods for identifying candidate biomarkers
US10646540B2 (en) 2016-11-18 2020-05-12 City Of Hope Peptide inhibitors of twist
WO2018098241A1 (en) 2016-11-22 2018-05-31 University Of Rochester Methods of assessing risk of recurrent prostate cancer
TW202313978A (en) 2016-11-23 2023-04-01 美商阿尼拉製藥公司 Serpina1 irna compositions and methods of use thereof
CN110249082B (en) 2016-12-01 2023-07-07 诺迪勒思附属公司 Method for determining protein
EP3555292A1 (en) 2016-12-16 2019-10-23 Alnylam Pharmaceuticals, Inc. Methods for treating or preventing ttr-associated diseases using transthyretin (ttr) irna compositions
KR102514213B1 (en) 2016-12-16 2023-03-27 트위스트 바이오사이언스 코포레이션 Immune synaptic variant library and its synthesis
US20210072255A1 (en) 2016-12-16 2021-03-11 The Brigham And Women's Hospital, Inc. System and method for protein corona sensor array for early detection of diseases
DE202017107858U1 (en) 2016-12-16 2018-05-28 The Brigham And Women's Hospital, Inc. Device for a protein corona sensor array for the early detection of diseases
WO2018136202A2 (en) 2016-12-23 2018-07-26 Plexxikon Inc. Compounds and methods for cdk8 modulation and indications therefor
JP7104048B2 (en) 2017-01-13 2022-07-20 セルラー リサーチ, インコーポレイテッド Hydrophilic coating of fluid channels
US11208697B2 (en) 2017-01-20 2021-12-28 Decipher Biosciences, Inc. Molecular subtyping, prognosis, and treatment of bladder cancer
EP3571309A4 (en) 2017-01-20 2020-11-25 Children's Hospital Medical Center Methods and compositions relating to oprm1 dna methylation for personalized pain management
WO2018140521A1 (en) 2017-01-24 2018-08-02 Sequenom, Inc. Methods and processes for assessment of genetic variations
KR102607101B1 (en) 2017-01-26 2023-11-29 제트엘아이피 홀딩 리미티드 CD47 antigen binding unit and its uses
US20190390278A1 (en) 2017-01-26 2019-12-26 Oklahoma Medical Research Foundation Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
CN110382708A (en) 2017-02-01 2019-10-25 赛卢拉研究公司 Selective amplification is carried out using blocking property oligonucleotides
US10240205B2 (en) 2017-02-03 2019-03-26 Population Bio, Inc. Methods for assessing risk of developing a viral disease using a genetic test
EP3586255A4 (en) 2017-02-22 2021-03-31 Twist Bioscience Corporation Nucleic acid based data storage
US11179413B2 (en) 2017-03-06 2021-11-23 Novartis Ag Methods of treatment of cancer with reduced UBB expression
CA3055925A1 (en) 2017-03-09 2018-09-13 Decipher Biosciences, Inc. Subtyping prostate cancer to predict response to hormone therapy
US11746381B2 (en) 2017-03-10 2023-09-05 Cancer Diagnostics Research Innvovations, LLC Methods for diagnosing and treating gastric cancer using miRNA expression
CN110913865A (en) 2017-03-15 2020-03-24 特韦斯特生物科学公司 Library of variants of immune synapses and synthesis thereof
EP3601602B1 (en) 2017-03-29 2024-04-10 Crown Bioscience, Inc. (Taicang) System and method for determining cetuximab sensitivity on gastric cancer
WO2018187191A1 (en) 2017-04-03 2018-10-11 Jounce Therapeutics, Inc Compositions and methods for the treatment of cancer
TWI801377B (en) 2017-04-18 2023-05-11 美商阿尼拉製藥公司 Methods for the treatment of subjects having a hepatitis b virus (hbv) infection
US20210008135A1 (en) 2017-04-28 2021-01-14 Merck Sharp & Dohme Corp. Biomarkers for cancer therapeutics
CN110869512A (en) * 2017-05-09 2020-03-06 雷瑞生物传感器有限责任公司 System and method for identifying and differentiating genetic samples
US11078542B2 (en) 2017-05-12 2021-08-03 Decipher Biosciences, Inc. Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness
CA3063283A1 (en) 2017-05-17 2018-11-22 Microbio Pty Ltd Methods and agents for identifying or classifying microbes based on polymorphisms within ribosomal rna genes
EP3625248A4 (en) 2017-05-18 2021-01-20 The Rockefeller University Compositions and methods for diagnosing and treating diseases and disorders associated with mutant kcnj5
WO2018213803A1 (en) 2017-05-19 2018-11-22 Neon Therapeutics, Inc. Immunogenic neoantigen identification
AU2018273791A1 (en) 2017-05-22 2019-12-12 Edith Cowan University Biomarker of disease
US10538808B2 (en) 2017-05-26 2020-01-21 Vibrant Holdings, Llc Photoactive compounds and methods for biomolecule detection and sequencing
WO2018223055A1 (en) 2017-06-02 2018-12-06 Affymetrix, Inc. Array-based methods for analysing mixed samples using differently labelled allele-specific probes
WO2018223053A1 (en) 2017-06-02 2018-12-06 Affymetrix, Inc. Array-based methods for analysing mixed samples using differently labelled allele-specific probes
US11535886B2 (en) 2017-06-02 2022-12-27 Affymetrix, Inc. Array-based methods for analysing mixed samples using different allele-specific labels, in particular for detection of fetal aneuploidies
CA3059559A1 (en) 2017-06-05 2018-12-13 Becton, Dickinson And Company Sample indexing for single cells
US10428067B2 (en) 2017-06-07 2019-10-01 Plexxikon Inc. Compounds and methods for kinase modulation
WO2018231864A1 (en) 2017-06-12 2018-12-20 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
SG11201912057RA (en) 2017-06-12 2020-01-30 Twist Bioscience Corp Methods for seamless nucleic acid assembly
WO2018231589A1 (en) 2017-06-14 2018-12-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method for determining lymphoma type
JP2020523997A (en) 2017-06-19 2020-08-13 マサチューセッツ インスティテュート オブ テクノロジー Automated method for scalable parallelized enzymatic biopolymer synthesis and modification using microfluidic devices
EP3655418A4 (en) 2017-06-22 2021-05-19 Triact Therapeutics, Inc. Methods of treating glioblastoma
KR102558931B1 (en) 2017-06-23 2023-07-21 인스크립타 인코포레이티드 Nucleic acid-guided nucleases
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity
US11420941B2 (en) * 2017-06-29 2022-08-23 Cowper Sciences Inc. Methods and systems for mask alignment in manufacturing process of arrays
US11739386B2 (en) 2017-07-21 2023-08-29 Genecentric Therapeutics, Inc. Methods for determining response to PARP inhibitors
WO2019016772A2 (en) 2017-07-21 2019-01-24 Novartis Ag Compositions and methods to treat cancer
US11427826B2 (en) 2017-08-11 2022-08-30 City of Hopw RNA aptamers against transferrin receptor (TfR)
US20230160016A1 (en) 2017-08-31 2023-05-25 Novartis Ag Methods of selecting a treatment for cancer patients
CN111094938A (en) * 2017-09-01 2020-05-01 生物辐射实验室股份有限公司 High power laser for western blotting
JP2020534813A (en) 2017-09-08 2020-12-03 ライフ テクノロジーズ コーポレイション Methods for improved homologous recombination and compositions thereof
CN111315889A (en) 2017-09-08 2020-06-19 生命技术公司 Methods and compositions for enhancing homologous recombination
CN111566125A (en) 2017-09-11 2020-08-21 特韦斯特生物科学公司 GPCR binding proteins and synthesis thereof
US20200271643A1 (en) 2017-09-20 2020-08-27 Quanterix Corporation Methods and systems for the detection of analyte molecules
WO2019067991A1 (en) 2017-09-29 2019-04-04 Triact Therapeutics, Inc. Iniparib formulations and uses thereof
US11485966B2 (en) 2017-10-11 2022-11-01 Mgi Tech Co., Ltd. Method for improving loading and stability of nucleic acid
US10894242B2 (en) 2017-10-20 2021-01-19 Twist Bioscience Corporation Heated nanowells for polynucleotide synthesis
US11099202B2 (en) 2017-10-20 2021-08-24 Tecan Genomics, Inc. Reagent delivery system
US11721412B2 (en) 2017-10-23 2023-08-08 Nautilus Subsidiary, Inc. Methods for identifying a protein in a sample of unknown proteins
SG11202002753QA (en) 2017-10-26 2020-05-28 Nat Univ Singapore A new approach for universal monitoring of minimal residual disease in acute myeloid leukemia
US11124833B2 (en) 2017-10-27 2021-09-21 Colgate-Palmolive Company Salivary extracellular RNA biomarkers for gingivitis
US11866701B2 (en) 2017-11-01 2024-01-09 Alnylam Pharmaceuticals, Inc. Complement component C3 iRNA compositions and methods of use thereof
WO2019086603A1 (en) 2017-11-03 2019-05-09 Interna Technologies B.V. Mirna molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
EP3710587A1 (en) 2017-11-16 2020-09-23 Alnylam Pharmaceuticals, Inc. Kisspeptin 1 (kiss1) irna compositions and methods of use thereof
EP3714054A1 (en) 2017-11-20 2020-09-30 Alnylam Pharmaceuticals, Inc. Serum amyloid p component (apcs) irna compositions and methods of use thereof
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
WO2019109016A1 (en) 2017-12-01 2019-06-06 Millennium Pharmaceuticals, Inc. Biomarkers and methods for treatment with nae inhibitors
WO2019113506A1 (en) 2017-12-07 2019-06-13 The Broad Institute, Inc. Methods and compositions for multiplexing single cell and single nuclei sequencing
AR113490A1 (en) 2017-12-12 2020-05-06 Amgen Inc RNAi CONSTRUCTIONS TO INHIBIT THE EXPRESSION OF PNPLA3 AND METHODS OF USE OF THE SAME
KR20200110655A (en) 2017-12-18 2020-09-24 알닐람 파마슈티칼스 인코포레이티드 High mobility group box-1 (HMGB1) IRNA composition and method of use thereof
WO2019126037A1 (en) 2017-12-19 2019-06-27 City Of Hope Modified tracrrnas grnas, and uses thereof
EP3728636A1 (en) 2017-12-19 2020-10-28 Becton, Dickinson and Company Particles associated with oligonucleotides
EP3728321A1 (en) 2017-12-22 2020-10-28 F. Hoffmann-La Roche AG Use of pilra binding agents for treatment of a disease
JP7458678B2 (en) 2017-12-29 2024-04-01 ノーティラス・サブシディアリー・インコーポレイテッド Decoding approach method for protein identification
KR20200106067A (en) 2018-01-04 2020-09-10 트위스트 바이오사이언스 코포레이션 DNA-based digital information storage
AU2019211446A1 (en) 2018-01-25 2020-09-10 Biogen Ma Inc. Methods of treating spinal muscular atrophy
PE20211304A1 (en) 2018-02-09 2021-07-20 Genentech Inc THERAPEUTIC AND DIAGNOSTIC METHODS FOR INFLAMMATORY DISEASES MEDIATED BY MASTOCYTES
US11859250B1 (en) 2018-02-23 2024-01-02 Children's Hospital Medical Center Methods for treating eosinophilic esophagitis
CN112236528A (en) 2018-04-04 2021-01-15 诺迪勒思生物科技公司 Method for producing nano-and micro-arrays
IT201800004253A1 (en) 2018-04-05 2019-10-05 Compositions and methods for the treatment of hereditary dominant catecholaminergic polymorphic ventricular tachycardia.
US11957695B2 (en) 2018-04-26 2024-04-16 The Broad Institute, Inc. Methods and compositions targeting glucocorticoid signaling for modulating immune responses
EP3788138A1 (en) 2018-05-02 2021-03-10 Novartis AG Regulators of human pluripotent stem cells and uses thereof
JP7358388B2 (en) 2018-05-03 2023-10-10 ベクトン・ディキンソン・アンド・カンパニー Molecular barcoding at opposite transcript ends
US11773441B2 (en) 2018-05-03 2023-10-03 Becton, Dickinson And Company High throughput multiomics sample analysis
WO2019213660A2 (en) 2018-05-04 2019-11-07 The Broad Institute, Inc. Compositions and methods for modulating cgrp signaling to regulate innate lymphoid cell inflammatory responses
CA3099046A1 (en) 2018-05-09 2019-11-14 Vibrant Holdings, Llc Methods of synthesizing a polynucleotide array using photoactivated agents________________________________________________________
TW202016304A (en) 2018-05-14 2020-05-01 美商阿尼拉製藥公司 Angiotensinogen (agt) irna compositions and methods of use thereof
WO2019222706A1 (en) 2018-05-18 2019-11-21 Twist Bioscience Corporation Polynucleotides, reagents, and methods for nucleic acid hybridization
EP3802847A4 (en) * 2018-05-29 2022-03-09 Centrillion Technologies, Inc. Increasing efficiency of photochemical reactions on substrates
US10801064B2 (en) 2018-05-31 2020-10-13 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
US11814750B2 (en) 2018-05-31 2023-11-14 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
EP3827094A1 (en) 2018-07-24 2021-06-02 Affymetrix, Inc. Array based method and kit for determining copy number and genotype in pseudogenes
WO2020033700A1 (en) 2018-08-08 2020-02-13 Pml Screening, Llc Mathods for assessing the risk of developing progressive multifocal leukoencephalopathy caused by john cunningham virus by genetic testing
AR114551A1 (en) 2018-08-13 2020-09-16 Alnylam Pharmaceuticals Inc COMPOSITIONS OF hdRNA AGENTS AGAINST HEPATITIS B VIRUS (HBV) AND METHODS FOR THEIR USE
EP3837380A4 (en) 2018-08-17 2022-05-11 Cellecta, Inc. Multiplex preparation of barcoded gene specific dna fragments
US20210317429A1 (en) 2018-08-20 2021-10-14 The Broad Institute, Inc. Methods and compositions for optochemical control of crispr-cas9
JP2022500504A (en) 2018-09-14 2022-01-04 プレリュード コーポレーションPrelude Corporation How to choose treatment for subjects at risk of invasive breast cancer
AU2019344776A1 (en) 2018-09-18 2021-01-21 Alnylam Pharmaceuticals, Inc. Ketohexokinase (KHK) iRNA compositions and methods of use thereof
CN113015746A (en) 2018-09-19 2021-06-22 拉荷亚免疫研究所 PTPRS and proteoglycans in rheumatoid arthritis
TW202028465A (en) 2018-09-28 2020-08-01 美商阿尼拉製藥公司 Transthyretin (ttr) irna compositions and methods of use thereof for treating or preventing ttr-associated ocular diseases
US11639517B2 (en) 2018-10-01 2023-05-02 Becton, Dickinson And Company Determining 5′ transcript sequences
JP2022512590A (en) 2018-10-05 2022-02-07 エーザイ・アール・アンド・ディー・マネジメント株式会社 Biomarkers for therapy containing sorafenib compounds
ES2939143T3 (en) 2018-10-05 2023-04-19 Eisai R&D Man Co Ltd Biomarkers for a Combination Therapy Comprising Lenvatinib and Everolimus
WO2020076897A1 (en) 2018-10-09 2020-04-16 Genecentric Therapeutics, Inc. Detecting cancer cell of origin
US20220401460A1 (en) 2018-10-10 2022-12-22 Dana-Farber Cancer Institute, Inc. Modulating resistance to bcl-2 inhibitors
CA3116539C (en) 2018-10-18 2023-10-03 Oklahoma Medical Research Foundation Biomarkers for a systemic lupus erythematosus (sle) disease activity immune index that characterizes disease activity
WO2020096631A2 (en) 2018-11-07 2020-05-14 Seer, Inc. Compositions, methods and systems for protein corona analysis and uses thereof
US11932849B2 (en) 2018-11-08 2024-03-19 Becton, Dickinson And Company Whole transcriptome analysis of single cells using random priming
EP3660172A1 (en) 2018-11-28 2020-06-03 Bioscreening and Diagnostics LLC Method for detection of traumatic brain injury (tbi)
WO2020113237A1 (en) 2018-11-30 2020-06-04 Caris Mpi, Inc. Next-generation molecular profiling
CN112368077B (en) 2018-12-07 2023-11-24 元素生物科学公司 Flow cell device and use thereof
SG11202105711SA (en) 2018-12-10 2021-06-29 Amgen Inc Rnai constructs for inhibiting pnpla3 expression
EP3894552A1 (en) 2018-12-13 2021-10-20 Becton, Dickinson and Company Selective extension in single cell whole transcriptome analysis
AU2019406778A1 (en) 2018-12-17 2021-07-22 Massachusetts Institute Of Technology Crispr-associated transposase systems and methods of use thereof
CA3123617A1 (en) 2018-12-20 2020-06-25 Praxis Precision Medicines, Inc. Compositions and methods for the treatment of kcnt1 related disorders
EP3677693A1 (en) 2019-01-03 2020-07-08 Ecole Polytechnique Federale De Lausanne (EPFL) EPFL-TTO Transpochimeric gene trancripts (tcgts) as cancer biomarkers
US11371076B2 (en) 2019-01-16 2022-06-28 Becton, Dickinson And Company Polymerase chain reaction normalization through primer titration
EP3914728B1 (en) 2019-01-23 2023-04-05 Becton, Dickinson and Company Oligonucleotides associated with antibodies
KR20210124308A (en) 2019-01-30 2021-10-14 트루바인딩 아이엔씨. Anti-GAL3 antibodies and uses thereof
EP3917571A4 (en) 2019-01-31 2022-10-12 Agency For Science, Technology And Research Cnx/erp57 inhibitor for use in the treatment or prevention of cancer
EP3917953A4 (en) 2019-02-01 2023-02-22 Health Research, Inc. Methods and compositions for treating resistant and recurrent forms of cancer
WO2020176654A1 (en) 2019-02-27 2020-09-03 Madera Therapeutics, LLC Use of caseinolytic protease p function as a biomarker of drug response to imipridone-like agents
EP3924739A1 (en) 2019-02-12 2021-12-22 Biogen MA Inc. Biomarkers of progressive multifocal leukoencephalopathy
CA3131689A1 (en) 2019-02-26 2020-09-03 Twist Bioscience Corporation Variant nucleic acid libraries for glp1 receptor
CN113785057A (en) 2019-02-26 2021-12-10 特韦斯特生物科学公司 Variant nucleic acid libraries for antibody optimization
WO2020186101A1 (en) 2019-03-12 2020-09-17 The Broad Institute, Inc. Detection means, compositions and methods for modulating synovial sarcoma cells
JP2022525322A (en) 2019-03-14 2022-05-12 インシリクサ, インコーポレイテッド Methods and systems for time-gate fluorescence-based detection
WO2020186235A1 (en) 2019-03-14 2020-09-17 The Broad Institute, Inc. Compositions and methods for modulating cgrp signaling to regulate intestinal innate lymphoid cells
EP3942023A1 (en) 2019-03-18 2022-01-26 The Broad Institute, Inc. Compositions and methods for modulating metabolic regulators of t cell pathogenicity
WO2020191069A1 (en) 2019-03-18 2020-09-24 The Broad Institute, Inc. Modulation of type 2 immunity by targeting clec-2 signaling
US20220177863A1 (en) 2019-03-18 2022-06-09 The Broad Institute, Inc. Type vii crispr proteins and systems
US20220175848A1 (en) 2019-04-01 2022-06-09 The Broad Institute, Inc. Methods and compositions for cell therapy
WO2020201267A1 (en) 2019-04-01 2020-10-08 Københavns Universitet Identification of pan-gamma secretase inhibitor (pan-gsi) theranostic response signatures for cancers
EP3952849A4 (en) 2019-04-12 2023-03-01 The Regents Of The University Of California Compositions and methods for increasing muscle mass and oxidative metabolism
JP2022529294A (en) 2019-04-17 2022-06-20 アイジェノミクス、ソシエダッド、リミターダ Improved methods for early diagnosis of uterine leiomyoma and leiomyoma
US11965208B2 (en) 2019-04-19 2024-04-23 Becton, Dickinson And Company Methods of associating phenotypical data and single cell sequencing data
AU2020265250A1 (en) 2019-04-30 2021-11-18 Larimar Therapeutics, Inc. Frataxin-sensitive markers for determining effectiveness of frataxin replacement therapy
WO2020225420A1 (en) 2019-05-08 2020-11-12 Scienion Ag Assay plate with nano-vessels and sample recovery assembly
EP3969591A1 (en) 2019-05-15 2022-03-23 Squadra Lifesciences, Inc Aptamers against glioblastoma
WO2020236967A1 (en) 2019-05-20 2020-11-26 The Broad Institute, Inc. Random crispr-cas deletion mutant
CN113924368A (en) 2019-05-30 2022-01-11 美国安进公司 RNAI constructs for inhibiting SCAP expression and methods of use thereof
EP3980541A1 (en) 2019-06-04 2022-04-13 Apterna Limited Aptamers against transferrin receptor (tfr)
AU2020289591A1 (en) 2019-06-07 2021-12-23 Scribe Therapeutics Inc. Engineered CasX systems
US11332738B2 (en) 2019-06-21 2022-05-17 Twist Bioscience Corporation Barcode-based nucleic acid sequence assembly
JP2022538433A (en) 2019-06-27 2022-09-02 ロシュ シークエンシング ソリューションズ,インコーポレイティド Peptide library with enhanced subsequence diversity and method of using same
US11939622B2 (en) 2019-07-22 2024-03-26 Becton, Dickinson And Company Single cell chromatin immunoprecipitation sequencing assay
WO2021022109A1 (en) 2019-08-01 2021-02-04 Alnylam Pharmaceuticals, Inc. SERPIN FAMILY F MEMBER 2 (SERPINF2) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
WO2021022108A2 (en) 2019-08-01 2021-02-04 Alnylam Pharmaceuticals, Inc. CARBOXYPEPTIDASE B2 (CPB2) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
WO2021026172A1 (en) 2019-08-05 2021-02-11 Seer, Inc. Systems and methods for sample preparation, data generation, and protein corona analysis
US20220282333A1 (en) 2019-08-13 2022-09-08 The General Hospital Corporation Methods for predicting outcomes of checkpoint inhibition and treatment thereof
EP4013870A1 (en) 2019-08-13 2022-06-22 Alnylam Pharmaceuticals, Inc. Small ribosomal protein subunit 25 (rps25) irna agent compositions and methods of use thereof
US20220340911A1 (en) 2019-08-13 2022-10-27 Amgen Inc. Rnai constructs for inhibiting slc30a8 expression and methods of use thereof
WO2021041922A1 (en) 2019-08-30 2021-03-04 The Broad Institute, Inc. Crispr-associated mu transposase systems
CN114729368A (en) 2019-09-09 2022-07-08 斯克里贝治疗公司 Compositions and methods for immunotherapy
US20220348925A1 (en) 2019-09-09 2022-11-03 Scribe Therapeutics Inc. Compositions and methods for the targeting of sod1
TW202124445A (en) 2019-09-18 2021-07-01 瑞士商諾華公司 Nkg2d fusion proteins and uses thereof
US11793787B2 (en) 2019-10-07 2023-10-24 The Broad Institute, Inc. Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis
WO2021076828A1 (en) 2019-10-18 2021-04-22 Alnylam Pharmaceuticals, Inc. Solute carrier family member irna compositions and methods of use thereof
WO2021081026A1 (en) 2019-10-22 2021-04-29 Alnylam Pharmaceuticals, Inc. Complement component c3 irna compositions and methods of use thereof
WO2021086982A2 (en) 2019-10-28 2021-05-06 Beckman Coulter, Inc. Compounds for the identification of microbial classes and uses thereof
US11844800B2 (en) 2019-10-30 2023-12-19 Massachusetts Institute Of Technology Methods and compositions for predicting and preventing relapse of acute lymphoblastic leukemia
JP2023500661A (en) 2019-11-01 2023-01-10 アルナイラム ファーマシューティカルズ, インコーポレイテッド HUNTINGTIN (HTT) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF
WO2021092145A1 (en) 2019-11-06 2021-05-14 Alnylam Pharmaceuticals, Inc. Transthyretin (ttr) irna composition and methods of use thereof for treating or preventing ttr-associated ocular diseases
CN114729350A (en) 2019-11-08 2022-07-08 贝克顿迪金森公司 Obtaining full-length V (D) J information for immunohistorian sequencing using random priming
US20230056569A1 (en) 2019-11-22 2023-02-23 Alnylam Pharmaceuticals, Inc. Ataxin3 (atxn3) rnai agent compositions and methods of use thereof
EP4069865A4 (en) 2019-12-02 2023-12-20 Caris MPI, Inc. Pan-cancer platinum response predictor
CA3159316A1 (en) 2019-12-06 2021-06-10 Benjamin OAKES Compositions and methods for the targeting of rhodopsin
EP4069846A1 (en) 2019-12-07 2022-10-12 Scribe Therapeutics Inc. Compositions and methods for the targeting of htt
IL293824A (en) 2019-12-13 2022-08-01 Alnylam Pharmaceuticals Inc Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof
TW202138559A (en) 2019-12-16 2021-10-16 美商阿尼拉製藥公司 Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof
WO2021127610A1 (en) 2019-12-20 2021-06-24 EDWARD Via COLLEGE OF OSTEOPATHIC MEDICINE Cancer signatures, methods of generating cancer signatures, and uses thereof
US20230167424A1 (en) 2020-01-10 2023-06-01 Scribe Therapeutics Inc. Compositions and methods for the targeting of pcsk9
US20230089426A1 (en) 2020-01-13 2023-03-23 Jounce Therapeutics, Inc. Methods for the treatment of cancer
WO2021146207A1 (en) 2020-01-13 2021-07-22 Becton, Dickinson And Company Methods and compositions for quantitation of proteins and rna
WO2021154941A1 (en) 2020-01-31 2021-08-05 Alnylam Pharmaceuticals, Inc. Complement component c5 irna compositions for use in the treatment of amyotrophic lateral sclerosis (als)
CN115380122A (en) 2020-02-10 2022-11-22 奥布赛瓦股份公司 Biomarkers for oxytocin receptor antagonist therapy
WO2021167841A1 (en) 2020-02-18 2021-08-26 Alnylam Pharmaceuticals, Inc. Apolipoprotein c3 (apoc3) irna compositions and methods of use thereof
EP4114947A1 (en) 2020-03-05 2023-01-11 Alnylam Pharmaceuticals, Inc. Complement component c3 irna compositions and methods of use thereof for treating or preventing complement component c3-associated diseases
CA3174725A1 (en) 2020-03-06 2021-09-10 Alnylam Pharmaceuticals, Inc. Ketohexokinase (khk) irna compositions and methods of use thereof
MX2022011460A (en) 2020-03-18 2022-12-15 Scribe Therapeutics Inc Compositions and methods for the targeting of c9orf72.
EP4121534A1 (en) 2020-03-18 2023-01-25 Alnylam Pharmaceuticals, Inc. Compositions and methods for treating subjects having a heterozygous alanine-glyoxylate aminotransferase gene (agxt) variant
JP2023519274A (en) 2020-03-26 2023-05-10 アルナイラム ファーマシューティカルズ, インコーポレイテッド CORONAVIRUS iRNA COMPOSITIONS AND METHODS OF USE THEREOF
WO2021206917A1 (en) 2020-04-07 2021-10-14 Alnylam Pharmaceuticals, Inc. ANGIOTENSIN-CONVERTING ENZYME 2 (ACE2) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
WO2021206922A1 (en) 2020-04-07 2021-10-14 Alnylam Pharmaceuticals, Inc. Transmembrane serine protease 2 (tmprss2) irna compositions and methods of use thereof
CA3172579A1 (en) 2020-04-15 2021-10-21 David C. Duffy Methods and systems related to highly sensitive assays and by deliveringcapture objects
MX2022013525A (en) 2020-04-27 2023-01-24 Alnylam Pharmaceuticals Inc Apolipoprotein e (apoe) irna agent compositions and methods of use thereof.
BR112022021136A2 (en) 2020-04-30 2022-11-29 Alnylam Pharmaceuticals Inc COMPLEMENT FACTOR B IRNA COMPOSITIONS (CFB) AND METHODS OF USE THEREOF
EP4146797A1 (en) 2020-05-06 2023-03-15 Orchard Therapeutics (Europe) Limited Treatment for neurodegenerative diseases
EP4146395A2 (en) 2020-05-08 2023-03-15 Scienion GmbH Assay plate with nano-vessels and sample recovery assembly
WO2021231779A1 (en) 2020-05-14 2021-11-18 Becton, Dickinson And Company Primers for immune repertoire profiling
WO2021231673A1 (en) 2020-05-15 2021-11-18 Korro Bio, Inc. Methods and compositions for the adar-mediated editing of leucine rich repeat kinase 2 (lrrk2)
WO2021231685A1 (en) 2020-05-15 2021-11-18 Korro Bio, Inc. Methods and compositions for the adar-mediated editing of transmembrane channel-like protein 1 (tmc1)
EP4150089A1 (en) 2020-05-15 2023-03-22 Korro Bio, Inc. Methods and compositions for the adar-mediated editing of retinoschisin 1 (rs1)
CA3162416C (en) 2020-05-15 2023-07-04 Korro Bio, Inc. Methods and compositions for the adar-mediated editing of argininosuccinate synthetase (ass1)
WO2021231692A1 (en) 2020-05-15 2021-11-18 Korro Bio, Inc. Methods and compositions for the adar-mediated editing of otoferlin (otof)
EP4150076A1 (en) 2020-05-15 2023-03-22 Korro Bio, Inc. Methods and compositions for the adar-mediated editing of methyl-cpg binding protein 2 (mecp2)
EP4150087A1 (en) 2020-05-15 2023-03-22 Korro Bio, Inc. Methods and compositions for the adar-mediated editing of gap junction protein beta 2 (gjb2)
WO2021231698A1 (en) 2020-05-15 2021-11-18 Korro Bio, Inc. Methods and compositions for the adar-mediated editing of argininosuccinate lyase (asl)
BR112022024501A2 (en) 2020-06-01 2023-05-09 Amgen Inc RNAI CONSTRUCTS TO INHIBIT THE EXPRESSION OF HSD17B13 AND METHODS OF THEIR USE
US11408000B2 (en) 2020-06-03 2022-08-09 Triplet Therapeutics, Inc. Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activity
EP4162050A1 (en) 2020-06-09 2023-04-12 Alnylam Pharmaceuticals, Inc. Rnai compositions and methods of use thereof for delivery by inhalation
IL299063A (en) 2020-06-18 2023-02-01 Alnylam Pharmaceuticals Inc XANTHINE DEHYDROGENASE (XDH) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
BR112023000428A2 (en) 2020-07-10 2023-03-14 Inst Nat Sante Rech Med METHODS AND COMPOSITIONS TO TREAT EPILEPSY
US11932901B2 (en) 2020-07-13 2024-03-19 Becton, Dickinson And Company Target enrichment using nucleic acid probes for scRNAseq
WO2022047359A1 (en) 2020-08-31 2022-03-03 Berg Llc Protein biomarkers for pancreatic cancer
WO2022058427A1 (en) 2020-09-16 2022-03-24 Novigenix Sa Biomarkers for immune checkpoint inhibitors treatment
WO2022066847A1 (en) 2020-09-24 2022-03-31 Alnylam Pharmaceuticals, Inc. Dipeptidyl peptidase 4 (dpp4) irna compositions and methods of use thereof
EP4225917A1 (en) 2020-10-05 2023-08-16 Alnylam Pharmaceuticals, Inc. G protein-coupled receptor 75 (gpr75) irna compositions and methods of use thereof
EP4232582A1 (en) 2020-10-23 2023-08-30 Alnylam Pharmaceuticals, Inc. Mucin 5b (muc5b) irna compositions and methods of use thereof
CA3196729A1 (en) 2020-11-11 2022-05-19 Tural AKSEL Affinity reagents having enhanced binding and detection characteristics
WO2022103999A1 (en) 2020-11-13 2022-05-19 Alnylam Pharmaceuticals, Inc. COAGULATION FACTOR V (F5) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
WO2022106460A2 (en) 2020-11-18 2022-05-27 Astrazeneca Ab Steroid sparing
CN116635533A (en) 2020-11-20 2023-08-22 贝克顿迪金森公司 Profiling of high and low expressed proteins
EP4256053A1 (en) 2020-12-01 2023-10-11 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhibition of hao1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression
US20240100185A1 (en) 2020-12-03 2024-03-28 Scribe Therapeutics Inc. Compositions and methods for the targeting of ptbp1
EP4256054A1 (en) 2020-12-03 2023-10-11 Scribe Therapeutics Inc. Engineered class 2 type v crispr systems
WO2022125490A1 (en) 2020-12-08 2022-06-16 Alnylam Pharmaceuticals, Inc. Coagulation factor x (f10) irna compositions and methods of use thereof
US20240055076A1 (en) 2020-12-09 2024-02-15 Cambridge Enterprise Limited Treatment of diseases associated with variant novel open reading frames
US20240060071A1 (en) 2020-12-16 2024-02-22 Cambridge Enterprise Limited Treatment of cancer associated with dysregulated novel open reading frame products
US20240060070A1 (en) 2020-12-16 2024-02-22 Cambridge Enterprise Limited Treatment of cancer associated with variant novel open reading frames
EP4274896A1 (en) 2021-01-05 2023-11-15 Alnylam Pharmaceuticals, Inc. Complement component 9 (c9) irna compositions and methods of use thereof
WO2022162588A1 (en) 2021-01-28 2022-08-04 Cambridge Enterprise Limited Method of treatment of malaria by targetting open reading frames
KR20230146048A (en) 2021-02-12 2023-10-18 알닐람 파마슈티칼스 인코포레이티드 Superoxide dismutase 1 (SOD1) IRNA compositions and methods of using them to treat or prevent superoxide dismutase 1- (SOD1-)-related neurodegenerative diseases
US20240122865A1 (en) 2021-02-19 2024-04-18 Pfizer Inc. Methods of Protecting RNA
EP4298220A1 (en) 2021-02-25 2024-01-03 Alnylam Pharmaceuticals, Inc. Prion protein (prnp) irna compositions and methods of use thereof
BR112023016645A2 (en) 2021-02-26 2023-11-14 Alnylam Pharmaceuticals Inc KETOHEXOKINASE (KHK) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
BR112023017737A2 (en) 2021-03-04 2023-10-03 Alnylam Pharmaceuticals Inc ANGIOPOIETIN-SIMILAR IRNA COMPOSITIONS 3 (ANGPTL3) AND METHODS OF USE THEREOF
WO2022192419A2 (en) 2021-03-09 2022-09-15 Massachusetts Institute Of Technology Methods of treating inflammatory bowel disease (ibd) with anti- tnf-blockade
EP4305169A1 (en) 2021-03-12 2024-01-17 Alnylam Pharmaceuticals, Inc. Glycogen synthase kinase 3 alpha (gsk3a) irna compositions and methods of use thereof
IL307239A (en) 2021-03-29 2023-11-01 Alnylam Pharmaceuticals Inc Huntingtin (htt) irna agent compositions and methods of use thereof
EP4314293A1 (en) 2021-04-01 2024-02-07 Alnylam Pharmaceuticals, Inc. Proline dehydrogenase 2 (prodh2) irna compositions and methods of use thereof
CA3214833A1 (en) 2021-04-06 2022-10-13 Bpgbio, Inc. Protein markers for the prognosis of breast cancer progression
CA3214821A1 (en) 2021-04-06 2022-10-13 Guisong WANG Protein markers for estrogen receptor (er)-positive-like and estrogen receptor (er)-negative-like breast cancer
EP4320440A1 (en) 2021-04-06 2024-02-14 BPGbio, Inc. Protein markers for estrogen receptor (er)-positive luminal a(la)-like and luminal b1 (lb1)-like breast cancer
IL307926A (en) 2021-04-26 2023-12-01 Alnylam Pharmaceuticals Inc Transmembrane protease, serine 6 (tmprss6) irna compositions and methods of use thereof
EP4330396A1 (en) 2021-04-29 2024-03-06 Alnylam Pharmaceuticals, Inc. Signal transducer and activator of transcription factor 6 (stat6) irna compositions and methods of use thereof
WO2022237974A1 (en) 2021-05-12 2022-11-17 Ecole Polytechnique Federale De Lausanne (Epfl) Krab-containing zinc finger protein and cancer
WO2022245583A1 (en) 2021-05-18 2022-11-24 Alnylam Pharmaceuticals, Inc. Sodium-glucose cotransporter-2 (sglt2) irna compositions and methods of use thereof
EP4341405A1 (en) 2021-05-20 2024-03-27 Korro Bio, Inc. Methods and compositions for adar-mediated editing
EP4347889A1 (en) 2021-05-28 2024-04-10 Centre Hospitalier Universitaire Vaudois (CHUV) Novel incrna controlling cardiac fibrosis
WO2022256283A2 (en) 2021-06-01 2022-12-08 Korro Bio, Inc. Methods for restoring protein function using adar
WO2022256395A1 (en) 2021-06-02 2022-12-08 Alnylam Pharmaceuticals, Inc. Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof
KR20240017911A (en) 2021-06-04 2024-02-08 알닐람 파마슈티칼스 인코포레이티드 Human chromosome 9 open reading frame 72 (C9orf72) iRNA preparation composition and method of using the same
AR126070A1 (en) 2021-06-08 2023-09-06 Alnylam Pharmaceuticals Inc COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING STARGARDT DISEASE AND/OR DISORDERS ASSOCIATED WITH RETINOL BORDER PROTEIN 4 (RBP4)
US11756285B2 (en) 2021-06-10 2023-09-12 Bank Of America Corporation Image processing system and method for image noise removal
US20230194709A9 (en) 2021-06-29 2023-06-22 Seagate Technology Llc Range information detection using coherent pulse sets with selected waveform characteristics
WO2023278410A1 (en) 2021-06-29 2023-01-05 Korro Bio, Inc. Methods and compositions for adar-mediated editing
WO2023285616A1 (en) 2021-07-14 2023-01-19 Cambridge Enterprise Limited Treatment of schizophrenia and bipolar disorder
KR20240036041A (en) 2021-07-21 2024-03-19 알닐람 파마슈티칼스 인코포레이티드 Metabolic Disorder-Associated Target Gene iRNA Composition and Methods of Using Same
WO2023003995A1 (en) 2021-07-23 2023-01-26 Alnylam Pharmaceuticals, Inc. Beta-catenin (ctnnb1) irna compositions and methods of use thereof
WO2023009687A1 (en) 2021-07-29 2023-02-02 Alnylam Pharmaceuticals, Inc. 3-hydroxy-3-methylglutaryl-coa reductase (hmgcr) irna compositions and methods of use thereof
AU2022323090A1 (en) 2021-08-03 2024-02-01 Alnylam Pharmaceuticals, Inc. Transthyretin (ttr) irna compositions and methods of use thereof
TW202337474A (en) 2021-08-04 2023-10-01 美商艾拉倫製藥股份有限公司 Irna compositions and methods for silencing angiotensinogen (agt)
CA3228733A1 (en) 2021-08-13 2023-02-16 Alnylam Pharmaceuticals, Inc. Factor xii (f12) irna compositions and methods of use thereof
WO2023044370A2 (en) 2021-09-17 2023-03-23 Alnylam Pharmaceuticals, Inc. Irna compositions and methods for silencing complement component 3 (c3)
CA3232420A1 (en) 2021-09-20 2023-03-23 Alnylam Pharmaceuticals, Inc. Inhibin subunit beta e (inhbe) modulator compositions and methods of use thereof
WO2023064530A1 (en) 2021-10-15 2023-04-20 Alnylam Pharmaceuticals, Inc. Extra-hepatic delivery irna compositions and methods of use thereof
WO2023069754A2 (en) 2021-10-22 2023-04-27 Amgen Inc. Rnai constructs for inhibiting gpam expression and methods of use thereof
CA3234835A1 (en) 2021-10-22 2023-04-27 Korro Bio, Inc. Methods and compositions for disrupting nrf2-keap1 protein interaction by adar mediated rna editing
AU2022378567A1 (en) 2021-10-29 2024-04-11 Alnylam Pharmaceuticals, Inc. Complement factor b (cfb) irna compositions and methods of use thereof
WO2023076450A2 (en) 2021-10-29 2023-05-04 Alnylam Pharmaceuticals, Inc. HUNTINGTIN (HTT) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF
WO2023122762A1 (en) 2021-12-22 2023-06-29 Camp4 Therapeutics Corporation Modulation of gene transcription using antisense oligonucleotides targeting regulatory rnas
US20230215515A1 (en) 2021-12-23 2023-07-06 Illumina Software, Inc. Facilitating secure execution of external workflows for genomic sequencing diagnostics
WO2023122363A1 (en) 2021-12-23 2023-06-29 Illumina Software, Inc. Dynamic graphical status summaries for nucelotide sequencing
WO2023129764A1 (en) 2021-12-29 2023-07-06 Illumina Software, Inc. Automatically switching variant analysis model versions for genomic analysis applications
WO2023141314A2 (en) 2022-01-24 2023-07-27 Alnylam Pharmaceuticals, Inc. Heparin sulfate biosynthesis pathway enzyme irna agent compositions and methods of use thereof
WO2023196937A1 (en) 2022-04-06 2023-10-12 Larimar Therapeutics, Inc. Frataxin-sensitive markers for monitoring frataxin replacement therapy
KR20230147016A (en) * 2022-04-13 2023-10-20 고려대학교 산학협력단 System and method for highly precision dna photosynthesis
WO2023235818A2 (en) 2022-06-02 2023-12-07 Scribe Therapeutics Inc. Engineered class 2 type v crispr systems
EP4314267A1 (en) 2022-06-07 2024-02-07 Scribe Therapeutics Inc. Compositions and methods for the targeting of pcsk9
WO2023240074A1 (en) 2022-06-07 2023-12-14 Scribe Therapeutics Inc. Compositions and methods for the targeting of pcsk9
WO2023240201A1 (en) 2022-06-08 2023-12-14 Larimar Therapeutics, Inc. Frataxin-sensitive markers for monitoring progression and treatment of leigh syndrome
WO2023240277A2 (en) 2022-06-10 2023-12-14 Camp4 Therapeutics Corporation Methods of modulating progranulin expression using antisense oligonucleotides targeting regulatory rnas
WO2024020572A1 (en) 2022-07-22 2024-01-25 New York Stem Cell Foundation, Inc. Methods and compositions for the treatment of ptsd
WO2024028794A1 (en) 2022-08-02 2024-02-08 Temple Therapeutics BV Methods for treating endometrial and ovarian hyperproliferative disorders
WO2024039776A2 (en) 2022-08-18 2024-02-22 Alnylam Pharmaceuticals, Inc. Universal non-targeting sirna compositions and methods of use thereof
WO2024056902A2 (en) 2022-09-16 2024-03-21 Christopher Shaw Compositions and methods for treating neurological diseases

Family Cites Families (306)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR333561A (en) 1903-07-03 1903-11-28 Georges Rollet Method and apparatus for cleaning clothes
US3862056A (en) * 1967-12-15 1975-01-21 Allied Chem Semiconductor polymer compositions comprising a grafted block copolymer of synthetic rubber and polyolefin and carbon black
IL33640A (en) * 1969-01-16 1973-05-31 Kabi Ab Test strip packaged-unit
US3730844A (en) 1971-08-27 1973-05-01 Purdue Research Foundation Polynucleotide analysis
DE2150691C2 (en) * 1971-10-12 1982-09-09 Basf Ag, 6700 Ludwigshafen Photosensitive mixture and use of a photosensitive mixture for the production of a planographic printing plate
DE2242394A1 (en) * 1972-08-29 1974-03-14 Basf Ag MIXTURES OF SUBSTANCE HARDLED UNDER THE EFFECT OF LIGHT
JPS5183B2 (en) * 1973-03-07 1976-01-05
US3939350A (en) * 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
JPS6112373B2 (en) * 1974-09-04 1986-04-08 Hitachi Ltd
SE407115B (en) * 1975-10-06 1979-03-12 Kabi Ab PROCEDURES AND METAL ELECTRODES FOR THE STUDY OF ENZYMATIC AND OTHER BIOCHEMICAL REACTIONS
US4238757A (en) * 1976-03-19 1980-12-09 General Electric Company Field effect transistor for detection of biological reactions
DE2612359C3 (en) 1976-03-24 1978-10-26 Konishiroku Photo Ind. Co., Ltd., Tokio Electrophotographic recording material
US4259223A (en) * 1976-03-29 1981-03-31 California Institute Of Technology Cross-linked polyvinyl pyridine coated glass particle catalyst support and aqueous composition or polyvinyl pyridine adducted microspheres
US4145406A (en) * 1977-04-11 1979-03-20 Miles Laboratories, Inc. Specific binding - adsorbent assay method and test means
US4086254A (en) * 1977-04-13 1978-04-25 The Upjohn Company Photocleavable steroids
US4121222A (en) 1977-09-06 1978-10-17 A. B. Dick Company Drop counter ink replenishing system
US4180739A (en) 1977-12-23 1979-12-25 Varian Associates, Inc. Thermostatable flow cell for fluorescence measurements
US4448534A (en) * 1978-03-30 1984-05-15 American Hospital Corporation Antibiotic susceptibility testing
US4269933A (en) 1978-06-08 1981-05-26 E. I. Du Pont De Nemours And Company Methods of developing photopolymerizable compositions containing an 0-nitroaromatic compound as photoinhibitor
US4216245A (en) 1978-07-25 1980-08-05 Miles Laboratories, Inc. Method of making printed reagent test devices
US4258001A (en) * 1978-12-27 1981-03-24 Eastman Kodak Company Element, structure and method for the analysis or transport of liquids
US4427415A (en) * 1979-01-05 1984-01-24 Cleveland Patrick H Manifold vacuum biochemical test method and device
US4314821A (en) * 1979-04-09 1982-02-09 Minnesota Mining And Manufacturing Company Sandwich immunoassay using piezoelectric oscillator
US4342905A (en) 1979-08-31 1982-08-03 Nippon Kogaku K.K. Automatic focusing device of a microscope
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4327073A (en) 1980-04-07 1982-04-27 Huang Henry V Automated method for quantitative analysis of biological fluids
US4478967A (en) 1980-08-11 1984-10-23 Minnesota Mining And Manufacturing Company Photolabile blocked surfactants and compositions containing the same
US4444892A (en) * 1980-10-20 1984-04-24 Malmros Mark K Analytical device having semiconductive organic polymeric element associated with analyte-binding substance
IL61351A (en) * 1980-10-27 1983-12-30 Yeda Res & Dev Organometallic polymers,their preparation and compositions of co-ordination compounds containing them
US4711955A (en) 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
EP0063810B1 (en) 1981-04-29 1986-03-05 Ciba-Geigy Ag New devices and kits for immunological analysis
US4373071A (en) 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4339528A (en) * 1981-05-19 1982-07-13 Rca Corporation Etching method using a hardened PVA stencil
US4430299A (en) * 1981-06-18 1984-02-07 Coulter Electronics, Inc. Apparatus for monitoring chemical reactions
US4498774A (en) 1981-07-22 1985-02-12 Iowa State University Research Foundation, Inc. Micro-polarimeter for high performance liquid chromatography
US4395486A (en) 1981-08-19 1983-07-26 Medical College Of Ga. Research Inst., Inc. Method for the direct analysis of sickle cell anemia
USRE33064E (en) * 1981-09-18 1989-09-19 Prutec Limited Method for the determination of species in solution with an optical wave-guide
FI63596C (en) 1981-10-16 1983-07-11 Orion Yhtymae Oy MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER
US4444878A (en) * 1981-12-21 1984-04-24 Boston Biomedical Research Institute, Inc. Bispecific antibody determinants
US5073484A (en) * 1982-03-09 1991-12-17 Bio-Metric Systems, Inc. Quantitative analysis apparatus and method
US4500919A (en) 1982-05-04 1985-02-19 Massachusetts Institute Of Technology Color reproduction system
US4483920A (en) 1982-05-17 1984-11-20 Hahnemann University Immobilization of message RNA directly from cells onto filter material
US4556643A (en) 1982-07-26 1985-12-03 Agracetus Assay method and probe for polynucleotide sequences
US4624915A (en) * 1982-07-29 1986-11-25 Board Of Trustees Of Michigan State University Positive selection sorting of cells
US4477556A (en) 1982-08-18 1984-10-16 E. I. Du Pont De Nemours And Company Acidic o-nitroaromatics as photoinhibitors of polymerization in positive working films
US4455089A (en) 1982-08-25 1984-06-19 Iowa State University Research Foundation, Inc. Refractive index and absorption detector for liquid chromatography based on Fabry-Perot interferometry
US5599720A (en) 1982-08-27 1997-02-04 Multilyte Limited Measurement of analyte concentration
US4973493A (en) * 1982-09-29 1990-11-27 Bio-Metric Systems, Inc. Method of improving the biocompatibility of solid surfaces
US4722906A (en) * 1982-09-29 1988-02-02 Bio-Metric Systems, Inc. Binding reagents and methods
US4588682A (en) 1982-12-13 1986-05-13 Integrated Genetics, Inc. Binding nucleic acid to a support
DE3376685D1 (en) 1982-12-21 1988-06-23 Ares Serono Nv Assay technique
US4516833A (en) 1982-12-27 1985-05-14 University Of Dayton Production of high performance optical spatial filters
DE3301833A1 (en) * 1983-01-20 1984-07-26 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig METHOD FOR SIMULTANEOUS SYNTHESIS OF SEVERAL OLIGONOCLEOTIDES IN A SOLID PHASE
US4994373A (en) 1983-01-27 1991-02-19 Enzo Biochem, Inc. Method and structures employing chemically-labelled polynucleotide probes
US4555491A (en) 1983-01-31 1985-11-26 Iowa State University Research Foundation, Inc. Sulfide chemiluminescence detection
US4575433A (en) 1983-01-31 1986-03-11 Iowa State University Research Foundation, Inc. Method of generating chemiluminescent light
US4634574A (en) 1983-01-31 1987-01-06 Iowa State Research Foundation, Inc. Apparatus for use in sulfide chemiluminescence detection
US4591570A (en) 1983-02-02 1986-05-27 Centocor, Inc. Matrix of antibody-coated spots for determination of antigens
US4537861A (en) 1983-02-03 1985-08-27 Elings Virgil B Apparatus and method for homogeneous immunoassay
NZ207394A (en) * 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4584277A (en) 1983-04-05 1986-04-22 Syntex (U.S.A.) Inc. Fluorescent multiparameter particle analysis
GB8311018D0 (en) 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
US4533682A (en) 1983-04-29 1985-08-06 Desoto, Inc. Imidazolidine-blocked amine polymers
GB8314523D0 (en) * 1983-05-25 1983-06-29 Lowe C R Diagnostic device
US4517338A (en) * 1983-06-20 1985-05-14 Chiron Corporation Multiple reactor system and method for polynucleotide synthesis
US4987065A (en) 1983-07-05 1991-01-22 Enzo Biochem, Inc. In vivo labelling of polynucleotide sequences
US4542102A (en) * 1983-07-05 1985-09-17 Molecular Diagnostics, Inc. Coupling of nucleic acids to solid support by photochemical methods
US4713326A (en) * 1983-07-05 1987-12-15 Molecular Diagnostics, Inc. Coupling of nucleic acids to solid support by photochemical methods
US4626684A (en) * 1983-07-13 1986-12-02 Landa Isaac J Rapid and automatic fluorescence immunoassay analyzer for multiple micro-samples
US4677054A (en) 1983-08-08 1987-06-30 Sloan-Kettering Institute For Cancer Research Method for simple analysis of relative nucleic acid levels in multiple small samples by cytoplasmic dot hybridization
US4719615A (en) * 1983-08-22 1988-01-12 Optical Data, Inc. Erasable optical data storage medium
US4598049A (en) 1983-08-31 1986-07-01 Systec Inc. General purpose gene synthesizer
EP0155950B1 (en) 1983-09-02 1990-01-17 Molecular Biosystems, Inc. Oligonucleotide polymeric support system
US4569967A (en) * 1983-10-24 1986-02-11 The Salk Institute For Biological Studies Synthesis of N-substituted peptide amides
US4580895A (en) * 1983-10-28 1986-04-08 Dynatech Laboratories, Incorporated Sample-scanning photometer
US4849513A (en) 1983-12-20 1989-07-18 California Institute Of Technology Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups
US5171534A (en) 1984-01-16 1992-12-15 California Institute Of Technology Automated DNA sequencing technique
US5821058A (en) 1984-01-16 1998-10-13 California Institute Of Technology Automated DNA sequencing technique
US4613566A (en) 1984-01-23 1986-09-23 President And Fellows Of Harvard College Hybridization assay and kit therefor
JPS60155942A (en) 1984-01-25 1985-08-16 Fuji Photo Film Co Ltd Spot deposition apparatus of liquid specimen
FI71768C (en) 1984-02-17 1987-02-09 Orion Yhtymae Oy Enhanced nucleic acid reagents and process for their preparation.
GB8405437D0 (en) 1984-03-01 1984-04-04 Amersham Int Plc Detecting polynucleotide sequences
US4704353A (en) * 1984-04-27 1987-11-03 Molecular Devices Corporation Photoresponsive redox detection and discrimination
EP0164206B1 (en) 1984-05-02 1988-11-02 Brendan James Hamill An apparatus for the chemical synthesis of oligonucleotides
US4766062A (en) 1984-05-07 1988-08-23 Allied Corporation Displacement polynucleotide assay method and polynucleotide complex reagent therefor
JPS60248699A (en) * 1984-05-23 1985-12-09 Fujisawa Pharmaceut Co Ltd Preparation of urogastrone
US4670380A (en) 1984-05-23 1987-06-02 Molecular Diagnostics, Inc. Assays utilizing labeled nucleic acid probes
US4555490A (en) * 1984-06-08 1985-11-26 The United States Of America As Represented By The Department Of Health And Human Services Rapid visualization system for gel electrophoresis
IL75464A (en) 1984-06-12 1990-08-31 Orgenics Ltd Method and apparatus for multi-analyte assay
DE3586772T2 (en) * 1984-07-24 1993-03-04 Coselco Mimotopes Pty Ltd METHOD FOR DETERMINING MIMOTOPES.
US4767927A (en) 1984-08-16 1988-08-30 Kabushiki Kaisha Toshiba Apparatus for reading radiation image information stored in imaging plate
US4755458A (en) 1984-08-30 1988-07-05 Enzo Biochem, Inc. Composition and method for the detection of the presence of a polynucleotide sequence of interest
US4563417A (en) * 1984-08-31 1986-01-07 Miles Laboratories, Inc. Nucleic acid hybridization assay employing antibodies to intercalation complexes
US4681859A (en) * 1984-09-21 1987-07-21 Ortho Diagnostic Systems Inc. Fluorescence polarization immunoassay for heavy antigens
US5258506A (en) 1984-10-16 1993-11-02 Chiron Corporation Photolabile reagents for incorporation into oligonucleotide chains
DE3440141A1 (en) * 1984-11-02 1986-05-07 Heiner Dipl.-Chem. Dr. 8000 München Eckert Use of bistrichloromethyl carbonate as a proreagent for phosgene
US4820630A (en) 1984-11-23 1989-04-11 Digene Diagnostics, Incorporated Assay for nucleic acid sequences, particularly genetic lesions, using interactive labels
US4719179A (en) 1984-11-30 1988-01-12 Pharmacia P-L Biochemicals, Inc. Six base oligonucleotide linkers and methods for their use
US5242794A (en) 1984-12-13 1993-09-07 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
US5064754A (en) 1984-12-14 1991-11-12 Mills Randell L Genomic sequencing method
US4670379A (en) 1984-12-19 1987-06-02 E. I. Du Pont De Nemours And Company Polynucleotide hydridization assays employing catalyzed luminescence
US5026840A (en) * 1985-01-10 1991-06-25 Molecular Diagnostics, Inc. Photochemical nucleic acid-labeling reagent having a polyalklamine spacer
US4713347A (en) * 1985-01-14 1987-12-15 Sensor Diagnostics, Inc. Measurement of ligand/anti-ligand interactions using bulk conductance
US4767700A (en) 1985-02-15 1988-08-30 Beckman Research Institute Of The City Of Hope Detection of particular nucleotide sequences
US5096807A (en) 1985-03-06 1992-03-17 Murex Corporation Imaging immunoassay detection system with background compensation and its use
EP0194132A3 (en) * 1985-03-06 1988-08-03 Murex Corporation Imaging immunoassay detection system and method
US4631211A (en) * 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
US6040166A (en) 1985-03-28 2000-03-21 Roche Molecular Systems, Inc. Kits for amplifying and detecting nucleic acid sequences, including a probe
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
DE3513168A1 (en) * 1985-04-12 1986-10-16 Thomas 8000 München Dandekar BIOSENSOR CONSISTING OF A SEMICONDUCTOR BASED ON SILICON OR CARBON-BASED (ELECTRONIC PART) AND NUCLEIN BASE (OR. OTHER BIOL. MONOMERS)
US4720786A (en) * 1985-04-19 1988-01-19 Fuji Photo Film Co., Ltd. Method of compensating for offset distortion in rows of electrophoretic patterns
WO1986006487A1 (en) * 1985-04-22 1986-11-06 Commonwealth Serum Laboratories Commission Method for determining mimotopes
NZ215865A (en) * 1985-04-22 1988-10-28 Commw Serum Lab Commission Method of determining the active site of a receptor-binding analogue
US4797355A (en) * 1985-06-13 1989-01-10 Amgen Inc. Methods for attaching polynucleotides to supports
JPS61290311A (en) 1985-06-19 1986-12-20 Hitachi Ltd Apparatus and method for inspecting soldered zone
FR2583772B1 (en) 1985-06-20 1987-08-28 Roussel Uclaf NEW MEDIA, THE PREPARATION OF SUCH MEDIA, THE NEW INTERMEDIATES OBTAINED, THEIR APPLICATION TO THE SYNTHESIS OF OLIGONUCLEOTIDES AND THE NEW NUCLEOSIDES AND OLIGONUCLEOTIDES RELATED TO THE MEDIA THUS OBTAINED
FR2584090B1 (en) 1985-06-27 1987-08-28 Roussel Uclaf NEW SUPPORTS, THEIR PREPARATION AND THE INTERMEDIATES OBTAINED, THEIR APPLICATION TO THE SYNTHESIS OF OLIGONUCLEOTIDES AND THE NEW NUCLEOSIDES AND OLIGONUCLEOTIDES RELATED TO THE SUPPORTS OBTAINED
US4719087A (en) * 1985-07-01 1988-01-12 Baxter Travenol Laboratories, Inc. Tray for analyzing system
EP0212807A3 (en) * 1985-07-15 1988-01-07 Imperial Chemical Industries Plc Coloured compound containing a cationic group and a reactive group
JPS6221151A (en) 1985-07-19 1987-01-29 Matsushita Electric Ind Co Ltd Formation of pattern
DD254998A1 (en) 1985-07-26 1988-03-16 Zeiss Jena Veb Carl ARRANGEMENT FOR THE IMAGE AND ANALYSIS OF FLUORESCENCE SIGNALS
JPS63500400A (en) 1985-08-05 1988-02-12 レエイクスニフエルシテイト レイデン Labeled polymers, their preparation and use for immunological or immunocytochemical assays
JPS6242057A (en) * 1985-08-19 1987-02-24 Fuji Photo Film Co Ltd Signal processing method for determining base sequence of nucleic acid
EP0213825A3 (en) 1985-08-22 1989-04-26 Molecular Devices Corporation Multiple chemically modulated capacitance
US4731335A (en) * 1985-09-13 1988-03-15 Fisher Scientific Company Method for treating thin samples on a surface employing capillary flow
SE450171B (en) 1985-10-18 1987-06-09 Carl Urban Ungerstedt DEVICE FOR AUTOMATIC COLLECTION OF SMALL LIQUID VOLUMES
US4888278A (en) * 1985-10-22 1989-12-19 University Of Massachusetts Medical Center In-situ hybridization to detect nucleic acid sequences in morphologically intact cells
US4822566A (en) * 1985-11-19 1989-04-18 The Johns Hopkins University Optimized capacitive sensor for chemical analysis and measurement
US4868105A (en) 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
US4882269A (en) 1985-12-13 1989-11-21 Princeton University Amplified hybridization assay
US4637861A (en) * 1985-12-16 1987-01-20 Allied Corporation Stabilized, lipid membrane-based device and method of analysis
DE3785591T2 (en) 1986-01-10 1993-09-02 Amoco Corp COMPETITIVE HOMOGENEOUS TEST.
US5447841A (en) 1986-01-16 1995-09-05 The Regents Of The Univ. Of California Methods for chromosome-specific staining
US4855225A (en) 1986-02-07 1989-08-08 Applied Biosystems, Inc. Method of detecting electrophoretically separated oligonucleotides
US4758727A (en) 1986-02-12 1988-07-19 Ohio State University Research Foundation Method and apparatus for the measurement of low-level laser-induced fluorescence
JPH0685387B2 (en) 1986-02-14 1994-10-26 株式会社東芝 Alignment method
US4868103A (en) 1986-02-19 1989-09-19 Enzo Biochem, Inc. Analyte detection by means of energy transfer
US5348855A (en) 1986-03-05 1994-09-20 Miles Inc. Assay for nucleic acid sequences in an unpurified sample
NO870613L (en) 1986-03-05 1987-09-07 Molecular Diagnostics Inc DETECTION OF MICROORGANISMS IN A SAMPLE CONTAINING NUCLEIC ACID.
EP0240729A3 (en) * 1986-03-05 1988-08-24 Fuji Photo Film Co., Ltd. Method of analyzing autoradiograph for determining base sequence of nucleic acid
US4728591A (en) * 1986-03-07 1988-03-01 Trustees Of Boston University Self-assembled nanometer lithographic masks and templates and method for parallel fabrication of nanometer scale multi-device structures
US4925785A (en) 1986-03-07 1990-05-15 Biotechnica Diagnostics, Inc. Nucleic acid hybridization assays
CA1284931C (en) 1986-03-13 1991-06-18 Henry A. Erlich Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids
US5310893A (en) 1986-03-31 1994-05-10 Hoffmann-La Roche Inc. Method for HLA DP typing
US5604099A (en) 1986-03-13 1997-02-18 Hoffmann-La Roche Inc. Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids
US4894796A (en) * 1986-03-17 1990-01-16 Westinghouse Electric Corp. Automatic transfer switch with programmable display
US5256549A (en) 1986-03-28 1993-10-26 Chiron Corporation Purification of synthetic oligomers
US5153319A (en) 1986-03-31 1992-10-06 University Patents, Inc. Process for preparing polynucleotides
US4875169A (en) 1986-04-11 1989-10-17 Iowa State University Research Foundation, Inc. Method for improving the limit of detection in a data signal
US4846552A (en) 1986-04-16 1989-07-11 The United States Of America As Represented By The Secretary Of The Air Force Method of fabricating high efficiency binary planar optical elements
US4981783A (en) 1986-04-16 1991-01-01 Montefiore Medical Center Method for detecting pathological conditions
US4857656A (en) * 1986-05-08 1989-08-15 Sanshin Kagaku Kogyo Co., Ltd. Active esters used for production of esters or amides and process for producing esters or amides
GB8612221D0 (en) * 1986-05-20 1986-06-25 Amersham Int Plc Assaying species in sample
US4811218A (en) 1986-06-02 1989-03-07 Applied Biosystems, Inc. Real time scanning electrophoresis apparatus for DNA sequencing
US4808508A (en) * 1986-07-01 1989-02-28 Hoechst Celanese Corporation Negative working color proofing process comprising diazo compound and polyvinyl acetal/polyvinyl alcohol/polyvinyl acetate resin
WO1988001058A1 (en) 1986-08-06 1988-02-11 Roger Philip Ekins Determination of analyte concentration using two labelling markers
US4786684A (en) * 1986-08-21 1988-11-22 The Mount Sinai School Of Medicine Of The City University Of New York Benzylthioether-linked solid support-bound thiol compounds and method for peptide synthesis
GB8621337D0 (en) * 1986-09-04 1986-10-15 Agricultural Genetics Co Non-radioactive nucleic acid hybridization probes
DE3631662A1 (en) * 1986-09-17 1988-03-24 Biotechnolog Forschung Gmbh METHOD FOR SIMULTANEOUS SYNTHESIS OF SEVERAL PEPTIDES ON A SOLID PHASE
JPS6384499A (en) * 1986-09-26 1988-04-15 Toho Yakuhin Kogyo Kk Production of delta sleep inducing peptide by enzyme
US5021550A (en) 1986-10-07 1991-06-04 Thomas Jefferson University Method for preventing deletion sequences in solid phase synthesis
GB8624637D0 (en) 1986-10-14 1986-11-19 Emi Plc Thorn Electrical device
US4979959A (en) * 1986-10-17 1990-12-25 Bio-Metric Systems, Inc. Biocompatible coating for solid surfaces
US4877745A (en) 1986-11-17 1989-10-31 Abbott Laboratories Apparatus and process for reagent fluid dispensing and printing
US5028525A (en) 1986-11-24 1991-07-02 Regents Of The University Of California Method of preparing and applying single stranded DNA probes to double stranded target DNAs in situ
WO1988004777A1 (en) * 1986-12-15 1988-06-30 Ultra Diagnostics Corporation Monomeric phthalocyanine reagents
JPS63167313A (en) 1986-12-27 1988-07-11 Hitachi Ltd Automatic focus control method
JPH0664057B2 (en) * 1987-01-06 1994-08-22 富士写真フイルム株式会社 Signal processing method for autoradiographic analysis
US4762881A (en) * 1987-01-09 1988-08-09 E. I. Du Pont De Nemours And Company Photoreactive benzoylphenylalanines and related peptides
US5077085A (en) 1987-03-06 1991-12-31 Schnur Joel M High resolution metal patterning of ultra-thin films on solid substrates
US5079600A (en) * 1987-03-06 1992-01-07 Schnur Joel M High resolution patterning on solid substrates
US4794150A (en) * 1987-03-11 1988-12-27 Samuel Steel Synthesis of peptide analogs
AU601021B2 (en) 1987-03-11 1990-08-30 Molecular Diagnostics, Inc. Assay for necleic acid sequences in a sample
US5037882A (en) 1987-03-11 1991-08-06 Steel Samuel L Synthesis of oligonucleotide analogs
US5026773A (en) 1987-03-11 1991-06-25 Samuel Steel Apparatus for a solid phase synthesis of peptide analogs
JPS63223557A (en) 1987-03-13 1988-09-19 Nec Corp Production of semiconductor biosensor
US5525464A (en) 1987-04-01 1996-06-11 Hyseq, Inc. Method of sequencing by hybridization of oligonucleotide probes
US6270961B1 (en) 1987-04-01 2001-08-07 Hyseq, Inc. Methods and apparatus for DNA sequencing and DNA identification
US5202231A (en) 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
NZ224284A (en) * 1987-04-24 1990-11-27 Unilever Plc Porous substrate containing gel for use in chemical synthesis, separation etc
US5100777A (en) 1987-04-27 1992-03-31 Tanox Biosystems, Inc. Antibody matrix device and method for evaluating immune status
US4833332A (en) * 1987-06-12 1989-05-23 E. I. Du Pont De Nemours And Company Scanning fluorescent detection system
SE458968B (en) 1987-06-16 1989-05-22 Wallac Oy BIOSPECIFIC ANALYTICAL PROCEDURE FOR MULTIPLE ANALYTICS WHICH DO NOT INCLUDE PARTICULAR COATING AND LABELING WITH FLUORESCING LABEL SUBSTANCES
US4874500A (en) 1987-07-15 1989-10-17 Sri International Microelectrochemical sensor and sensor array
US4921805A (en) 1987-07-29 1990-05-01 Life Technologies, Inc. Nucleic acid capture method
GB8803000D0 (en) 1988-02-10 1988-03-09 Ekins Roger Philip Determination of ambient concentrations of several analytes
US5149625A (en) 1987-08-11 1992-09-22 President And Fellows Of Harvard College Multiplex analysis of DNA
CA1321488C (en) * 1987-08-22 1993-08-24 Martin Francis Finlan Biological sensors
US5011770A (en) 1987-09-04 1991-04-30 Molecular Devices, Inc. DNA detection method
US4923901A (en) * 1987-09-04 1990-05-08 Millipore Corporation Membranes with bound oligonucleotides and peptides
US5006464A (en) 1987-10-01 1991-04-09 E-Y Laboratories, Inc. Directed flow diagnostic device and method
US4981985A (en) 1987-10-20 1991-01-01 Trustees Of The University Of Pennsylvania Synthesis of photolabile chelators for multivalent cations
PT89121A (en) * 1987-12-04 1989-12-29 Du Pont PROCESS FOR THE PREPARATION OF INTERLEUQUIN-2 FIXED AND INTERLEUKIN-2 CONTAINING AN EXTENSION IN THE TERMINAL-CARBOXYL WITH ACTIVITY OF INTERLEUQUIN-2 NATURAL
US4886741A (en) * 1987-12-09 1989-12-12 Microprobe Corporation Use of volume exclusion agents for the enhancement of in situ hybridization
CA1335721C (en) * 1987-12-24 1995-05-30 Patrick E. Guire Biomolecule attached to a solid surface by means of a spacer and methods of attaching biomolecules to surfaces
US4844617A (en) 1988-01-20 1989-07-04 Tencor Instruments Confocal measuring microscope with automatic focusing
EP0328256A1 (en) * 1988-01-21 1989-08-16 Owens-Corning Fiberglas Corporation Glass fibers coated with agarose for use as column packing or chromatographic media for bioseparations
US5082830A (en) 1988-02-26 1992-01-21 Enzo Biochem, Inc. End labeled nucleotide probe
GB8810400D0 (en) * 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
FR2628530B1 (en) * 1988-03-08 1994-01-28 Chemunex Sa APPARATUS AND METHOD FOR DETECTION AND NUMERATION OF FLUORESCENT PARTICLES, CARRIED BY A SOLID SUPPORT
US4946942A (en) * 1988-03-11 1990-08-07 Bioresearch, Inc. Urethane-protected amino acid-N-carboxyanhydrides
US4988617A (en) 1988-03-25 1991-01-29 California Institute Of Technology Method of detecting a nucleotide change in nucleic acids
IL89964A0 (en) 1988-04-15 1989-12-15 Montefiore Med Center Method for determining malignant progression,cdna,polypeptides encoded thereby and pharmaceutical compositions containing the same
US5002867A (en) * 1988-04-25 1991-03-26 Macevicz Stephen C Nucleic acid sequence determination by multiple mixed oligonucleotide probes
US6054270A (en) 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
WO1989011548A1 (en) * 1988-05-20 1989-11-30 Cetus Corporation Immobilized sequence-specific probes
US5013669A (en) 1988-06-01 1991-05-07 Smithkline Diagnostics, Inc. Mass producible biologically active solid phase devices
US5108576A (en) * 1988-06-13 1992-04-28 Ohmicron Corporation Pyroelectric thermometric device
DE3923165A1 (en) 1988-07-15 1990-01-18 Hitachi Ltd MAGNETIC DISK DEVICE
EP0425485B1 (en) * 1988-07-22 2000-10-04 SurModics, Inc. Preparation of polymeric surfaces
US5281540A (en) * 1988-08-02 1994-01-25 Abbott Laboratories Test array for performing assays
US5188963A (en) 1989-11-17 1993-02-23 Gene Tec Corporation Device for processing biological specimens for analysis of nucleic acids
US4992383A (en) 1988-08-05 1991-02-12 Porton Instruments, Inc. Method for protein and peptide sequencing using derivatized glass supports
US5225326A (en) 1988-08-31 1993-07-06 Research Development Foundation One step in situ hybridization assay
US5206137A (en) 1988-09-08 1993-04-27 Lifecodes Corporation Compositions and methods useful for genetic analysis
EP0358796B1 (en) 1988-09-14 1993-04-28 Siemens Aktiengesellschaft Diagnostic x-ray device with luminescent storage screen
GB8822228D0 (en) 1988-09-21 1988-10-26 Southern E M Support-bound oligonucleotides
JP2897027B2 (en) 1988-10-27 1999-05-31 スズキ株式会社 Immunological agglutination detector
SE8804074D0 (en) * 1988-11-10 1988-11-10 Pharmacia Ab SENSOR UNIT AND ITS USE IN BIOSENSOR SYSTEM
US5200051A (en) * 1988-11-14 1993-04-06 I-Stat Corporation Wholly microfabricated biosensors and process for the manufacture and use thereof
US5869237A (en) 1988-11-15 1999-02-09 Yale University Amplification karyotyping
US5215889A (en) 1988-11-18 1993-06-01 The Regents Of The University Of California Catalytic and reactive polypeptides and methods for their preparation and use
US5489507A (en) 1988-11-30 1996-02-06 Perkin-Elmer Corporation DNA detection by color complementation
US5047524A (en) 1988-12-21 1991-09-10 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US4992583A (en) 1989-01-06 1991-02-12 The Goodyear Tire & Rubber Company Process for synthesizing N-chlorothio-sulfonamides
US5077210A (en) 1989-01-13 1991-12-31 Eigler Frances S Immobilization of active agents on substrates with a silane and heterobifunctional crosslinking agent
US4984857A (en) 1989-01-17 1991-01-15 Iowa State University Research Foundation, Inc. Linearization of scan velocity of resonant vibrating-mirror beam deflectors
US4921348A (en) 1989-01-26 1990-05-01 Iowa State University Research Foundation, Inc. Method and means for a spatial and temporal probe for laser-generated plumes based on density gradients
IT1232252B (en) 1989-02-22 1992-01-28 Rotta Research Lab DERIVATIVES OF N N PHENYL BENZAMIDE WITH ANTI-ULTER AND ANTIALLERIC ACTIVITY AND PROCEDURE FOR THEIR PREPARATION
US5081584A (en) 1989-03-13 1992-01-14 United States Of America Computer-assisted design of anti-peptides based on the amino acid sequence of a target peptide
EP0392546A3 (en) 1989-04-14 1991-09-11 Ro Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Process for determination of a complete or a partial contents of very short sequences in the samples of nucleic acids connected to the discrete particles of microscopic size by hybridization with oligonucleotide probes
US5112962A (en) 1989-04-19 1992-05-12 Northwestern University Labile anchors for solid phase polynucleotide synthesis
US5219726A (en) 1989-06-02 1993-06-15 The Salk Institute For Biological Studies Physical mapping of complex genomes
US6346413B1 (en) 1989-06-07 2002-02-12 Affymetrix, Inc. Polymer arrays
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5547839A (en) * 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US5242974A (en) 1991-11-22 1993-09-07 Affymax Technologies N.V. Polymer reversal on solid surfaces
US5800992A (en) * 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US6406844B1 (en) 1989-06-07 2002-06-18 Affymetrix, Inc. Very large scale immobilized polymer synthesis
US5527681A (en) 1989-06-07 1996-06-18 Affymax Technologies N.V. Immobilized molecular synthesis of systematically substituted compounds
US6379895B1 (en) * 1989-06-07 2002-04-30 Affymetrix, Inc. Photolithographic and other means for manufacturing arrays
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
GB2233654A (en) 1989-07-07 1991-01-16 Nat Res Dev Immobilised polynucleotides
DE3924454A1 (en) 1989-07-24 1991-02-07 Cornelis P Prof Dr Hollenberg THE APPLICATION OF DNA AND DNA TECHNOLOGY FOR THE CONSTRUCTION OF NETWORKS FOR USE IN CHIP CONSTRUCTION AND CHIP PRODUCTION (DNA CHIPS)
US5061075A (en) 1989-08-07 1991-10-29 Alfano Robert R Optical method and apparatus for diagnosing human spermatozoa
US5141813A (en) 1989-08-28 1992-08-25 Clontech Laboratories, Inc. Multifunctional controlled pore glass reagent for solid phase oligonucleotide synthesis
US5196305A (en) * 1989-09-12 1993-03-23 Eastman Kodak Company Diagnostic and amplification methods using primers having thymine at 3' end to overcome primer-target mismatch at the 3' end
EP0498801B1 (en) * 1989-09-15 1998-11-04 Chiron Mimotopes Pty. Ltd. Solid surface for peptide synthesis
US5232829A (en) 1989-09-29 1993-08-03 Hoffmann-La Roche Inc. Detection of chlamydia trachomatis by polymerase chain reaction using biotin labelled lina primers and capture probes
US5252743A (en) 1989-11-13 1993-10-12 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
US5297288A (en) * 1989-11-28 1994-03-22 United States Biochemical Corporation System for use with a high resolution scanner for scheduling a sequence of software tools for determining the presence of bands in DNA sequencing samples
US5215882A (en) 1989-11-30 1993-06-01 Ortho Diagnostic Systems, Inc. Method of immobilizing nucleic acid on a solid surface for use in nucleic acid hybridization assays
FI896202A (en) * 1989-12-22 1991-06-23 Ahlstroem Valmet METHOD OCH ANORDNING VID INLOPPSLAODAN AV EN PAPPERS-, KARTONG- ELLER TORKMASKIN.
US5091652A (en) 1990-01-12 1992-02-25 The Regents Of The University Of California Laser excited confocal microscope fluorescence scanner and method
US5192407A (en) 1990-01-30 1993-03-09 Iowa State University Research Foundation, Inc. Means and method of detection in chemical separation procedures
US6506558B1 (en) * 1990-03-07 2003-01-14 Affymetrix Inc. Very large scale immobilized polymer synthesis
US5494810A (en) 1990-05-03 1996-02-27 Cornell Research Foundation, Inc. Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease
US5100626A (en) 1990-05-24 1992-03-31 Levin Andrew E Binding assay device with removable cassette and manifold
GB9014263D0 (en) 1990-06-27 1990-08-15 Dixon Arthur E Apparatus and method for spatially- and spectrally- resolvedmeasurements
GB9015793D0 (en) 1990-07-18 1990-09-05 Medical Res Council Confocal scanning optical microscope
US5306641A (en) 1990-07-27 1994-04-26 Saccocio Edward J Apparatus and method for determining gel rate of polymerizable compositions
US5235028A (en) 1990-08-31 1993-08-10 University Of Minnesota Polyethylene glycol derivatives for solid-phase applications
US5491224A (en) * 1990-09-20 1996-02-13 Bittner; Michael L. Direct label transaminated DNA probe compositions for chromosome identification and methods for their manufacture
DE69132843T2 (en) * 1990-12-06 2002-09-12 Affymetrix Inc N D Ges D Staat Identification of nucleic acids in samples
ATE244065T1 (en) 1990-12-06 2003-07-15 Affymetrix Inc METHODS AND REAGENTS FOR VERY LARGE SCALE IMMOBILIZED POLYMER SYNTHESIS
RU1794088C (en) 1991-03-18 1993-02-07 Институт Молекулярной Биологии Ан@ Ссср Method of dna nucleotide sequence determination and a device for its realization
US5380489A (en) * 1992-02-18 1995-01-10 Eastman Kodak Company Element and method for nucleic acid amplification and detection using adhered probes
US5198871A (en) 1991-06-18 1993-03-30 Southwest Research Institute Laser-induced-fluorescence inspection of jet fuels
US5491570A (en) * 1991-07-26 1996-02-13 Accuwave Corporation Methods and devices for using photorefractive materials at infrared wavelengths
AU2422492A (en) * 1991-08-07 1993-03-02 H & N Instruments, Inc. Synthesis of chain chemical compounds
US5474796A (en) 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5291763A (en) * 1991-09-18 1994-03-08 Cuisinot Charles P Universal lock for quick release mechanism
US5556961A (en) 1991-11-15 1996-09-17 Foote; Robert S. Nucleosides with 5'-O-photolabile protecting groups
US5846708A (en) 1991-11-19 1998-12-08 Massachusetts Institiute Of Technology Optical and electrical methods and apparatus for molecule detection
US5384261A (en) 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
DE69233331T3 (en) * 1991-11-22 2007-08-30 Affymetrix, Inc., Santa Clara Combinatorial Polymersynthesis Strategies
US5324633A (en) 1991-11-22 1994-06-28 Affymax Technologies N.V. Method and apparatus for measuring binding affinity
US5667667A (en) 1992-04-24 1997-09-16 Isis Innovation Limited Electrochemical treatment of surfaces
GB9218131D0 (en) 1992-08-26 1992-10-14 Slater James H A method of marking a liquid
US5288514A (en) * 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US5386221A (en) * 1992-11-02 1995-01-31 Etec Systems, Inc. Laser pattern generation apparatus
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5382512A (en) * 1993-08-23 1995-01-17 Chiron Corporation Assay device with captured particle reagent
US5381224A (en) 1993-08-30 1995-01-10 A. E. Dixon Scanning laser imaging system
JPH0772378A (en) 1993-09-02 1995-03-17 Nikon Corp Focusing device
ES2176308T3 (en) 1993-10-28 2002-12-01 Houston Advanced Res Ct POROUS MICROSTRUCTURE DEVICE THAT ALLOWS A FLOW.
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US5571639A (en) 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5727098A (en) * 1994-09-07 1998-03-10 Jacobson; Joseph M. Oscillating fiber optic display and imager
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5776737A (en) 1994-12-22 1998-07-07 Visible Genetics Inc. Method and composition for internal identification of samples
US6673533B1 (en) * 1995-03-10 2004-01-06 Meso Scale Technologies, Llc. Multi-array multi-specific electrochemiluminescence testing
US5707806A (en) 1995-06-07 1998-01-13 Genzyme Corporation Direct sequence identification of mutations by cleavage- and ligation-associated mutation-specific sequencing
US5777888A (en) 1995-08-09 1998-07-07 Regents Of The University Of California Systems for generating and analyzing stimulus-response output signal matrices
US5698393A (en) 1995-08-18 1997-12-16 Abbott Laboratories Method for elimination of rheumatoid factor interference in diagnostic assays
US5871697A (en) 1995-10-24 1999-02-16 Curagen Corporation Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
WO1999042813A1 (en) * 1998-02-23 1999-08-26 Wisconsin Alumni Research Foundation Method and apparatus for synthesis of arrays of dna probes
US6306643B1 (en) * 1998-08-24 2001-10-23 Affymetrix, Inc. Methods of using an array of pooled probes in genetic analysis
US6346423B1 (en) * 1999-07-16 2002-02-12 Agilent Technologies, Inc. Methods and compositions for producing biopolymeric arrays
US6171797B1 (en) * 1999-10-20 2001-01-09 Agilent Technologies Inc. Methods of making polymeric arrays

Also Published As

Publication number Publication date
US5143854A (en) 1992-09-01
SG13595G (en) 1995-06-16
DE69032888D1 (en) 1999-02-18
US6329143B1 (en) 2001-12-11
JPH04505763A (en) 1992-10-08
GB2248840A (en) 1992-04-22
DE69012119T2 (en) 1994-12-22
ES2058921T3 (en) 1994-11-01
AU7765594A (en) 1995-05-04
IL94551A0 (en) 1991-03-10
KR970001578B1 (en) 1997-02-11
US6630308B2 (en) 2003-10-07
JP2005112867A (en) 2005-04-28
CA2278878A1 (en) 1990-12-08
FI915723A0 (en) 1991-12-04
TW434254B (en) 2001-05-16
NL191992C (en) 1996-12-03
JP2004002386A (en) 2004-01-08
AU5837190A (en) 1991-01-07
NL9022056A (en) 1992-03-02
CA2054706A1 (en) 1990-12-08
IL94551A (en) 1995-03-30
NL191992B (en) 1996-08-01
WO1990015070A1 (en) 1990-12-13
CA2278878C (en) 2002-09-17
US20050214828A1 (en) 2005-09-29
US6225625B1 (en) 2001-05-01
DE69032888T2 (en) 1999-07-29
US20020192693A1 (en) 2002-12-19
US20020064796A1 (en) 2002-05-30
US6660234B2 (en) 2003-12-09
US20030013100A1 (en) 2003-01-16
US20030082831A1 (en) 2003-05-01
US20050148027A1 (en) 2005-07-07
US5405783A (en) 1995-04-11
EP0902034A2 (en) 1999-03-17
US6747143B2 (en) 2004-06-08
CA2278883C (en) 2001-12-04
EP0953835A1 (en) 1999-11-03
US20030064391A1 (en) 2003-04-03
JPH11315095A (en) 1999-11-16
EP0619321B1 (en) 1999-01-07
EP0476014A1 (en) 1992-03-25
EP0902034A3 (en) 1999-05-26
AU672723B2 (en) 1996-10-10
EP0619321A1 (en) 1994-10-12
DE953835T1 (en) 2002-06-13
ATE110738T1 (en) 1994-09-15
AU651795B2 (en) 1994-08-04
KR970001577B1 (en) 1997-02-11
DK0476014T3 (en) 1994-11-14
BR9007425A (en) 1992-07-21
KR920701235A (en) 1992-08-11
NZ233886A (en) 1993-02-25
US5510270A (en) 1996-04-23
US5445934A (en) 1995-08-29
HU223462B1 (en) 2004-07-28
US6491871B1 (en) 2002-12-10
US6291183B1 (en) 2001-09-18
NO301233B1 (en) 1997-09-29
HK61395A (en) 1995-05-05
ES2129101T3 (en) 1999-06-01
GB9125996D0 (en) 1992-02-05
US20030235853A1 (en) 2003-12-25
JP3759161B2 (en) 2006-03-22
DE69012119D1 (en) 1994-10-06
DK0619321T3 (en) 1999-08-30
HU904730D0 (en) 1992-02-28
FI109130B (en) 2002-05-31
CA2054706C (en) 2001-08-28
US20060210452A1 (en) 2006-09-21
NO914826D0 (en) 1991-12-06
ATE175421T1 (en) 1999-01-15
US6403957B1 (en) 2002-06-11
JPH1121293A (en) 1999-01-26
HK64195A (en) 1995-05-05
CA2278883A1 (en) 1990-12-08
US6261776B1 (en) 2001-07-17
GB2248840B (en) 1993-12-01
EP0476014B1 (en) 1994-08-31
US6646243B2 (en) 2003-11-11
NO914826L (en) 1991-12-06
HUT59938A (en) 1992-07-28

Similar Documents

Publication Publication Date Title
CA2391491A1 (en) Very large scale immobilized peptide synthesis
US6406844B1 (en) Very large scale immobilized polymer synthesis
US5324633A (en) Method and apparatus for measuring binding affinity
RU2107072C1 (en) Method of preparing amino acid or nucleotide sequences on substrate, method of screening large number of amino acid sequences, and screening substrate

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued